sequence,citation_id,target_id,dbaasp_id,citation,target,cluster_id
RKRIHIGPGRAFYTT,1,2,12,Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1,Escherichiacoli,2497
FLPKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,2,3,53,Peptide fragments of a beta-defensin derivative with potent bactericidal activity,Pseudomonasaeruginosa,32
DAACAAHCLFRGRSGGYCNGKRVCVCR,3,1,59,"Synthesis and structure-function study about tenecin 1, an antibacterial protein from larvae of Tenebrio molitor",None_target,1468
ALWKTLLKKVLKAAAKAALKAVLVGANA,4,4,102,Antibacterial properties of dermaseptin S4 derivatives with in vivo activity,Staphylococcusaureus,33
GLRKRLRKFRNKIKEKLKKI,5,2,104,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes.",Escherichiacoli,875
GLRKRLRKPRNKPKEKLKKI,6,2,127,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli,875
GLRKRKRKFRNKKKEKLKKI,6,2,128,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli,875
GLRKALRKFRNKIKEALKKI,6,2,129,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli,875
GLRKRLRKARNKIKEKLKKI,6,2,130,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli,875
GLRKRLRKFRNKIKQKLKKI,6,2,131,"Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes",Escherichiacoli,875
LLGDLLRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,7,5,140,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
LLGDLLRKSKEKIGKEFKRIVQR,7,5,141,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
KRIVQRIKDFLRNLVPRTES,7,5,142,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
SKEKIGKEFKRIVQRIKDFLR,7,5,143,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
FKRIVQRIKDFLR,7,5,144,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,2498
RLFDKIRQVIRKF,7,5,145,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,2048
KRIVQRIKDFLR,7,5,146,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,1861
GFKRIVQRIKDFLRNLV,7,5,147,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
GIKEFKRIVQRIKDFLRNLV,7,5,150,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
GIKEWKRIVQRIKDFLRNLV,7,5,152,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
GIKQFKRIVQRIKDFLRNLV,7,5,153,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
GIKEFKREFQRIKDFLRNLV,7,5,154,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,635
GRFKRFRKPFKKLFKKIS,7,5,156,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,1907
GRFKRIRKKLKKLFKKIS,7,5,158,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,1907
GRFKRFRKKFKKLFK,7,5,159,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,1907
RRRFPWVCWPFLRRR,8,6,161,Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides,Aspergillusfumigatus,2499
RFPWWWPFLR,8,6,162,Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides,Aspergillusfumigatus,2500
KWKSFIKKLTSAAKKVVTTAKPLISS,9,2,165,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKLFKKIGIGAVLKVLTTGLPALIS,9,2,166,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KWKLFKKIGIGAVLKVLTTGLPALKLTK,9,2,167,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KWKSFIKKLTTAVKKVLTTGLPALIS,9,2,168,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKSFIKKLTSAAKKVTTAAKPLTK,9,2,169,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKKFIKKIGIGAVLKVLTTGLPALKLTKK,9,2,170,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KKWKKFIKKIGIGAVLTTPGAKK,9,2,171,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KWKSFIKKLTSAAKKVVTTAKPLALIS,9,2,172,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKSFIKKLTKAAKKVVTTAKKPLIV,9,2,173,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKKFIKSLTKSAAKTVVKTAKKPLIV,9,2,174,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2503
KWKLFKKIGIGAVLKVLTTGLPALKLTLK,9,2,175,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KLFKKIGIGAVLKVLTTGLPALKLTLK,9,2,176,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KWKFKKIGIGAVLKVLTTGLPALKLTLK,10,2,177,Biological properties of structurally related alpha-helical cationic antimicrobial peptide,Escherichiacoli,2501
KLWKLFKKIGIGAVLKVLTTGLPALKLTLK,9,2,178,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2501
KWKSFIKNLTKGGSKILTTGLPALIS,9,2,179,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKKFIKNLTKGGSKILTTGLPALIS,9,2,180,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KWKSFIKKLTSAAKKVLTTGLPALIS,9,2,181,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KKWWKAQKAVNSGPNALQTLAQ,9,2,182,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2504
KKWWKAKKFANSGPNALQTLAQ,9,2,183,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2504
KKWWKFIKKAVNSGTTGLQTLAS,9,2,184,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2505
KWKSFIKKLTSVLKKVVTTAKPLISS,9,2,185,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2502
KKKSFIKLLTSAKVSVLTTAKPLISS,9,2,186,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2506
WKVFKSFIKKASSFAQSVLD,9,2,187,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2507
KKWRKSFFKQVGSFDNSV,9,2,188,Biological properties of structurally related alpha-helical cationic antimicrobial peptides,Escherichiacoli,2508
YVLWKRKRFIFI,11,2,189,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2509
YVLWKRKRWIFI,11,2,190,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2509
YVLWKRKRYIFI,11,2,191,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2509
YVLFKRKRFIFI,11,2,192,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2510
YVLLKRKRLIFI,11,2,193,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2511
YVLAKRKRAIFI,11,2,194,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2512
GWKRKRFG,11,2,195,Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide,Escherichiacoli,2513
FQWQRNMRKVRGPPVS,12,2,272,Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111,Escherichiacoli,2324
FQWQRNMRKVR,12,2,273,Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111,Escherichiacoli,2324
FQWQRNPRKVR,12,2,274,Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111,Escherichiacoli,2324
SGSLSTFFRLFNRSFTQALGK,13,7,327,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans,34
TFFRLFNRSFTQALGK,13,7,328,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans,34
TFFRLFNR,13,7,331,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans,35
FKKFWKWFRRF,13,7,333,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans,36
TRRRLFNRSFTQALGKSGGGFKKFWKWFRRF,13,7,334,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans,37
TFFRLFNRSGGGFKKFWKWFRRF,13,7,335,"Targeted killing of Streptococcus mutans by a pheromone-guided ""smart"" antimicrobial peptide",Streptococcusmutans,37
RHRHRHRH,14,8,339,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,38
RHRHRHRHRHRH,14,8,341,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,39
HRHRHRHRHR,14,8,342,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,40
KHKHKHKHKH,14,8,343,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,41
RGRGRGRGRG,14,8,344,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,42
GHGHGHGHGH,14,8,345,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,43
RCRCRCRCRC,14,8,346,Antimicrobial activity of a chelatable poly(arginyl-histidine) produced by the ergot fungus Verticillium kibiense,Bacillussubtilis,44
RLLRRLLRRLLRRLLRRLLR,15,8,354,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,860
APKAMRLLRRLLRRLLR,15,8,355,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,45
RLLRRLLRRLLRLQKKGI,15,8,356,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,46
APKAMRLLRRLLRLQKKGI,15,8,357,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,47
PKAMRLLRRLLRLQKKG,15,8,358,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,47
APKAMHSAKKFGKAFVGEIMLQKKGI,15,8,359,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,13
KLFKRWKHLFR,16,7,373,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,48
RLLKRFKHLFK,16,7,374,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,49
KLLQTFKQIFR,16,7,376,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,50
RILKELKNLFK,16,7,377,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,51
KLVEQLKEIFR,16,7,380,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,52
RVLQEIKQILK,16,7,381,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,53
KLAENVKEILR,16,7,384,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,54
RALHEAKEALK,16,7,385,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,55
YLFQTWQHLFR,16,7,388,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,56
YLLTEFQHLFK,16,7,389,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,57
KLLQTFNQIFR,16,7,392,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,58
TILQSLKNIFK,16,7,393,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,59
KLVQQLKNIFR,16,7,396,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,60
RVLNQVKQILK,16,7,397,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,61
KLAQKVKRVLR,16,7,400,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,62
RALKRIKHVLK,16,7,402,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,63
KLKKLLKKLKKLLK,16,7,404,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,64
KLKKLLKRWRRWWR,16,7,408,Novel synthetic antimicrobial peptides against Streptococcus mutans,Streptococcusmutans,830
KRLFKKLLFSLRKY,17,9,488,"Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides",Candidapseudotropicalis,65
SSSKEENRIIPGGI,17,9,489,"Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides",Candidapseudotropicalis,66
ELDRICGYGTARCRKKCRSQEYRIGRCPNTYACCLRK,18,10,490,Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.,Staphylococcuscarnosus,1253
RRGWVLALVLRYGRR,20,2,520,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli,2514
RRGWVLALYLRYGRR,20,2,522,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli,2514
RRGWALRLVLAY,20,2,524,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli,2515
WVLVLRLGY,20,2,526,Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity,Escherichiacoli,2516
KSCCRNTWARNCYNVCRLPGTISREICAKKCRCKIISGTTCPSDYPK,22,12,596,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
CCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTC,22,12,597,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
CCRNTWARNCYNVCRLPGTISREICAKKCRCKIISGTTC,22,12,598,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
TWARNCYNVCRLPGTISREICAKKCD,22,12,599,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
TWARNCYNVCRLPGTISREICAKKCR,22,12,600,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
REISAKKSD,22,12,602,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2518
REISAKKSR,22,12,603,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2519
VCRLPGTISREICA,22,12,604,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
TWARNSYNVSRLP,22,12,605,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
ALWMTLLKKVLKAAAKAALDAVLVGANA,23,2,607,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWDTLLKKVLKAAAKAALNAVLVGANA,23,2,608,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWDTLLKKVLKAAAKAALDAVLVGANA,23,2,609,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWMTLLKKVLKAAAKAALKAVLVGANA,23,2,610,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWKTLLKKVLKAAAKAALNAVLVGANA,23,2,611,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWMTLLKKVLKAAAKAALN,23,2,612,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWMTLLKKVLKAAAK,23,2,613,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWMTLLKKVLK,23,2,614,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,2520
TLLKKVLKAAAK,23,2,615,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,2521
TLLKKVLKAAAKAALNAVLVGANA,23,2,616,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
KVLKAAAKAALNAVLVGANA,23,2,617,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
AAAKAALNAVLVGANA,23,2,618,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
ALWKTLLKKVLKAAAK,23,2,619,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
FLGALFKVA,24,8,627,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,67
FLGALFKVASK,24,8,632,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,68
FLGALFKVASKV,24,8,633,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,69
FLGALFKVASKVL,24,8,634,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,69
GALFKVASKVL,24,8,635,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,70
LGALFKVASKVLP,24,8,636,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,71
GALFKVASKVLPS,24,8,637,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,72
ALFKVASKVLPSV,24,8,638,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,73
LFKVASKVLPSVK,24,8,639,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,74
FLKALFKVASKVL,24,8,640,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,75
FLKALFKVALKVL,24,8,641,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,76
ALGALFKVASKVL,25,8,642,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.,Bacillussubtilis,77
WLGALFKVASKVL,25,8,643,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.,Bacillussubtilis,78
WLGALFKVASK,24,8,644,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,78
FWGALFKVASK,24,8,645,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,79
FLWALFKVASK,24,8,646,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,80
FLGAWFKVASK,24,8,651,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,81
FLGALWKVASK,24,8,653,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,82
FLGALFWVASK,24,8,654,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,83
FLGALFKWASK,24,8,655,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,84
FLGALFKVWSK,24,8,656,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,85
FLGALFKVAWK,24,8,663,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,86
FLGALFKVASW,24,8,664,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,87
FLGLLFKVASK,24,8,665,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,88
FLGKLFKVASK,24,8,666,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,89
FLGFLFKVASK,24,8,667,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,90
FLGALFKLASK,24,8,668,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,91
FLGALFKKASK,24,8,669,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,92
FLGALFKFASK,24,8,670,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,93
FLGWLFKWASK,24,8,671,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,94
LCYCRRRFCVCVGR,26,2,675,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
RGGRLCYARRRFAVCVGR,26,13,682,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Neisseriagonorrhoeae,2437
RGGRLAYCRRRFCVAVGR,26,2,683,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
KNLRRIIRKGIHIIKKYG,27,3,696,Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides.,Pseudomonasaeruginosa,1660
KNLRRITRKIIHIIKKYG,27,3,697,Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides.,Pseudomonasaeruginosa,1660
RRWQWRMKKLG,28,2,717,Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity,Escherichiacoli,1206
HPLKQYWWRPSI,28,2,718,Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity,Escherichiacoli,537
VTCDILSVEAKGVKLNDAACAAHCLFRGRSGGYCNGKRVCVCR,3,4,719,"Synthesis and structure-function study about tenecin 1, an antibacterial protein from larvae of Tenebrio molitor",Staphylococcusaureus,1468
GDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,31,2,765,"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37",Escherichiacoli,635
RKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,31,2,766,"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37",Escherichiacoli,635
KLFKRIVKRILKFLRKLV,31,2,767,"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37",Escherichiacoli,635
RVKRVWPLVIRTVIA,32,4,773,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus,95
RVKRVWPLVIRTVIAGYNLYRAI,32,4,774,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus,95
LVIRTVIAGYNLYRAIKKK,32,4,775,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus,95
VWPLVIRTVIAGYNLYRAIKKK,32,4,776,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus,95
RVKRVWPLVIRTVIALYNLYRAIKKK,32,4,777,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus,95
RVKRVWKLVIRLVKALYKLYRAIKKK,32,4,778,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Staphylococcusaureus,95
SLSRYAKLANRLA,33,2,819,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli,538
PKLLETFLSKWIG,33,2,820,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli,194
SLSRYAKLANRLANPKLLETFLSKWIG,33,2,821,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli,194
GATAIKQVKKLFKKWGW,34,14,830,Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A.,Lactobacillussakei,2281
KPVPIIYCNRRTGKCQRM,35,15,853,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
VPIIYCNRRTGKCQRM,35,15,854,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
IIYCNRRTGKCQRM,35,15,855,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
YCNRRTGKCQRM,35,15,856,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
GSKKPVPIIYCNRRTGKCQR,35,15,857,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
GSKKPVPIIYCNRRTGKCQ,35,15,859,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
GSKKPVPIIYCNRRTGKC,35,15,861,"Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.",Aerococcusviridans,1905
GSKKPVPIIYCNRRGKCQRM,36,2,865,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli,1905
GSKKPVPIIYCNRRTKCQRM,36,2,866,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli,1905
GSKKPVPIIYCNRRKCQRM,36,2,867,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli,1905
GSKKPVPIIYCNRRATGKCQRM,36,2,868,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli,1905
GSKKPVPIIYCNRRAATGKCQRM,36,2,869,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli,1905
GSKKPVPIIYANRRTGKAQRM,36,2,870,"Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide.",Escherichiacoli,1905
RAGLQFPVGRVHRLLRK,37,8,873,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
AGLQFPVGRVHRLLRK,37,8,874,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
GLQFPVGRVHRLLRK,37,8,875,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
LQFPVGRVHRLLRK,37,8,876,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
QFPVGRVHRLLRK,37,8,877,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
FPVGRVHRLLRK,37,8,878,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
PVGRVHRLLRK,37,8,879,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,96
TRSSRAGLQFPVGRVHR,37,8,880,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
RAGLQFPVGRVHRLLR,37,8,881,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
RAGLQFPVGRVHRLL,37,8,882,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
RAGLQFPVGRVHRL,37,8,883,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
RAGLQFLVGRVHRLLRK,37,8,884,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
RKGLQKLVGRVHRLLRK,37,8,885,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,1542
RVHRLLRRVHRLLRRVHRLLR,37,8,886,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,1543
RAGLQFPVGRLLRRLLRRLLR,37,8,887,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,1544
RAGLQFPVGGIGKFLHSAKKFGK,37,8,888,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,1545
TRSSRAGLQWPVGRVHRLLRK,38,2,889,Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.,Escherichiacoli,882
TRSSRAGLQWAVGRVHRLLRK,38,2,890,Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor.,Escherichiacoli,882
FLGWLFKVASK,25,8,926,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5.,Bacillussubtilis,1546
VKKFPWWWPFLKK,39,2,951,Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.,Escherichiacoli,2256
RRFPWWWPFRR,39,2,952,Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.,Escherichiacoli,539
KKFPWWWPFKK,39,2,953,Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure.,Escherichiacoli,539
GLFGKLQKKFGRKAISYAVKKARGKH,40,2,968,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli,540
GLFGKLIKKKGRKAISYAVKKARGKH,40,2,969,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli,540
GLFGKLIKKFLRKAISYAVKKARGKH,40,2,970,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli,540
GKLIKKFGRKAISYAVKKARGKH,40,2,971,N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins.,Escherichiacoli,540
GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,41,2,974,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,2012
KYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,41,2,975,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,2012
YCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,41,2,976,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,2012
KEEQIGKSSTRGRKSSRRKK,41,2,978,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,2012
KSSTRGRKSSRRKK,41,2,979,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,541
RGRKSSRRKK,41,2,980,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,542
RGRKSSRRK,41,2,981,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,543
KYYSRVRGGRSAVLSSLPK,41,2,982,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,2012
GIINTLQKYYSRVRGGR,41,2,983,Antimicrobial characterization of human beta-defensin 3 derivatives.,Escherichiacoli,2012
GWKKWFTKGERLSQRHFA,42,16,1000,Novel antimicrobial peptides derived from flatfish genes.,Aeromonassalmonicida,544
GFLGILFHGVHHGRKKALHMNSERRS,42,16,1002,Novel antimicrobial peptides derived from flatfish genes.,Aeromonassalmonicida,545
RLCRIVVIRVCR,43,2,1060,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli,546
RLSRIVVIRVSR,43,2,1061,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli,986
RRLCRIVVIRVCRR,43,2,1063,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli,546
RRCPIVVIRVCR,43,2,1065,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli,547
KKCPIVVIRVCK,43,2,1067,Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.,Escherichiacoli,547
KRLRKFRNKIKEKLKKIG,44,3,1068,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,875
RKRLRKFRNKIKEKLKKIGQKI,44,3,1070,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,875
KNLRRIIRKIIHIIKKYG,44,3,1074,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,1660
RRRCPIVVIRVCRR,45,2,1082,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli,547
RRRLCPIVIRVCRR,45,2,1083,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli,548
RLCRIVPVIRVCR,45,2,1086,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli,549
RLCRIVWVIRVCR,45,2,1087,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli,550
RRLCRIVWVIRVCRR,45,2,1088,"Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide.",Escherichiacoli,550
FKCRRWQWRMKKLGAPSITCVRRAFA,46,17,1096,Antibacterial activity in bovine lactoferrin-derived peptides.,Listeriamonocytogenes,114
KKLGAPSITCVRRAFA,46,17,1097,Antibacterial activity in bovine lactoferrin-derived peptides.,Listeriamonocytogenes,2029
GFIATLCTKVLDFGIDKLIQLIEDK,47,18,1105,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus,1547
GEILCNLCTGLINTLENLLTTKGADKVK,47,18,1107,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus,1548
GEILANLATGLINTLENLLTTKGADKVK,47,18,1108,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus,1548
IKHQGLPQE,48,19,1110,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1549
VLNENLLR,48,19,1111,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1550
IAHQGLPQE,48,19,1112,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1551
IKAQGLPQE,48,19,1114,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1552
IAAQGLPQE,48,19,1115,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1553
KHQGLPQE,48,19,1116,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1554
VLNENLLA,48,19,1117,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1555
VLNENLAR,48,19,1119,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1556
VLNENALR,48,19,1120,Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.,Cronobactersakazakii,1557
CTRPNYNKRKRIHIG,49,2,1122,Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1.,Escherichiacoli,551
RIVFAVLSIVNRVRQ,49,2,1123,Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1.,Escherichiacoli,552
LGKEEQIGRASNSGRKCARKKK,50,3,1144,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
FLPKTLRKFF,50,3,1145,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,1558
LRKFFARIRGGR,50,3,1146,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
RGGRAAVLNA,50,3,1147,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,1559
IRGGRAAVLNALGKEEQIGRAS,50,3,1148,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
LPKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,1,1150,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,None_target,32
PKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1152,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
LRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1153,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
FFARIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1154,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
RIRGGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1155,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
GGRAAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1157,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
AAVLNALGKEEQIGRASNSGRKCARKKK,50,3,1158,Peptide fragments of a beta-defensin derivative with potent bactericidal activity.,Pseudomonasaeruginosa,32
AKKIRVRLSA,51,2,1170,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,553
QAKIRVRLSA,51,2,1171,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,554
QKAIRVRLSA,51,2,1172,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,555
QKKARVRLSA,51,2,1173,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,556
QKKIAVRLSA,51,2,1174,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,557
QKKIRARLSA,51,2,1175,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,558
QKKIRVALSA,51,2,1176,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,559
QKKIRVRASA,51,2,1177,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,560
QKKIRVRLAA,51,2,1178,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,561
QRKIRVRLSA,51,2,1179,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,561
QKRIRVRLSA,51,2,1180,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,561
QRRIRVRLSA,51,2,1181,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,561
KIRVRLSA,51,2,1182,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,562
QKKIRVRLSA,51,2,1183,Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification.,Escherichiacoli,561
KWKLFKKIGAVLKVL,52,2,1187,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli,500
KWKKFKKIGAVLKVL,52,2,1188,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli,500
KWKLFKKIGKVLKVL,52,4,1189,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Staphylococcusaureus,500
KWKLFKKIGAVLKKL,52,2,1190,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli,500
KWKKFKKIGKVLKVL,52,2,1191,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli,500
KWKKFKKIGAVLKKL,52,2,1192,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli,500
KWKLFKKIGKVLKKL,52,2,1193,Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.,Escherichiacoli,500
KVDKGSYLPRP,53,2,1208,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli,563
VDKGRYLEAPTPPRPIYNRN,53,2,1209,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli,564
DKGRYLEAPTRPRPERNRK,53,2,1210,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli,564
VDKGSYLPRPTPYSPRPPIYNRN,53,2,1211,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli,565
VDKGSYLPRPTPTPRYRPIYNRN,53,2,1212,"Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin",Escherichiacoli,565
ADADDDDDK,54,20,1220,"Small, anionic, and charge-neutralizing propeptide fragments of zymogens are antimicrobial.",Pasteurellahaemolytica,566
KGWGSFFKKAAHVGKHVGKAALTHYL,55,21,1227,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,1560
ALWKTMLKKAAHVGKHVGKAALTHYLN,55,21,1229,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,1560
SIGSAFKKAAHVGKHVGKAALTHYLN,55,21,1230,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,1560
GWGSFFKKAAHVGKHVGKAALGAAARRRK,55,21,1232,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,1560
ALWKTMLKKAAHVGKHVGKAALGAAARRRK,55,21,1233,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,1560
SIGSAFKKAAHVGKHVGKAALGAAARRRK,55,21,1235,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,1560
EFKRIVQRIKDFLRNLV,56,3,1242,"Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37",Pseudomonasaeruginosa,635
EWKRWVQRWKDWLRNLV,56,3,1244,"Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37",Pseudomonasaeruginosa,1561
KYYGNGVTCGKHSCSVDWGKATTCIINNGAAAWATGGHQGNHKC,58,14,1255,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei,649
KYYGNGVTCGKHSCSVDWGKATTCIINNGAIAWATGGHQGNHKC,58,14,1256,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei,649
KYYGNGVTCGKHSCSVDWGKATTCIINNGALAWATGGHQGNHKC,58,14,1258,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei,649
KYYGNGVTCGKHSCSVDWGKATTCIINNGADAWATGGHQGNHKC,58,14,1260,Engineering increased stability in the antimicrobial peptide pediocin PA-1.,Lactobacillussakei,649
RVVRVVRRVVRR,59,3,1264,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1562
RRVVRRVRRVVRRVVRVVRRVVRR,59,3,1265,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1563
VRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR,59,3,1266,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1563
RVVRVVRRVVRRVRRVVRRVVRVVRRVVRRVRRVVRRVVRVVRRVVRR,59,3,1267,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1563
RVVRVVRRWVRR,59,3,1268,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1564
RRWVRRVRRWVRRVVRVVRRWVRR,59,3,1269,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1563
VRRVWRRVVRVVRRWVRRVRRWVRRVVRVVRRWVRR,59,3,1270,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1563
RVVRVVRRWVRRVRRVWRRVVRVVRRWVRRVRRWVRRVVRVVRRWVRR,59,3,1271,De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.,Pseudomonasaeruginosa,1563
KKVVFKVKFKK,60,6,1274,In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide.,Aspergillusfumigatus,567
LIKIVPAMICAVTKKC,61,4,1275,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus,526
SNNFGAKLSSTKVGK,62,2,1277,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,568
SNKGAIKGLMVKGVK,62,2,1278,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,569
VTNVGGKVVTGKTAK,62,2,1279,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,570
GAAAAGKVVGGKGGK,62,2,1280,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,571
ALLSPYKYSTTKVVK,62,2,1281,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,572
GKSNFLKSYVSKHPK,62,2,1282,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,573
SQSSVDKLNWYKQRK,62,2,1283,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,574
GKAPKLKIFDTKNLK,62,2,1284,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,575
RSGTDFKLTISKLQK,62,2,1285,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,576
PDDFATKYSQQKYTK,62,2,1286,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,577
SNGPVKKWGSIKGLK,62,2,1287,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,578
DVSIEDKVISLKGDK,62,2,1288,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,579
HSIIGRKLVVHKKAK,62,2,1289,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,580
KHGATVKTALGKILK,62,2,1290,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,581
VKYLEFKSESIKQVK,62,2,1291,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,582
DMQSLFKQYFQKMTK,62,2,1292,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,583
AGTSLVKFFSSKMNK,62,2,1293,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2395
LPGSSKKFSVYKDQK,62,2,1294,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2396
TSLGGWKLIQQKMDK,62,2,1295,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2397
GNDYLHKLTQRKSVK,62,2,1296,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2398
EIENGVKWVSFKGAK,62,2,1297,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2399
YTGIFTKQVLSKLKK,62,2,1298,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2400
GSHLVEKLYLVKERK,62,2,1299,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2401
GISLANKMSLAKWEK,62,2,1300,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2402
DEKIYLIKVADVDQR,62,2,1301,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2403
LMEIHHRASQDTPKE,62,2,1302,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2404
WYADHSDQYQLLDTP,62,2,1303,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2405
DLVELAMLEADRMSR,62,2,1304,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2406
QDNYWVTQGLNILSG,62,2,1305,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2407
DEKIYLKKVADKDQK,62,2,1306,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2403
LMEIHHKASQDKPKK,62,2,1307,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2404
WYADHSKQYQLKDTK,62,2,1308,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2405
DLVELAKLEADKMSK,62,2,1309,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2408
QDNYWVKQGLNKLSK,62,2,1310,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2407
TPIESHQVEKRKSNT,62,2,1311,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2409
MHMNVQNGKWDSDPS,62,2,1312,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2410
TPIESHKVEKRKSNK,62,2,1313,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2409
MHMNVQKGKWDKDPK,62,2,1314,The generation of antimicrobial peptide activity: a trade-off between charge and aggregation?,Escherichiacoli,2410
GLIKIVPAMICAVTKKC,61,4,1315,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus,526
GGLIKIVPAMICAVTKKC,61,4,1316,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus,526
LGGLIKIVPAMICAVTKKC,61,4,1317,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus,526
FLGGLIKIVPAMICAVTKK,61,4,1318,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus,526
KYYGNGVTCGKHSCSVDWGKATTSIINNGAMAWATGGHQGNHKS,63,22,1326,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
KYYGNGVHCGKHSCTVDWGTAIGCIGNNAAANWATGGNAGWNKC,63,22,1327,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
KYYGNGVHCGKHSCTVDWGTAITCIGNNAAANWATGGNAGWNKC,63,22,1328,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
KYYGNGVHCGKHSCTVDWGTAITSIGNNAAANWATGGNAGWNKS,63,22,1329,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
KYYGNGVHCGKHSCTVDWGTAITSIGNNAAANWATGGNAGWNK,63,22,1330,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNKS,63,22,1331,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
KYYGNGVHCGKHSCTVDWGTAITNIGNNAAANWATGGNAGWNK,63,22,1332,A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum.,Lactobacilluscoryneformis,649
TKCFQWQRNMRKVRGPPVSCIKRDS,64,2,1362,N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.,Escherichiacoli,2324
TKCFQWQRNMRKVR,65,2,1377,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
KCFQWQRNMRKVR,65,2,1378,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRNMRKVR,65,2,1379,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
AFQWQRNMRKVR,65,2,1381,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CAQWQRNMRKVR,65,2,1382,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFAWQRNMRKVR,65,2,1383,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQAQRNMRKVR,65,2,1385,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWARNMRKVR,65,2,1386,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQANMRKVR,65,2,1387,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRAMRKVR,65,2,1389,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRNARKVR,65,2,1390,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRNMAKVR,65,2,1391,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRNMRAVR,65,2,1392,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRNMRKAR,65,2,1393,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWQRNMRKVA,65,2,1394,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWKRNMRKVR,65,2,1396,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFQWKRAMRKVR,65,2,1400,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFAWKRNMRKVR,65,2,1401,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFAWQRAMRKVR,65,2,1402,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2324
CFALKKAMKKVR,65,2,1403,Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin.,Escherichiacoli,2411
FAKKLAKKLKKLAKKLAK,66,2,1417,Antimicrobial peptide therapeutics for cystic fibrosis.,Escherichiacoli,1276
KRFHSVGSLIQRLQQMIRDLSEATRHGIRKITRPKLLLAS,67,2,1433,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli,2412
GWKKWLRKGAKHLGQAAIKGLAS,42,16,1435,Novel antimicrobial peptides derived from flatfish genes.,Aeromonassalmonicida,2413
RGLRRLGRKIAHGVKKYG,68,23,1486,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1906
LGRKIAHGVKKYGPTVLRII,68,23,1487,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1906
KIAHGVKKYGPTVLRIIRIAG,68,23,1488,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1906
RGLRALGRKIAHGVKAYG,68,23,1489,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1906
KNIRRIIRKIIHIIKKYG,68,23,1498,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1660
NLRRIIRKIIHIIKKY,68,23,1500,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1660
NIRRIIRKIIHIIKKY,68,23,1508,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1660
LRRIIRKIIHIIKK,68,23,1509,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1660
IRRIIRKIIHIIKK,68,23,1510,Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells.,Mannheimiahaemolytica,1660
RGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1529,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1565
HGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1530,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1565
KPHGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1531,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1565
HRPGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1532,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1565
KPRPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,69,1,1533,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1565
KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGLVGGALTCL,69,1,1534,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1565
KNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1535,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1566
KPNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1536,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1566
HNGYGGSGNHWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1537,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1566
KNGYGGSGNR,69,1,1538,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1567
RPWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,69,1,1539,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.,None_target,1566
ARGLTYNKPCLYGT,70,2,1572,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2414
AMRLTGNKPCLYGT,70,2,1573,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2414
AMRLTYNKPCLGGT,70,2,1574,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2414
AMRLTYNKGCLYGT,70,2,1575,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2414
AMRLTYNKPGLYGT,70,2,1576,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2414
AGRLTGNKGGLGGT,70,2,1577,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2415
SIITGTKEAKLPQLWKQIACRLYNTC,70,2,1579,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2416
SIITMTKEAKLGQLWKQIACRLYNTC,70,2,1580,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2416
SIITMTKEAKLPQLGKQIACRLYNTC,70,2,1581,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2416
SIITMTKEAKLPQLWKQIACRLGNTC,70,2,1582,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2416
SIITGTKEAKLGQLGKQIACRLGNTC,70,2,1583,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2416
FRSGILKLASKIGSVLCAVLKNC,70,2,1593,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2417
AKAGGIPPHVIPQIVPVRIRPLCGNV,70,2,1597,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,261
AKAWGIGGHVIGQIVGVRIRGLCGNV,70,2,1598,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2418
AKAWGIPPHVIPQIVPVRIRPLGGNV,70,2,1599,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,261
AKAGGIGGHVIGQIVGVRIRGLGGNV,70,2,1600,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2418
GFGDSVKEGLKNAAVTILNKIKCKISECPPA,70,2,1602,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2419
GFWDSVKEGLKNAAVTILNKIKCKISECGGA,70,2,1603,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2419
GFGDSVKEGLKNAAVTILNKIKCKISECGGA,70,2,1604,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2419
FIGGLRRLFATVVGTVVCAINKLGGG,70,2,1606,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2420
FIPGLRRLFATVVPTVVGAINKLPPG,70,2,1607,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2420
FIGGLRRLFATVVGTVVGAINKLGGG,70,2,1608,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2420
DDGDKGMLKWKNDFFQEF,70,2,1609,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2421
DDPDKGGLKWKNDFFQEF,70,2,1611,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2421
DDPDKGMLKGKNDFFQEF,70,2,1612,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2421
DDGDKGGLKGKNDFFQEF,70,2,1613,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2421
GLLDSVKEGLKKVAGQLLDTLKCKISGCTGA,71,2,1615,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,807
GFFDRIKALTKNVTLELLNTITGKLPVTPP,70,2,1616,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2422
GFFDRIKALTKNVTLELLNTITCKLGVTGG,70,2,1617,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2422
GFFDRIKALTKNVTLELLNTITGKLGVTGG,70,2,1618,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2422
SFGAKNAVKNGLQKLRNQCQANNGQGPFCDIFKKNP,70,2,1622,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2423
SFGAKNAVKNGLQKLRNQCQANNYQGGFCDIFKKNG,70,2,1623,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2423
SFGAKNAVKNGLQKLRNQCQANNGQGGFCDIFKKNG,70,2,1624,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,2423
CVHWMTNTARTACIAP,71,2,1626,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,460
CVHGMTNTARTACIAP,70,2,1627,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,460
CVHWGTNTARTACIAP,70,2,1628,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,460
CVHWMTNTARTACIAG,70,2,1629,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,460
CVHGGTNTARTACIAG,70,2,1630,Antioxidant peptidomics reveals novel skin antioxidant system.,Escherichiacoli,460
ACHAHCQSVGRRGGYCGNFRMTCYCY,72,4,1633,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus,2331
LVRVRRGFGCPFDER,72,4,1634,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus,2331
NCIQQCVSKGAQGGYCTNEKCTCY,72,4,1635,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus,1568
GFRTAHVDLVCPDNPD,72,4,1636,Sequence characterization and expression patterns of two defensin-like antimicrobial peptides from the tick Haemaphysalis longicornis,Staphylococcusaureus,1569
HSSGYTRPLRKPSRPIFIRPI,73,24,1717,Solution structure of synthetic penaeidin-4 with structural and functional comparisons with penaeidin-3,Fusariumoxysporum,2424
VKRFKKFFRKLKKSV,74,8,1738,Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.,Bacillussubtilis,1694
AIHNLAHKLLKKLTRAVKKLAN,75,2,1912,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2425
AIHKLAHKLLKKLLKAVKKLAK,75,2,1913,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2426
AIHKLAHKLLKKLLRAVKKLAN,75,2,1914,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2425
AIHKLAHKLLKKTLRAVKKLAN,75,2,1915,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2426
AIHKLAHKLTKKTLRAVKKLAN,75,2,1916,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2426
AIHKLAHKTLKKTLRAVKKLAN,75,2,1917,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2426
AIHKLAHKLLPKTLRAVKKLAN,75,2,1918,Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin.,Escherichiacoli,2426
GLVSSIGKALGGLLVDVVKSKGQPA,76,25,1994,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea.",Bacilluscereus,443
VFQFLGKIIKKVGNFVKGFSKVF,77,4,2004,Effects of pH and salinity on the antimicrobial properties of clavanins.,Staphylococcusaureus,1570
GGHGGHGGHGGHGGHGGH,78,26,2011,"Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris.",Erwiniaherbicola,873
KWKSFLKTFKSAVKTVLHTALKAISS,79,2,2012,Interaction of cationic antimicrobial peptides with model membranes.,Escherichiacoli,2522
KWKSFLRTLKSPAKTVFHTALKAISS,79,2,2013,Interaction of cationic antimicrobial peptides with model membranes.,Escherichiacoli,2522
KWKSFLRTFKSPVRTVFHTALKPISS,79,2,2014,Interaction of cationic antimicrobial peptides with model membranes.,Escherichiacoli,2522
RWSVYAYVRVRGVLVRYRRSW,80,4,2026,Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.,Staphylococcusaureus,1976
KWCVYAYVKVKGVLVKYKKCW,80,4,2027,Multiple peptide resistance factor (MprF)-mediated Resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol.,Staphylococcusaureus,1976
GLFGRLRDSLQRGGQKILEKAERIWCKIKDIFRG,81,3,2030,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,1800
ISRLAGLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ,81,3,2032,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,1571
GLRKRLRKFRNKIKEKLKKIG,81,3,2035,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
RKFRNKIKEKLKKIG,81,3,2036,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
LRKFRNKIKEKLKKIGQKI,81,3,2037,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
LRKFRNKIKEKLKKIGQKIQG,81,3,2038,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
KIKEKLKKIGQKI,81,3,2039,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,1572
KIKEKLKKIGQKIQG,81,3,2040,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
KIKEKLKKIGQKIQGLL,81,3,2041,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
KLLLKLLK,82,27,2050,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii,2523
LKLLLKLLK,82,27,2051,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii,2524
KLLLKLLLKLLK,82,27,2053,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii,2525
KLLKLLLKLLLKLLK,82,27,2055,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii,405
KLLKLLLKLLLKLWK,82,27,2056,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii,2526
KLLKLLKLLKLLKLWK,82,27,2060,The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes.,Acholeplasmalaidlawii,2527
RILSILRHQNLLKE,84,28,2107,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa,913
TLRGDERILSILRHQNLLKE,84,28,2108,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa,913
TLRGDERILSILRHQNLLKELQDLALQGAK,84,28,2109,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa,913
RILSILRHQNLLKELQDLALQGAK,84,28,2110,"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.",Neurosporacrassa,913
LKIAKGIIKSL,85,4,2125,Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom.,Staphylococcusaureus,1573
GNNRPVYIPRPRPPHPRLV,86,2,2133,Antibiotic Peptides,Escherichiacoli,2542
GNNRPVYIPQPRPPHPRPIRV,86,2,2134,Antibiotic Peptides,Escherichiacoli,2542
KVNVNAIKKGGKAIGKGFKVISAASTAH,87,2,2155,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,306
VFIDILDKMENAIHKAAQAGIG,88,29,2256,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,283
KWKLFKKIEKVGQNIRDGIIKAGPAVAWVGQATQIAK,88,29,2257,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,2096
KWKVFKKIEKNGRNIRNGIVKAGPAIAVLGEAKAL,88,29,2258,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,2096
SWLSKTAKKLENSAKKRISEGIAIAQGPR,88,29,2259,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,1069
GIGAVLTTGLPALISWIKRKRQQ,88,29,2260,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,1858
PRRRRSSSRP,88,29,2262,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,1339
VRRRRRPR,88,29,2263,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,1340
VSRRRRRRGGRRRR,88,29,2264,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,1341
NLVSGLIEARKYLEQLHRKLKNRKV,89,30,2295,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,1342
LLAGLAANFLPTIICKISYKC,90,31,2317,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,1296
FAGLAANFLPTIICKISYKC,90,31,2319,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,1296
FLKLLKKLAAKFLPTIICKISYKC,90,31,2320,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,1296
FLKLLKKLAAKFL,90,31,2321,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,2528
FLKLLKKLAAKLF,90,31,2322,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,2529
FLGALFKALSKLL,90,31,2323,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,2530
FLKLLAGLLKNFA,90,31,2324,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,2531
GIWGTLAKIGIKAVPRVISMLKKKQ,91,32,2349,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Lactococcuslactis,2532
GANLAKKFYTYINKFINYAW,92,4,2350,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1343
GANAAKKFATIAKKFINYLW,92,4,2351,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1344
GANALKKYFTILKKFFKLAW,92,4,2352,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1345
GIKIAKKAITIAKKIAKIYW,92,4,2353,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1346
GAKYAKYIYNFYKYIAKYIW,92,4,2354,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1347
GAKYAKIIYNYLKKIANALW,92,4,2355,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1347
GAKALTKAATAFTKFYKTIW,92,4,2356,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1348
GATYAKKIIKTITKIATTAW,92,4,2357,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1349
GYNYAKKLANLAKKFANALW,92,4,2358,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1350
GLTFLKKILNFAKKIYTAIW,92,4,2359,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1351
GANAAKKLATFAKKIFTAYW,92,4,2360,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1352
GANAAKKFANLIKKIFNYIW,92,4,2361,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1353
GYKYINNIIKYINKFFKYIW,92,4,2362,Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.,Staphylococcusaureus,1354
KVHGSLARAGKVRGQTPK,93,4,2375,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,891
KVAKQEKKKKKTGRAKRR,93,4,2376,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,891
FVNVVPTFGKKKGPNANS,93,4,2378,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,891
KVAKQEKKKKKT,93,4,2379,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,1355
TGRAKRRMQYNRR,93,4,2380,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,891
RAKRRMQY,93,4,2381,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,1356
QEKKKKKTGRAKRR,93,4,2382,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,891
SMLSVLKNLGKVGLGFVASKINKQS,94,2,2386,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLAVLKNLGKVGLGFVACKINKQC,94,2,2388,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLGVLKNLGKVGLGFVACKINKQC,94,2,2389,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLRNLGKVGLGFVACKINKQC,94,2,2390,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLGRVGLGFVACKINKQC,94,2,2391,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLKKVGLGFVACKINKQC,94,2,2392,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLKKVKLKFVACKINKQC,94,2,2393,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLEKVELEFVACKINKQC,94,2,2394,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLKVLKNLGKVGLGFVACKINKQC,94,2,2395,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLGKVGLGFVAAKIAKQA,94,2,2396,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLGKVGLGFVA,94,2,2397,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKKLGKVGLGFVACKINKQC,94,2,2398,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLGKVGLGFVKCKINKQC,94,2,2399,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLGKVGLGFVACKIKKQC,94,2,2400,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
SMLSVLKNLGKVGLGFVACKINKKC,94,2,2401,"Antimicrobial properties of the frog skin peptide, ranatuerin-1 and its [Lys-8]-substituted analog.",Escherichiacoli,427
KLKFKLKQ,95,33,2411,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae,1357
LKLKFKLKQ,95,33,2412,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae,1358
KLKLKFKLKQ,96,33,2413,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria,Pseudomonassyringae,1359
KLKLKLKQ,95,33,2420,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae,1360
KLKLKLKE,95,33,2421,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae,1360
LKLKLKLQ,95,33,2422,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae,1361
KKLKLKKQ,95,33,2423,De novo designed cyclic cationic peptides as inhibitors of plant pathogenic bacteria.,Pseudomonassyringae,1362
PRLKVYLPRYKVYSTAAGRYQLLSRYWDAYR,97,25,2498,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus,1363
PRLKVYLPRYKVYSTAAGRYQLLSRYW,97,25,2499,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus,1363
KVYLPRYKVYSTAAGRYQLL,97,25,2500,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus,1363
AAGRYQLLSRYWDAYR,97,25,2501,Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.,Bacilluscereus,1363
GFMKYIGPLIPHAVKAISKLI,98,2,2512,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli,2533
GFMKYIKPLIPHAVKAISKLI,98,2,2513,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli,2533
GFMKYIKPLIPHAVKAIKKLI,98,2,2514,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli,2533
FVGALFKALSKLL,99,4,2521,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1364
FLGAVFKALSKLL,99,4,2522,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1365
FLGALFKAVSKLL,99,4,2523,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1366
FLGALFKALSKVL,99,4,2525,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1367
FLGALFKALSKLV,99,4,2526,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1368
FLGALVKALSKLL,99,4,2527,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1369
FLGAVVKALSKLL,99,4,2529,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1370
FLGALFKVVSKLL,99,4,2530,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1371
FLGVLFKVLSKLL,99,4,2531,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1372
FLGALAKALSKLL,99,4,2532,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1373
FAGAAFKALSKLL,99,4,2533,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1374
FLKALFKALSKLL,99,4,2534,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1375
FLKALFKALKKLL,99,4,2535,Correlation between the activities of alpha-helical antimicrobial peptides and hydrophobicities represented as RP HPLC retention times.,Staphylococcusaureus,1376
CGGWHRLRC,100,34,2539,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity,Micrococcuslysodeikticus,1377
SGGWHRLRS,101,34,2540,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1378
CGGWKRLRC,101,34,2541,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1379
CGGWKRKRC,101,34,2542,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1380
SGGYCGGWHRLRC,101,34,2543,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
CGGWHRLRCTSYRSG,101,34,2544,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
CGGYSGGWHRLRSTSYRCG,101,34,2545,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
CGGYSGGWKRKRSTSYRCG,101,34,2546,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
SGGYCGGWHRLRCTSYRSG,101,34,2547,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
SGGYCGGWKRKRCTSYRSG,101,34,2548,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
CGGYCGGWHRLRCTSYRCG,101,34,2549,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
CGGYCGGWKRKRCTSYRCG,101,34,2550,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
GFGSPNNYQSHRHSKSIPGR,101,34,2551,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,2323
NYQSHRHSKS,101,34,2552,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1381
SKSIPGRSG,101,34,2553,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1382
CGGYSSSGSGSGSTSYRCG,101,34,2554,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1383
CKSIPGRCG,101,34,2555,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1384
CKKWKRKRC,101,34,2557,Key role of the loop connecting the two beta strands of mussel defensin in its antimicrobial activity.,Micrococcuslysodeikticus,1385
SIGRRGGYCAGIIKQTCTCYR,102,2,2596,Babesial vector tick defensin against Babesia sp. parasites.,Escherichiacoli,2331
RSGGYCNGKRVCVCR,103,4,2637,"Identification and characterization of the antimicrobial peptide corresponding to C-terminal beta-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor.",Staphylococcusaureus,1468
VLSAADKGNVKAAWGKVGGHAAEYGAEALERM,104,35,2644,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1611
VLSAADKGNVKAAWGKVGGHAAEYGAEAL,104,35,2645,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1611
VLSAADKGNVKAAWGKVGGHAAEYGAEA,104,35,2647,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1611
VLSAADKGNVKAAWGKVGGHAAEYGAE,104,35,2648,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1611
VLSAADKGNVKAAWGKVGGHAAE,104,35,2649,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1611
FLSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAALTKAVEHLDDLPGALSEL,104,35,2655,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
LSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAALTKAVEHLDDLPGALSEL,104,35,2656,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
FLSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAAL,104,35,2657,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
LSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAAL,104,35,2658,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
FLSFPTTKTYFPHF,104,35,2659,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
FLSFPTTKTYFPH,104,35,2660,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
LSFPTTKTYFPHF,104,35,2661,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2534
FPTTKTYFPH,104,35,2683,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2535
PTTKTYFPHF,104,35,2684,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2536
VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,104,35,2685,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1612
VTLASHLPSDFTPAVHASLDKFLANVSTVL,104,35,2686,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1612
VTLASHLPSDFTPAVHASLDKFLANVS,104,35,2687,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1612
STVLTSKYR,104,35,2688,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2537
ARNFGKFFTPVLQADFQKVVAGVANALAHRYH,104,35,2690,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1615
FTPVLQADFQKVVAGVANALAHRYH,104,35,2692,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1615
QADFQKVVAGVANALAHRYH,104,35,2693,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1615
MLTAEEKAAVTAFWGKVKVDEVGGEALGRL,104,35,2696,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,1616
MLTAEEKAAVTAF,104,35,2697,Bovine hemoglobin: an attractive source of antibacterial peptides,Salmonellaenteritidis,2538
KGRGKQGGKVRAKAKTR,105,7,2720,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
KGRGKQGGKVRAKAK,105,7,2721,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
KGRGKQGGKVRAKA,105,7,2722,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
GRGKQGGKVRAKAKTRSS,105,7,2723,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
AGRGKQGGKVRAKAKTRSS,105,7,2724,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
SGRGKQGGKVRAKAKTRSS,105,7,2725,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
RGRGKQGGKVRAKAKTRSS,105,7,2726,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
DGRGKQGGKVRAKAKTRSS,105,7,2727,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
KRGKQGGKVRAKAKTRSS,105,7,2728,"Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide",Streptococcusmutans,882
FEDLPNFGHIQVKVFNHGEHIHH,106,36,2739,Crustacean immunity. Antifungal peptides are generated from the C terminus of shrimp hemocyanin in response to microbial challenge.,Alternariabrassicicola,2668
AANIPFKVHFRCKSIFC,107,2,2825,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli,2539
AVNIPFKVHFR,107,2,2828,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli,2539
CWTKSIPPRPC,107,2,2835,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli,2286
CWTASIPPRPC,107,2,2836,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli,2286
CWTVSIPPRPC,107,2,2837,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli,2286
IGKEFKRIVQRIKDFLRNL,108,2,2841,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKKFKRIVQRIKDFLRNL,108,2,2842,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKKFKRIVQRIKKFLRNL,108,2,2843,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKKFKRIVQRIKKFLRKL,108,2,2844,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKKFKRIVKRIKKFLRKL,108,2,2845,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKLFKRIVQRIKKFLRNL,108,2,2846,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKLFKRIVQRILKFLRNL,108,2,2847,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKLFKRIVKRILKFLRKL,108,2,2848,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
ILKLFKRIVKRILKFLRKL,108,2,2849,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKKWKRIVKRIKKFLRKL,108,2,2850,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
IGKKFKRIVKRIKKWLRKL,108,2,2851,Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37,Escherichiacoli,635
KKKKKFLLLQ,109,33,2899,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1386
KKKKLFKLLQ,109,33,2900,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1387
KKKLKFKLLQ,109,33,2901,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1388
KKLKKFKLLQ,109,33,2902,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1389
KLKKKFKLLQ,109,33,2903,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1390
LKKKKFKLLQ,109,33,2905,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1391
KKKKLFLKLQ,109,33,2906,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1392
KKKLKFLKLQ,109,33,2907,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1393
KKLKKFLKLQ,109,33,2908,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1394
KLKKKFLKLQ,109,33,2909,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1395
LKKKKFLKLQ,109,33,2910,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1396
KKKLLFKKLQ,109,33,2911,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1397
KKLKLFKKLQ,109,33,2912,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1398
KLKKLFKKLQ,109,33,2913,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1399
LKKKLFKKLQ,109,33,2914,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1400
KKKKLFLLKQ,109,33,2915,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1401
KKKLKFLLKQ,109,33,2916,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1402
KKLKKFLLKQ,109,33,2917,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1403
KLKKKFLLKQ,109,33,2931,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1404
LKKKKFLLKQ,109,33,2932,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,1405
KKKLLFKLKQ,109,33,2933,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,922
KKLKLFKLKQ,109,33,2934,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,923
KLKKLFKLKQ,109,33,2977,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,924
LKKKLFKLKQ,109,33,2978,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,925
KKLLKFKLKQ,109,33,2987,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,926
LKKLKFKLKQ,109,33,2988,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,927
KLLKKFKLKQ,109,33,3010,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,928
LKLKKFKLKQ,109,33,3011,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,929
RPVYIPQPRPPHPRL,110,2,3012,Functional and structural characterization of apidaecin,Escherichiacoli,2542
YIPQPRPPHPRL,110,2,3013,Functional and structural characterization of apidaecin,Escherichiacoli,2542
PQPRPPHPRL,110,2,3014,Functional and structural characterization of apidaecin,Escherichiacoli,2540
QPRPPHPRL,110,2,3015,Functional and structural characterization of apidaecin,Escherichiacoli,2541
LLKKKFKLKQ,109,33,3016,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,930
KKKLLFLKKQ,109,33,3017,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,931
KKLKLFLKKQ,109,33,3018,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,932
KLKKLFLKKQ,109,33,3019,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,933
LKKKLFLKKQ,109,33,3020,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,934
KKLLKFLKKQ,109,33,3021,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,935
KLKLKFLKKQ,109,33,3022,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,936
LKKLKFLKKQ,109,33,3023,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,937
KLLKKFLKKQ,109,33,3024,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,938
RREAEPEAEPGNNRPVYIPQPRPPHPRL,110,2,3026,Functional and structural characterization of apidaecin,Escherichiacoli,2542
PRPPHPPRPPHPRL,110,2,3027,Functional and structural characterization of apidaecin,Escherichiacoli,2543
PRPPHPPRPPHPPRPPHPRL,110,2,3028,Functional and structural characterization of apidaecin,Escherichiacoli,2544
PRPPHPPRPPHPPRPPHPPRPPHPRL,110,2,3029,Functional and structural characterization of apidaecin,Escherichiacoli,2544
LKLKKFLKKQ,109,33,3031,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,939
LLKKKFLKKQ,109,33,3032,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,940
KKLLLFKKKQ,109,33,3033,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,941
KLKLLFKKKQ,109,33,3034,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,942
LKKLLFKKKQ,109,33,3036,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,943
KLLKLFKKKQ,109,33,3037,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,944
LKLKLFKKKQ,109,33,3038,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,945
LLKKLFKKKQ,109,33,3039,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,946
KLLLKFKKKQ,109,33,3040,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,947
LKLLKFKKKQ,109,33,3041,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,948
LLKLKFKKKQ,109,33,3042,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,949
LLLKKFKKKQ,109,33,3043,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,950
KKLLKFKKLQ,109,33,3044,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,951
KLKLKFKKLQ,109,33,3045,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,952
LKKLKFKKLQ,109,33,3046,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,953
KLLKKFKKLQ,109,33,3047,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,954
LKLKKFKKLQ,109,33,3048,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,955
LLKKKFKKLQ,109,33,3049,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,956
KLLLKFKKLQ,109,33,3057,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,957
KKKLKFKKLQ,109,33,3058,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,958
LLLKKFKKLQ,109,33,3059,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,959
LKKKKFKKLQ,109,33,3060,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,960
LKLLKFKKLQ,109,33,3061,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,961
KKLKKFKKLQ,109,33,3062,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,962
LLKLKFKKLQ,109,33,3063,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,963
KLKKKFKKLQ,109,33,3064,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,964
LLLLKFKKLQ,109,33,3066,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,965
KKKKKFKKLQ,109,33,3067,Improvement of cyclic decapeptides against plant pathogenic bacteria using a combinatorial chemistry approach,Pseudomonassyringae,966
GEKLKKIGQKIKNFFQKL,111,2,3073,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli,1571
GKKLKKIGQKIKNFFQKL,111,2,3074,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli,1571
GEKLKKIGKKIKNFFQKL,111,2,3075,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli,875
GEKLKKIGQKIKKFFQKL,111,2,3076,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli,1571
GEKLKKIGQKIKNFFKKL,111,2,3077,"CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity",Escherichiacoli,1571
VRRFGWWWGFLRR,112,2,3078,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli,2256
VRRFAWWWAFLRR,112,2,3079,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli,2256
VRRFPFFFPFLRR,112,2,3080,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli,2256
VRRFPAAAPFLRR,112,2,3081,"Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide",Escherichiacoli,2545
GILDTLKQFAKGVGKDLVKGAAQGVLSTVS,113,18,3082,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQGVLSTV,113,18,3083,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQGVLST,113,18,3084,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQGVLS,113,18,3085,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQGVL,113,18,3086,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQGV,113,18,3087,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQG,113,18,3088,Solution structure and membrane interaction mode of an antimicrobial peptide gaegurin 4,Micrococcusluteus,2192
YGRKKRRQRRRD,114,37,3089,Biological activity of Tat (47-58) peptide on human pathogenic fungi,Saccharomycescerevisiae,2148
GEILCNLCTGLINTLENLLTTK,47,18,3090,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus,1548
DKVKDYISSLCNKAS,47,18,3091,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus,967
ANAICAKIHAC,47,18,3092,"Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.",Micrococcusluteus,968
RQKDKRPYSERKNQYTGPQFLYPPERIPP,116,8,3165,"Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm: purification, cDNA cloning and molecular characterization.",Bacillussubtilis,801
NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGRPCCRTRYD,117,2,3168,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli,2546
NNEAQCEQAGGRCSKDHCFHLHTRAFGHCQRGVPCCRRVYD,117,2,3169,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli,2546
NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGDPCCRTDYD,117,2,3170,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli,2546
NNEAQCEQAGGDCSKDHCFHLHTRAFGHCQRGVPCCRDVYD,117,2,3171,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli,2546
KIWWWWRKR,118,3,3203,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,969
RWRRWKWWL,118,3,3204,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,970
WRWWKIWKR,118,3,3205,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,971
WKRWWKKWR,118,3,3206,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,972
WKKWWKRRW,118,3,3207,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,973
LRWWWIKRI,118,3,3209,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,974
RKRLKWWIY,118,3,3210,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,975
KKRWVWIRY,119,3,3211,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning ,Pseudomonasaeruginosa,976
KWKIFRRWW,118,3,3212,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,977
RKWIWRWFL,118,3,3213,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,978
IWWKWRRWV,118,3,3214,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,979
RRFKFIRWW,118,3,3215,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,980
AVWKFVKRV,118,3,3216,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,981
AWRFKNIRK,118,3,3217,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,982
KRIMKLKMR,118,3,3218,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,983
AIRRWRIRK,118,3,3219,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,984
VVLKIVRRF,118,3,3220,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,985
RLARIVVIRVAR,118,3,3221,Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning,Pseudomonasaeruginosa,986
FFHLHFHY,120,4,3229,"Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes.",Staphylococcusaureus,987
LLGDFFRKSKEK,121,2,3390,Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.,Escherichiacoli,635
IGKEFKRIVQRIKDFLRNLVPRTES,121,2,3391,Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.,Escherichiacoli,635
GKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,122,1,3502,None_article0,None_target,988
KPWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,123,1,3505,None_article1,None_target,988
KKGGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,124,1,3508,None_article2,None_target,988
KKWKWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,125,1,3511,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
KKWGWLPWVDPAYEFIKGFGKGAIKEGNKDKWKNI,125,1,3514,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
KKWGWLAWVQPAYEFIKGFGKGAIKEGNKDKWKNI,125,1,3517,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
KPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3520,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
GKGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3521,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
GPGGWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3522,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
GPGKWLAWLQPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3523,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
GPGKWLPWLDPAYDFVTGLAKGIGKEGNKNKWKNV,125,1,3524,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,988
EGTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKKH,126,1,3541,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGNGIGRVAYWVGKAMGNMSDVNQASRINRKKKH,126,1,3542,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGQGIGPVAYWVGKAMGNMSDVNQASRINRKKKH,126,1,3543,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
SVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH,126,1,3569,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
SVFSKIGQAVGPAAYWILKGLGNMSDVNQADRINRKKH,126,1,3570,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
SVFSKIGNAVGRAAYWILKGLGNMSDVNQADRINRKKH,126,1,3571,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNV,126,1,3589,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKNKWKNV,126,1,3592,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKWGWLAWVDPAYEFIKGFGKGIGKEGNKNKWKNV,126,1,3595,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKKKPLFGLFFGLF,127,38,3598,KKKKPLFGLFFGLF: a cationic peptide designed to exert antibacterial activity.,Bacillusmegateriurm,990
KKWGWLAWVDPAYEFIKGLAKGIGKEGNKNKWKNV,126,1,3600,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKWGWLAWVDPAYEFVTGLAKGIGKEGNKNKWKNV,126,1,3603,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKWGWLAWVDPAYDFVTGLAKGIGKEGNKNKWKNV,126,1,3606,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKWGWLAWLQPAYDFVTGLAKGIGKEGNKNKWKNV,126,1,3609,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
KKWGWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,126,1,3612,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,988
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKH,126,1,3620,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQADRINRKKKH,126,1,3623,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGQGIGRVAYWVGKGLGNMSDVNQASRINRKKKH,125,1,3626,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis,None_target,989
GTWDDIGQGIGRVAYWVGKGLGNMSDVNQADRINRKKKH,126,1,3629,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGQGIGRVAYWILKGLGNMSDVNQADRINRKKKH,126,1,3632,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGQGIGPAAYWILKGLGNMSDVNQADRINRKKKH,126,1,3635,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GTWDDIGNAVGPAAYWILKGLGNMSDVNQADRINRKKKH,126,1,3638,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKKH,126,1,3641,Analysis of the two-peptide bacteriocins lactococcin G and enterocin 1071 by site-directed mutagenesis.,None_target,989
GLFSKFAGKGIKNFLNKGVKHIGKE,128,2,3697,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
QVFTLIKGATQLIRKTLGEQ,128,2,3710,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
KVQNQHGQVVKIFHH,129,39,3756,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri,764
VQNQHGQVVKIFHH,129,39,3757,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri,764
NQHGQVVKIFHH,129,39,3758,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri,764
GICRCICGRGICRCICGR,130,3,3807,Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.,Pseudomonasaeruginosa,97
GICRCICGRRICRCICGR,131,40,3809,Activity of alpha- and theta-defensins against primary isolates of HIV-1.,HIV-1A,97
GVCRCVCRRGVCRCVCRR,132,2,3857,"The cyclic cystine ladder in ?-defensins is important for structure and stability, but not antibacterial activity.",Escherichiacoli,97
GRDYRTSLTIVQKLKKMVDKPTQRSVSNAATRVSR,133,41,3860,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis,98
TGRSRWRDVSRNFMRRYQSRVIQGLVAGETAQQIS,133,41,3861,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis,99
GRDYRTSLTIVQKLKKMVDK,133,41,3862,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis,98
TRVSRTGRSRWRDVSRNFMR,133,41,3863,"Granulysin, a T cell product, kills bacteria by altering membrane permeability.",Mycobacteriumtuberculosis,1162
QRSVSNAATRVCRTGRSRWRDVCRNFMRR,134,42,3867,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1162
QRSVSNAATRVSRTGRSRWRDVSRNFMRR,134,42,3868,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1162
QRSVSNAATRVCRT,134,42,3869,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1162
RDVCRNFMRR,134,42,3870,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1163
RDVCRNFMRRYQSRVIQGLV,134,42,3871,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,99
QRSVSNAATRVCRTGRSRW,134,42,3872,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1162
GRSRWRDVCRNFMRR,134,42,3873,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1162
GQSQWRDVCRNFMRR,134,42,3874,Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin.,Salmonellatyphimurium,1162
RCVCRRGVCRCVCTRGFC,135,2,3891,De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,Escherichiacoli,97
ALYKKFKKKLLKSLKRLG,136,2,3901,Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.,Escherichiacoli,1164
ALYKRLFKKLKKF,136,2,3902,Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.,Escherichiacoli,1165
PLYKKIIKKLLES,137,2,3903,Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.,Escherichiacoli,1166
ALYKKIIKKLLESAKKLG,137,2,3904,Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.,Escherichiacoli,1167
ALYKKLLKKLLKSAKKLG,137,2,3905,Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.,Escherichiacoli,1168
LYKKIIKKLLES,138,43,3907,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum,100
LYAKIIKKLLES,138,43,3908,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum,101
LYAAIIKKLLES,138,43,3909,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum,102
LYAAIIAKLLES,138,43,3910,Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.,Plasmodiumfalciparum,103
FLGVVFKLASKVFPAVFGKV,139,2,3949,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLKVVFKLASKVFPAVFGKV,139,2,3950,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKLASKVFPAVFGKV,139,2,3951,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKKASKVFPAVFGKV,139,2,3952,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVFKAVFGKV,139,2,3953,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVFPAVFKKV,139,2,3954,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLKKVFKLASKVFPAVFGKV,139,2,3955,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKKASKVFPAVFGKV,139,2,3956,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKLASKVFKAVFGKV,139,2,3957,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKLASKVFPKVFGKV,139,2,3958,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKLASKVFPAVFKKV,139,2,3959,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLKVVFKKASKVFPAVFGKV,139,2,3960,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKKASKVFKAVFGKV,139,2,3961,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKKASKVFPKVFGKV,139,2,3962,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKKASKVFPAVFKKV,139,2,3963,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGGVFKLASKVFPAVFGKV,139,2,3964,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGSVFKLASKVFPAVFGKV,139,2,3965,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
FLGVVFKGASKVFPAVFGKV,139,2,3966,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKSASKVFPAVFGKV,139,2,3967,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGGVFKGASKVFPAVFGKV,139,2,3968,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGSVFKSASKVFPAVFGKV,139,2,3969,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
FLGVVVKLASKVFPAVFGKV,139,2,3970,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLVSKVFPAVFGKV,139,2,3971,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLAVKVFPAVFGKV,139,2,3972,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVVPAVFGKV,139,2,3973,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVFPAVVGKV,139,2,3974,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVVKGASKVFPAVFGKV,139,2,3975,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKGVSKVFPAVFGKV,139,2,3976,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKGAVKVFPAVFGKV,139,2,3977,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKGASKVVPAVFGKV,139,2,3978,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKGASKVFPAVVGKV,139,2,3979,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVVKKASKVFPAVFGKV,139,2,3980,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKKVSKVFPAVFGKV,139,2,3981,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKKAVKVFPAVFGKV,139,2,3982,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKKASKVVPAVFGKV,139,2,3983,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKKASKVFPAVVGKV,139,2,3984,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVFGAVFGKV,139,2,3986,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLKVVFKLASKVFGAVFGKV,139,2,3987,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKLASKVFGAVFGKV,139,2,3988,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKKASKVFGAVFGKV,139,2,3989,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVFGKVFGKV,139,2,3990,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGVVFKLASKVFGAVFKKV,139,2,3991,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGKVFKGASKVFGAVFGKV,139,2,3992,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
FLGGVFKKASKVFGAVFGKV,139,2,3993,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
GVSVAGAKKVKVLFVFPFLF,139,2,3994,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1170
FLFRVASKVFPALIGKFKKK,139,2,3995,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1171
RKVAPALIKSFVFLFKFKKG,139,2,3996,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1172
LGALFRVASKVFPAVISMVK,139,2,3997,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1173
SVPSVGAVLFFKRAAVMKLI,139,2,3998,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1174
LPVLFKLASKVFPAVFSSLK,139,2,3999,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1173
VSVKKVLPFAPLKSLLSFAF,139,2,4000,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1175
FLFGLASKVFPAVYCKVTRK,139,2,4001,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1176
FLPVLVKVFRYSKKTAAGCF,139,2,4002,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1177
SFVFKLASKVVPSVFSALTR,139,2,4003,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1173
ASPTVFRSSVFLSLFVVAKK,139,2,4004,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1178
LPVVFRVASKVFPALISKLT,139,2,4005,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1173
KVFIATLVVSSFLLAKPPRV,139,2,4006,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1179
THIHMNARLLIRSPFTDPQL,139,2,4007,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1180
RKRKSDVDFEAEFELFEDDD,139,2,4008,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1181
AATGTGKTAAFALPVLERLI,139,2,4009,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1182
PYSLKNGENWLLSEEIIRYP,139,2,4010,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1183
KFDPLEGAPMARGIVLEKVG,139,2,4011,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1184
HTGRSGPATGHSGHSSTHGS,139,2,4012,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1185
ALFSLASKVVPSVFSMVTKK,139,2,4013,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
MVVFSVPKFKSTVAKLLSSA,139,2,4014,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1186
VVFRVASKVFPAVYCTVSKK,139,2,4015,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
TAKVVVFVSFSYVVPKKRAC,139,2,4016,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1187
LSAVGKIASKVVPSVIGAFK,139,2,4017,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1188
GVSSPIVAVKFKGAVASLIK,139,2,4018,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1189
PVIGKLASKVVPSVFSMIKR,139,2,4019,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1190
SRVPLKSPVKIVGSKVMIFA,139,2,4020,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1191
GLMSLVKDIAKLAAKQGAKQ,139,2,4021,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1192
GLKKDALQSIVKKAQLAAMG,139,2,4022,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1193
SALGRVASKVFPAVYCSITK,139,2,4023,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
LYSPTCVKAAVSRFIGKVSA,139,2,4024,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1194
GFIGKLASKVVPSVYCKVTG,139,2,4025,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1101
ALGKLASKVFPAVYCTISRK,139,2,4026,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
KYGPALVIAVKKSCSLTFRA,139,2,4027,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1102
PVVFSVASKVVPSLISALKR,139,2,4028,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1103
KSPFVLVVSSRVAAVIKSLP,139,2,4029,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1104
PAVFKIASKVVPSVYCKVSR,139,2,4030,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
KVYVVKIAVPCFPKSARSVS,139,2,4031,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1105
GALFGLASKVFPAVFGAFKK,139,2,4032,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
SAVGKLASKVFPAVFSMVTK,139,2,4033,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1190
FMKVLAVFGSVVTSAPKASK,139,2,4034,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1106
VKDLAKFIAKTVAKQGGCYL,139,2,4035,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1107
ALVYAGIKKTAFLKVQKCDG,139,2,4036,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1108
GVVGKLASKVVPSVFGSFTK,139,2,4037,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1101
SVKPVGSSVVKGTALVKFFG,139,2,4038,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1109
SAVGSVASKVVPSLISKVTK,139,2,4039,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1110
STVKVASKLAVVVSPISKGS,139,2,4040,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1111
MKSIAKFIAKTVAKQGAKQG,139,2,4041,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1112
AKKAQKSGAQTIVKIFAKGM,139,2,4042,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1113
LPAVFKLASKVVPSVFGLVK,139,2,4043,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
VVAKKFFVLVKGLAPVLSPS,139,2,4044,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1114
SVIGKIASKVVPSVYCAISK,139,2,4045,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
IASAVPVCVKGKISKSYISV,139,2,4046,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1115
PVVGRVASKVFPAVIGLVKK,139,2,4047,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
VKRAGKGVAVVPSPLFKIVV,139,2,4048,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1116
LSFVGRVASKVVPSLISMIK,139,2,4049,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1188
SSSIPIKMVLVRALVFVKSG,139,2,4050,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1117
SALGRLASKVVPAVIGKVTT,139,2,4051,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1101
TLVGVVAKLVATKIGSSPRA,139,2,4052,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1118
LGVVGSLASKVVPAVISKVK,139,2,4053,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1103
PKVVGLSIVVVKAKVSSALG,139,2,4054,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1119
LPAVFKLASKVFPAVYCKAS,139,2,4055,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,462
PSLLYKAKAVFCKPSAVAVF,139,2,4056,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1120
VVGRVASKVVPSLIGLFTTK,139,2,4057,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1121
FKVVISKPGLSVRVGTALVT,139,2,4058,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1122
SVVFGVASKVVPSVIGKVKT,139,2,4059,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1123
VFSVKGGKPSVVIKVVVAST,139,2,4060,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1124
FLPFVGRIASKVVPSVIGKV,139,2,4061,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
GKKLAKTIAKEVAKQGAKFA,139,2,4062,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,201
SKFPLAGIFSVPGVKRVVVI,139,2,4063,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1125
VIAFAKTKEAKAKLKGQAKG,139,2,4064,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1126
FVGSLASKVVPSVFGAIKTK,139,2,4065,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1101
KTVPVVLKASIKVSSAGFGF,139,2,4066,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1127
LPVVFKIASKVVPSVISKIT,139,2,4067,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1169
KIVKVITVKSISPASLVPVF,139,2,4068,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1128
GAVFGVASKVVPSVFSAIKK,139,2,4069,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1123
SVKVAKSVIPSAVFAGGKVF,139,2,4070,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1129
FVGGVASKVVPSVYCKVSKK,139,2,4071,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,2236
KVGKGSYPCSFVKVVAKVSV,139,2,4072,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1130
VVFKLASKVVPSVYCTITKK,139,2,4073,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1296
VKTKCSVPAVVYILVKTFKS,139,2,4074,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1131
GALFSLASKVVPAVIGLIKK,139,2,4075,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1132
LPVLFSSAIAKVGIKLGAKV,139,2,4076,A linguistic model for the rational design of antimicrobial peptides.,Escherichiacoli,1133
KSKEKIGKEFKRIVQRIKDFLRNLVPRTES,141,4,4105,Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense.,Staphylococcusaureus,635
CLRIGMRGRELMGGIGKTM,142,4,4106,Antibacterial potential of hGlyrichin encoded by a human gene.,Staphylococcusaureus,104
VRLEFKLQQTSCRKRDWKKP,143,2,4114,Chemerin is an antimicrobial agent in human epidermis.,Escherichiacoli,1134
QGSPARCRFCCRCCPRMRGCGICCRF,144,44,4124,Cloning and expression of a hepcidin gene from a marine fish (Pseudosciaena crocea) and the antimicrobial activity of its synthetic peptide.,Aeromonashydrophila,105
QRFSQPTFKLPQGRLTLSRKFR,145,2,4125,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1135
QRFSQPTFKLPQGRLTLSRKF,145,2,4126,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1135
ESGNEPLWLYQGDNIPKAPSTAEHPFLPSIIDDVKFNPDRRYAR,145,2,4127,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1136
ESGNEPLWLYQGDNIPKAPSTAEHPFLPSIIDDVKFNPDRRYA,145,2,4128,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1136
SLGTPDHYHGGRHSISRGSQSTGPTHPGYNRRNAR,145,2,4129,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1137
SLGTPDHYHGGRHSISRGSQSTGPTHPGYNRRNA,145,2,4130,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1137
SVETLASQEHLSSLPMDSQETLLRGTR,145,2,4131,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1138
SVETLASQEHLSSLPMDSQETLLRGT,145,2,4132,Functional analysis of four processing products from multiple precursors encoded by a lebocin-related gene from Manduca sexta.,Escherichiacoli,1138
KRKSPKTPFDNTPGAWFAHLILGC,146,45,4144,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Lactobacillusrhamnosus,106
KRKSPKTPFDNTPGAWFAHLILGS,146,45,4145,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Lactobacillusrhamnosus,106
RRGFWKRLRRRLRRFGDRIRNRFRNFREKLPDPFPG,147,2,4176,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli,1139
GAARKSIRLHRLYTWKATIYTR,148,2,4180,Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,Escherichiacoli,1140
GSCSCSGTISPYGLRTCRATKTKPSHPTTKETHPQTLPT,148,2,4181,Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,Escherichiacoli,1141
GKWGWIYITILFADVGGFKSSRHPEERRVQERRFKRITRGPD,148,2,4182,Novel antimicrobial peptides identified from an endoparasitic wasp cDNA library.,Escherichiacoli,1142
IKKVASVIGGL,150,2,4249,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1143
KVASVIGGL,150,2,4250,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1144
GLFDVIKKVASVIGG,150,2,4251,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFDVIKKVASVIG,150,2,4252,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFDVIKKVASVI,150,2,4253,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFDVIKKVASV,150,2,4254,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFDVIKKVAS,150,2,4255,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFDVIKKV,150,2,4256,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1145
DVIKKVASVIG,150,2,4258,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1146
GLFDVIKASVIGGL,150,2,4260,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1147
GLFDVVIGGL,150,2,4261,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1148
GLFAVIKKVASVIGG,150,2,4262,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFAVIKKVASVIG,150,2,4263,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFAVIKKVASVI,150,2,4264,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2459
GLFAVIKKVASV,150,2,4265,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,1149
FLSLIPKLVKKIIKAFK,152,4,4299,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus,107
FLGMIPKLIKKLIKAFK,152,4,4300,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus,107
RRQRRTSKLMKRGGKLAKLAKKLAKLAK,153,46,4305,A proapoptotic peptide for the treatment of solid tumors.,Murinefibrosarcoma,1150
GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVEYHK,154,2,4310,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
KTSPDVEYHK,154,2,4312,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1152
GLWNSIKIAGKKLFVNVLDKIRCKVAGGC,154,2,4313,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
GLWDSIKIAGKKLFVNVLDKIRCKVAGGC,154,2,4314,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
GLWNSIKIAGKNLFVNVLDKIRCKVAGGC,154,2,4315,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
GLWNSIKIAGKKLFVNVLDKIRSKVAGGS,154,2,4316,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
GKKLFVNVLDKIRCKVAGGC,154,2,4317,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG,155,2,4322,"In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus.",Escherichiacoli,1153
MPKRKAEGDAKGDKAKV,156,2,4325,HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?,Escherichiacoli,1154
GEKVPKGKKGKADAGKEGNNPAENGDAKTDQAQKAEGAGDAK,156,2,4326,HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?,Escherichiacoli,1155
KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK,156,2,4327,HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes?,Escherichiacoli,1156
AWNTYDYMKREHSLVKPYQG,157,8,4334,"Macrobrachium rosenbergii mannose binding lectin: Synthesis of MrMBL-N20 and MrMBL-C16 peptides and their antimicrobial characterization, bioinformatics and relative gene expression analysis.",Bacillussubtilis,108
GPVSAVLTELRCTCLRVTLRVNPKTIGKLQVFPAGPQCSKVEVVASLKNG,158,47,4341,The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.,Streptococcuspyogenes,1157
APFLKKVIQKILDSGNKKN,158,47,4342,The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial.,Streptococcuspyogenes,1158
HRKKHHGKRNSNRAHQGKHETYGHKTPY,159,3,4345,CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity.,Pseudomonasaeruginosa,109
GFSSIFRGVAKFASKGLGKKLAKLGVKLVACKISKQC,160,4,4386,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
GFSSIFRGVAKFASKGLGKDLAKLGVDLVASKISKQS,160,4,4387,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
GFSSIFRGVAKFASKGLGKDLAKLGVDLVA,160,4,4388,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
RGVAKFASKGLGKDLAKLGVDLVACKISKQC,160,4,4389,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
KFASKGLGKDLAKLGVDLVACKISKQC,160,4,4390,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
KGLGKDLAKLGVDLVACKISKQC,160,4,4391,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
GLGKDLAKLGVDLVACKISKQC,160,4,4392,"Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells.",Staphylococcusaureus,110
FLPILASLAAKFGPKLFSLVTKKS,161,4,4418,"Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa.",Staphylococcusaureus,111
GLPRKILAAIAKKKGKAKGPLKLVAKA,162,8,4441,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis,112
GLPRKILCAIAKKKGKCKGPLKLVCKC,162,8,4442,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis,112
GLPRKILCAIAKKKGKAKGPLKLVCKA,162,8,4446,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis,112
GLPRKILAAIAKKKGKCKGPLKLVAKC,162,8,4447,"Lasiocepsin, a novel cyclic antimicrobial peptide from the venom of eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).",Bacillussubtilis,112
AWLDKLKSLGKVVG,163,2,4470,Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,Escherichiacoli,2085
KVALGVAQNYLNPQQ,163,2,4471,Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,Escherichiacoli,2085
HNKQEGRDHDKSKGHFHRVVIHHKGGKAH,164,2,4479,Identification of novel semenogelin I-derived antimicrobial peptide from liquefied human seminal plasma.,Escherichiacoli,1159
KKFFLKVLTKIRCKVAGGCRT,165,2,4498,Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.,Escherichiacoli,1151
FLGALFHALSKLL,166,31,4524,Constructing bioactive peptides with pH-dependent activities.,Humanlung,1160
FLGALFKALSHLL,166,31,4525,Constructing bioactive peptides with pH-dependent activities.,Humanlung,1161
FLGALFHALSHLL,166,31,4526,Constructing bioactive peptides with pH-dependent activities.,Humanlung,1796
PAWRKAFRWAWRMLKKAA,166,31,4527,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2675
PAWHHAFHWAWRMLKKAA,166,31,4528,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2675
PAWRKAFRWAWHMLHHAA,166,31,4529,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2675
PAWRHAFHWAWHMLHKAA,166,31,4530,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2675
GLFAVIKKVASVIGGL,166,31,4531,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2459
GLFAVIHKVASVIGGL,166,31,4532,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2459
GLFAVIKHVASVIGGL,166,31,4533,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2459
GLFAVIHHVASVIGGL,166,31,4534,Constructing bioactive peptides with pH-dependent activities.,Humanlung,2459
GFGCNGPWNEDDLRCHNHCKSIKGYKGGYCAKGGFVCKCY,167,4,4535,"High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus.",Staphylococcusaureus,1467
KTLTGKTITLE,168,48,4546,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,113
CRRLCYKQRCVTYC,169,2,4547,Synthesis and properties of cyclic gomesin and analogues.,Escherichiacoli,2676
QCRRLCYKQRCVTYCRGR,169,2,4548,Synthesis and properties of cyclic gomesin and analogues.,Escherichiacoli,2676
MAFKKLEKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK,170,4,4571,"cDNA cloning and characterization of the antibacterial peptide cecropin 1 from the diamondback moth, Plutella xylostella L.",Staphylococcusaureus,2096
FKCRRWQWRWKKLGAKPVPIIYCNRRTGKCQRM,171,4,4586,"Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33.",Staphylococcusaureus,114
AAAAGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCET,172,28,4596,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCET,172,28,4597,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCET,172,28,4598,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCRT,172,28,4599,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCRT,172,28,4600,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCET,172,28,4601,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCET,172,28,4602,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCRT,172,28,4603,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCRT,172,28,4604,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCET,172,28,4605,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCAAECKRRGYKGGHCGSFANVNCWCRT,172,28,4606,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCNGECLLRGYKGGHCGSFANVNCWCRT,172,28,4607,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCET,172,28,4608,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
DKLIGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCRT,172,28,4609,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
AAAAGSCVWGAVNYTSDCAAECLLRGYKGGHCGSFANVNCWCRT,172,28,4610,Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities.,Neurosporacrassa,115
SWLRDIWDWICEVLSDFK,173,49,4631,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDLWDWICEVLSDFK,173,49,4632,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWLCEVLSDFK,173,49,4633,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWICELLSDFK,173,49,4634,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDLWDWLCEVLSDFK,173,49,4635,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDLWDWICELLSDFK,173,49,4636,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWLCELLSDFK,173,49,4637,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDLWDWLCELLSDFK,173,49,4638,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWVCEVLSDFK,173,49,4639,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWACEVLSDFK,173,49,4640,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWGCEVLSDFK,173,49,4641,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWSCEVLSDFK,173,49,4642,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWECEVLSDFK,173,49,4643,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
SWLRDIWDWKCEVLSDFK,173,49,4644,Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.,HepatitisC,1325
ELLKAVRLIK,174,4,4645,Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells.,Staphylococcusaureus,116
RLRKAVRLIK,174,50,4646,Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells.,Enterococcusfaecium,2677
ELSKAVRLIK,174,50,4647,Effects of positively charged arginine residues on membrane pore forming activity of Rev-NIS peptide in bacterial cells.,Enterococcusfaecium,2678
RAGLQWPIGRLLRRLLRRLLR,175,2,4648,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli,1544
RVVRQWPIGRVVRRVVRRVVR,175,2,4649,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli,1647
KLLKQWPIGKLLKKLLKKLLK,175,2,4650,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli,1544
KVVKQWPIGKVVKKVVKKVVK,175,2,4651,Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb,Escherichiacoli,1647
RRLMAAKAESRK,176,51,4653,"Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice.",Porphyromonasgingivalis,117
RLMAAKAESRK,177,51,4655,"Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice",Porphyromonasgingivalis,118
RRLMAAKAESR,176,51,4657,"Antimicrobial activity and mechanism of action of a novel cationic ?-helical dodecapeptide, a partial sequence of cyanate lyase from rice.",Porphyromonasgingivalis,119
GRRRRSVQWCA,178,4,4663,Discovery and development of a synthetic peptide derived from lactoferrin for clinical use,Staphylococcusaureus,2324
RRSVQWCA,178,4,4665,Discovery and development of a synthetic peptide derived from lactoferrin for clinical use,Staphylococcusaureus,120
APRKNVRW,179,2,4672,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2679
APRKNVRF,179,2,4673,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2680
APRKNVKW,179,2,4674,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2679
VCYCRRRFCVCVGR,180,2,4676,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2437
ECYCRRRFCVCVGR,180,2,4677,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2437
RGGRLCYCRRRFCVCT,180,2,4678,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2437
RGGRLCYCRRRFCVCI,180,2,4680,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2437
RGGRLCYCRRRFCVCE,180,2,4681,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2437
LCYCRRRFCVC,180,2,4682,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2437
CYCRRRFCVC,180,2,4683,Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions,Escherichiacoli,2681
FKCRRWQWRMKKLGAPSITCVRRAF,181,2,4698,Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.,Escherichiacoli,114
FKCRRWQWRMKKLGA,181,2,4699,Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.,Escherichiacoli,114
RRWQWRMKK,181,2,4700,Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.,Escherichiacoli,2682
APRKNLKW,179,2,4701,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2683
APRKQLKW,179,2,4702,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2684
APRRQLKW,179,2,4704,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2684
APKKQLKW,179,2,4706,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2684
AFRKQLKW,179,2,4708,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2685
LFRKQLKW,179,2,4709,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida",Escherichiacoli,2686
FWGALAKGALKLIVSLFSSFSKKD,182,4,4728,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus,121
FWGALAKGALKLIGVSLFSSFSKKD,182,4,4729,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus,121
FWGALAKGALKLIVGSLFSSFSKKD,182,4,4730,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus,121
FWGALAKGALKLIGVGSLFSSFSKKD,182,4,4731,Amino acid substitutions in an alpha-helical antimicrobial arachnid peptide affect its chemical properties and biological activity towards pathogenic bacteria but improves its therapeutic index.,Staphylococcusaureus,121
RCYCRRRFCVCVGR,26,2,4762,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
RGGRLCYCRRRFCVCR,26,2,4770,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
RCYCRRRFCVCR,26,2,4780,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
RCYARRRFAVCR,26,2,4782,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
RAYCRRRFCVAR,26,2,4785,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
LCYTRPRFTVCV,26,2,4787,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2687
YQWQRRMRKLGAPSIT,183,2,4849,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli,2029
YQWQRRMKLGAPSIT,183,2,4850,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli,2688
WQRRMRKLGAPSIT,183,2,4851,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli,2029
WQRRMKLGAPSIT,183,2,4852,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli,2688
YQWQRRMRLGAPSIT,183,2,4853,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli,2688
YQWQRMRKLGAPSIT,183,2,4854,Antimicrobial peptide of korean native goat lactoferrin and identification of the part essential for this activity.,Escherichiacoli,2029
WFRKQLKW,184,2,4855,"A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: design, synthesis, activity against multidrug-resistant bacteria and Candida.",Escherichiacoli,2689
FRRWWKWFK,185,3,4864,Identification of novel antibacterial peptides by chemoinformatics and machine learning.,Pseudomonasaeruginosa,122
FFHHIFRAIVHVGKTIHRLVTG,186,2,4868,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFHHIFRGIVHVAKTIHRLVTG,186,2,4869,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
KNLRRIIRKGIHIIKKYF,188,2,4872,"Membrane interactions of novicidin, a novel antimicrobial peptide: phosphatidylglycerol promotes bilayer insertion.",Escherichiacoli,1660
FFHHIFRAIVHVAKTIHRLVTG,186,2,4873,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFHHIFRPIVHVGKTIHRLVTG,186,2,4874,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFHHIFRGIVHVPKTIHRLVTG,186,2,4875,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFHHIFRPIVHVPKTIHRLVTG,186,2,4882,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFHHIFRAIVHVPKTIHRLVTG,186,2,4884,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFHHIFRPIVHVAKTIHRLVTG,186,2,4887,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
AAHHIARPIVHVGKTIHRLVTG,186,2,4894,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFAAIFRPIVHVGKTIHRLVTG,186,2,4896,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
FFAAIFAPIVHVGKTIHRLVTG,186,2,4897,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
KPWRFRRAIRRVRWRKVAPYIPFVVKTVGKK,189,4,4898,Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources.,Staphylococcusaureus,123
KWCFCVCYRGICYCRCRG,190,2,4901,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli,1257
KWCFCVCYRGICRCRCRG,190,2,4902,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli,1257
KWCRCVCRRGICYCRCRG,190,2,4903,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli,1257
KWCRCVCRRGICRCRCRG,190,2,4904,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli,97
KWCRCVCRRGICRCRCRK,190,2,4905,Marked increase in membranolytic selectivity of novel cyclic tachyplesins constrained with an antiparallel two-beta strand cystine knot framework.,Escherichiacoli,97
GIINTLQKYYWRVRGGRWAVLSWLPKEEQIGKWSTRGRKWWRRKK,191,3,4938,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa,2012
GIINTLQKYYFRVRGGRFAVLSFLPKEEQIGKFSTRGRKFFRRKK,191,3,4939,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa,2012
GIINTLQKYYYRVRGGRYAVLSYLPKEEQIGKYSTRGRKYYRRKK,191,3,4940,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa,2012
GIINTLQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKAARRKK,191,3,4941,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa,2012
GIINTLQKYYSRVRGGRSAVLSSLPKEEQIGKSSTRGRKSSRRKK,191,3,4942,Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells.,Pseudomonasaeruginosa,2012
MAGNSSNFIHKIKQIFTHR,192,52,4949,Induction of bacteriocin production in Lactobacillus sake by a secreted peptide.,Enterococcusfaecalis,2691
FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRNLVPRTES,194,2,5007,PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.,Escherichiacoli,635
LFCKGGSCHFGGCPSHLIKVGSCFGFRSCCAWPWNA,195,25,5010,Initial insights into structure-activity relationships of avian defensins.,Bacilluscereus,124
FALLGDFFRKSKEKIGKEFKRIVQRIKDFFRKLVPRTES,194,2,5011,PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.,Escherichiacoli,635
FALLGDFFRKSKEKIGKEFKRIVKRIKDFFRNLVPRTES,194,2,5013,PCR-based site-specific mutagenesis of peptide antibiotics FALL-39 and its biologic activities.,Escherichiacoli,635
KWRRWVRWI,196,2,5034,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2692
KLRRWVRWI,196,2,5035,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2693
KWRRWVRWL,196,2,5036,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2694
KLRRWVRWL,196,2,5037,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2695
KWRRWIRWL,196,2,5038,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2694
KWRRWIRWW,196,2,5039,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2696
KKLFKKILKFL,196,2,5041,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2697
KKLFKKIKKFL,196,2,5042,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2698
KKLFKKALKFL,196,2,5043,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2699
KKLFKKGLKFL,196,2,5044,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2700
GKLFKKILKFL,196,2,5045,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2701
GKLFKKILKIL,196,2,5046,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2702
KKLIKKILKIL,196,2,5047,Novel short antibacterial and antifungal peptides with low cytotoxicity: Efficacy and action mechanisms.,Escherichiacoli,2703
KILRGVSKKIMRTFLRRISKDILTGKK,197,2,5048,Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens.,Escherichiacoli,2704
VSAVAKVAMKKGAALLKKMGVKISPLK,198,53,5075,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,125
KQLKKVSAVAKVAMKKGAALLKKMGVK,198,53,5076,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,125
VGKVLKQLKKVSAVAKVAMKKGAALLK,198,53,5078,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,125
KFGKIVGKVLKQLKKVSAVAKVAMKKG,198,53,5079,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,126
GKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5080,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,126
FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5081,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,126
FKIKPGKVLDKFGKIVGKVLKQLKKVS,198,53,5083,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,126
FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5084,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,126
FSISPGKVLDKFGKIVGKVLKQLKKVSAVAKV,198,53,5085,Lytic activity and structural differences of amphipathic peptides derived from trialysin.,Trypanosomacruzi,126
GRLRNLIEKAGQNIRGKIQGIGRRIKDILKNLQPRPQV,199,54,5108,The cathelicidin-like peptide derived from panda genome is a potential antimicrobial peptide.,Acinetobactercalcoaceticus,2705
ILENLLARSTNEDREGSIF,200,34,5113,Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin.,Micrococcuslysodeikticus,1087
AKKVFKRLGIGAVLKVLTTG,201,8,5124,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis,2501
AKKVFKRLGIGAVLWVLTTG,201,8,5126,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis,2501
AKKVFKRLGIGAVLKVLTWG,201,8,5127,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis,719
AKKVFKRLGIGAVLWVLTWG,201,8,5128,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis,719
AWKVFKRLGIGAVLWVLTWG,201,8,5129,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis,719
AKKVFKRLGIGAVLKVLKKG,201,8,5130,"Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12).",Bacillussubtilis,719
GFKLKGMARISCLPNGQWSNFPPKCIRECAMVSS,204,3,5159,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa,385
GFKLKGKAKISCLPNGQWSNFPPKCIRECAMVSS,204,3,5160,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa,385
HAEHKVKIGVEQKYGQFPQGTEVTYTCSGNYFLM,204,3,5162,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa,386
HAEHKVKIKVKQKYGQFPQGTEVTYTCSGNYFLM,204,3,5163,High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.,Pseudomonasaeruginosa,386
AWASFFKKAAHVGKHVGKAALTHYL,205,4,5164,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus,1560
GWGSFFKKAAHVAKHVAKAALTHYL,205,4,5165,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus,1560
AWASFFKKAAHVAKHVAKAALTHYL,205,4,5166,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus,1560
GWGSFFKKAAAVGKAVGKAALTAYL,205,4,5167,Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity.,Staphylococcusaureus,387
SADVAGAVIDGASLSFKILKTVLEALGNVKRK,206,1,5168,Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.,None_target,388
GASLSFKILKTVLEALGNVKRK,206,1,5169,Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.,None_target,388
GASLSFKILKTVLEALGNV,206,1,5170,Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.,None_target,388
GSTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS,207,55,5180,The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens.,Campylobacterjejuni,2706
KKVADKVLLLKQLRIMRL,208,2,5183,"Solution structure of termite-derived antimicrobial peptide, spinigerin, as determined in SDS micelle by NMR spectroscopy.",Escherichiacoli,444
GKIPVKAIKQAGKVIGKGLRAINIAGTTHDVVSFFRPKKKKH,209,2,5187,"Solution structure, antibacterial activity, and expression profile of Manduca sexta moricin.",Escherichiacoli,307
YGAAKKAAKAAKKAAKAA,210,2,5191,Promotion of peptide antimicrobial activity by fatty acid conjugation.,Escherichiacoli,2707
YGAKAKAAKAAKAKAAKA,210,2,5192,Promotion of peptide antimicrobial activity by fatty acid conjugation.,Escherichiacoli,2708
KLFKRHLKWKII,210,2,5193,Promotion of peptide antimicrobial activity by fatty acid conjugation.,Escherichiacoli,2709
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP,212,2,5243,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
PRPPRLPRPRPRPLPFPRPGPRPIPRPLPFP,212,2,5244,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
RRIRPRPPRLPRPRPRPLPFPRP,212,2,5245,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
PRPPRLPRPRPRPLPFPRP,212,2,5246,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
RRIRPRPPRLPRPRPRPL,212,2,5247,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
RRIRPRPPRLPRPRPR,212,2,5248,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
RRIRPRPPRLPRPRP,212,2,5249,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
RRIRPRPPRLPRP,212,2,5250,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
PRPLPFPRPGPRPI,212,2,5251,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
PRPLPFPRPGPRPIPRPLPFPRPGPRPI,212,2,5252,Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.,Escherichiacoli,2710
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,214,24,5262,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCGKYGFCGSGPQYCG,214,24,5263,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKVGFCGSGPQYCG,214,24,5264,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKNGFCGSGPQYCG,214,24,5265,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGVCGSGPQYCG,214,24,5266,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGNCGSGPQYCG,214,24,5267,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
GSKGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQVCG,214,24,5268,The chitin-binding capability of Cy-AMP1 from cycad is essential to antifungal activity.,Fusariumoxysporum,0
SIGSALKKALPVAKKIGKIALPIAKAALP,215,2,5300,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli,2713
NWKGIAAMAKKLL,216,1,5301,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
SIGSALKKALPVAKKIG,215,2,5302,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli,2713
GKIALPIAKAALPVAAGLVG,215,2,5303,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli,2713
KNWKGIAGMAKKLLGENWELM,216,1,5304,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKGIAGMAKKLLGENWKLM,216,1,5305,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKKIAGMAKKLLKKNWKLM,216,1,5307,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKGIAGMAKKLLGKNW,216,1,5308,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKGIAGMAKKLLGKNWELMEK,216,1,5309,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKGIAGMAKKLLGKNWELMKK,216,1,5310,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKGIAGMAKKLLGKNWKLMKK,216,1,5311,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,None_target,389
KNWKGIAGMAKKLLGKNWKLM,216,8,5313,Design of a novel membrane-destabilizing peptide selectively acting on acidic liposomes.,Bacillussubtilis,389
RIIDLLARVRRPQKPKFVTVWVR,217,2,5318,Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Escherichiacoli,2233
RIIDLLWRVRRPQKPKFVTVAVR,217,2,5319,Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Escherichiacoli,2233
ACPIFTKIQGTYRGKAKCK,218,2,5321,Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.,Escherichiacoli,734
ACPIFTKIQGTYRGRAKCR,218,2,5322,Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.,Escherichiacoli,734
SCLPKEEQIGKSTRGRKCRRKK,218,2,5325,Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.,Escherichiacoli,2012
GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR,219,17,5335,Biosynthesis and antimicrobial evaluation of backbone-cyclized ?-defensins.,Listeriamonocytogenes,390
GWGSFFKKAAHVAKHVGKAALTHYL,220,2,5347,Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity.,Escherichiacoli,1560
GWGSFFKKAAHVGKHVAKAALTHYL,220,2,5348,Effects of two glycine residues in positions 13 and 17 of pleurocidin on structure and bacterial cell selectivity.,Escherichiacoli,1560
FSEAIKKIIDFLGEGLFDIIKKIAESF,221,2,5350,"Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells.",Escherichiacoli,1
GLFDIIKKIAESFKFSEAIKKIIDFLG,221,2,5351,"Dimerization of aurein 1.2: effects in structure, antimicrobial activity and aggregation of Candida albicans cells.",Escherichiacoli,2
GIIKVIKSLIEQFTGK,222,56,5353,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis,1091
VGTIIKIIKAIIDIFAK,222,56,5355,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis,1092
RRRRRRPPCEDVNGQCQPRGNPCLRLRGACPRGSRCCMPTVAAH,223,2,5357,Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.,Escherichiacoli,3
RRPPCEDVNGQCQPRGNPCLRLRGACPRGSRCCMPTVAAH,223,2,5358,Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.,Escherichiacoli,3
GIRKWFKKAAHVGKEVGKVALNACL,224,57,5361,The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents.,Humanpromyelocytic,4
GLPKCGETCVGGTCNTPGCTCSWPVCTRN,225,1,5376,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGDTCVGGTCNTPGCTCSWPVCTRN,225,1,5377,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGEKCVGGTCNTPGCTCSWPVCTRN,225,1,5378,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCKGGTCNTPGCTCSWPVCTRN,225,1,5379,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCKTPGCTCSWPVCTRN,225,1,5380,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNKPGCTCSWPVCTRN,225,1,5381,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCKCSWPVCTRN,225,1,5382,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCTCSWPKCTRN,225,1,5384,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCTCSWPVCTRK,225,1,5386,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCTCSKPVCTRN,225,1,5388,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCNCSWPVCTRK,225,1,5389,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCTCSWPVCTKN,225,1,5391,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
GLPVCGETCVGGTCNTPGCTCSWPVCTRN,225,1,5392,Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.,None_target,2129
FGTGVKRKAQCDLKSK,226,2,5412,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli,5
GIGRIGKVHAANLIKIPKG,226,2,5413,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli,6
KKVIIEYVKIEA,226,2,5414,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli,7
VKEEVKFSKKW,226,2,5415,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli,8
KFKLKSLKIIEYKQ,226,2,5416,Mining antimicrobial peptides from small open reading frames in Ciona intestinalis.,Escherichiacoli,9
GIGKFLKKAKKFGKAFVKILKK,227,1,5419,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,None_target,2501
AIFIFIRWLLK,228,8,5420,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis,1098
AIFIFIRWLLKLGHHGR,228,8,5421,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis,1098
RWLLKLGHHGR,228,8,5422,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis,1098
RWLLKLGHHGRAPP,228,8,5423,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis,1098
KLGHHGRAPP,228,8,5424,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis,391
KQSHKKGGHSFPKEKIS,229,2,5438,Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.,Escherichiacoli,1153
KMDSRWRWKSSKK,229,2,5439,Unraveling the antifungal activity of a South American rattlesnake toxin crotamine.,Escherichiacoli,10
MASRAAGLAARLARLALRAL,230,25,5452,Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity.,Bacilluscereus,392
MASRAARLAARLARLALRAL,230,58,5453,Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity.,Carnobacteriummobile,392
MAARAARLAARLARLALRAL,230,58,5454,Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity.,Carnobacteriummobile,392
LGRVDIHVWDGVYI,231,1,5457,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,393
VDIHVWDGVVDIHVWDGV,231,1,5458,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,394
VDIHVWDGV,231,1,5459,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,395
VDIHVWAGV,231,1,5461,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,396
VDIHVWSGV,231,1,5462,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,396
VDIHVWEGV,231,1,5463,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,397
VEIHVWEGV,231,1,5464,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,398
CVDIHVWDGVC,231,1,5465,Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus.,None_target,399
RAGLQFPVGRLLRRLLR,232,1,5466,"A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells.",None_target,1544
GSKKPVPIIYCNRRSGKCQRM,233,2,5467,Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332.,Escherichiacoli,1905
GILKTIKSIASKVANTVQKLKRKAKNAVA,234,59,5468,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Acinetobacterbaumannii,2108
GILKTIKSIASKVANTVQKLKRKAKNAV,234,59,5469,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Acinetobacterbaumannii,2108
IKSIASKVANTVQKLKRKAKNAV,234,4,5470,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,2108
IKSIASKVANTVQKLKRKAKNAVA,234,4,5471,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,2108
IASKVANTVQKLKRKAKNAV,234,4,5472,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,2108
IASKVANTVQKLKRKAKNAVA,234,4,5473,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,2108
KVANTVQKLKRKAKNAV,234,4,5474,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,2108
KVANTVQKLKRKAKNAVA,234,4,5475,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,2108
GILKTIKSIASKLKRKAK,234,2,5476,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Escherichiacoli,11
GILNTIKSIASKLKRKAK,234,2,5477,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Escherichiacoli,11
KLKRKAKNAV,234,4,5478,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,400
KLKRKAKNAVA,234,4,5479,Enhanced antimicrobial activity of novel synthetic peptides derived from vejovine and hadrurin.,Staphylococcusaureus,401
KKLKKLKKKWKKLKKKLK,235,4,5491,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus,402
KKLKKLLKKWKKLLKKLK,235,4,5492,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus,403
KLLKKLLKLWKKLLKKLK,235,4,5493,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus,404
KLLKLLLKLWKKLLKLLK,235,4,5495,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus,405
KLLKLLLKLWLKLLKLLL,235,4,5496,Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.,Staphylococcusaureus,405
AGYLLGKINLKALAALAKKIL,236,43,5499,Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei.,Plasmodiumfalciparum,1974
KWKSFLKKLTSAAKKVLTTALKPISS,237,2,5520,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli,2502
KWKSFLKTLKSPVKTVFYTALKPISS,237,2,5521,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli,2522
KWKSFLKTFKSPVKTVFYTALKPISS,237,2,5522,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli,2522
KWKSFLKTFKSPARTVLYTALKPISS,237,2,5523,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli,2522
KWKSFLKTFKSPARTVLHTALKPISS,237,2,5524,Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.,Escherichiacoli,2522
KFFKFFKFF,238,2,5541,Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.,Escherichiacoli,12
AVVKVPLKKFKSIRE,239,8,5548,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis,2479
AVVKVPLKKFKSIRETMKEKGLLEDF,239,8,5549,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis,2479
CVYAYVRVRGVLVRYRRCW,240,50,5582,The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism.,Enterococcusfaecium,1976
RWCVYAYVRVAGVLVRYRRCW,240,50,5583,The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism.,Enterococcusfaecium,1976
KKKKGIGKFLHSAKKFGKAFVGEIMNS,241,2,5611,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,13
KKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,241,2,5612,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,13
AAAAAAAAAAGIGKFLHSAKKFGKAFVGEIMNS,241,2,5613,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,13
RRRRRRRRRRGIGKFLHSAKKFGKAFVGEIMNS,241,2,5614,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,13
KKKKKKKKKKKKKKKKKKKKGIGKFLHSAKKFGKAFVGEIMNS,241,2,5615,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,13
GIGKFLHSAKKFGKAFVGEIMNSKKKKKKKKKK,241,2,5616,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,14
KKFLHSAKKWLKAFVKLFKNW,241,2,5617,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,15
GIGKLFLHAAKKFAKAFVAEKMNS,241,2,5618,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,16
KKKKKKKKKKGIGKLFLHAAKKFAKAFVAEKMNS,241,2,5619,Augmentation of the antibacterial activity of magainin by positive-charge chain extension.,Escherichiacoli,16
SPIHARYQRGVIPGPRWPYYRVGSGSGLKSVRNRWA,242,42,5621,Expression in Pichia Pastoris and biological activity of Avian ?-defensin 6 and its mutant peptide without cysteines.,Salmonellatyphimurium,17
GFFALIPKIISSPLFKTLLSAV,243,2,5629,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli,2090
ISSPLFKTLLSAVGSALSSSGGQE,243,2,5631,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli,2090
GFFALIPKIIS,243,2,5632,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli,18
PKLLKTFLSKWIG,244,2,5639,Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities.,Escherichiacoli,21
GIWKSLFTKLLKG,244,2,5640,Biological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities.,Escherichiacoli,19
FLPLLAGLCKITRKCAANFLPKIF,245,2,5645,Structure-function studies on the amphibian peptide brevinin 1E: translocating the cationic segment from the C-terminal end to a central position favors selective antibacterial activity.,Escherichiacoli,20
CKLLKTFLSKWIC,246,2,5657,Consequences of introducing a disulfide bond into an antibacterial and hemolytic peptide.,Escherichiacoli,21
PKLLKKFLKKWIG,247,2,5661,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,21
PKLLKTFLSKWKKIG,247,2,5662,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,21
PKLLKFLSKWIG,247,2,5663,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,22
PKLLKTFLKWIG,247,2,5664,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,23
PKLKTFLSKWIG,247,2,5665,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,24
PKLLKFLKWIG,247,2,5666,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,25
PKLKFLSKWIG,247,2,5667,"Addition and omission analogs of the 13-residue antibacterial and hemolytic peptide PKLLKTFLSKWIG: structural preferences, model membrane binding and biological activities.",Escherichiacoli,26
SLFGTFAKMALKGASKLIPHLLPSRQQ,248,2,5709,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,2265
GVFGLLAKAALKGASKLIPHLLPSRQQ,248,2,5710,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,2265
GLKEVAHSAKKFAKGFISGLTGS,248,2,5713,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,27
GWLPTFGKILRKAMQLGPKLIQPI,248,2,5715,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,28
GVWSTILGGLKKFAKGGLDAIVNPK,248,2,5716,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,2266
GFMSKVANFAKKFAKGGVNAIMNQK,248,2,5718,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,2266
GMATKAGTAFGKAAKAIIGAAL,248,2,5720,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,29
FSPQMLQDIIEKKTKIL,249,31,5724,Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene.,Humanlung,30
FSPQMLQDIIEAATAIL,249,31,5725,Functional analysis of an alpha-helical antimicrobial peptide derived from a novel mouse defensin-like gene.,Humanlung,30
GFREKHFQRFVKYAVPESTLR,250,60,5727,"MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity",Stenotrophomonassp.,406
TVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF,250,60,5728,"MeuTXKbeta1, a scorpion venom-derived two-domain potassium channel toxin-like peptide with cytolytic activity",Stenotrophomonassp.,407
LLAIVGNLLKSLL,251,4,5733,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,408
LLPIVANLLKSLL,251,4,5734,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,409
LLPIVGALLKSLL,251,4,5735,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,410
LLPIVGNLLKALL,251,4,5737,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,411
LLPIVVNLLKSLL,251,4,5738,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,412
LLPIVINLLKSLL,251,4,5739,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,412
LLPIVANLLKALL,251,4,5740,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,409
KKLLPIVANLLKSLL,251,4,5741,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,413
KLVKWIIKTVNKFTKK,252,2,5745,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
KLPKWIIKTVNKFTKK,252,2,5746,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
IGKLVKWIIKTVNKFTKK,252,2,5747,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
IGKLPKWIIKTVNKFTKK,252,2,5748,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
STIGKLVKWIIKTVNKFTKK,252,2,5749,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
STIGKLPKWIIKTVNKFTKK,252,2,5750,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
IISTIGKLVKWIIKTVNKFTKK,252,2,5751,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
IISTIGKLPKWIIKTVNKFTKK,252,2,5752,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
AQKIISTIGKLVKWIIKTVNKFTKK,252,2,5753,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
AQKIISTIGKLPKWIIKTVNKFTKK,252,2,5754,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
MAQKIISTIGKLVKWIIKTVNKFTKK,252,2,5755,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
MAQKIISTIGKLPKWIIKTVNKFTKK,252,2,5756,Conformation and activity of delta-lysin and its analogs.,Escherichiacoli,31
IISTIGDLVKWIIDTV,253,2,5767,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli,2312
IISTIGKLVKWIIDTV,253,2,5768,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli,31
IISTIGDLVKWIIKTV,253,2,5769,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli,2312
IISTIGKLVKWIIKTV,253,2,5770,Generation of analogs having potent antimicrobial and hemolytic activities with minimal changes from an inactive 16-residue peptide corresponding to the helical region of Staphylococcus aureus delta-toxin.,Escherichiacoli,31
HTCHFRRRPKVRKFKLYHEGKFWCPG,254,8,5777,Characterization of two isoforms of antiliopolysacchride factors (Sp-ALFs) from the mud crab Scylla paramamosain.,Bacillussubtilis,414
HTCHIRRRPKFRKFKLYHEGKFWCPG,254,8,5778,Characterization of two isoforms of antiliopolysacchride factors (Sp-ALFs) from the mud crab Scylla paramamosain.,Bacillussubtilis,414
YVPKIPKPQPNKPNFPSFPGHGPFNPHASRFPR,255,60,5784,Characterization of a chimeric antimicrobial peptide uncovers evolutionary significance of exon-shuffling.,Stenotrophomonassp.,415
PIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRP,256,2,5819,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
PLPFPRPGPRPIPRPLPFPRPGPRPIPRP,256,2,5820,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
PLPFPRPGPRPIPRP,256,2,5821,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
RRIRPRPPRLPRPRPRPLPFPRPG,256,2,5822,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
RRIRPRPPRLPRPRPRP,256,2,5823,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
PRPPRLPRPRPRPLPFPRPG,256,2,5825,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
PPRLPRPRPRPLPFPRPG,256,2,5826,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
RLPRPRPRPLPFPRPG,256,2,5827,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
PRPRPRPLPFPRPG,256,2,5829,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,1195
PRPRPLPFPRPG,256,2,5830,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,1196
PRPLPFPRPG,256,2,5831,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
FWGALAKGALKLIGSLFSSFSKKD,257,2,5842,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli,121
FWGALAKGALKLIGPGSLFSSFSKKD,257,2,5843,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli,121
FWGLKGLKKFSKKL,257,2,5844,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli,1197
FWGLKGLKGPGKFSKKL,257,2,5845,Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.,Escherichiacoli,1198
ARLKKCFNKVTGYCRKKCKVGERYEIGCLSGKLCCAN,258,2,5855,Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,Escherichiacoli,1199
EQLKKCWNNYVQGHCRKICRVNEVPEALCENGRYCCLNIK,258,2,5856,Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,Escherichiacoli,1200
LQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,258,2,5857,Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins.,Escherichiacoli,2012
LVQRGRFGRFLRKIRRFRPKVTITIQGSARF,259,2,5859,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli,1027
LVQRGRFGRFLRKI,259,2,5860,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli,1078
LVQRGRFGRFLRKIR,259,2,5861,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli,1078
LVQRGRFGRFLRKIRRFR,259,2,5862,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli,1027
RRFRPKVTITIQGSARF,259,2,5863,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli,1027
PKVTITIQGSARF,259,2,5864,"The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.",Escherichiacoli,1201
TYMPVEEGEYIVNISYADQPKKNSPFTAKKQPGPKVDLSGVKAYGPG,260,56,5865,A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes.,Staphylococcusepidermidis,416
MPVGIVIAPKKSPFTAKKPGPVLSGVKAGPG,260,56,5866,A novel antifungal peptide designed from the primary structure of a natural antimicrobial peptide purified from Argopecten purpuratus hemocytes.,Staphylococcusepidermidis,417
RICSRGKNCVSRPGVGSIIGRPGGGSLIGRPGGGSV,261,2,5875,"Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss.",Escherichiacoli,1202
YVRTCMIKKEGWGKCLIDTTCAHSCKNRGYIGGDCKTCYCLVNC,262,24,5878,Cloning and functional expression of a mungbean defensin VrD1 in Pichia pastoris.,Fusariumoxysporum,869
SSMKLSFRARAYGFRGPGPQL,263,18,5879,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus,418
SSMKLSFRARAYGFRGPGLQL,263,18,5880,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus,418
SSMKLSFRARAYSFRGPGPQL,263,18,5881,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus,418
KPYLKRFQVYYKGRMWC,264,15,5890,Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon.,Aerococcusviridans,1519
QLLIRMIYKNILFYLVPGPGHGAEPERRNIKYL,265,61,5891,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,419
VAPIAKYLATALAKWALKQGFAKLKS,266,2,5892,BTM-P1 polycationic peptide biological activity and 3D-dimensional structure.,Escherichiacoli,1203
RMIYKNILFYLVPGPGHGAEPERRNIKYL,265,61,5893,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,419
QLLIRMIYKNI,265,61,5894,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,420
LFYLVPGPGHG,265,61,5895,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,419
AEPERRNIKYL,265,61,5896,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,421
YQLLIRMIYKNI,265,61,5897,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YALLIRMIYKNI,265,61,5898,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,638
YQALIRMIYKNI,265,61,5899,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YQLAIRMIYKNI,265,61,5900,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YQLLARMIYKNI,265,61,5901,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YQLLIAMIYKNI,265,61,5902,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YQLLIRAIYKNI,265,61,5903,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YQLLIRMAYKNI,265,61,5904,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
YQLLIRMIAKNI,265,61,5905,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,639
YQLLIRMIYANI,265,61,5906,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,640
YQLLIRMIYKAI,265,61,5907,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,641
YQLLIRMIYKNA,265,61,5908,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
MWKWFHNVLSSWQLLADKRPARDYNRK,267,62,5909,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid,1204
MWKWFHNVLSWWWLLADKRPARDYNRK,267,62,5910,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid,1204
MRKWFHNVLSSGQLLADKWPAWDYNWK,267,62,5911,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid,1204
MWKEFHNVLSSGQLLADKRWARWYNRW,267,62,5912,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid,1204
MWKWFHNVLSSGQLLADKWWAWWYNWW,267,62,5913,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid,1204
YQLLIRMIY,265,61,5915,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,642
YQLLIRMI,265,61,5916,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,643
YQLLIRPIYKNI,265,61,5918,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,637
LSELDDRADALQAGASQFETSAAKLKRKYWWKN,265,61,5919,A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.,HIV-1,644
GVLDILKGAAKDLAGHVATKVI,268,4,5933,Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,Staphylococcusaureus,645
GVLDILKGAAKDLAGH,268,4,5934,Antimicrobial peptide from the skin secretion of the frog Leptodactylus syphax.,Staphylococcusaureus,645
MTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE,269,8,5950,Structure-activity relationship of human liver-expressed antimicrobial peptide 2.,Bacillussubtilis,1808
SNQGGSPLPRSV,270,61,5965,Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,HIV-1,646
LPLPAPSFHRTT,270,61,5966,Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,HIV-1,647
KPKQIKPPLPSV,270,61,5967,Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.,HIV-1,648
AMDPTKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIPGKC,271,17,5974,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes,649
AMDPTKYYGNGVYCNSKKCWVDFGQASGCIGQTVVGGWLGGAIPGKC,271,17,5975,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes,649
AMDPTKYYGNGVYCNSKKCWVDWGSASGCIGQTVVGGWLGGAIPGKC,271,17,5976,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes,649
AMDPTKYYGNGVYCNSKKCWVDWGQGSGCIGQTVVGGWLGGAIPGKC,271,17,5977,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes,649
AMDPTKYYGNGVYCNSKKCWVDWGQASGCIGQTVVGGWLGGAIVGKC,271,17,5978,In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes.,Listeriamonocytogenes,649
KFRRQRPRLSHKGPMPF,272,5,5981,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV,2727
RPRLSHKGPMPF,272,5,5983,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV,2727
PRLSHKGPMPF,272,5,5984,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV,1205
APKEWMEWDREINNYTSLIHSLIKQGI,273,61,5986,Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.,HIV-1,1490
APKEWMAWAREIAAYAKLIAALI,273,61,5987,Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.,HIV-1,650
APKEWMAWAREIAAYAKLIAALIKQGI,273,61,5988,Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.,HIV-1,650
KILEPFRKQNPDIVIYQYMD,274,61,5991,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,651
SPAIFQSSMTKILEPFRKQN,274,61,5992,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,652
PDIVIYQYMDDLYVGSDLEI,274,61,5993,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,653
ELVNQIIEQLIKKEKVYLAW,274,61,5994,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,654
IQAQPDQSESELVNQIIEQL,274,61,5995,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,655
IKKEKVYLAWVPAHKGIGN,274,61,5996,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,656
FRKQNPDIVIYQYMD,274,61,5997,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,651
NQIIEQLIKKEKVY,274,61,5999,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,654
ESELVSQIIEQLIKK,274,61,6000,Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.,HIV-1,657
AEAMSQVTN,275,61,6010,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,658
AAAMSQVTN,275,61,6011,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,659
AEAASQVTN,275,61,6012,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,660
AEAMAQVTN,275,61,6013,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,658
AEAMSQVAN,275,61,6014,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,658
AEAMSQVT,275,61,6015,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,661
VTNTATIM,275,61,6020,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,662
AEAMSQVTNTATIM,275,61,6021,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,663
AEAASQVTNTATIM,275,61,6022,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,664
AEASQVTNTATIM,275,61,6023,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,665
AEAMSQVANTATIM,275,61,6024,Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.,HIV-1,663
TYGDTWAGVEAIIRI,276,61,6026,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,666
HFPRIWLHSLGQHIY,276,61,6027,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,667
TWAGVEAIIRILQQL,276,61,6028,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,668
VEAIIRILQQLLFIH,276,61,6029,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,669
IRILQQLLFIHFRIG,276,61,6030,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,670
QQLLFIHFRIGCQHS,276,61,6031,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,671
FIHFRIGCQHSRIGI,276,61,6032,Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).,HIV-1,672
KGEAMHGQVDCSPGIWQLDC,277,61,6033,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,673
ASCDKCQLKGEAMHG,277,61,6034,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,674
KCQLKGEAMHGQVDC,277,61,6035,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,675
KGEAMHGQVDCSPGI,277,61,6036,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,673
MHGQVDCSPGIWQLD,277,61,6037,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,673
VDCSPGIWQLDCTHL,277,61,6038,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,673
PGIWQLDCTHLEGKI,277,61,6039,Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.,HIV-1,676
FTQGVGNPVSCARNKGICVPSRCPGNNRQIGTCLGPPVKCCRRK,278,4,6040,Molecular cloning and characterization of lingual antimicrobial peptide cDNA of Bubalus bubalis.,Staphylococcusaureus,677
FKCRRWQWRMKKLGKRSKNKGFKEQAKSLLKWILD,279,63,6041,Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.,Aggregatibacteractinomycetemcomitans,1206
WKLFKKILKVL,280,24,6043,Sporicidal activity of synthetic antifungal undecapeptides and control of Penicillium rot of apples.,Fusariumoxysporum,1207
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,281,30,6056,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASLWEWF,281,30,6058,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,678
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELL,281,30,6060,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL,281,30,6061,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEEWDREINEYTSRIESLIRESQEQQEKNEQELREL,281,30,6062,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
MTWMAWDRAIANYAALIHALIEAAQNQQEKNEAALLEL,281,30,6064,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRASQEQQEKNEAELREL,281,30,6066,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL,281,30,6067,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
ILGPVLGLVSRTLRRVLGIL,89,30,6069,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,679
GLRSRIWLWVLLMIWQESNRFKRM,89,30,6072,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,680
GLKKLLGKLLKKLGKLLLK,282,2,6073,APD2: the updated antimicrobial peptide database and its application in peptide design.,Escherichiacoli,681
GLRRLLGRLLRRLGRLLLR,89,30,6074,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,681
GGLKKLGKKLEGAGKRVFNAAEKALP,283,64,6078,Generation and characterization of the antibacterial activity of a novel hybrid antimicrobial peptide comprising functional domains from different insect cecropins.,Alcaligenesfaecalis,1209
IAQQAANVAATARG,283,64,6079,Generation and characterization of the antibacterial activity of a novel hybrid antimicrobial peptide comprising functional domains from different insect cecropins.,Alcaligenesfaecalis,1208
MGGLKKLGKKLEGAGKRVFNAAEKALPIAQQAANVAATARG,283,64,6080,Generation and characterization of the antibacterial activity of a novel hybrid antimicrobial peptide comprising functional domains from different insect cecropins.,Alcaligenesfaecalis,1209
GIINTLQKYYARVRGGRYAVLSVLPKEEQIGKVSTRGRKKVRRKK,284,48,6082,"Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue.",Bacillusmegaterium,2012
GIINTLQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKCARRKK,285,3,6084,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa,2012
FLPKTLRKFFARIRGGRAAVLNALGKEEQIGRASNSGRKAARKKK,285,3,6085,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa,32
FLPKTLRKFFARIRGGRAAVLNA,285,3,6086,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa,32
LGKEEQIGRASNSGRKAARKKK,285,3,6087,Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.,Pseudomonasaeruginosa,32
MTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL,281,30,6096,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAILREL,281,30,6097,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAALREL,281,30,6098,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRAAQELQEKNEAALREL,281,30,6099,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAILREL,281,30,6100,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAALREL,281,30,6101,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAVLREL,281,30,6102,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAALREL,281,30,6103,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
MLSLIFLHRLKSMRKRLDRKLRLWHRKNYP,286,2,6104,"Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.",Escherichiacoli,1210
TTWEAWDRAIAEYAARIEALIRALQELQEKNEAILREL,281,30,6105,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRAAQELQEKLEAALRE,281,30,6106,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
TTWEAWDRAIAEYAARIEALIRALQELQEKLEAILREL,281,30,6107,"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.",HIV-1IIIB,1490
WNSLKIDNLDV,287,61,6108,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,682
WASLKIDNLDV,287,61,6109,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,683
WNALKIDNLDV,287,61,6110,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,682
WNSAKIDNLDV,287,61,6112,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,684
FKCWRWQWRWKKLGA,288,2,6113,"Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.",Escherichiacoli,1212
KWKLFKKIFKCWRWQWRWKKLGA,288,2,6114,"Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.",Escherichiacoli,1211
FKCWRWQWRWKKLGAKVFKRLEKLFSKI,288,2,6115,"Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.",Escherichiacoli,1212
WNSLAIDNLDV,287,61,6116,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,682
WNSLKADNLDV,287,61,6117,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,685
WNSLKIANLDV,287,61,6118,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,682
WNSLKIDALDV,287,61,6119,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,682
WNSLKIDNADV,287,61,6120,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,1574
WNSLKIDNLAV,287,61,6121,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,1575
RVRRPVYIPQPRPPHPRL,289,2,6122,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
WNSLKIDNLDA,287,61,6123,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,682
WNSLKIANLAV,287,61,6124,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,1576
RPVRPVYIPQPRPPHPRL,289,2,6125,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
RGVRPVYIPQPRPPHPRL,289,2,6127,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
WKFALKVDSPDV,287,61,6128,Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.,HIV-1,1577
RNPRPVYIPQPRPPHPRL,289,2,6129,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
RLNRPVYIPQPRPPHPRL,289,2,6130,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
RLPRPVYIPQPRPPHPRL,289,2,6131,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
VVRRPVYIPQPRPPHPRL,289,2,6132,"Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system.",Escherichiacoli,2542
SSLLEKGLDGAKKAVGGLGKLGKDA,290,3,6135,Resistance to dermcidin-derived peptides is independent of bacterial protease activity.,Pseudomonasaeruginosa,338
GFCIPIRCPGHTRQIGTCFGPRVKSCRKW,291,2,6207,Artificial beta-defensin based on a minimal defensin template.,Escherichiacoli,677
RCPGHTRQIGTSFGPRVKSCRKW,291,2,6208,Artificial beta-defensin based on a minimal defensin template.,Escherichiacoli,677
EEHEKYHSNW,292,61,6210,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1578
ASCDKCQLKG,292,61,6211,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,674
HGQVDCSPGIWQLDCTH,292,61,6212,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,673
PAETGQET,292,61,6214,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1579
TAYFLLKLAGRW,292,61,6215,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
HTDNGSNF,292,61,6218,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1581
ACWWAGIKQEF,292,61,6219,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
FGIPYNPQSQ,292,61,6220,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1583
ESMNKELKKI,292,61,6221,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1584
VRDQAEHLKT,292,61,6222,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1585
FIHNFKRK,292,61,6223,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1586
GYSAGERIVD,292,61,6224,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1587
WKGPAKLLWK,292,61,6225,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1588
VPRRKAKI,292,61,6226,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1589
KWKLFKKIEKVGQRVRDAVISAGPAVATVAQATALAK,293,2,6228,Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity.,Escherichiacoli,2096
AAYFLLKLAGRW,292,61,6230,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAAFLLKLAGRW,292,61,6231,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYALLKLAGRW,292,61,6232,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFALKLAGRW,292,61,6233,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFLAKLAGRW,292,61,6237,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFLLALAGRW,292,61,6239,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFLLKAAGRW,292,61,6241,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFLLKLAARW,292,61,6244,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1590
TAYFLLKLAGAW,292,61,6245,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
RRRRWFWF,294,2,6246,"Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.",Escherichiacoli,1213
RRRRRWFWFW,294,2,6247,"Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.",Escherichiacoli,1214
TAYFLLKLAGRA,292,61,6248,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
RRRRRRWFWFWF,294,2,6249,"Cyclic antimicrobial R-, W-rich peptides: the role of peptide structure and E. coli outer and inner membranes in activity and the mode of action.",Escherichiacoli,1215
AAWWAGIKQEF,292,61,6250,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACAWAGIKQEF,292,61,6252,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWAAGIKQEF,292,61,6253,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWWAAIKQEF,292,61,6254,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWWAGAKQEF,292,61,6255,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWWAGIAQEF,292,61,6256,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
SRSELIVHQR,295,65,6257,Functional characterization of a synthetic hydrophilic antifungal peptide derived from the marine snail Cenchritis muricatus.,Botrytiscinerea,1216
ACWWAGIKAEF,292,61,6258,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWWAGIKQAF,292,61,6259,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWWAGIKQEA,292,61,6260,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
TASFLLKLAGRW,292,61,6261,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFLLILAGRW,292,61,6262,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
TAYFLLKLAGRL,292,61,6263,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1580
ASWWAGIKQEF,292,61,6264,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACGWAGIKQEF,292,61,6265,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWGAGIKQEF,292,61,6266,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
ACWWAGIRQEF,292,61,6267,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1582
WRGALKLLFYAT,292,61,6290,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1591
FEQKIGAWWCA,292,61,6294,Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.,HIV-1,1592
WKLLSKAQEKFGKNKSRFKCRRWQWRMKKLG,296,2,6304,"Expression, purification, and antibacterial activity of bovine lactoferrampin-lactoferricin in Pichia pastoris.",Escherichiacoli,378
IHAEIKNSLKIDNLDVNRCIEAL,297,61,6319,Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.,HIV-1,1593
AELRCMCIKTTSGIH,298,8,6322,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1594
ELRCMCIKTTSGIHP,298,8,6323,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1594
LRCMCIKTTSGIHPK,298,8,6324,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1594
RCMCIKTTSGIHPKN,298,8,6325,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1594
CMCIKTTSGIHPKNI,298,8,6326,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1594
MCIKTTSGIHPKNIQ,298,8,6327,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1594
DAPRIKKIVQKKLAG,298,8,6328,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1595
APRIKKIVQKKLAGD,298,8,6329,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1595
PRIKKIVQKKLAGDE,298,8,6330,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1596
RIKKIVQKKLAGDES,298,8,6331,Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.,Bacillussubtilis,1596
QSHLSMCSVCCNCCKNYKGCGFCCRF,299,66,6333,Recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization.,Corynebacteriumglutamicum,1597
GNNRPVYIPQPRPHPRL,300,2,6335,"Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation.",Escherichiacoli,2542
GNNRVYIPQPRPHPRL,300,2,6336,"Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation.",Escherichiacoli,2542
KQLTEAVQKITTESIVIWGK,301,61,6339,Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.,HIV-1,1598
ETWETWWTEYWQATWIPEWE,301,61,6340,Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.,HIV-1,1599
LQDSGLEVNIVTDSQYALGI,301,61,6341,Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.,HIV-1,1600
WQCLTLTHRGFVLLTITVLR,302,61,6357,Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.,HIV-1,1601
RRRFVAEQDAIHSRVSREVPTLSDSV,303,4,6370,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1602
WQCLTLTHRG,304,61,6371,Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,HIV-1,1601
RRRFVAQQNAIHSRVSRQVPTLSNSV,303,4,6372,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1602
WFVLLTITVLR,304,61,6373,Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,HIV-1,1603
WQSLTLTHRG,304,61,6374,Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.,HIV-1,1604
RRRFVVQQDTISPRLEVDERFLPNSVQEQI,303,4,6375,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1605
RRRFVVQQNTISPRLQVNQRFLPNSVQQQI,303,4,6376,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1605
RRRSVGEEDAIPSHIEVNKFFLRKPAKEHI,303,4,6377,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1606
RRRSVGQQNAIPSHIQVNKFFLRKPAKQHI,303,4,6378,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1606
HRRSVAHQEEASLHVKTDELPSPDTVREQL,303,4,6379,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1607
HRRSVAHQQQASLHVKTNQLPSPNTVRQQL,303,4,6380,Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.,Staphylococcusaureus,1607
KLLSHSLL,305,18,6412,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1608
RRSQARKCSRGNGGKIGSIRCRGGGTRLGGGSLIGR,306,67,6414,Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.,Yersiniaruckeri,1217
RRGKPSGGSRGSKMGSKDSKGGWRGRPGSGSRPGFG,306,67,6415,Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri.,Yersiniaruckeri,784
LSFPTTKTYFPHFDLSHGSAQVKGHGAKVAAA,305,18,6416,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,2534
VTLASHLPSDFTPAVHASLDKF,305,18,6417,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1612
SAADKGNVKAAWGKVGGHAAEYGAEALERMFLSF,305,18,6418,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1611
VLSAADKGNVKAAWGKVGGHAAEYGAEALERMF,305,18,6419,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1611
LDDLPGALSELSDLHAHKLRVDPVNFKLLSHSL,305,18,6420,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1614
VNFKLLSHSLL,305,18,6421,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1609
TKAVEHLDDLPGALSELSDLHAHKLRVDPVNFKLLSHSLL,305,18,6422,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1614
LHAHKLRVDPVNFKLLSHSLLVTL,305,18,6423,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1614
NKPFVFLM,307,30,6427,Short cyclic peptides derived from the C-terminal sequence of alpha1-antitrypsin exhibit significant anti-HIV-1 activity.,HIV-1IIIB,1610
VLSAADKGNVKAAWGKVGGHAAEYGAEALERMFLSFPTTKTYFPHF,305,18,6428,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1611
ASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,305,18,6430,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1612
LVTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR,305,18,6435,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1612
HGKKVLDSFSNGMKHLDDLKGTFAALSELH,305,18,6436,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1613
AALSELHCDKLHVDPENFKLL,305,18,6437,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1614
ARNFGKEFTPV,305,18,6438,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1615
DLKGTFAALSELHCDKLHVDPENFKL,305,18,6439,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1614
LDDLKGTFAALSELHCDKLHVDPENFKLLGNVLVVVLARNFGKEFTPVL,305,18,6440,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1614
ARNFGKEFTPVLQADFQKVVAGVANALAHRYH,305,18,6441,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1615
LTAEEKAAVTAFWGKVKVDEVGGEALGRLLVVY,305,18,6443,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,1616
TKAVEHLDDLPGALSELSDL,305,18,6444,Obtaining antimicrobial peptides by controlled peptic hydrolysis of bovine hemoglobin.,Micrococcusluteus,2534
EEYTKKIEEYTKKIEEYTKKIEEYTKKIEEYTKKI,308,61,6456,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1,1617
WMEWDREIEEYTKKIEEYTKKIEEYTKKIEEYTKKI,308,61,6457,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1,1617
EEYTKKIEEYTKKIEEYTKKIEEYTKKIWASLWNWF,308,61,6458,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1,1617
WMEWDREIEEYTKKIEEYTKKIEEYTKKIWASLWNWF,308,61,6459,Rationally designed anti-HIV peptides containing multifunctional domains as molecule probes for studying the mechanisms of action of the first and second generation HIV fusion inhibitors.,HIV-1,1617
WEEWDKKIEEYTKKIEELIKKS,310,68,6474,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3,1617
WMEWDREINNYTSLIHSLIEESQNQQEKN,310,68,6475,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3,1490
WEEWDKKIEEYTKKIEELIKKSEEQQKKN,310,68,6476,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3,1617
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL,310,68,6477,"SC29EK, a peptide fusion inhibitor with enhanced alpha-helicity, inhibits replication of human immunodeficiency virus type 1 mutants resistant to enfuvirtide.",HIV-1NL4-3,1490
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW,311,61,6504,Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.,HIV-1,1490
RQLLSGIVQQQNNLLRAIEAQQHLLQK,312,61,6534,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1492
RKSYKCLHKRCR,313,7,6542,Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans.,Streptococcusmutans,1868
RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR,314,2,6543,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli,1884
TIAMRAINNYRWRSKNQNTFLR,314,2,6544,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli,1884
RPPQFTRAQWFAIQHISLN,314,2,6545,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli,1884
AQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFLR,314,2,6546,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli,1884
AQWFAIQHISLNPPRSTIAMRAINNYRWR,314,2,6547,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli,1884
ISLNPPRSTIAMRAINNYRWRSKNQNTFLR,314,2,6551,Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.,Escherichiacoli,1884
RQLLSGIVQQQNNLLRAIEAQQHLL,312,61,6555,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1492
RQLLSGIVQQQNNLLRAIEAQQH,312,61,6557,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1492
SGIVQQQNNLLRAIEAQQHLLQ,312,61,6559,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1492
RGGLSGIVQQQNNLLRAIEAQQHLLQ,312,61,6561,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1492
HQTLSGIDQEQNNLTRLIEAQIHELQK,312,61,6563,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1491
RQLLSGIDQEQNNLTRLIEAQIHELQK,312,61,6565,Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.,HIV-1,1491
FFTPVLQADFQKVVAGVANALAHRYH,315,35,6567,RYH: a minimal peptidic sequence obtained from beta-chain hemoglobin exhibiting an antimicrobial activity.,Salmonellaenteritidis,1615
SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL,316,61,6569,Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.,HIV-1,1492
SGIDQEQNNLTRLIEAQIHELQLTQWKIKQLLARILK,316,61,6574,Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.,HIV-1,1491
SGIVQQLNNQLRAEEANQHLEQLSVWGSKQNQARRLK,316,61,6576,Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.,HIV-1,1492
GRKKRRQRRR,317,30,6581,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB,1493
RRKKRRQRRR,317,30,6583,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB,1494
GRKKRRRRRR,317,30,6584,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB,1495
RRKKRRRRRR,317,30,6585,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB,1496
RRRRRRRRRR,317,30,6586,Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.,HIV-1IIIB,1496
TGEKVWDRGNVTLLCDCP,318,61,6599,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1497
LPAFCQAIGWGDPITHWS,318,61,6600,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1498
FCQAIGWGDPITHWSHGQ,318,61,6601,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1498
AIGWGDPITHWSHGQNRW,318,61,6602,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1498
PITHWSHGQNRWPLSCPQ,318,61,6603,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1499
HGQNRWPLSCPQYVYGSV,318,61,6604,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1500
SDRDTVVELSEWGVPCAT,318,61,6605,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1501
DTVVELSEWGVPCATCIL,318,61,6606,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1501
VELSEWGVPCATCILDRR,318,61,6607,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1501
RFPFHRCGAGPKLTKDLE,318,61,6608,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1502
LVRRRSELMGRRNPVCPG,318,61,6610,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1503
LQEVDAGNFIPPPRWLLL,318,61,6611,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1504
WVNQLAVLGLPAVDAAVA,318,61,6612,Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.,HIV-1,1505
TRQARRNRRRRWRERQR,319,30,6616,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB,1506
TRQARRNRRRRWRERQRAAAAC,319,30,6617,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB,1506
TRQARRNRRRRWRERQRAAAACYGRKKRRQRRR,319,30,6618,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB,1506
MPKTRRRPRRSQRKRPPTPWP,319,30,6619,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB,1507
MPKTRRRPRRSQRKRPPTPWPYGRKKRRQRRR,319,30,6620,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB,1507
RPRGRRGSRPSGAERRRRRAAAA,319,30,6621,"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.",HIV-1IIIB,1508
TDVILMCFSIDSPDSLENI,320,61,6624,A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.,HIV-1,1509
DDMSVISELICTSPLDFIN,320,61,6625,A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.,HIV-1,1510
YTSLIHSLIEEGQNQQEKNEQELLELDKWASLWNWF,321,61,6626,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF,321,61,6627,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEVQNQQEKNEQELLELDKWASLWNWF,321,61,6628,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEELQNQQEKNEQELLELDKWASLWNWF,321,61,6629,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEIQNQQEKNEQELLELDKWASLWNWF,321,61,6630,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEMQNQQEKNEQELLELDKWASLWNWF,321,61,6631,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEPQNQQEKNEQELLELDKWASLWNWF,321,61,6632,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEETQNQQEKNEQELLELDKWASLWNWF,321,61,6633,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEFQNQQEKNEQELLELDKWASLWNWF,321,61,6634,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEYQNQQEKNEQELLELDKWASLWNWF,321,61,6635,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEWQNQQEKNEQELLELDKWASLWNWF,321,61,6637,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEENQNQQEKNEQELLELDKWASLWNWF,321,61,6638,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEQQNQQEKNEQELLELDKWASLWNWF,321,61,6639,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEDQNQQEKNEQELLELDKWASLWNWF,321,61,6640,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEEQNQQEKNEQELLELDKWASLWNWF,321,61,6641,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEEHQNQQEKNEQELLELDKWASLWNWF,321,61,6642,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
YTSLIHSLIEERQNQQEKNEQELLELDKWASLWNWF,321,61,6643,Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.,HIV-1,1490
GCKKYRRFRWKFKGKFWFWG,322,69,6647,A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.,HIV-1Ba-L,1218
GKKYRRFRWKFKFGKWFWFG,322,69,6648,A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.,HIV-1Ba-L,1218
RSQKEGLHYTCSSHFPYSQYQFWK,323,70,6656,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2,1511
RSQKEGLHYTCS,323,70,6657,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2,1511
CSSHFPYSQYQFWK,323,70,6659,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2,1511
QKEGLHYTCSSHFPYSQYQF,323,70,6661,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2,1511
EGLHYTCSSHFPYSQY,323,70,6662,Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.,HIV-1YU2,1511
RINNIPWSEAMM,324,70,6670,Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.,HIV-1YU2,1512
IYWNVSGW,327,61,6724,Peptide inhibitors of HIV-1 egress.,HIV-1,1513
GRFKRFRKKFKKLFKKIS,7,5,6735,Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins,HIV,1907
KKTWWKTWWTKWSQPKKKRKV,328,2,6760,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli,1219
KKTWWKTWWTKWSQPKK,328,2,6761,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli,1219
KKTWWKTWWTKWSQP,328,2,6762,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli,1219
KKTWWKTWWTKW,328,2,6763,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli,1220
KKTWWKTWWTKWKK,328,2,6764,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli,1221
KKPWWKPWWPKWKK,328,2,6765,Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.,Escherichiacoli,1222
LRKLRKRLVRLASHLRKLRKRLL,329,2,6768,An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.,Escherichiacoli,1223
LRKLRKRLLLRKLRKRLL,329,2,6769,An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.,Escherichiacoli,1224
CLRKLRKRLLC,329,2,6770,An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.,Escherichiacoli,1225
SHGAVSLTMCKLTSGKYPNCRYKEKRQNKSYVVACKPPQKKDSQQFHLVPVHLDRVL,330,2,6790,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli,1226
TSGKYPNCRYKEKRQNKSYVVACKPPQKKDSQQFHLVPVHLDRVL,330,2,6791,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli,1226
KPKGMTSSQWFKIQHMQPSPQACNSAMKNINKHTKRCKDLNTFLH,330,2,6797,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli,1648
EPFSSVAATCQTPKIACKNGDKNCHQSHGAVSLTMCKLTSGKYPNCRYKEKR,330,2,6803,Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.,Escherichiacoli,1227
GIGKHVGKALKGLKGLLKGLGEC,331,1,6806,None_article3,None_target,1514
GLKGLLGKALKGIGKHIGKAQGC,332,1,6807,None_article4,None_target,1515
RWKIFKKIEKMGGSYCNRRTGKCQRM,333,8,6852,Biological activities of cecropin B-thanatin hybrid peptides.,Bacillussubtilis,114
KLAKLAKKLAKLAK,334,59,6855,Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.,Acinetobacterbaumannii,1516
AKVTMTCSAS,335,33,6868,Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.,Pseudomonassyringae,1517
WHWRIRKKLR,336,2,6872,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli,1228
WHWTWLRIRKKLR,336,2,6873,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli,1229
WHWTWLPKKKRKV,336,2,6874,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli,1229
WHWTWLPRRRK,336,2,6875,Design of multifunctional peptides expressing both antimicrobial activity and shiga toxin neutralization activity.,Escherichiacoli,1229
DDALKKLLKKLLKKL,337,72,6895,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus,1230
DDALHHLLHHLLHHL,337,72,6896,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus,1231
DDALRRLLRRLLRRL,337,72,6908,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus,1230
DDALKHLLKHLLKHL,337,72,6909,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus,1232
DDALRHLLRHLLRHL,337,72,6910,pH-dependent antifungal lipopeptides and their plausible mode of action.,Aspergillusflavus,1232
LQKYYCRVRGGRCAVLS,338,2,6913,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
LQKYYARVRGGRAAVLSALPKEEQIGKASTRGRKAARRKK,338,2,6916,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
LQKYYWRVRGGRWAVLSWLPKEEQIGKWSTRGRKWWRRKK,338,2,6918,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
LQKYYARVRGGRAAVLS,338,2,6919,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
LQKYYWRVRGGRWAVLS,338,2,6920,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
AVLSALPKEEQIGKASTRGRKAARRKK,338,2,6921,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
AVLSWLPKEEQIGKWSTRGRKWWRRKK,338,2,6922,Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.,Escherichiacoli,2012
GLKALKKVFQGIHEAIKLINNHVQ,339,2,6923,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFKGIHEAIKLINNHVQ,339,2,6924,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFQGIHKAIKLINNHVQ,339,2,6925,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFQGIHEAIKLINKHVQ,339,2,6926,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFQGIHEAIKLINNHVK,339,2,6927,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLKALKKVFQGIHKAIKLINNHVQ,339,2,6928,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLKALKKVFKGIHKAIKLINNHVQ,339,2,6929,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLKALKKVFKGIHKAIKLINKHVQ,339,2,6931,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLKALKKVFKGIHKAIKLINKHVK,339,2,6932,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNAFKKVFQGIHEAIKLINNHVQ,339,2,6933,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKFFQGIHEAIKLINNHVQ,339,2,6934,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFQGFHEAIKLINNHVQ,339,2,6935,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFQGIHEAFKLINNHVQ,339,2,6936,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
GLNALKKVFQGIHEAIKLFNNHVQ,339,2,6937,"Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.",Escherichiacoli,890
DKPKKKPPPPAGPPPPPPPPPGPPPPGP,340,73,7009,Structural and functional studies on a proline-rich peptide isolated from swine saliva endowed with antifungal activity towards Cryptococcus neoformans.,Cryptococcusneoformans,1518
KFFRKLKKSVKKRAKKFFKKPRVIGVSIPF,341,2,7011,Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.,Escherichiacoli,1694
KFFRKLAKSVKKAAKEFFKKPRVIGVSIPF,341,2,7012,Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.,Escherichiacoli,1694
GCKFTVKPYLKRFQVYYKGRMWCG,342,15,7013,Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.,Aerococcusviridans,1519
GCTYNVKPDIQGFELYFIGSVTCG,342,15,7015,Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.,Aerococcusviridans,1520
GCRFTVKPYIKRIQLHYKGKMWCG,342,15,7016,Functional divergence in shrimp anti-lipopolysaccharide factors (ALFs): from recognition of cell wall components to antimicrobial activity.,Aerococcusviridans,1519
SRWPSPGRPRPFPGRPKPIFRPR,343,2,7019,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
SRWPSPGRPRPFPGRPKPIF,343,2,7020,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
SRWPSPGRPRPFPG,343,2,7021,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
WPSPGRPRPFPGRPKPIFRPR,343,2,7022,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
SPGRPRPFPGRPKPIFRPR,343,2,7024,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
GRPRPFPGRPKPIFRPR,343,2,7025,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
PRPFPGRPKPIFRPR,343,2,7026,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,885
RRRPRPPYLPRPRPPPFFPPRLPPRI,343,2,7028,"Structure-activity relationships of the antimicrobial peptide arasin 1 - and mode of action studies of the N-terminal, proline-rich region.",Escherichiacoli,1006
WKWLKKWIK,344,41,7041,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1521
ILRWKWRWWRWRR,344,41,7042,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1522
ILPWKWRWWKWRR,344,41,7043,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1522
FCPRRYKQIGTGLPGTKCK,345,2,7044,Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.,Escherichiacoli,2088
RWRRKWWWW,344,41,7045,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1523
WRKFWKYLK,344,41,7046,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1524
KRWWKWWRR,344,41,7047,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1525
RRWWKWWWR,344,41,7048,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1526
RLWWWWRRK,344,41,7049,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1527
KWKWWWRKI,344,41,7050,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1528
RIRRWKFRW,344,41,7051,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1529
RLKRWWKFL,344,41,7052,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1530
RWWRWRKWW,344,41,7053,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1531
KRWWWWRFR,344,41,7055,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1532
RGCICRCIGRGCICRCIG,346,74,7056,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,1533
KRWWRKWWR,344,41,7057,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1534
RRWWRWVVW,344,41,7058,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1535
GICRCICGGGICRCICGR,346,74,7059,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,97
GICRCICGGGICRCICGG,346,74,7060,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,97
WFKMRWWGR,344,41,7061,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1536
GICHCICGGGICHCICGG,346,74,7062,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,1537
KFKWWRMLI,344,41,7063,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1538
FIKWKFRWWKWRK,344,41,7064,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1522
RIKRWWWWR,344,41,7065,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1539
RWRWWWRVY,344,41,7066,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1540
HQFRFRFRVRRK,344,41,7067,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1541
LKRRWKWWI,344,41,7068,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1618
RRRIKIRWY,344,41,7069,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1619
RLWWKIWLK,344,41,7070,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1620
KRRWRIWLV,344,41,7071,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1621
FFIYVWRRR,344,41,7072,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1622
IRMRIRVLL,344,41,7073,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1623
RWWRKIWKW,344,41,7074,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1624
LRFILWWKR,344,41,7075,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1625
RWWIRIRWH,344,41,7076,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1626
RRRWWKLMM,344,41,7077,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1627
LRRWIRIRW,344,41,7078,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1628
RKFRWWVIR,344,41,7079,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1629
WKIVFWWRR,344,41,7080,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1630
RQRRVVIWW,344,41,7081,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1631
RRWRVIVKW,344,41,7082,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1632
RRWKIVVIRWRR,344,41,7083,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1633
RLWRIVVIRVKR,344,41,7084,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1634
RLRRIVVIRVFR,344,41,7085,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1635
VRLRIRVRVIRK,344,41,7086,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1636
RRYHWRIYI,344,41,7087,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1637
RKWKIKWYW,344,41,7088,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1638
YRLRVKWKW,344,41,7089,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1639
WKWRVRVTI,344,41,7090,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1640
RTKKWIVWI,344,41,7091,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1641
NWRKLYRRK,344,41,7092,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1642
GICRCICGGGICHCICGG,346,74,7093,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,97
GICHCICGGGICRCICGG,346,74,7094,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,97
YKFRWRIYI,344,41,7095,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1643
KRKKRFKWW,344,41,7096,Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.,Mycobacteriumtuberculosis,1644
RICRCICGRRICRCICGR,346,74,7097,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,97
GVCRCLCRRGVCRCICRR,346,74,7098,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,1645
GICRCICGKGICRCICGR,346,74,7099,Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.,Bacillusanthracis,97
RWWRWWRRWWRR,347,4,7105,"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.",Staphylococcusaureus,1646
RVVRQWPIGRVVRRVVRRVVRL,348,8,7106,Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics.,Bacillussubtilis,1647
RVVRQWPIGRVVRRVVRRVVRF,348,8,7107,Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics.,Bacillussubtilis,1647
RVVRQWPIGRVVRRVVRRVVRY,348,8,7108,Display of multimeric antimicrobial peptides on the Escherichia coli cell surface and its application as whole-cell antibiotics.,Bacillussubtilis,1647
RWKRWWRRKK,349,2,7112,Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties.,Escherichiacoli,686
KPKGMTSSQWFKIQHMQPSPQASNSAMKNINKHTKRSKDLNTFLH,350,75,7120,"Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.",Mycobacteriumvaccae,1648
RGVRPVVQGVKEKVR,351,8,7121,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,1649
RVVRPVVQGVKEKVR,351,8,7122,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,1649
RVVRPVVQGVKQKVR,351,8,7123,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,1649
RVVRPVVQVVKEKVR,351,8,7124,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,1650
RVVRPVVQVVKQKVR,351,8,7125,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,1650
RIIRPIIQIIKQKIR,351,8,7126,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,1651
RLLRPLLQLLKQKLR,351,8,7127,De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.,Bacillussubtilis,2177
GSKKPVPIIYCQRRTGKCQRM,352,2,7136,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli,1905
GSKKPVPIIYCNRRTAKCQRM,352,2,7137,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli,1905
GSKKPVPIIYCQRRSGKCQRM,352,2,7138,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli,1905
GSKKPVPIIYCQRRTAKCQRM,352,2,7139,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli,1905
GSKKPVPIIYCNRRSAKCQRM,352,2,7140,"Application of S-thanatin, an antimicrobial peptide derived from thanatin, in mouse model of Klebsiella pneumoniae infection.",Escherichiacoli,1905
QKALNEINQF,353,25,7141,Structure-activity relationships of ?s-casein peptides with multifunctional biological activities.,Bacilluscereus,1652
TKKTKLTEEEKNRL,353,25,7142,Structure-activity relationships of ?s-casein peptides with multifunctional biological activities.,Bacilluscereus,1653
WLRRIKAWLRR,354,76,7163,Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs.,Staphylococcuspseudintermedius,1654
WLRRIKAWLRRIKA,354,76,7164,Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs.,Staphylococcuspseudintermedius,1654
KFFKFFKFFK,354,76,7166,Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs.,Staphylococcuspseudintermedius,1655
AFHHIFRGIVHVGKTIHRLVTG,355,2,7167,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FAHHIFRGIVHVGKTIHRLVTG,355,2,7168,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FFHHIARGIVHVGKTIHRLVTG,355,2,7169,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
KFHHIFRGIVHVGKTIHRLVTG,355,2,7170,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
GKPRPYSPRPTPHPRL,356,2,7173,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli,373
GRPNPVNNKPTSHPRPIRV,356,2,7175,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli,687
GRPNPVNNKPTPHPRPIRV,356,2,7177,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli,687
KAANRIKYFQ,357,77,7180,Synthetic antimicrobial peptides: From choice of the best sequences to action mechanisms.,Klebsiellapneumoniae,688
GATIRAVNSR,357,77,7182,Synthetic antimicrobial peptides: From choice of the best sequences to action mechanisms.,Klebsiellapneumoniae,689
FKHHIFRGIVHVGKTIHRLVTG,355,2,7186,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FFHHIKRGIVHVGKTIHRLVTG,355,2,7187,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
WFHHIFRGIVHVGKTIHRLVTG,355,2,7188,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FWHHIFRGIVHVGKTIHRLVTG,355,2,7189,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FFHHIWRGIVHVGKTIHRLVTG,355,2,7190,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FFHHIFRGIKHVGKTIHRLVTG,355,2,7213,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
KFHHIFRGIKHVGKTIHRLVTG,355,2,7214,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FKHHIFRGIKHVGKTIHRLVTG,355,2,7215,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FFHHIKRGIKHVGKTIHRLVTG,355,2,7216,Role of phenylalanine and valine10 residues in the antimicrobial activity and cytotoxicity of piscidin-1.,Escherichiacoli,2690
FLFKLIPKAIKKLISKFK,358,56,7227,"Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1.",Staphylococcusepidermidis,1656
NSQIRPLPDKGLDLSIRDASIKIRGKWKARKNFIK,359,78,7234,Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.,Enterobacteraerogenes,1657
VRIHISGSSLGWLIQLFRKRIESLLQKS,359,78,7235,Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.,Enterobacteraerogenes,1658
KWKARKNFIKGSSLGWLIQLFRKR,359,78,7236,Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.,Enterobacteraerogenes,1659
KKHRKHRKHRKHGGSGGSKNLRRIIRKGIHIIKKYG,360,3,7239,"Stability and activity in sputum of G10KHc, a potent anti-Pseudomonas antimicrobial peptide.",Pseudomonasaeruginosa,1660
RAGLQFPVGKLLKKLLKRLKR,361,8,7241,High-level expression of an antimicrobial peptide histonin as a natural form by multimerization and furin-mediated cleavage.,Bacillussubtilis,1544
RRWYRWWR,362,79,7292,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,690
RRWYRWWRRRWYRWWR,362,79,7293,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,691
RWWRWWRRWWRWWR,362,79,7295,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,692
YRWWRWARRW,362,79,7299,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,693
YRWWRWARRWYRWWRWARRW,362,79,7300,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,693
RRRRRRRWWWRRRRRRRR,362,79,7304,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,694
RRRRRRRRRRRRRRRWWW,362,79,7305,Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.,HSV-1,695
KIGAKIKIGAKIKIGAKI,363,8,7385,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,1661
LGGAATGVIGYISNQTCPTTACTRAC,363,8,7389,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,1662
KLKHVGLHVGKLK,364,3,7404,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa,1663
KHVGKAALTHYL,364,3,7405,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa,1664
KKAAHVGKHVGKAAKK,364,3,7406,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa,1560
KKAAHVGKHVGKAAL,364,3,7407,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa,1560
GWGSFFKKAAHVG,364,3,7408,"Antimicrobial activity of pleurocidin is retained in Plc-2, a C-terminal 12-amino acid fragment.",Pseudomonasaeruginosa,387
RRRPRPPYLPRPRPPPFFPPRL,365,2,7469,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
RRRPRPPYLPRPRPPPFF,365,2,7470,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
RRRPRPPYLPRPRPP,365,2,7471,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
PFFPPRLPPRIPPGFPPRFPPRFP,365,2,7472,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
PRLPPRIPPGFPPRFPPRFP,365,2,7473,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
PRIPPGFPPRFPPRFP,365,2,7474,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
VDKPPYLPRPPPPRRIYNNR,366,2,7475,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VDKPPYLPRPTPPRRIYNNR,366,2,7476,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VDKPPYLPRPHPPRRIYNNR,366,2,7477,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VDKPPYLPRPKPPRRIYNNR,366,2,7478,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VDKPPYLPRPRPPRRIYNNR,366,2,7479,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VDKPPYLPRPRPPRRIYNRN,366,2,7481,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VDKPPYLPRPRPPRRIYNR,366,2,7483,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
GFCWNVCVYRNGVRVCHRRCN,367,2,7485,Recombinant production of the antimicrobial peptide NZ17074 in Pichia pastoris using SUMO3 as a fusion partner.,Escherichiacoli,174
VDKPPYLPRPRPPRRIYN,366,2,7488,Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.,Escherichiacoli,1787
VYQHQKAMKPWIQPKTKVIPYVRYL,368,19,7503,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
KAMKPWIQPKTKVIPYVRYL,368,19,7504,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPYVRYL,368,19,7505,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
KAMKPWIQPKTKVIP,368,19,7506,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
AIQPKTKVIPYVRYL,368,19,7507,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WAQPKTKVIPYVRYL,368,19,7510,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIAPKTKVIPYVRYL,368,19,7511,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQAKTKVIPYVRYL,368,19,7512,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPATKVIPYVRYL,368,19,7513,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKAKVIPYVRYL,368,19,7514,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTAVIPYVRYL,368,19,7515,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKAIPYVRYL,368,19,7516,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVAPYVRYL,368,19,7517,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIAYVRYL,368,19,7518,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPAVRYL,368,19,7519,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPYARYL,368,19,7520,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPYVAYL,368,19,7521,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPYVRAL,368,19,7522,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPYVRYA,368,19,7523,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPYV,368,19,7524,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIP,368,19,7526,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPATAVIPYVAYL,368,19,7527,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPATAVIPYVRYL,368,19,7530,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPATKVIPYVAYL,368,19,7532,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQAKTKVIAYVRYL,368,19,7534,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
TKVIPYVRYL,368,19,7535,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1666
WIQPKTKVIPAVRAL,368,19,7537,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1685
WIQPKTKVIPWWWWW,368,19,7538,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1665
TKVIPYVRYLWWWWW,368,19,7539,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1666
WIQPKTKVIPFFFFF,368,19,7540,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1665
TKVIPYVRYLFFFFF,368,19,7541,Structure-activity relationship of synthetic variants of the milk-derived antimicrobial peptide ?s2-casein f(183-207).,Cronobactersakazakii,1666
TKNYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC,369,18,7543,Improved Antimicrobial Activities of Synthetic-Hybrid Bacteriocins Designed from Enterocin E50-52 and Pediocin PA-1.,Micrococcusluteus,649
KYYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA,369,18,7544,Improved Antimicrobial Activities of Synthetic-Hybrid Bacteriocins Designed from Enterocin E50-52 and Pediocin PA-1.,Micrococcusluteus,2101
QPEWFKARRWQWRMKKLGA,370,2,7545,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli,696
TISQPEWFKARRWQWRMKKLGA,370,2,7546,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli,696
TISQAEWFKARRWQWRMKKLGA,370,2,7547,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli,696
TASQAEWFKARRWQWRMKKLGA,370,2,7548,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli,696
EWFKARRWQWRMKKLGA,370,2,7549,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli,114
EWFKARRWGWRMKKLQA,370,2,7550,Designed low amphipathic peptides with alpha-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism.,Escherichiacoli,2029
KGCALVKVRGLTLKVCK,371,3,7557,In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Pseudomonasaeruginosa,1667
KWCRKWQWRGVKFIKCV,371,3,7558,In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Pseudomonasaeruginosa,1668
HKCAKIKWRGVHVKYCA,371,3,7559,In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.,Pseudomonasaeruginosa,1669
RWRLLLLKKH,372,50,7565,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecium,697
RWRLLLLKKR,372,52,7566,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,698
RWRLLLLKKF,372,52,7567,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,699
HWRLLLLKKH,372,50,7568,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecium,700
RWRLLLLKRH,372,52,7569,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,697
RWRLLLLKWH,372,52,7570,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,701
RWRLLLLLRWR,372,52,7571,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,702
RWRLLGLLKRH,372,52,7572,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,703
RWRLLLLLKRH,372,52,7573,Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.,Enterococcusfaecalis,704
ELDRICGYGTARRKKCR,373,2,7574,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli,1253
ELDRIGYGTARCRKKCR,373,2,7575,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli,705
ELDRICGYGTARCRKKR,373,2,7576,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli,1253
ELCDRICGYGTARCRKKCR,373,2,7577,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli,1253
ELCCDRIGCYTARCRKKRSCCL,373,2,7578,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli,706
KRSQEYRIGRCPNTYACLKR,373,2,7579,Antimicrobial activity of human ?-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.,Escherichiacoli,1253
NGVQPKYRWWRWWRRWW,374,56,7584,Improving the antibacterial activity and selectivity of an ultra short peptide by hydrophobic and hydrophilic amino acid stretches.,Staphylococcusepidermidis,1670
NGVQPKYRWWRWWRRWWW,374,56,7585,Improving the antibacterial activity and selectivity of an ultra short peptide by hydrophobic and hydrophilic amino acid stretches.,Staphylococcusepidermidis,1670
KESRAKKFQRQHMDSDSSPSSSSTYSNQMMRRRNMTQGRSKPVNTFVH,375,2,7639,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,707
KPPQFTWAQWFETQHINMTSQQSTNAMQVINNYQRRSKNQNTFLL,375,2,7640,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,1884
RPPQFTRAQWFAIQHISLNPPRSTIAMRAINNYRWRSKNQNTFL,375,2,7641,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,1884
QDGMYQRFLRQHVHPEETGGSDRYSNLMMQRRKMTLYHSKRFNTFIH,375,2,7642,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,708
QDNSRYTHFLTQHYDAKPQGRDDRYSESIMRRRGLTSPSKDINTFIH,375,2,7643,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,709
WPKRLTKAHWFEIQHIQPSPLQSNRAMSGINNYTQHSKHQNTFLH,375,2,7644,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,1648
KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH,375,2,7645,Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus.,Escherichiacoli,1648
GLFRALLRLLRSLWRLLLRA,377,42,7655,Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.,Salmonellatyphimurium,710
GLRRALLRLLRSLRRLLLRA,377,42,7656,Selectivity for and destruction of Salmonella typhimurium via a membrane damage mechanism of a cell-penetrating peptide ppTG20 analogue.,Salmonellatyphimurium,710
SAVGRHLRRFGLRKHRKH,378,2,7659,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,711
SAVGRHLRRFLLRKHRKH,378,2,7660,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,711
SAVLRHLRRFLLRKHRKH,378,2,7661,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,711
SKVGRHGRRFGHRAHRKL,378,2,7662,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,515
SKVGRHLRRFGHRAHRKL,378,2,7663,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,515
SKVGRHLRRFLHRAHRKL,378,2,7664,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,515
SKVLRHLRRFLHRAHRKL,378,2,7665,"Rational design of anti-microbial peptides with enhanced activity and low cytotoxicity based on the structure of the arginine/histidine-rich peptide, chensinin-1.",Escherichiacoli,515
GLARALTRLLRQLTRQLTRA,379,42,7672,Antibacterial activity and dual mechanisms of peptide analog derived from cell-penetrating peptide against Salmonella typhimurium and Streptococcus pyogenes.,Salmonellatyphimurium,712
VQWRIRVCVIRA,380,4,7675,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1819
VQWRIRIAVIRA,380,4,7676,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1820
VCWRIRVAVIRA,380,4,7677,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1821
VQLRIRVCVIRR,380,4,7678,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1822
KQWRIRVAVIRA,380,4,7679,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1820
VQWRIRVAVIRK,380,4,7680,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1820
VQLRIRVCVIRK,380,4,7681,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1822
KQWRIRVCVIRA,380,4,7682,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1819
VQLRCRVCVIRK,380,4,7683,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1823
VQWRIRIAVIRK,380,4,7684,In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method.,Staphylococcusaureus,1820
KFFKKLKKAVKKGFKKFAKV,381,2,7702,Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.,Escherichiacoli,1694
RCPGRTRQIGTIFGPRIKCRSW,382,2,7703,N-terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine ?-defensin-2 results in salt-resistant antibacterial activity.,Escherichiacoli,677
LVQRFHAYLHKFREAFMNVGAAAAVEGTKAA,383,80,7717,Probing protein sequences as sources for encrypted antimicrobial peptides.,Xanthomonasaxonopodis,713
GLWSTIKQKGKE,383,80,7732,Probing protein sequences as sources for encrypted antimicrobial peptides.,Xanthomonasaxonopodis,714
HRILMRIRQMMT,384,81,7748,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
ARILMRIRQMMT,384,81,7749,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1825
HRALMRIRQMMT,384,81,7750,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRIAMRIRQMMT,384,81,7751,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRILARIRQMMT,384,81,7752,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRILMRARQMMT,384,81,7753,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRILMRIAQMMT,384,81,7754,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRILMRIRAMMT,384,81,7755,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRILMRIRQAMT,384,81,7756,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1826
HRILMRIRQMAT,384,81,7757,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
HRILMRIRQMMA,384,81,7758,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1824
LMRIRQMMT,384,81,7759,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1827
HRILMRIR,384,81,7760,Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.,Porcinereproductive,1828
GGLFYVKHKEQQRKRF,157,8,7762,"Macrobrachium rosenbergii mannose binding lectin: Synthesis of MrMBL-N20 and MrMBL-C16 peptides and their antimicrobial characterization, bioinformatics and relative gene expression analysis.",Bacillussubtilis,1829
GFGCNGPWQEDDVKCHNHCKSIKGYKGGYCAKGGFVCKCY,385,4,7764,"In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus.",Staphylococcusaureus,1467
IAAAGLPQE,386,19,7771,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1830
AKHQGLPQE,386,19,7772,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1831
IKHQGLPQA,386,19,7773,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1832
IKHAGLPQE,386,19,7774,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1833
IKHRGLPQE,386,19,7780,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1834
IKHQGRPQE,386,19,7782,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1835
IRHQGLPQE,386,19,7784,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1549
IRRQGLPE,386,19,7786,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1836
IHHQGLPQE,386,19,7788,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1837
IKQGLPQE,386,19,7789,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1838
IHQGLPQE,386,19,7792,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1839
IKHQGLPQEE,386,19,7793,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1840
IKHQGLPQED,386,19,7795,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1841
VLNENLAA,386,19,7798,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1842
VLNENLRR,386,19,7801,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1843
VLNENAAR,386,19,7802,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1844
VINENLLR,386,19,7803,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1845
VLNANLLR,386,19,7804,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1846
VLNEALLR,386,19,7805,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1847
VLNENLLH,386,19,7806,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1848
VLNENARL,386,19,7807,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1849
VALNENLLR,386,19,7808,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1850
VLNDNLLR,386,19,7809,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1851
VLNENLLK,386,19,7810,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1550
VANENLLR,386,19,7813,Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.,Cronobactersakazakii,1852
SFKKFWGGVKAIFKGARKGWK,387,2,7819,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli,992
FFKKFWGGVKAIFKGARKGWK,387,2,7820,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli,992
SVKKFWGGVKAIFKGARKGLK,387,2,7821,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli,992
FVKKFWGGVKAIFKGARKGLK,387,2,7824,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli,992
GWGDTFGKVLKNFAKVAGVKAAK,387,2,7827,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli,715
GWGDTFLKTMAKIAKVGPKLLHS,387,2,7830,Identification of antimicrobial peptides from teleosts and anurans in expressed sequence tag databases using conserved signal sequences.,Escherichiacoli,716
RKSKEKIGKEFKRIVQRIKDF,388,2,7832,Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.,Escherichiacoli,635
LLGDFFRKSKEKIGKEFKRIVQR,389,2,7837,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli,635
LLGDFFRKAKEKIGKEFKRIVQR,389,2,7838,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli,635
LLGDFFRKVKEKIGKEFKRIVQR,389,2,7839,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli,635
LLGDFFRKAKEKIGKEFKRIVQRIKDFLRNLVPRTES,389,2,7840,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli,635
LLGDFFRKVKEKIGKEFKRIVQRIKDFLRNLVPRTES,389,2,7841,"Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins.",Escherichiacoli,635
RGCVYAYVRVRGVLVRYRRCW,390,4,7856,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RSCVYAYVRVRGVLVRYRRCW,390,4,7857,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RRCVYAYVRVRGVLVRYRRCW,390,4,7858,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCGYAYVRVRGVLVRYRRCW,390,4,7859,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCSYAYVRVRGVLVRYRRCW,390,4,7860,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCRYAYVRVRGVLVRYRRCW,390,4,7861,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYGYVRVRGVLVRYRRCW,390,4,7864,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYSYVRVRGVLVRYRRCW,390,4,7865,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYRYVRVRGVLVRYRRCW,390,4,7866,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYGRVRGVLVRYRRCW,390,4,7867,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYSRVRGVLVRYRRCW,390,4,7868,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYRRVRGVLVRYRRCW,390,4,7869,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRGRGVLVRYRRCW,390,4,7870,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKGVCICRKTSFKDLWDKRF,392,4,7872,"Structure and antimicrobial activity relationship of royalisin, an antimicrobial peptide from royal jelly of Apis mellifera.",Staphylococcusaureus,795
VTCDLLSFKGQVNDSACAANCLSLGKAGGHCEKGVCICRK,392,4,7873,"Structure and antimicrobial activity relationship of royalisin, an antimicrobial peptide from royal jelly of Apis mellifera.",Staphylococcusaureus,795
RWCVYAYVRSRGVLVRYRRCW,390,4,7877,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRRRGVLVRYRRCW,390,4,7879,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGGLVRYRRCW,390,4,7880,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGSLVRYRRCW,390,4,7881,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGRLVRYRRCW,390,4,7882,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVGVRYRRCW,390,4,7883,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVSVRYRRCW,390,4,7884,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVRVRYRRCW,390,4,7885,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVLGRYRRCW,390,4,7897,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVLSRYRRCW,390,4,7899,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVLRRYRRCW,390,4,7900,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVLVRYRRCG,390,4,7902,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVLVRYRRCS,390,4,7903,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
RWCVYAYVRVRGVLVRYRRCR,390,4,7905,Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.,Staphylococcusaureus,1976
NTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,393,4,7910,N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.,Staphylococcusaureus,2012
QKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,393,4,7912,N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.,Staphylococcusaureus,2012
KKLFKKILKYL,394,80,7913,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,2697
KKLFKKILKYLAGPA,394,80,7918,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLKDEL,394,80,7919,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLKKLFKKILKYL,394,80,7920,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,718
KKLFKKILKYLAGPAKKLFKKILKYL,394,80,7921,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
GKKLFKKILKYLAGPAKKLFKKILKYL,394,80,7922,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
SKKLFKKILKYLAGPAKKLFKKILKYL,394,80,7923,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLAGPAKKLFKKILKYLAGPA,394,80,7924,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLKKLFKKILKYLKDEL,394,80,7926,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,718
KKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7928,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLAGPALYKLIKKFLKKKDEL,394,80,7929,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
GKKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7930,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
SKKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7931,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLAGPAKKLFKKILKYLAGPAKDWEHLKDWEHLKDWEHLKDEL,394,80,7932,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLKKLFKKILKYLKKLFKKILKYL,394,80,7933,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,718
KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYL,394,80,7934,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLAGPAKKLFKKILKYLAGPAKKLFKKILKYLKDEL,394,80,7935,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KDWEHLKDWEHLKDWEHL,394,80,7936,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KDWEHLKDWEHLKDWEHLKDEL,394,80,7937,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLTTGLPALISW,394,80,7938,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,720
KKLFKKILKYLAGPATTGLPALISW,394,80,7939,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
GKKLFKKILKYLAGPATTGLPALISW,394,80,7940,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
SKKLFKKILKYLAGPATTGLPALISW,394,80,7941,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLTTGLPALISWKDEL,394,80,7942,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,720
KKLFKKILKYLAGPATTGLPALISWKDEL,394,80,7943,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLGIGAVLKVLTTGLKDEL,394,80,7944,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,719
KKLFKKILKYLTTGLPALISAGPASILAPLGTTLYKLIKKFLKKKDEL,394,80,7945,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,720
KKLFKKILKYLKFLHSAK,394,80,7947,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,719
KKLFKKILKYLAGPAKFLHSAK,394,80,7949,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
GKKLFKKILKYLAGPAKFLHSAK,394,80,7950,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
SKKLFKKILKYLAGPAKFLHSAK,394,80,7951,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLKFLHSAKKDEL,394,80,7952,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,719
KKLFKKILKYLAGPAKFLHSAKKDEL,394,80,7954,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLAGPAKFLHSAKAGPAKDWEHLKDWEHLKDWEHLKDEL,394,80,7955,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLGIGKFLHSAK,394,80,7956,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,719
KKLFKKILKYLAGPAGIGKFLHSAK,394,80,7958,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
GKKLFKKILKYLAGPAGIGKFLHSAK,394,80,7959,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
SKKLFKKILKYLAGPAGIGKFLHSAK,394,80,7960,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLGIGKFLHSAKKDEL,394,80,7961,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,719
KKLFKKILKYLAGPAGIGKFLHSAKKDEL,394,80,7962,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
KKLFKKILKYLAVAVVGQATQIAKKDEL,394,80,7963,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,2096
KKLFKKILKYLAGPAVAVVGQATQIAKKDEL,394,80,7964,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,2096
AVAVVGQATQIAKKKLFKKILKYLKDEL,394,80,7965,Derivatives of the antimicrobial peptide BP100 for expression in plant systems.,Xanthomonasaxonopodis,717
SPEEARVKILTAIPEMREEDLSEE,395,2,7996,"Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",Escherichiacoli,721
SKHWLWLW,396,4,8096,"Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.",Staphylococcusaureus,1853
RRGWLALRLVLAY,397,2,8100,A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.,Escherichiacoli,722
SKVWRHWRRFWHRAHRKK,398,2,8105,Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b.,Escherichiacoli,515
KYLNFAKWLKGANLAKYANA,399,82,8108,Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy.,Humangastric,1854
RRRRWWWW,400,4,8109,Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.,Staphylococcusaureus,1855
EEEEWWWW,400,4,8112,Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogens.,Staphylococcusaureus,1856
CNGRCGGKLAKLAKKLAKLAK,401,83,8125,An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.,Humanfibrosarcoma,1150
VTCDLLSAEAKGVKVNHAACAAHCLLKRKRGGYCNKRRICVCRN,402,4,8150,A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus.,Staphylococcusaureus,1468
KFFARLLASVRAAVKKFRKKPRLIGLSTLL,403,2,8158,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli,723
AFFARLLASVRAAVKAFAKKPRLIGLSTLL,403,2,8159,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli,723
LKKLKGRVSRSFLFFVKLRPAKRTLKKRIL,403,2,8160,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli,724
YSLKKTSMKIIPFTRL,404,2,8164,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,725
KKTSMKIIPFTRL,404,2,8165,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,725
PPPVIKFNRPFLMWIVERDTRSILFMGKIVNPKAP,404,2,8166,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,726
LQTKLKKLLGLESVF,404,2,8167,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,727
PPGASPRKKPRKQ,404,2,8168,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,728
VERIPLVRFKSIKKQLHERGDL,404,2,8169,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,729
YPYYGTNLYQRRPAIAINNPYVPRTYYANPAVVRPHAQIPQRQYLPNSHPPTVVRRP,405,7,8172,Identification of multifunctional peptides from human milk.,Streptococcusmutans,1857
PCRGRSCGPRLRGGYTLIGRPVKNQNRPKYMWV,406,2,8202,A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria.,Escherichiacoli,1022
GIGAVLKVLTTGLCALISWIKRKRQQ,407,4,8209,Melittin peptides exhibit different activity on different cells and model membranes.,Staphylococcusaureus,1858
YWKKWKKLRRIFMLV,408,2,8214,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,730
WWKRWKKLRRIFLML,408,2,8215,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,730
WWKRWKRIRRIFMMV,408,2,8216,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,731
WWKWWKRLRRLFLLV,408,2,8217,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,732
KWKLFKGIRAVLKVL,408,2,8218,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,500
GWRLIKKILRVFKGL,408,2,8219,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,733
KWKLFLGILAVLKVL,408,2,8220,Machine learning assisted design of highly active peptides for drug discovery.,Escherichiacoli,500
RPHGAGEGIDRVPAGPSPSEVGLAIPSGK,409,51,8267,Novel antimicrobial peptide specifically active against Porphyromonas gingivalis.,Porphyromonasgingivalis,1859
KWKLFKKIFKRIVQRIKDFLR,410,74,8268,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis,1861
KWKLFKKIAKKFAKAFVAEIM,410,74,8269,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis,1860
FKRIVQRIKDFLRGIGKFLHSAKKF,410,74,8270,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis,2048
GIGKFLHSAKKFFKRIVQRIKDFLR,410,74,8271,"Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.",Bacillusanthracis,1861
HLNKRVQRELIGWLDWLK,411,84,8278,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from ?-amylase of rice.,Eikenellacorrodens,1862
DNRMVNHFVQEFKRKHKK,412,51,8279,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from heat shock protein 70 of rice.,Porphyromonasgingivalis,1863
SQRQATKDAGVIS,412,51,8280,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from heat shock protein 70 of rice.,Porphyromonasgingivalis,1864
RARFEELNMDLFRR,412,51,8281,Antimicrobial activity and mechanism of action of a novel cationic ?-helical octadecapeptide derived from heat shock protein 70 of rice.,Porphyromonasgingivalis,1865
ACPIFTKIQGTYRGKAKRIGRRIC,413,2,8283,A hybrid cationic peptide composed of human ?-defensin-1 and humanized ?-defensin sequences exhibits salt-resistant antimicrobial activity.,Escherichiacoli,734
KGIRGYKGGYCKGAFKQTCKCY,414,8,8286,Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi.,Bacillussubtilis,2331
KGIRGYKGGYKGAFKQTKY,414,8,8287,Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi.,Bacillussubtilis,1866
CGNFLKRTCICVKK,415,17,8299,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2327
CSGIIKQTCTCYRK,415,17,8303,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2331
CNGPFNIVCSCY,415,17,8305,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2329
GFLSILKKVLP,416,1,8333,Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity.,None_target,464
FRKSKEKIGKEFKRI,417,85,8343,The ATPase activity of the mycobacterial plasma membrane is inhibited by the LL37-analogous peptide LLAP.,Mycobacteriumsmegmatis,635
GRKSAKKIGKRAKRI,417,85,8344,The ATPase activity of the mycobacterial plasma membrane is inhibited by the LL37-analogous peptide LLAP.,Mycobacteriumsmegmatis,735
MWITNGGVANWYFVLAR,418,4,8350,"Isolation, purification, and detection of the antimicrobial activity of the antimicrobial peptide CcAMP1 from Coridius chinensis (Hemiptera: Dinidoridae)",Staphylococcusaureus,465
GYLEQLLR,419,2,8358,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,736
LGYLEQLLR,419,2,8359,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,737
YLEQLLRL,419,2,8360,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,738
YLEQLLRLK,419,2,8361,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,739
LGYLEQLLRL,419,2,8362,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,740
LEQLLRLKKY,419,2,8363,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,741
LEQLLRLK,419,2,8364,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,742
HIQKEDVPSERYLGYLEQLLRLK,419,2,8365,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,743
HIQKEDVPSERYLGYLEQLLRLKK,419,2,8366,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,743
HIQKEDVPSERYLGYLEQLLRLKKYK,419,2,8367,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,743
NENLLRFF,419,2,8368,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,744
LNENLLRF,419,2,8369,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,745
RPKHPIKHQGLPQEVLNENLLRFF,419,2,8370,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2360
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGK,419,2,8371,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2360
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGKEK,419,2,8375,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2360
RPKHPIKHQGLPQEVLNENLLRFFVAPFPEVFGKEKV,419,2,8376,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2360
YPELFRQF,419,2,8377,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2361
IVLNPWDQVK,419,2,8378,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2362
TKLTEEEKNRLNFLKKISQRYQ,419,2,8379,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2363
TVYQHQKAMKPWIQPKTKVIPYVRYL,419,2,8380,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,1685
TKLTEEEKNRLNFLKKISQRYQKFALPQYLK,419,2,8381,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2363
VPYPQRDMPIQAFL,419,2,8382,Virtual screening of a milk peptide database for the identification of food-derived antimicrobial peptides.,Escherichiacoli,2364
GIGKALHSAKKFGKAFVGEIMNS,420,2,8388,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFAHSAKKFGKAFVGEIMNS,420,2,8389,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFLHSAKKAGKAFVGEIMNS,420,2,8390,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFLHSAKKFAKAFVGEIMNS,420,2,8391,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFLHSAKKFGKAAVGEIMNS,420,2,8392,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFLHSAKKFGKAFAGEIMNS,420,2,8393,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFLHSAKKFGKAFVAEIMNS,420,2,8394,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
GIGKFLHSAKKFGKAFVGEAMNS,420,2,8395,Influence of hydrophobic residues on the activity of the antimicrobial peptide magainin 2 and its synergy with PGLa.,Escherichiacoli,13
FFGWLIKGAIHAGKAIHGLI,421,86,8421,Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model.,Helicobacterpylori,991
FWGFLGKLAMKAVPSLIGGNKSSSK,422,4,8439,Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity.,Staphylococcusaureus,466
FWGFLGKLAMKAVPSLIGGNKK,422,4,8440,Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity.,Staphylococcusaureus,466
WGIRRILKYGKRS,424,2,8497,Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Escherichiacoli,2365
WGIRDILKYGKPS,424,2,8499,Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Escherichiacoli,2365
WGIHRILKYGKPS,424,2,8501,Structural insights into and activity analysis of the antimicrobial peptide myxinidin.,Escherichiacoli,2365
SKCKCSRKGPKIR,425,2,8502,CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.,Escherichiacoli,2366
LQSTKRFIKWYNAWNEKRR,425,2,8503,CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.,Escherichiacoli,2367
YSDVKKLEMKPKYPHCEEKMVIITTKSVSRYRGQEHCLHPK,425,2,8504,CXCL14 displays antimicrobial activity against respiratory tract bacteria and contributes to clearance of Streptococcus pneumoniae pulmonary infection.,Escherichiacoli,2368
RRIRPRPPRLPRPRPC,426,2,8508,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli,2710
RRIRPRPPRLPRPC,426,2,8510,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli,2710
RRIRPRPR,426,2,8512,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli,2369
RRIRPRPRC,426,2,8513,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli,2370
IRPRPPRLPRPRPRPLPYPRP,426,2,8515,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli,2710
RRIRPRPPRLPRPRPRPLPYPRP,426,2,8517,Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7.,Escherichiacoli,2710
ACYCRIPACIAGERRYGTCIYQGRLWAFCC,363,8,8589,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,425
DSHAKRHHGTKRKFHEKHHSHRGT,427,65,8605,De-novo design of antimicrobial peptides for plant protection.,Botrytiscinerea,1899
FLGMLLHGVGHAIHGLIHGKQNVE,428,2,8611,"Molecular, genomic, and expressional delineation of a piscidin from rock bream (Oplegnathus fasciatus) with evidence for the potent antimicrobial activities of Of-Pis1 peptide.",Escherichiacoli,2371
ALKYRLFKKLKKF,429,4,8641,In vitro determination of the short-chain synthetic peptide RP13 antimicrobial activity.,Staphylococcusaureus,467
VAVLVLGA,430,52,8642,Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.,Enterococcusfaecalis,2372
IVSSMFVSA,430,52,8643,Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.,Enterococcusfaecalis,2373
LLLGAATG,430,52,8644,Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains.,Enterococcusfaecalis,2374
KLRKLFRKLLKLIRKLLR,431,67,8646,Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.,Yersiniaruckeri,404
RGRKVVRRKK,432,77,8647,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,Klebsiellapneumoniae,2375
RGRKVVRR,432,1,8656,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,None_target,468
RGRKGGRRKK,432,77,8674,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,Klebsiellapneumoniae,2376
RGRKGGRR,432,1,8683,N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide Permeabilization.,None_target,469
GTVRRFPWWWPFLRR,433,2,8709,"Recombinant expression, antimicrobial activity and mechanism of action of tritrpticin analogs containing fluoro-tryptophan residues.",Escherichiacoli,2256
GEGFLGMLLHGVGHAIHGLIHGK,434,2,8752,"Piscidin: Antimicrobial peptide of rock bream, Oplegnathus fasciatus.",Escherichiacoli,2371
LLSNVAGLLKQFAK,435,2,8769,Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides.,Escherichiacoli,2722
LLRRVAGLLKQFAK,435,2,8770,Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides.,Escherichiacoli,2377
LLRRVARLLKRFAK,435,2,8771,Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides.,Escherichiacoli,2378
CAIEHMRTPLKPFSFGPPYNL,436,8,8779,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,470
PPYNLNSHTQEYSKPEDTFD,436,8,8780,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,471
DTFDYKKFGYRYDSLELEGR,436,8,8781,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,472
LEGRSISRIDELIQQRQEKD,436,8,8782,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,474
QEKDRTFAGFLLKGFGTSAS,436,8,8783,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,473
KFGYRYDSLELEGRSISRIDELIQQR,436,8,8784,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,474
TSASVSLQVCRVDHTCKDAGYF,436,8,8785,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,475
YFTILGGSAEMPWAFDRLYKYDITKTL,436,8,8786,Identification of candidate antimicrobial peptides derived from abalone hemocyanin.,Bacillussubtilis,476
TLISWIKNKRKQRPRVSRRRRRRGGRRRR,437,3,8787,Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate.,Pseudomonasaeruginosa,1031
KNKRKRRRRRRGGRRRR,437,3,8788,Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate.,Pseudomonasaeruginosa,477
GPIRRPKPRPRPRPE,438,34,8791,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus,1087
GPIRRPKPRPRQRPE,438,34,8792,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus,478
GPIRRPKPRPRPE,438,34,8793,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus,479
GPIRRPEPRPRPE,438,34,8794,"Expression, tissue localization and synergy of antimicrobial peptides and proteins in the immune response of the oyster Crassostrea gigas.",Micrococcuslysodeikticus,1087
HTASDAAAAAALTAANAAAAAAASMA,439,2,8795,Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus.,Escherichiacoli,2379
VDRGWGNGCGLFGKGG,440,2,8809,"Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.",Escherichiacoli,1429
VARGWGNGCGLFGKGG,440,2,8810,"Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.",Escherichiacoli,1429
VARGWKRKCPLFGKGG,440,2,8811,"Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control.",Escherichiacoli,1429
LAAKLTKAATKLTAALTKLAAALT,441,52,8814,A polyalanine peptide derived from polar fish with anti-infectious activities,Enterococcusfaecalis,167
WKKILSKIKKLLK,442,4,8829,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,480
IKKWLSKIKKLLK,442,4,8830,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,481
IKKIWSKIKKLLK,442,4,8831,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,482
IKKILSKIKKWLK,442,4,8832,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,483
IKKILSKIKKLWK,442,4,8833,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,484
IKKIWSKIKKWLK,442,4,8840,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,483
IKKIWSKIKKLWK,442,4,8841,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,482
IKKILSKIKKWWK,442,4,8842,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,483
IKKIWSKIKKWWK,442,4,8843,Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action.,Staphylococcusaureus,483
GFGCNGPWSEKDMHCHNHCKSIKGYKGGYCAKGGFICKCY,443,4,8870,Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus.,Staphylococcusaureus,1467
GIGAVLKVLTTGLPALKSWIKRKRQQ,444,17,8871,Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants.,Listeriamonocytogenes,2501
IIGAVLKVLTTGLPALISWIKRKRQQ,444,17,8872,Characterization of antimicrobial activity against Listeria and cytotoxicity of native melittin and its mutant variants.,Listeriamonocytogenes,2501
GWWRRTVDKVRNAGRKVAGFASKACGALGH,445,8,8873,"Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications.",Bacillussubtilis,485
WGHKLRSSWNKVKHAVKKGAGYASGACRVLGH,445,8,8878,"Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications.",Bacillussubtilis,486
WWRRRRRRRR,446,4,8884,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus,487
WWWRRRRRRRR,446,4,8885,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus,488
WWWWRRRRRRRR,446,4,8886,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus,489
RRRRWWWWRRRR,446,4,8887,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus,490
RWRRWRRWRRWR,446,4,8888,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus,491
WRRRRRRRR,446,4,8889,Membrane interaction and secondary structure of de novo designed arginine-and tryptophan peptides with dual function.,Staphylococcusaureus,492
PMLRVRLASHLRKLRKRLLR,447,2,8920,A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells.,Escherichiacoli,1407
LRVRLASHLRKLRKRLLR,447,2,8921,A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells.,Escherichiacoli,1407
PGKYGFYTHVFRLKKWIQKVI,447,2,8925,A new cryptic cationic antimicrobial peptide (AMP) from human apolipoprotein E with anti-bacterial activity and immunomodulatory effects on human cells.,Escherichiacoli,1470
GLPGPLGPAGPK,448,87,8929,"Collagencin, an antibacterial peptide from fish collagen: Activity, structure and interaction dynamics with membrane.",Listeriainnocua,493
KRKILILIKRK,449,2,8931,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2380
KRKILILILIL,449,2,8932,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2381
ILILILILKRK,449,2,8933,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2382
KRKILILIGSG,449,2,8934,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2383
GSGILILIKRK,449,2,8935,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2384
KRKSGSGSKRK,449,2,8936,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2385
GMAKLLAKVLPHVVKLIK,450,18,8944,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus,494
GMASKLAKVLPHVVKLIK,450,18,8945,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus,495
GMASLLAKVLPKVVKLIK,450,18,8946,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus,495
GMASLWAKVLPHVVKLIK,450,18,8947,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus,494
VKSWIRKLVHR,451,4,8949,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus,496
WLKGLIKFIR,451,4,8950,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus,497
KRRKWHSVVLI,451,4,8951,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus,498
EHMDRILAQLL,451,4,8952,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus,499
KWKLFKKIGAVLKVLTTG,451,4,8953,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus,500
WKLFLKAVKKLL,451,4,8954,Antimicrobial peptides design by evolutionary multiobjective optimization.,Staphylococcusaureus,501
RIKRFWPVVIRTVVAGYNLYRAIKK,452,2,8956,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYNLYRAIK,452,2,8957,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYNLYRAI,452,2,8958,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYNLYRA,452,2,8959,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYNLYR,452,2,8960,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYNLY,452,2,8961,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYNL,452,2,8962,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGYN,452,2,8963,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAGY,452,2,8964,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVVAG,452,2,8965,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
KRKRKILILIKRK,449,2,8966,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2386
RKRKILILIKRK,449,2,8967,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2387
RKILILIKRK,449,2,8968,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2388
KILILIKRK,449,2,8969,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2389
ILILIKRK,449,2,8970,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,2390
VAKGLIKGVKAKGELPAKGVFKGLKESIGKRAVLKG,453,2,8975,Aedesin: structure and antimicrobial activity against multidrug resistant bacterial strains.,Escherichiacoli,2391
RIKRFWPVVIRTVVA,452,2,8976,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRTVV,452,2,8977,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,2392
RIKRFWPVVIRTV,452,2,8978,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RIKRFWPVVIRT,452,2,8979,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,2392
RIKRFWPVVIR,452,2,8980,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,2392
IKRFWPVVIRTVVAGYNLYRAIKKK,452,2,8981,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
KRFWPVVIRTVVAGYNLYRAIKKK,452,2,8982,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RFWPVVIRTVVAGYNLYRAIKKK,452,2,8983,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
FWPVVIRTVVAGYNLYRAIKKK,452,2,8984,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
WPVVIRTVVAGYNLYRAIKKK,452,2,8985,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
PVVIRTVVAGYNLYRAIKKK,452,2,8986,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
VVIRTVVAGYNLYRAIKKK,452,2,8987,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
VIRTVVAGYNLYRAIKKK,452,2,8988,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
IRTVVAGYNLYRAIKKK,452,2,8989,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
RTVVAGYNLYRAIKKK,452,2,8990,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
TVVAGYNLYRAIKKK,452,2,8991,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,95
VVAGYNLYRAIKKK,452,2,8992,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,2393
VAGYNLYRAIKKK,452,2,8993,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,2393
AGYNLYRAIKKK,452,2,8994,Structure-function relationship of antimicrobial peptide cathelicidin  Pc-CATH1,Escherichiacoli,2393
LKAAAAAAKLAAKAAKAALKAAAAAAKL,454,2,9012,Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2.,Escherichiacoli,2394
STLHLVLRLRGG,168,85,9024,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Mycobacteriumsmegmatis,503
RLGRLVSLHTLG,168,48,9025,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,502
ATLHLVLRLRGG,168,48,9026,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,503
SALHLVLRLRGG,168,48,9027,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,503
LKGCWTKSIPPKPCF,455,2,9028,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
STAHLVLRLRGG,168,48,9029,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,504
STLALVLRLRGG,168,48,9030,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,505
STLHAVLRLRGG,168,48,9031,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,506
STLHLALRLRGG,168,48,9032,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,507
STLHLVARLRGG,168,48,9033,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,508
STLHLVLALRGG,168,48,9034,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,509
CWTKSIPPKPCF,455,2,9035,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
STLHLVLRARGG,168,48,9036,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,510
STLHLVLRLAGG,168,48,9037,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,511
AALKGCWTKSIPPKPCFGF,455,2,9038,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
GCWTKSIPPKPCF,455,2,9039,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
STLHLVLRLRAG,168,48,9040,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,512
STLHLVLRLRGA,168,48,9041,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,513
LKGCWTKSIPPKPCFGK,455,2,9042,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
ALKGCWTKSIPPKPCFGK,455,2,9043,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
LKGCWTKSIPPKPCFG,455,2,9044,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
EVEPSDTIENVKAKIQ,168,48,9045,Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.,Bacillusmegaterium,514
LKGCWTKSIPPKPCFGF,455,2,9046,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
LKGCWTKSIPPKPCFGG,455,2,9047,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
CWTKSIPPKPC,455,2,9048,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
CWTKSIPPKPG,455,2,9049,Trypsin inhibitory loop is an excellent lead structure to design serine protease inhibitors and antimicrobial peptides,Escherichiacoli,2286
SKVWRHWRRFWHRAHRLH,456,4,9101,Structure-activity analysis and biological studies of chensinin-1b analogues ,Staphylococcusaureus,515
SKVWRHWRRFW,457,4,9104,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,515
SKVWRHWRRFWHR,456,4,9108,Structure-activity analysis and biological studies of chensinin-1b analogues ,Staphylococcusaureus,515
WPKRLTKAHWFEIQHIQPSPLQCNRAMSGINNYTQHCKHQNTFLH,458,2,9115,Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation.,Escherichiacoli,1648
KRKILILIKRKRK,459,2,9116,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2609
KRKILILIKRKR,459,2,9117,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2610
KRKILILIKR,459,2,9118,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2611
KRKILILIK,459,2,9119,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2612
KRKILILI,459,2,9120,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2613
GTFIKQQRKQKQQRHHTSGTRKRMAK,460,2,9124,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2614
ASITHVKNRGKYIYMHLKFRKTNVLI,460,2,9126,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2615
KKVWFIFHVCPKLKQRIL,460,2,9127,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2616
NYISFFRKCKNSQST,460,2,9128,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2617
GTKRGKLCRISRLAL,460,2,9129,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2618
MKTFLRLYRSLINKVLH,460,2,9131,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2619
VGRKHSILNCIPYLKKKKIMRL,460,2,9132,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2620
RMKLNAKKLSFC,460,2,9133,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2621
HNSSKQWSHWLWHNGIRI,460,2,9134,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,2622
KRKILILILIKRK,459,2,9135,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2623
KRKLILIKRK,459,2,9136,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2624
KRKILIKRK,459,2,9137,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2625
KRKLIKRK,459,2,9138,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2626
KRKGSGKRK,459,2,9142,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2627
VWRHWRRFWHR,456,4,9143,Structure-activity analysis and biological studies of chensinin-1b analogues ,Staphylococcusaureus,515
WRHWRRFWHR,457,4,9144,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,516
VWRHWRRFW,457,4,9145,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,517
VWRHWRRFWH,457,4,9146,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,515
RHWRRFWHR,457,4,9147,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,518
RHWRRFWH,457,4,9148,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,519
RRFWHRAH,457,4,9151,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,520
VWRKWRRFW,457,4,9153,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,521
VWRRWRRFW,457,4,9154,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,521
VWRKWRRFWKR,457,4,9155,Structure-activity analysis and biological studies of chensinin-1b analogues,Staphylococcusaureus,522
VWRRWRRFWRR,461,4,9156,Structure-activity analysis and biological studies of chensinin-1b analogues.,Staphylococcusaureus,522
GIGKFLKKAKKGIGAVLKVLTTGL,462,2,9158,"Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.",Escherichiacoli,2501
GIGKALKKAKKGIGAVLKVLTTGL,462,2,9159,"Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization.",Escherichiacoli,2501
RKRKLILILIKRKR,459,2,9161,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2628
KRKLILKRILIKRK,459,2,9162,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2629
RKLILKRKRILIKR,459,2,9163,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2630
KLILKRKRKRILIK,459,2,9164,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2631
LILKRKRKRKRILI,459,2,9165,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2632
RRRIIIIIRRR,459,2,9166,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2633
KKKIIIIIKKK,459,2,9167,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2634
RRRLLLLLRRR,459,2,9168,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2635
KKKLLLLLKKK,459,2,9169,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2636
RRRVVVVVRRR,459,2,9170,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2633
KKKVVVVVKKK,459,2,9171,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2637
RRRFFFFFRRR,459,2,9172,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2638
KKKFFFFFKKK,459,2,9173,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2639
KKKIIIIIIKKK,459,2,9174,Rational design of artificial β-strand-forming antimicrobial peptides with biocompatible properties,Escherichiacoli,2640
NKKAGLFVVQFPKKY,463,48,9191,"Design and synthesis of cationic antibacterial peptide based on Leucrocin I sequence, antibacterial peptide from crocodile (Crocodylus siamensis) white blood cell extracts",Bacillusmegaterium,523
KKKKQSWYAAAGDAIVSFGEG,464,1,9200,Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.,None_target,2342
AMAINNWVRVPPCDQVCSRSNPEKDECCRAHGHAFHAHCNGGMNCYRR,465,88,9209,"Characterization and regulation of expression of an antifungal peptide from hemolymph of an insect, Manduca sexta.",Listeriafleischmannii,2641
RTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRGFRRRCWCTKRC,466,89,9213,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,423
RTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRDDFQCWCTKRC,466,89,9214,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,423
GRCRDDFRCWCTKRC,466,89,9215,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,423
GRCRGFRRRCFCTTHC,466,89,9216,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,805
GRCRDDFRC,466,89,9217,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,2642
GRCRGFRRRC,466,89,9218,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,2643
GPCASDHNC,466,89,9222,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,2644
GLLKSLCKKFVKGHLGELIEELTTSDD,467,4,9227,"Identification, expression and antibacterial activities of an antimicrobial peptide NK-lysin from a marine fish Larimichthys crocea.",Staphylococcusaureus,524
VCNEIGLLKSLCKKFVKGHLGE,467,4,9228,"Identification, expression and antibacterial activities of an antimicrobial peptide NK-lysin from a marine fish Larimichthys crocea.",Staphylococcusaureus,525
SGKLCCRRKK,468,2,9229,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli,2645
FLGGLIKIVPAMICAVTKKCHHHHHH,469,4,9230,Secretory ranalexin produced in recombinant Pichia pastoris exhibits additive or synergistic bactericidal activity when used in combination with polymyxin B or linezolid against multi-drug resistant bacteria.,Staphylococcusaureus,526
SGKLYYRRKK,468,2,9231,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli,2646
SGKLWWRRKK,468,2,9232,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli,2647
SGKRWWRRKK,468,2,9233,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli,2648
RGKRWWRRKK,468,2,9234,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli,2649
RKKRWWRRKK,468,2,9236,"Design of Short Membrane Selective Antimicrobial Peptides Containing Tryptophan and Arginine Residues for Improved Activity, Salt-Resistance, and Biocompatibility",Escherichiacoli,2650
GRKKRRQRRRPPQ,470,2,9244,Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action.,Escherichiacoli,2651
GRKKRRQRRRPWQ,470,1,9246,Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action.,None_target,527
KKKFPWWWPFKKK,471,1,9313,"Effect of dimerization of a beta-turn antimicrobial peptide, PST13-RK, on antimicrobial activity and mammalian cell toxicity.",None_target,528
GRRPRPRPRP,472,4,9326,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,529
GRRPRPRPRPWWW,472,4,9327,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,530
GRRPRPRPRPWWWW,472,4,9328,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,531
GRRPRPRPRPWWWWW,472,4,9329,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,532
GRRPRPRPRPFFF,472,4,9333,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,533
GRRPRPRPRPFFFF,472,4,9334,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,534
GRRPRPRPRPFFFFF,472,4,9335,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,535
RRPRPRPRPFFFFF,472,4,9340,Highly selective end-tagged antimicrobial peptides derived from PRELP.,Staphylococcusaureus,536
TVVRRRGRSPRRRTPSPRRRRSQSPRRRRSQSRESQC,473,3,9344,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
TVVRRRGRSPRRRTPSPRRRRSQSPRRRR,473,3,9345,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
TVVRRRGRSPRRRTPSPRRRR,473,3,9346,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
TVVRRRGRSPRRR,473,3,9347,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,1443
GRSPRRRTPSPRRRRSQSPRRRRS,473,3,9348,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
RRRTPSPRRRRSQSPRRRRS,473,3,9349,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
RRRRSQSPRRRRS,473,3,9350,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
GRSPRRRTPSPRRRRSQSPRRRR,473,3,9351,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
SPRRRTPSPRRRRSQSPRRRR,473,3,9352,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
RRRTPSPRRRRSQSPRRRR,473,3,9353,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
SPRRRRSQSPRRRR,473,3,9354,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,1444
TVVRRRGRSPRRRTPSPRAARSQSPRAARSQSRESQC,473,3,9361,Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD).,Pseudomonasaeruginosa,2174
AAKIILNPKFRCFAAFC,474,2,9366,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli,2652
AVNIPFKVHLRCKAAFC,474,2,9367,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli,2539
AVNIPFKVHLRCFAAFC,474,2,9368,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli,2539
VHLRCKAAFC,474,2,9369,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli,2653
LKKLLKLLKKLLKLAG,475,2,9370,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli,2654
CKKLLKLCKKLLKLAG,475,2,9379,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli,2655
CKKLLKLLKKLCKLAG,475,2,9380,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli,2655
LKKLLKLCKKLCKLAG,475,2,9381,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli,2656
GIGAVLKVLTTGLPACISWCKRKRQQ,475,2,9385,Reduction of helical content by insertion of a disulfide bond leads to an antimicrobial peptide with decreased hemolytic activity.,Escherichiacoli,2501
EIEKFDKSKLK,476,4,9402,A peptide from human β thymosin as a platform for the development of new anti-biofilm agents for Staphylococcus spp. and Pseudomonas aeruginosa.,Staphylococcusaureus,1445
RRWVAWRNR,477,2,9436,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli,2657
RKWVAWRNR,477,2,9437,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli,2657
RWWVAWRNR,477,2,9438,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli,2658
RYWVAWRNR,477,2,9439,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli,2659
RKWVKWRNR,477,2,9440,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli,2660
RKWVYWRNR,477,2,9441,Improved antimicrobial activity of h-lysozyme (107-115) by rational Ala substitution.,Escherichiacoli,2661
KKVVFKVKFK,479,4,9471,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus,1446
FVVKKKKKVF,479,4,9477,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus,1447
FKVKFKVKVK,479,4,9478,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus,1448
LKVVFKVLFK,479,4,9479,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus,1449
KKVVFKVKFH,479,4,9480,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus,1450
HKVVFKVKFH,479,4,9481,Structure-activity relationship study: short antimicrobial peptides.,Staphylococcusaureus,1451
FFFLRRIF,480,2,9489,Structure-Activity Relationship-based Optimization of Small Temporin-SHf Analogs with Potent Antibacterial Activity,Escherichiacoli,2662
GSKKPVPIIYCNRRTGKCQRM,481,4,9490,The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro.,Staphylococcusaureus,1905
INLKILARLAKKIL,482,2,9494,Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.,Escherichiacoli,2663
RQIKIWFQNRRMKWKK,483,2,9524,Antimicrobial and cytolytic activities and plausible mode of bactericidal action of the cell penetrating peptide penetratin and its lys-linked two-stranded peptide.,Escherichiacoli,1409
KWKLFKKIFKRIVQRIKDFLRN,484,2,9530,Novel Hybrid Peptide Cecropin A (1-8)-LL37 (17-30) with Potential Antibacterial Activity.,Escherichiacoli,1861
ILSLRWRWKWWKK,485,41,9531,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,1452
ILSLRWWRKWWKK,485,41,9532,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,1452
ILSLRWRWWKWKK,485,41,9533,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,1452
IRKLKSWKWLRWL,485,41,9534,Combined Bioinformatic and Rational Design Approach To Develop Antimicrobial Peptides against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,1453
GWGRFFKKWWRVGKRVGK,486,7,9538,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1454
GWGRFFKKAARVGKRVGK,486,7,9542,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,387
GWGKFFKKAAKVGKKVG,486,7,9543,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,387
GWGKFFKKFFKVGK,486,7,9550,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1455
GWKKFFKKAAKVGK,486,7,9551,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,387
GWKKFFKKAKKVGK,486,7,9552,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1456
GWKKFFKKAKKVWK,486,7,9553,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1456
GWGKFFKKFFKFGK,486,7,9554,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1455
GWKKFFKKWKKVWK,486,7,9555,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1456
WGKFFKKFFKFGK,486,7,9556,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1455
WFKFFKKFFKKWK,486,7,9557,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1457
WGKFFKKFFKKGK,486,7,9566,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1455
FKFFKKFFKKWK,486,7,9567,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1457
FKFFKKFFKKW,486,7,9568,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1457
KFFKKFFKKW,486,7,9569,Pleurocidin congeners demonstrate activity against Streptococcus and low toxicity on gingival fibroblasts,Streptococcusmutans,1458
RKLKHMRF,487,4,9582,"A Head-to-Head Comparison of the Antimicrobial Activities of 30 Ultra-Short Antimicrobial Peptides Against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans",Staphylococcusaureus,1459
IWSFLIKAATKLLGVGSLFGGGKKDS,488,90,9593,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis,2491
IWSFLIKAATKLLPSLFGG,488,90,9594,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis,2491
VLSAADKNNVKGIFTKIAGHAEEYGAETLERMFTTYPPTKTY,489,2,9604,"Novel hemoglobin-derived antimicrobial peptides from chicken (Gallus gallus) blood: purification, structural aspects, and biological activity.",Escherichiacoli,1611
MLTAEDKKLIQQAWEKAASHQEEFGAEALTRMFTTYPQTKTY,489,2,9605,"Novel hemoglobin-derived antimicrobial peptides from chicken (Gallus gallus) blood: purification, structural aspects, and biological activity.",Escherichiacoli,1611
WWRRWWRR,490,3,9662,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1460
WWKKWWKK,490,3,9663,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1460
WRWWRRWWRR,490,3,9664,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1461
WKWWKKWWKK,490,3,9665,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1461
WRRWWRWWRRWWRR,490,3,9666,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1462
WKKWWKWWKKWWKK,490,3,9667,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1462
RWWRRWWRWWRRWWRR,490,3,9668,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1463
KWWKKWWKWWKKWWKK,490,3,9669,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1463
WRRWWRRWWRWWRRWWRR,490,3,9670,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1463
WKKWWKKWWKWWKKWWKK,490,3,9671,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1463
KWWKWWKKWWKK,490,3,9672,Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.,Pseudomonasaeruginosa,1646
IPRPIDTCRLRNGICFPGICRRPYYWIGTCNNGIGSCCARGWRS,491,91,9702,The Unusual Resistance of Avian Defensin AvBD7 to Proteolytic Enzymes Preserves Its Antibacterial Activity.,Streptococcussalivarius,1464
FIFHIIKGLFHAGKMIHGLVT,492,2,9707,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli,1056
FFFHIIKGLFHAGRMIHGLVNRRRHRH,492,2,9709,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli,1056
QKLCERPSGTWSGVCGNNNACKN,493,92,9727,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis,293
MQFITDLIKKAVDFFKGLFDNK,494,93,9736,Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging.,Jurkatcancer,1465
MQFITDLIKKAVDVFKGLFGNK,494,93,9737,Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging.,Jurkatcancer,1465
KWLRRPWRRWR,495,2,9740,NOVEL PEPTIDE AND USES THEREOF,Escherichiacoli,2664
KWLRWVRRRWW,495,2,9741,NOVEL PEPTIDE AND USES THEREOF,Escherichiacoli,2665
KWLRRVWRWWR,495,2,9744,NOVEL PEPTIDE AND USES THEREOF,Escherichiacoli,2666
GIFPIFAKLLGKVIKVASSLISKGRTK,496,31,9752,Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities.,Humanlung,1073
LVVAVTDGEADAAVEGLHDNTDFIHYGSHGKYPDNRPHGYPLD,497,24,9756,Molecular cloning of hemocyanin cDNA from Fenneropenaeus chinensis and antimicrobial analysis of two C-terminal fragments.,Fusariumoxysporum,2667
FEVLPNFKHIQVKVFNHGEHIHHH,497,24,9757,Molecular cloning of hemocyanin cDNA from Fenneropenaeus chinensis and antimicrobial analysis of two C-terminal fragments.,Fusariumoxysporum,2668
ENFFKEKERKGQRIRDAIISRRPRVETLAQAQKIIKGGD,498,94,9761,Galleria mellonella native and analogue peptides Gm1 and ΔGm1. II) anti-bacterial and anti-endotoxic effects.,Salmonellaenterica,1466
KKSLLAKAKNFGGKVITIFKA,499,95,9763,Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.,Arthrobacterglobiformis,1058
GGFGCPFNIDNQGNCHNHCQSIRGRKGGYCHGIFKQTCKCYKPMGYKTRPPFILG,500,17,9781,Antiplasmodial Activity Is an Ancient and Conserved Feature of Tick Defensins.,Listeriamonocytogenes,1467
LRKRLRKFRNKIKEKLKKIGQKIQGFVPKL,501,25,9793,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus,875
LLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLVPRTES,501,25,9794,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus,875
RLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLQPSKQS,501,25,9795,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus,875
FTCDVLSAEGSFRGVSVKLNHSACATHCLFLKKRGGYCNNKAICVCRN,502,18,9796,Tribolium castaneum defensins are primarily active against Gram-positive bacteria.,Micrococcusluteus,1468
FTCDVLSAEGGFRGVSIKLNHAACAAHCLYLKKRGGYCNDKAVCVCRK,502,18,9797,Tribolium castaneum defensins are primarily active against Gram-positive bacteria.,Micrococcusluteus,1468
GFGCPFNANECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9812,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium,2323
GFGCPFNKNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9813,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium,2323
GFGCPFNRNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9814,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium,2323
GFGCPFNQNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9815,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium,2323
GFGCPFNLNECHAHCLSIGRKFGFCAGPLRATCTCGKQ,503,48,9816,Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin.,Bacillusmegaterium,2323
WWWLSRIW,504,2,9817,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli,2669
WWWLKRIW,504,2,9818,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli,2670
WWWLRKIW,504,2,9819,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli,2670
WWWLKKIW,504,2,9820,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli,2670
WWWLRRIW,504,2,9821,Design and surface immobilization of short anti-biofilm peptides.,Escherichiacoli,2670
ATYRTGRATRESLSGVEISGRLYRLR,505,2,9850,Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.,Escherichiacoli,2671
GKYGFYTHVFRLKKWIQKVIDQFGE,506,2,9884,Proteolysis of human thrombin generates novel host defense peptides.,Escherichiacoli,1470
WMQKVIDRFGG,507,4,9904,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1469
KKWMQKVIDRFGG,507,4,9905,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
RLKKWMQKVIDRFGG,507,4,9906,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
VFRLKKWMQKVIDRFGG,507,4,9907,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
THVFRLKKWMQKVIDRFGG,507,4,9908,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
FYTHVFRLKKWMQKVIDRFGG,507,4,9909,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
YGFYTHVFRLKKWMQKVIDRFGG,507,4,9910,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
GKYGFYTHVFRLKKWMQKVIDRFGG,507,4,9911,The C-terminal sequences of porcine thrombin are active as antimicrobial peptides.,Staphylococcusaureus,1470
GNGNLLGGLLRPVLGVVKGLTGGLGKK,508,4,9917,Thaulin-1: The first antimicrobial peptide isolated from the skin of a Patagonian frog Pleurodema thaul (Anura: Leptodactylidae: Leiuperinae) with activity against Escherichia coli.,Staphylococcusaureus,1471
KKYRYHLKPFSKK,509,2,9922,Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I.,Escherichiacoli,2672
KKYRYHLKPFCKK,509,2,9924,Synthesis and characterization of an antibacterial and non-toxic dimeric peptide derived from the C-terminal region of Bothropstoxin-I.,Escherichiacoli,2672
FLFSLIPSAIGGLISAFK,510,56,9959,Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides.,Staphylococcusepidermidis,1472
VTQPLAPVHNPISV,511,4,9960,"Antimicrobial activity and mechanism of PDC213, an endogenous peptide from human milk.",Staphylococcusaureus,1473
LGGDNYGTFSGSNGNNFQHGSN,512,96,9967,Molecular characterization and functional analysis of a piscidin gene in large yellow croaker (Larimichthys crocea).,Edwardsiellatarda,2673
PHVALKPGKLKFIIPSPKRPVKLLSGGNTLHLVSTTKT,513,2,9968,Novel human bioactive peptides identified in apolipoprotein B: evaluation of their therapeutic potential.,Escherichiacoli,2674
PHVALKPGKLKFIIPSPKRPVKLLSG,513,2,9969,Novel human bioactive peptides identified in apolipoprotein B: evaluation of their therapeutic potential.,Escherichiacoli,2674
KIKKGFKKIFKRLPPIGVGVSIPLAGKR,514,59,9973,Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.,Acinetobacterbaumannii,996
GLFKKLRRKIKKGFKKIFKRL,514,59,9974,Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.,Acinetobacterbaumannii,996
AAGGVKKPKKAAAAKKSPKKPKKPAAA,515,4,9976,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1474
KAAAAKKSPKKPKKPAAAKK,515,4,9977,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1474
ARTKQTARKSTGGKAPRKQLAT,515,4,9978,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1475
AKAVKPKTAKPKTAKPKTAKA,515,4,9979,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1476
AVKPKTAKPKTAKPKTA,515,4,9980,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1476
AKKPVAKKAAGGVKKPK,515,4,9981,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1477
AKKPVAKKAAGGVKKPKK,515,4,9982,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1477
SPKKTKPVKPKKVA,515,4,9983,Discovery of Novel Antimicrobial Peptides from Varanus komodoensis (Komodo dragon) by Large Scale Analyses and De Novo-Assisted Sequencing using Electron Transfer Dissociation Mass Spectrometry.,Staphylococcusaureus,1478
SAVWRHWRRFWLRKHRKH,516,2,9988,Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.,Escherichiacoli,515
SAVWRWRRFWLRKRK,516,2,9989,Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.,Escherichiacoli,1233
SAVWRRWRRFWLRKRRKR,516,2,9990,Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.,Escherichiacoli,1233
RYRRKKKMKKALQYIKLLKE,518,4,10040,A New Synthetic Peptide Having Two Target of Antibacterial Action in E. coli ML35.,Staphylococcusaureus,1479
RRWQWRLCYCRRRFCVCVG,519,2,10041,Design of hybrid ?-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity,Escherichiacoli,1234
KWKLFKKIRGGRLCYCRRRFCVCV,519,2,10042,Design of hybrid ?-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity,Escherichiacoli,2437
NTVKETIKYLKSLFSHAFEVVKT,520,87,10043,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua,1480
NTVKETIKYLKSLFS,520,87,10044,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua,1480
NWVKEWIKYLKSLFSHAFEVVKT,520,87,10045,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua,1480
NKVKEWIKYLKSLFS,520,87,10046,"Design, Characterization and Antimicrobial activity of Novel Antimicrobial Peptide Derived from Bovine Lactophoricin.",Listeriainnocua,1480
KKSAGWVIPIGTLVK,521,2,10063,Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins.,Escherichiacoli,1235
KKSCHTGLKKSAGWVIPIGTLVKNGIIVR,521,2,10064,Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins.,Escherichiacoli,1235
KKSCHTGLDRSAGWVIPIGTLVKKAILPWDRK,521,2,10065,Antimicrobial effects of novel peptides cOT2 and sOT2 derived from Crocodylus siamensis and Pelodiscus sinensis ovotransferrins.,Escherichiacoli,1235
SRSEKAGLQFPVGRIGRMLKK,522,50,10072,"A novel antimicrobial peptide, scolopendin, from Scolopendra subspinipes mutilans and its microbicidal mechanism.",Enterococcusfaecium,882
KCRQWQSKIRRTNPIFCIRR,523,2,10073,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli,1236
KARQWQSKIRRTNPIFAIRR,523,2,10074,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli,1236
KARQWQWKIRRTWPIFAIRR,523,2,10075,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli,1236
KSRQWQWKIRRTWPIFSIRR,523,2,10076,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli,1236
KWRQWQSKWRRTNPWFWIRR,523,2,10077,Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.,Escherichiacoli,1236
RWQWRWQWR,524,2,10099,"Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076",Escherichiacoli,1237
GWLDVAKKIGKAAFNVAKNFLK,525,1,10138,Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,None_target,1481
FKCRRWQWRMKKLGAPS,526,2,10150,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli,114
FKAFRWAWRMKKLAAPS,526,2,10152,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli,1206
FKAWRWAWRMKKLAAPS,526,2,10153,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli,1206
FKAFRWAWRWKKLAAPS,526,2,10154,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli,1206
FKCWRWQWRWKKLGAPS,526,2,10156,Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules.,Escherichiacoli,1212
RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK,527,97,10181,Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells.,Humanmyelogenous,2096
KKKKKKKK,528,8,10231,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1482
FFFHIVKGLFHAGRMIHGLV,529,2,10233,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli,1056
IFGLLLHGAIHVGKLIHGLVRRH,529,2,10235,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli,991
FFRHIKSFWKGAKAIFRGARQG,529,2,10237,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli,992
KKKKKKKKK,528,8,10238,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1483
KKKKKKKKKK,528,8,10239,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1484
KKKKKKKKKKK,528,8,10240,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1485
KKKKKKKKKKKK,528,8,10241,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1486
KKKKKKKKKKKKK,528,8,10242,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1487
KKKKKKKKKKKKKK,528,8,10243,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,1488
FFPGIIKVASAILPTAICAITKRC,530,4,10248,"Identification and characterization of novel host defense peptides from the skin secretion of the fungoid frog, Hydrophylax bahuvistara (Anura: Ranidae).",Staphylococcusaureus,1489
FFPGIIKVAGAILPTAICAITKRC,530,4,10251,"Identification and characterization of novel host defense peptides from the skin secretion of the fungoid frog, Hydrophylax bahuvistara (Anura: Ranidae).",Staphylococcusaureus,1489
QGDGNFVIYTWKP,531,98,10254,Bacterial membrane binding and pore formation abilities of carbohydrate recognition domain of fish lectin.,Bacillusmycoides,2547
KAFAKLAARKA,533,4,10260,Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.,Staphylococcusaureus,2548
RRRRRRRR,528,8,10262,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2549
RRRRRRRRR,528,8,10263,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2550
RRRRRRRRRRR,528,8,10264,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2551
RRRRRRRRRRRR,528,8,10265,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2552
RRRRRRRRRRRRR,528,8,10266,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2553
RRRRRRRRRRRRRR,528,8,10267,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2554
PPPPPPPP,528,8,10269,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2555
PPPPPPPPP,528,8,10270,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2556
PPPPPPPPPP,528,8,10271,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2557
PPPPPPPPPPP,528,8,10272,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2558
PPPPPPPPPPPP,528,8,10273,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2559
PPPPPPPPPPPPP,528,8,10274,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2560
PPPPPPPPPPPPPP,528,8,10275,Inhibitory effect of short cationic homopeptides against Gram-positive bacteria,Bacillussubtilis,2561
FAKLAARLYRKA,533,4,10276,Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.,Staphylococcusaureus,2562
GLNALKKVFQGIHEAIKKINNHVQ,534,2,10295,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli,890
GLNALKKVFQGIHKAIKKINNHVQ,534,2,10296,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli,890
GLNALKKVFQPIHEAIKLINNHVQ,534,2,10297,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli,890
GLNALKKVFQPIHEAIKKINNHVQ,534,2,10298,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli,890
GLNALKKVFQPIHKAIKKINNHVQ,534,2,10299,Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.,Escherichiacoli,890
KRKIFLRTKILV,535,4,10304,Effect of tacticity-derived topological constraints in bactericidal peptides.,Staphylococcusaureus,2563
VLIKTRLFIKRK,535,4,10305,Effect of tacticity-derived topological constraints in bactericidal peptides.,Staphylococcusaureus,2564
RWKRWWRLL,536,3,10316,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2565
KWKRWWWFR,536,3,10317,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2566
RWKRWWRWI,536,3,10318,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2567
KWWRWRRWW,536,3,10319,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,1531
RWKKWWRWL,536,3,10320,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2568
KKRWWWWWR,536,3,10321,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2569
RKRWWWWFR,536,3,10322,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2570
IWKRWWWKR,536,3,10323,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2571
RIWKIWWKR,536,3,10324,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2572
IKKRWWWFR,536,3,10325,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2573
IKWKRWWWR,536,3,10326,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2574
KWWKIWRWR,536,3,10327,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2575
RIWKRWWFR,536,3,10328,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2576
RLWKRWWIR,536,3,10329,Optimization of antibacterial peptides by genetic algorithms and cheminformatics.,Pseudomonasaeruginosa,2577
FKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,537,2,10339,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli,1694
KRFKKFFKKLKNSVKKRAKKFFKK,537,2,10340,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli,1694
KRFKKFFKKLKKFVKKGFKKFAKV,537,2,10341,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli,1694
FKKFFKKLKNSVKKR,537,2,10342,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli,1694
AKKFFKKPRVIGVSIPF,537,2,10343,Structure-function relationship of king cobra cathelicidin.,Escherichiacoli,1694
YKWKIRFKR,539,3,10359,Improving short antimicrobial peptides despite elusive rules for activity.,Pseudomonasaeruginosa,2578
RWCVYARVRGVRYRRCW,540,4,10385,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus,2579
RWCVYACVRGVCYRRCW,540,4,10386,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus,2579
RWCVRARVRGVRYRRCW,540,4,10387,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus,2579
RWCVYARRRGVRYRRCW,540,4,10388,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus,2579
RWCVYARVRGRRYRRCW,540,4,10389,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus,2579
RWCVYARVRGVRYRRCR,540,4,10390,Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity.,Staphylococcusaureus,2579
ENFFKRIRRAGKRIRDAIISAAPAVETLAQAQKIIKGGD,541,2,10398,Antimicrobial activity and interactions of cationic peptides derived from Galleria mellonella cecropin D-like peptide with model membranes.,Escherichiacoli,1466
RNFFKRIRRAGKRIRKAIISAAPAVETLAQAQKIIKGGD,541,2,10399,Antimicrobial activity and interactions of cationic peptides derived from Galleria mellonella cecropin D-like peptide with model membranes.,Escherichiacoli,1466
RLLFRKIRRLKR,542,4,10402,A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa.,Staphylococcusaureus,2580
WGWRDIVRGIRKVAAPVLST,544,44,10438,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
DLIWKLLSKAQEKFGKNKSK,545,99,10439,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii,1722
DLIWRLLSRAQERFGKNRSR,545,99,10440,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii,1722
FKCKKWQWKMKKLG,545,99,10441,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii,1206
FRCRRWQWRMRRLG,545,99,10442,Effects of lactoferrin derived peptides on simulants of biological warfare agents.,Bacillusglobigii,1206
RLLRKFFRKLKKSV,546,4,10450,Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids.,Staphylococcusaureus,2582
TLEEFSAKL,544,44,10456,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2583
AGWRDIVRGIRKVAAPVLST,544,44,10457,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WAWRDIVRGIRKVAAPVLST,544,44,10458,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGARDIVRGIRKVAAPVLST,544,44,10459,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWADIVRGIRKVAAPVLST,544,44,10460,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRAIVRGIRKVAAPVLST,544,44,10461,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDAVRGIRKVAAPVLST,544,44,10468,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIARGIRKVAAPVLST,547,44,10469,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases,Aeromonashydrophila,2581
WGWRDIVAGIRKVAAPVLST,544,44,10470,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRAIRKVAAPVLST,544,44,10471,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGARKVAAPVLST,544,44,10472,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIAKVAAPVLST,544,44,10473,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRAVAAPVLST,544,44,10474,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRKAAAPVLST,544,44,10475,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRKVAAAVLST,544,44,10476,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRKVAAPALST,544,44,10477,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRKVAAPVAST,544,44,10478,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRKVAAPVLAT,544,44,10479,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
WGWRDIVRGIRKVAAPVLSA,544,44,10480,A natural peptide and its variants derived from the processing of infectious pancreatic necrosis virus (IPNV) displaying enhanced antimicrobial activity: a novel alternative for the control of bacterial diseases.,Aeromonashydrophila,2581
FFGWLIKPAIHAGKAIHGLIHRRRH,548,2,10485,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli,991
FFGWLIKGAIHAPKAIHGLIHRRRH,548,2,10486,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli,991
FFGWLIKGAIHAGKAIHPLIHRRRH,548,2,10487,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli,991
FFGWLIKGAIHAPKAIHPLIHRRRH,548,2,10488,Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities.,Escherichiacoli,991
GRKKRRQRRRGGWMWVTNLRTD,549,59,10519,The Anticancer Peptide TAT-RasGAP317-326 Exerts Broad Antimicrobial Activity.,Acinetobacterbaumannii,2584
MAGGKAGKDSGKAKAKAVSRSARAGLQFPVGRIHRHLK,550,34,10521,Mechanism study on a new antimicrobial peptide Sphistin derived from the N-terminus of crab histone H2A identified in haemolymphs of Scylla paramamosain.,Micrococcuslysodeikticus,882
KAKAKAVSRSARAGLQFPVGRIHRHLK,551,34,10522,A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma.,Micrococcuslysodeikticus,882
RSARAGLQFPVGRIHRHLK,551,34,10523,A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma.,Micrococcuslysodeikticus,882
VGRIHRHLK,551,34,10524,A truncated Sph12-38 with potent antimicrobial activity showing resistance against bacterial challenge in Oryzias melastigma.,Micrococcuslysodeikticus,2585
NLLNKALGTVNGLLGRS,552,2,10526,"Dendropsophin 1, a novel antimicrobial peptide from the skin secretion of the endemic Colombian frog Dendropsophus columbianus.",Escherichiacoli,1238
GLPVCGETCTLGTCSTQGCTCSWPICKRN,553,2,10534,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,993
FKARRWQWRMKK,554,2,10549,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli,1206
FKARRWQWRM,554,2,10550,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli,1206
FKARLWQWRM,554,2,10552,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli,1206
FKALLWQWRM,554,2,10553,Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.,Escherichiacoli,1239
KKKLFKKKLQ,555,33,10570,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2586
KLKKKKFKLQ,555,33,10571,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2587
LKKKKKKFLQ,555,33,10572,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2588
LKKKKKKLFQ,555,33,10573,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2589
KLKKKKLKFQ,555,33,10574,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2590
KKLKKLKKFQ,555,33,10575,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2591
KKKLLKKKFQ,555,33,10576,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2592
LKKKKFLKKQ,555,33,10577,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2593
LKKFKKKKLQ,555,33,10578,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2594
KLKKKFLKKQ,555,33,10579,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2595
KLKFKKKKLQ,555,33,10580,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2596
KFKKKLKKLQ,555,33,10581,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2597
KFKKKLLKKQ,555,33,10582,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2598
KFKLKKKKLQ,555,33,10583,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2599
KLKKKLKKFQ,555,33,10584,Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198.,Pseudomonassyringae,2600
GCRRLCYKQRCVTYCRGR,556,2,10601,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,1256
GCRRLCWKQRCVTYCRGR,556,2,10602,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,2676
GCRRLCYKQRCVTWCRGR,556,2,10603,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,1256
GCRRLCYRQRCVTYCRGR,556,2,10604,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,1256
GCRRLCWRQRCVTWCRGR,556,2,10605,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,2676
GCRALCYKQRCVTYCRGA,556,2,10606,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,1256
KCRRLCYRQRCVTYCRGR,556,2,10607,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,1256
GCRRWCYKQRCVTYCRGR,556,2,10609,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,2676
KCRRYCYRQRCVTYCRGR,556,2,10611,Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.,Escherichiacoli,2676
WKRRIKIWKKIR,557,3,10625,A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.,Pseudomonasaeruginosa,2601
WIRRIKKWIRRVHK,557,3,10626,A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.,Pseudomonasaeruginosa,2602
WLRRIKAWLRRKRK,557,3,10627,A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.,Pseudomonasaeruginosa,2603
VTADVLSFEAKGIAVNHSACALHCIALRKKGGSAQNGVCVCRN,558,2,10671,"Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle.",Escherichiacoli,1468
VTCDVLSFEAKGIAVNHSAAALHCIALRKKGGSCQNGVAVCRN,558,2,10672,"Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle.",Escherichiacoli,1468
VTCDVLSFEAKGIAVNHSACALHAIALRKKGGSCQNGVCVARN,558,2,10673,"Structure-activity relationships of the intramolecular disulfide bonds in coprisin, a defensin from the dung beetle.",Escherichiacoli,1468
RECKTESHRFKGPCITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,559,24,10685,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum,297
RTCESQSNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,559,24,10686,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum,297
RECKTESNTFPGICITKPPCRKACLTEGFTDGHCSKILRRCLCTKPC,559,24,10687,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum,297
RECKTESNTFPGICITKPPCRKACISEKFSGGDCSKILRRCLCTKPC,559,24,10688,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum,297
RECKTESNTFPGICITKPPCRKACISEKFTDGHCRGFRRRCLCTKPC,559,24,10689,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum,297
RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCFCTRPC,559,24,10690,Nicotiana alata Defensin Chimeras Reveal Differences in the Mechanism of Fungal and Tumor Cell Killing and an Enhanced Antifungal Variant.,Fusariumoxysporum,297
FLGGLIKIVPAMICAVRKKC,560,100,10698,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ,Streptococcuspneumoniae,526
GIHHILKYGKPS,561,2,10699,"Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Escherichiacoli,1240
KIKWILKYWKWS,561,2,10700,"Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Escherichiacoli,1241
RIRWILRYWRWS,561,2,10701,"Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.",Escherichiacoli,1241
FLGGLIKPVPAMICAVRKKC,562,100,10702,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae   ,Streptococcuspneumoniae,526
FLGGLIKRVPAMICAVRKKC,560,100,10704,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ,Streptococcuspneumoniae,526
FLGGLIKRPPAMICAVRKKC,560,100,10705,Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae ,Streptococcuspneumoniae,526
RRRRRFRRVIRRIRLPKYLTINTE,563,2,10715,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli,1242
RRRRRYRYWRRGLTIQGRPKSLPLNTGD,563,2,10716,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli,1243
WGRRWRIRIPRLPRPWPPRPKWPRSATINTDQ,563,2,10717,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli,1244
WPRFPKPRKPTYPGPTYPGPTWPRPTWRRSATIDTEH,563,2,10718,"Myticalins: A Novel Multigenic Family of Linear, Cationic Antimicrobial Peptides from Marine Mussels (Mytilus spp.)",Escherichiacoli,1245
GFGCPFNARRCHRHCRSIRRRAGYCAGRLRLTCTCVR,564,101,10719,"Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis.",Bacilluspumilus,2331
GFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCY,564,101,10720,"Functional characterization of two defensins, HlDFS1 and HlDFS2, from the hard tick Haemaphysalis longicornis.",Bacilluspumilus,2331
RKLPDAPGMHTWGGGGINTLQKYYCRVRG,565,102,10725,Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants.,Streptococcusoralis,1246
RKLPDAPGMHTWGGGGRCAVLSCLPKEQI,565,102,10726,Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants.,Streptococcusoralis,1246
RKLPDAPGMHTWGGGGKCSTRGRKCCRRKK,565,102,10727,Engineered chimeric peptides with antimicrobial and titanium-binding functions to inhibit biofilm formation on Ti implants.,Streptococcusoralis,1246
NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR,566,59,10752,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii,2604
EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,566,59,10753,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii,2604
EKALEKLIAIQKAIKGMLAGWFTGVGARRKR,566,59,10754,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii,2604
NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR,566,59,10755,Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2.,Acinetobacterbaumannii,2604
ACPIFTKIQGTCYRG,567,41,10756,Activity of human beta defensin-1 and its motif against active and dormant Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,2724
PRVIETKVHGREVTGLARNVSEENVDRLAKRWIK,568,41,10788,"A mycobacteriophage-derived trehalose-6,6'-dimycolate-binding peptide containing both antimycobacterial and anti-inflammatory abilities.",Mycobacteriumtuberculosis,2605
ECYRKSDIVTCEPWQKFCYREVTFFPNHPVYLSGCASECTETNSKWCCTTDKCNRARGG,569,41,10790,In vitro activities of small peptides from snake venom against clinical isolates of drug-resistant Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,2606
SFGVTIGIGPAGSPLLVGVGVSHSQD,570,2,10813,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli,1247
CFGGSLGIQYEDKINVGGGLSGDHC,570,2,10814,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli,1248
VDNANDLLSKVKKDKSD,570,2,10815,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli,1249
TSFLNELNKYNEKKFI,570,2,10816,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli,1250
VIDKAKMESLGITSRDTT,570,2,10817,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli,1251
KKFGGGKTERARKAMAVE,570,2,10818,Four novel antimicrobial peptides derived from human C8?-MACPF,Escherichiacoli,1252
IIPLPLGYFAKKKKKKDPVPLDQ,571,4,10828,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus,2607
VLPLLETCSMTCWENNQTFGK,571,4,10830,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus,2608
KCNTATCVTQRLADFLVRSSNTIGTVYAPTNVGAAAY,572,18,10831,High-Throughput Identification of Antimicrobial Peptides from Amphibious Mudskippers.,Micrococcusluteus,1671
RLLGNCLTVVMAAKLGTAFSPEIQCAWQK,572,18,10832,High-Throughput Identification of Antimicrobial Peptides from Amphibious Mudskippers.,Micrococcusluteus,1672
EFELDRICCGYGTARCRKKRSQEYRIGRCPNTYACCLRK,573,2,10860,Human ?-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.,Escherichiacoli,1253
EFELDRISSGYGTARCRKKRSQEYRIGRSPNTYASCLRK,573,2,10862,Human ?-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.,Escherichiacoli,1253
ELDRISSGYGTARCRKKRSQEYRIGRSPNTYASCLRK,573,2,10863,Human ?-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.,Escherichiacoli,1253
GCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK,574,4,10867,Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.,Staphylococcusaureus,2331
RWRWNRRTGRWRWY,575,2,10876,Biological consequences of improving the structural stability of hairpins that have antimicrobial activity.,Escherichiacoli,1254
LPRRNRWSKIWKKVVTVFS,576,4,10878,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1673
HLRRINKLLTRIGLYRHAFG,576,4,10879,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1674
NRFTARFRRTPWRLCLQFRQ,576,4,10880,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1675
VLHTGYRKFLHRSKRFFHLR,576,4,10881,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1676
TMSLRFWRWKVR,576,4,10882,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1677
AWRWKAFRNCWRVRSSSL,576,4,10883,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1678
RSITRPVLVRRRWRVRPVF,576,4,10884,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1679
SIKILKIYFIQGKRHWSF,576,4,10885,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1680
QVRWWGRYWRRKWATCR,576,4,10886,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1681
GTAWRWHYRARS,576,4,10887,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1682
KFVRLKIYCRDKNKGRGISF,576,4,10888,The rumen microbiome: an underexplored resource for novel antimicrobial discovery.,Staphylococcusaureus,1683
GSKRWRKFEKRVKKIFEETKEALPVVQGVVAVATAVGRR,577,2,10889,Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.,Escherichiacoli,1255
GSKRWRKFEKKVKKALEDAKEKLQEERVQKIVEHTKEALPVIKAVATVVGVVGRR,577,2,10890,Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.,Escherichiacoli,1255
GSKRWRKFEKRVKKVFEHTKEALPVIQGVATVVGAVGRR,577,2,10891,Identification and characterization of novel cecropins from the Oxysternon conspicillatum neotropic dung beetle.,Escherichiacoli,1255
KWICRRLWYRGRWITYCRWR,578,2,10897,Hairpin structure stability plays a role in the activity of two antimicrobial peptides.,Escherichiacoli,1256
KWWCFRVCYRGICYRRCRWK,578,2,10898,Hairpin structure stability plays a role in the activity of two antimicrobial peptides.,Escherichiacoli,1257
KWWVFRVVYRGIVYRRVRWK,578,2,10899,Hairpin structure stability plays a role in the activity of two antimicrobial peptides.,Escherichiacoli,1257
KQKLAKLKAKLQKLKQKLAKL,579,2,10912,Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers.,Escherichiacoli,1258
QIAALEQEIAALEQEIAALQ,579,2,10913,Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers.,Escherichiacoli,1259
RRGYGLKLALAKDGWALMLRLGFGRR,580,2,10914,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli,1260
RRGFSLKLALAKDGWALMLRLGYGRR,580,2,10915,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli,1260
RRGAGLGLALAKDGWALMLKLGFGRR,580,2,10916,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli,1260
RRGGGLELALAKDGWALMLDLGAGRR,580,2,10917,Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.,Escherichiacoli,1260
GRPNPVPNPKPPHPRL,581,2,10920,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli,584
GRPNPVPNPRPPHPRL,581,2,10921,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli,584
GNNRPVYIPQPKPPHPRL,581,2,10922,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli,2542
GKPKPYSPRPTSHPRPIRV,581,2,10923,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli,373
GKPRPYSPKPTSHPRPIRV,581,2,10924,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli,373
GKPRPYSPRPTSHPKPIRV,581,2,10925,The presence of arginine in the Pro-Arg-Pro motif augments the lethality of proline rich antimicrobial peptides of insect source.,Escherichiacoli,373
GKPRPYSPRPSSHPRPIRV,582,2,10926,"Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.",Escherichiacoli,373
GKPRPYPPRPPPHPRPIRV,582,2,10928,"Understanding the importance of glycosylated threonine and stereospecific action of Drosocin, a Proline rich antimicrobial peptide.",Escherichiacoli,373
RCYNGCCRRGYYGGCRCCAHPDEIPDPEYRAEPAYGHP,583,103,10932,A potent antimicrobial peptide derived from the protein LsGRP1 of Lilium.,Agrobacteriumtumefaciens,1684
LKKISQRYQKFALPQYLKTVYQHQKAMKPWIQPKTKVIPYVRYL,584,87,10933,A Simple Method to Separate the Antimicrobial Peptides from Complex Peptic Casein Hydrolysate and Identification of a Novel Antibacterial Domains within the Sequence of Bovine ?s-Casein,Listeriainnocua,1685
RLVRILVSKRPVAIKPYFRL,585,2,10944,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,585
TTSIRRRYQVSLIRRHRGKR,585,2,10945,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,586
TCRTNRPCFYDLDLNVCRCS,585,2,10946,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,587
SNGDGTLDAGSTCAPFYARA,585,2,10947,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,588
YYNPLPHDCGRDNNTDICSR,585,2,10948,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,589
LSVDKRPVLHPEHIYGHNHY,585,2,10949,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,590
IHRDQQHESFLDARPEPGLTE,585,2,10950,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,591
TIDFGVRNINQSNLVYDTER,585,2,10951,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,592
PCNPDHDYRPFGNFRIAFTT,585,2,10952,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,593
TRDTNDLISSRTAAPSMV,585,2,10953,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,594
LPLPSCSSHGGDADNTSQRN,585,2,10954,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,595
PNDPDSPCVYRMPNARGCSI,585,2,10955,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,596
YDLSDSNCLPANRDKRYYVI,585,2,10956,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,597
SMLAYVDKNDHINPPHSPRS,585,2,10957,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,598
DATPHAALFFTVKDHTAGDN,585,2,10958,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,599
SDDAQRCYPHNRTPFTYTYI,585,2,10959,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,600
EPCSPKNNYHDLFYRT,585,2,10960,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,601
CNPLNGADRRTDSFPRFTVI,585,2,10961,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,602
PDRAIDTYRTSPVADQRYNA,585,2,10964,Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries.,Escherichiacoli,603
WKKIRVRLSA,586,1,11027,Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties.,None_target,1686
KWKIRVRLSA,586,1,11030,Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties.,None_target,1687
KEFKRIVKRIKKFLRKLV,587,85,11036,Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages.,Mycobacteriumsmegmatis,635
GIGKFLKSKGKFGKA,588,41,11037,Effect of antimicrobial peptides on ATPase activity and proton pumping in plasma membrane vesicles obtained from mycobacteria.,Mycobacteriumtuberculosis,1688
KLIPIASKTCPAGKNLCYKI,589,2,11043,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli,604
KLIPILSKTIPAIKNLFYKI,589,2,11044,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli,605
KLIWILSKTIPAIKNLFYKI,589,2,11045,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli,605
KLIFILSKTIPAIKNLFYKI,589,2,11046,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli,605
KLILILSKTIPAIKNLFYKI,589,2,11047,Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity.,Escherichiacoli,605
DRVFKFACRRNKAAR,590,2,11048,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,606
NGKTWKKNRKACQVK,590,2,11049,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,607
RNSVRNRVMLWRTKR,590,2,11050,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,608
KAKRRARNLNQKKRK,590,2,11051,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,609
GIWTCRKKRA,590,2,11052,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,610
KKAKRRLLKK,590,2,11053,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,611
RQIKKAFRKMA,590,2,11054,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,612
KVKYFKRWLR,590,2,11055,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,613
AKRRLLKKMK,590,2,11056,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,614
RLKKHLKKIK,590,2,11057,Discovery of novel antimicrobial peptides: A transcriptomic study of the sea anemone Cnidopus japonicus.,Escherichiacoli,615
RVKASRRSASHPTYSEMIAAAIRAEKSRGG,591,17,11068,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes,1689
VGHNADLQIKLSIRRLLAAGVLKQTKGVGA,591,17,11069,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes,1690
LSIRRLLAAGVLKQTKGVGA,591,17,11070,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes,1690
VLKQTKGVGASGSFRLAKSD,591,17,11071,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes,1691
EMIAAAIRAEKSRGGSSRQS,591,17,11072,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes,1692
EMIAAAIRAEKSRGGSSRQSIQKYIKSHYK,591,17,11073,Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.,Listeriamonocytogenes,1692
FLPKLLAGLPSFLCLVFKKC,592,4,11076,"Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues.",Staphylococcusaureus,1693
FLPLLLAGLPKFLCLVFKKC,592,4,11077,"Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues.",Staphylococcusaureus,1693
KRFKKFFRKLKKSVKKRKKEFKKKPRVIKVSIPF,593,4,11085,The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Staphylococcusaureus,1694
KRFKKFFRKLKKSVKKRKKEFKKKPRVIGVSIPF,593,4,11086,The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Staphylococcusaureus,1694
AWKKTIRQYLKNKIKKKGRKAVIAW,594,2,11117,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AGKKTIRQYLKNKIKKKWRKAVIAW,594,2,11118,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AGKKTIRQYLKNKIKKKGRKWVIAW,594,2,11119,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AWKKTIRQYLKNEIKKKWRKAVIAW,594,2,11120,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AWKETIRQYLKNKIKKKWRKAVIAW,594,2,11121,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AWKKTIRQYLKNKIKKKWRKAVIAW,594,2,11122,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AWKEKIRQYLKNEIKKKWRKAVIAW,594,2,11123,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AWKETIRKYLKNEIKKKWRKAVIAW,594,2,11124,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
AWKEKIRKKLKNEIKKKWRKAVIAW,594,2,11125,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Escherichiacoli,616
LSLIAAAGKETIRQYLKNEIKKKGRKAVIAW,594,80,11126,"Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",Xanthomonasaxonopodis,616
GPHSANHVRGLARVGNANPGLYLAKYAFIPVILAAKPLSPTPTKT,595,2,11158,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli,617
GPRSSNHKRGLSRVGNSNPGKYLAKYSFRPVILSSKPLSPTPTKT,595,2,11159,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli,617
GPRSANHKRGLARVGNANPGKYLAKYSFRPVILSSKPLSPTPTKT,595,2,11160,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli,617
GPHSCNHQRGLCRVGNCNPGYYLAKYCFSPVILCCKPLSPTPTKT,595,2,11164,"Novel synthetic analogues of avian ?-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions.",Escherichiacoli,617
RRIRFRPPYLPRPGRRPRFPPPFPIPRIPRIP,596,2,11184,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli,618
RRIRFRPPYLPRPGRR,596,2,11185,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli,618
PYLPRPGRRPRFPPPFP,596,2,11186,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli,618
RPRFPPPFPIPRIPRIP,596,2,11187,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli,618
RRIPFWPPNWPGPWLPPWSPPDFRIPRILRKR,596,2,11188,The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome.,Escherichiacoli,619
NLVSALIEGRKYLKNVLK,597,4,11213,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus,240
KLNRLKEKNKAKNSKENN,597,4,11214,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus,240
NVLKKLNRLKEKNKAKNSKENN,597,4,11215,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus,240
GFLEKLKKGAKDFASALVNSIKGT,598,4,11217,"A Combined Molecular Cloning and Mass Spectrometric Method to Identify, Characterize, and Design Frenatin Peptides from the Skin Secretion of Litoria infrafrenata.",Staphylococcusaureus,1695
IKYLLVKLQGASQKTITLMLRRNNLYVMGYS,599,2,11272,"Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L. Evaluation of their antimicrobial properties and anti-biofilm activities.",Escherichiacoli,620
IKYLLVKLQGASQKTITLMLRRN,599,2,11273,"Novel bioactive peptides from PD-L1/2, a type 1 ribosome inactivating protein from Phytolacca dioica L. Evaluation of their antimicrobial properties and anti-biofilm activities.",Escherichiacoli,620
AFTHRRSYSTEYRYGTTVRGIRHRFL,600,2,11288,Antimicrobial activity of human ?-defensin 6 analogs: insights into the physico-chemical reasons behind weak bactericidal activity of HD6 in vitro.,Escherichiacoli,621
ELDRIGYGTARRKKR,601,2,11295,Engineering of a linear inactive analog of human ?-defensin 4 to generate peptides with potent antimicrobial activity.,Escherichiacoli,705
GIGRFLHSARRFGRAFVGEIMNS,602,2,11301,Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues.,Escherichiacoli,13
GLPVCGECFGGTCNTPGCSCDPWPMCSRN,603,16,11308,Chemical Synthesis and Functional Analysis of VarvA Cyclotide.,Aeromonassalmonicida,2129
TFFRLFNRSFT,604,7,11309,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
LSTFFRLFN,604,7,11310,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1696
STFFRLFNRSFTQ,604,7,11311,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
LSTFFRLFNRSFTQ,604,7,11312,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
TFFRLFNRGRRRRSVQWCA,604,7,11313,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
TFFRLFNRSFTGRRRRSVQWCA,604,7,11314,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
LSTFFRLFNGRRRRSVQWCA,604,7,11315,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
STFFRLFNRSFTQGRRRRSVQWCA,604,7,11316,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
LSTFFRLFNRSFTQGRRRRSVQWCA,604,7,11317,Selective activities of STAMPs against Streptococcus mutans.,Streptococcusmutans,1697
FKFGSFIKRMWRSKLAKKLRAKGKELLRDYA,605,25,11320,"Meucin-49, a multifunctional scorpion venom peptide with bactericidal synergy with neurotoxins.",Bacilluscereus,242
RGRKYYRRKK,606,3,11331,Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin,Pseudomonasaeruginosa,1698
CRWRWKCCKK,607,2,11335,CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties.,Escherichiacoli,622
SRWRWKSSKK,607,2,11336,CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties.,Escherichiacoli,623
MDVFMKGLSKAKEGVVAAAEKTKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTK,608,2,11339,Functional characterization of alpha-synuclein protein with antimicrobial activity.,Escherichiacoli,624
KKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQDYEPEA,608,2,11342,Functional characterization of alpha-synuclein protein with antimicrobial activity.,Escherichiacoli,625
KWRRKLKKLRPKKKRKV,609,104,11345,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani,1699
KWRRKLKKLR,609,104,11346,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani,1700
AWRRKLKALAPAKKAKV,609,104,11347,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani,1701
RKKRRQRRRRKKRRQRRR,609,104,11348,Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani.,Fusariumsolani,1702
ASEELLLRFQATSSGPILREEFE,610,2,11361,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,626
EQEENVVKIQAFWKGYKQRKEYM,610,2,11362,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,627
DNTDSVVKIQSWFRMATARKSYL,610,2,11363,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,628
DHNNEIVKIQSLLRANKARDDYK,610,2,11364,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,629
ANVGFVIQLQARLRGFLVRQKFA,610,2,11365,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,630
TWLPAVIKIQAHWRGYRQRKIYL,610,2,11366,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,631
ANLDAIIKIQAWARMWAARRQYL,610,2,11367,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,628
KNVNSIVKIQAFFRARKAQDDYR,610,2,11370,IQ-motif peptides as novel anti-microbial agents.,Escherichiacoli,632
GRFRRLGRKFKKLFKKYGP,611,2,11381,Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,Escherichiacoli,633
GLLRRLRKKIGEIFKKYG,611,2,11383,Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.,Escherichiacoli,634
RGGRLCYCRRRFCVCVGR,612,2,11385,Membranolytic selectivity of cystine-stabilized cyclic protegrins.,Escherichiacoli,2437
RGGCLCYCRRRFCVCVCR,612,2,11386,Membranolytic selectivity of cystine-stabilized cyclic protegrins.,Escherichiacoli,2437
FKCRRWQWRMK,613,2,11392,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli,1206
FKARRWAWRMK,613,2,11393,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli,1206
YKARRWAWRMK,613,2,11394,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli,1206
YKARRWAWRWK,613,2,11395,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli,114
YKAWRWAWRWK,613,2,11396,The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.,Escherichiacoli,1212
LGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFH,614,4,11405,Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.,Staphylococcusaureus,635
ALGDFFRKSKEKIGKEFKRIVQRIKDFLRNLAKRHHGYKRKFHLEY,614,4,11406,Expression in Escherichia coli of novel recombinant hybrid antimicrobial peptide AL32-P113 with enhanced antimicrobial activity in vitro.,Staphylococcusaureus,635
LKRLYKRLAKLIKRLYRYLKKPVR,615,4,11414,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1703
LKRVWKRVFKLLKRYWRQLKKPVR,615,4,11415,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LKRLYKRVFRLLKRYYRQLRRPVR,615,4,11416,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LKRVWKAVFKLLKRYWRQLKPVR,615,4,11417,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LKKLWKRVFRIWKRIFRYLKRPVR,615,4,11418,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
LRRLWKRLVRIIKRIYRQLKRPVR,615,4,11419,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
LRRLYKRVFRLLKRWWRYLKRPVR,615,4,11420,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LRRLWKRLVKILKRWFRYLRRPVR,615,4,11421,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
LRRLYKRVVKLWKRLFRQLRRPVR,615,4,11422,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1706
LKKLYKRVAKIWKRWIRYLKKPVR,615,4,11423,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
LKKLYKRLFKILKRILRYLRKPVR,615,4,11424,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
LKKLWKRLARLLKRFIRQLRRPVR,615,4,11425,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1707
LKKVYKRLARLLKRYIRYLRRPVR,615,4,11426,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1707
LKKVWKRVARLIKRWFRYLRRPVR,615,4,11427,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1703
LKKLYKRLFKLWKRLYRYLKKPVR,615,4,11428,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1703
LRRVYKRLARLIKRYLRQLKKPVR,615,4,11429,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LRKLWKRVVKIWKRYLRQLRRPVR,615,4,11430,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LRKLWKRLAKIIKRLYRYLRRPVR,615,4,11431,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1703
LKKVYKRVARLIKRLFRYLKRPVR,615,4,11432,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1703
LRRLWKRLVKLWKRFFRYLKKPVR,615,4,11433,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1706
LKKVWKRVFRILKRFLRYLKRPVR,615,4,11434,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LRRVYKRLFRLWKRIIRQLRRPVR,615,4,11435,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
LKKLWKRLARLWKRIIRQLKKPVR,615,4,11436,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1707
LRRVWKRVARIIKRLYRYLKRPVR,615,4,11437,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1703
LKRLWKRLFKILKRYYRYLRRPVR,615,4,11438,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1704
LRRLWKRVFKIIKRLFRQLKKPVR,615,4,11439,The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms.,Staphylococcusaureus,1705
KFKKLFKKLSPVIGKEFKRIVERIKRFLR,616,4,11495,Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.,Staphylococcusaureus,635
VNFLLHKIYGNIRYS,617,105,11496,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1708
GGEAVQKLVREVKDG,617,105,11497,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1709
GVARIRDLLIIESRI,617,105,11498,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1710
RIRDAIAHGYIVDKV,617,105,11499,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1711
YYGALHNTAHIVLGR,617,105,11500,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1712
VNGLLHKIYGNIRYS,617,105,11501,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1708
VNFLLHKIYDNIRYS,617,105,11502,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1708
VNFLLHKIYGNIRDS,617,105,11503,Prediction and characterization of a novel hemocyanin-derived antimicrobial peptide from shrimp Litopenaeus vannamei.,Vibrioparahaemolyticus,1708
SKFFRKARKKLGKGLQKIKNVLRKY,618,2,11519,"The novel cathelicidin of naked mole rats, Hg-CATH, showed potent antimicrobial activity and low cytotoxicity.",Escherichiacoli,635
KWKIFKKIEKVGRNIRNGIIKAVAVLGEAKAL,619,2,11526,A novel cecropin B-derived peptide with antibacterial and potential anti-inflammatory properties.	,Escherichiacoli,2096
CKILSKTIKCRIPCGRRKEY,620,44,11531,Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies.,Aeromonashydrophila,1713
KRCKNKMEGDDVAVSGRGARKAAKK,620,44,11532,Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies.,Aeromonashydrophila,1714
LEYWGKCTKAENRCKYKNDKGKDVLQNCPKFDNKKCTKDGNSCKWDSASKALTCY,621,106,11555,Characterization of a novel cysteine-rich antifungal protein from Fusarium graminearum with activity against maize fungal pathogens.,Fusariumverticillioides,1882
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESDYKDDDDKTKKTLRT,622,2,11556,Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.,Escherichiacoli,635
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESDYKDDDDKCQDSERTFY,622,2,11557,Collagen tethering of synthetic human antimicrobial peptides cathelicidin LL37 and its effects on antimicrobial activity and cytotoxicity.,Escherichiacoli,635
KKKKPLFGL,624,107,11579,Behavior of Antimicrobial Peptide K4 in a Marine Environment.,Vibriosplendidus,636
WWLWWLRWL,625,4,11624,Designing an ultra-short antibacterial peptide with potent activity against Mupirocin-resistant MRSA,Staphylococcusaureus,1715
GNPLKLFLPSTWVHFFKFLR,626,4,11674,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus,1716
FKKLYIEPVETKVDEINDNRRKANRKRFSAHQG,626,4,11675,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus,1717
AGWLIERYLVPNWHAFTSWLTAGKDAFSKGK,626,4,11676,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus,1718
KWRMCVDYTGFNKVCSKVFYFLFRID,626,4,11677,"Identification, Recombinant Expression, and Characterization of LHG2, a Novel Antimicrobial Peptide of Lactobacillus casei HZ1.",Staphylococcusaureus,1719
AWCFRVCYRGICYRRCR,627,2,11699,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KACFRVCYRGICYRRCR,627,2,11700,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWAFRVCYRGICYRRSR,627,2,11701,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCARVCYRGICYRRCR,627,2,11702,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
RNCMEVCVKGEKKHTGQGMIRRLRRNKNNSIFVVRKRV,628,108,11721,"TC38, a teleost TFPI-2 peptide that kills bacteria via penetration of the cell membrane and interaction with nucleic acids",Vibrioichthyoenteri,1720
CVKGGKKYKRQGKGHRMRRYRNNH,629,109,11731,A teleost TFPI-2 peptide that possesses a broad antibacterial spectrum and immunestimulatory properties,Vibriolitoralis,1721
DLIWKLLVKAQEKFGRGKPSKRVKKMRRQWQACKSSHHHHHH,630,4,11733,Heterologous expression of a broad-spectrum chimeric antimicrobial peptide in Lactococcus lactis: Its safety and molecular modeling evaluation,Staphylococcusaureus,1722
KWCFAVCYRGICYRRCR,627,2,11734,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRACYRGICYRRCR,627,2,11735,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVAYRGISYRRCR,627,2,11736,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCARGICYRRCR,627,2,11737,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYAGICYRRCR,627,2,11738,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRAICYRRCR,627,2,11739,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRGACYRRCR,627,2,11740,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVSYRGIAYRRCR,627,2,11741,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRGICARRCR,627,2,11742,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRGICYARCR,627,2,11743,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRGICYRACR,627,2,11744,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWSFRVCYRGICYRRAR,627,2,11745,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRGICYRRCA,627,2,11746,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWAFRVCYRGICYRRAR,627,2,11747,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVAYRGIAYRRCR,627,2,11748,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWAFRVAYRGIAYRRAR,627,2,11749,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRRCYAGICYRRCR,627,2,11750,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
RWCFRVCYRGICYRRCR,627,2,11751,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCGRVCYRGICYRRCR,627,2,11752,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCSRVCYRGICYRRCR,627,2,11753,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCGRGICYRRCR,627,2,11754,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYRGGCYRRCR,627,2,11755,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCARVCARGACYRRCR,627,2,11756,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFVCYRGICYRRCG,627,2,11757,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
AWCARVCYRGICYRRCR,627,2,11758,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
AWCFRVCARGICYRRCR,627,2,11759,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
AWCFRVCYRGACYRRCR,627,2,11760,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
KWCFRVCYAGICYRRCA,627,2,11761,Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.,Escherichiacoli,1257
SVFGQLVMGLILSSVFYNDD,631,4,11770,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus,1723
DDRGAAMFAVLFNAFSSLLE,631,4,11771,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus,1724
KLAMSMSFNFVFYFMVNFDD,631,4,11772,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus,1725
DDRFFFYWLMCIWCTFVMSH,631,4,11773,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus,1726
LATLLFTMCLNFCGVLAGDD,631,4,11774,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus,1727
DDGIFIAFIAINIILTVIFY,631,4,11775,Peptides as adjuvants for ampicillin and oxacillin against methicillin-resistant Staphylococcus aureus (MRSA).,Staphylococcusaureus,2109
GLRKRPRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,632,2,11776,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides.,Escherichiacoli,875
RRHCIKKCMKSRKHNERMIRIRRK,633,18,11777,"Molecular characterization, expression analysis, and bactericidal activity of the derivative peptides of TFPI-1 and TFPI-2 in half-smooth tongue sole, Cynoglossus semilaevis",Micrococcusluteus,2110
GLRKRLRKFRNKDKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11778,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKPKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11779,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKRKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11780,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKFKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11781,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKHKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11782,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKMKEKLKKIGQKIQGLLPKLAPRTDY,634,2,11783,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKECLKKIGQKIQGLLPKLAPRTDY,634,2,11784,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEDLKKIGQKIQGLLPKLAPRTDY,634,2,11785,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKDKKIGQKIQGLLPKLAPRTDY,634,2,11786,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKKKKIGQKIQGLLPKLAPRTDY,634,2,11787,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKPKKIGQKIQGLLPKLAPRTDY,634,2,11788,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLPKIGQKIQGLLPKLAPRTDY,634,2,11789,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKEGQKIQGLLPKLAPRTDY,634,2,11790,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY,634,2,11791,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKIGQKDQGLLPKLAPRTDY,634,2,11798,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKIGQKGQGLLPKLAPRTDY,634,2,11799,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKIGQKNQGLLPKLAPRTDY,634,2,11800,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKIGQKIQTLLPKLAPRTDY,634,2,11801,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
GLRKRLRKFRNKIKEKLKKIGQKIQGPLPKLAPRTDY,634,2,11802,The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides,Escherichiacoli,875
KCRRRKVHGPMIRIRKK,635,18,11803,"TO17: A teleost antimicrobial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in red drum, Sciaenops ocellatus.",Micrococcusluteus,2111
EVASFDKSKLK,636,4,11809,"Paracentrin 1, a synthetic antimicrobial peptide from the sea-urchin Paracentrotus lividus, interferes with staphylococcal and Pseudomonas aeruginosa biofilm formation.",Staphylococcusaureus,2112
GFGLGGLARILCLGNRQWSNFFKKLNRKCAMVKK,637,2,11818,An engineered arginine-rich ?-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.,Escherichiacoli,385
GFALAGLARILCLWFREFSGFFRRLNRRFAMRRR,637,2,11819,An engineered arginine-rich ?-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.,Escherichiacoli,898
GAALAGLAKILCLWAKEFTGAFKKLNKKFAMKKK,637,2,11820,An engineered arginine-rich ?-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice.,Escherichiacoli,898
MSGSHHHHHHGSSGENLYFQSLEVASFDKSKLK,638,4,11841,Antimicrobial and Antibiofilm Activity of a Recombinant Fragment of ?-Thymosin of Sea Urchin Paracentrotus lividus.,Staphylococcusaureus,825
FLGAVLKVAGKLVPAAI,639,4,11880,Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.,Staphylococcusaureus,245
FLGAVLKVCKISKKCAGKLVPAAI,639,4,11881,Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.,Staphylococcusaureus,2113
TPFLLVGTQIDLR,640,18,11934,Sarconesin: Sarconesiopsis magellanica Blowfly Larval Excretions and Secretions With Antibacterial Properties.,Micrococcusluteus,2114
LSKYGGQCSLKHNTCTYLKGGRNVIVNCPWFWNKKRCKSDRHHCEYDEHHRRVDCQTPV,641,110,11937,Rational Design and Biotechnological Production of Novel AfpB-PAF26 Chimeric Antifungal Proteins.,Penicilliumdigitatum,2115
GGLRSLGRKILRAWKKYG,642,2,11938,Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18.,Escherichiacoli,1005
IGLRGLGRKIALIHKKYG,642,2,11939,Structural insight into the mechanism of action of antimicrobial peptide BMAP-28(1-18) and its analogue mutBMAP18.,Escherichiacoli,899
AAAARRRR,643,4,11942,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2116
RRRRRRRWWWWWWW,643,4,11946,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2117
RRRRWWWWW,643,4,11947,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2118
FFFFRRRR,643,4,11958,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2119
LLLLRRRR,643,4,11959,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2120
IIIIRRRR,643,4,11960,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2121
YYYYRRRR,643,4,11961,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2119
TQQAFQKFLAAVTSALGKQYH,644,8,11963,"Antimicrobial function of SH?AP, a novel hemoglobin ? chain-related antimicrobial peptide, isolated from the liver of skipjack tuna, Katsuwonus pelamis.",Bacillussubtilis,2122
KKKKWWWW,643,4,11975,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,1855
RRRRRRRWWWWW,643,4,11977,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2123
RRRRRRRWWWWWW,643,4,11978,"Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.",Staphylococcusaureus,2124
GLRKRLRKFRNKIKEK,645,8,12019,Novel imidazolium salt--peptide conjugates and their antimicrobial activity.,Bacillussubtilis,875
KKRKAPKKKRKFA,646,1,12034,Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.,None_target,2125
LRLKKYKVPQL,647,2,12073,Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity against Human Cells of a Peptide Derived from Bovine ?S1-Casein,Escherichiacoli,900
AKKPFVQRVKNAASKAYNKLKGLAMQSQYG,648,2,12101,Chemical synthesis of a two-domain scorpion toxin LaIT2 and its single-domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities.,Escherichiacoli,1745
QSQYGCPIISNMCEDHCRRKKMEGQCDLLDCVCS,648,2,12102,Chemical synthesis of a two-domain scorpion toxin LaIT2 and its single-domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities.,Escherichiacoli,1745
RNCTWLFSTKLKLPA,649,48,12107,Identification of the first Crocodylus siamensis cathelicidin gene and RN15 peptide derived from cathelin domain exhibiting antibacterial activity.,Bacillusmegaterium,2126
PKILNKILGKILRLAAAFK,650,2,12113,"Fast and potent bactericidal membrane lytic activity of PaDBS1R1, a novel cationic antimicrobial peptide.",Escherichiacoli,901
GFGCNGPWSEDDLRCHRHCKSIKGYRGGYCAKGGFVCKCY,651,4,12115,Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide.,Staphylococcusaureus,1467
LKKLLKLLKLLKL,652,2,12127,Chain length dependence of antimicrobial peptide-fatty acid conjugate activity.,Escherichiacoli,902
KGVSGHGQHGVHG,653,79,12132,Further studies on the antiviral activity of alloferon and its analogues,HSV-1,1439
RGVSGHGQHGVHG,653,79,12133,Further studies on the antiviral activity of alloferon and its analogues,HSV-1,1439
AGVSGHGQHGVHG,653,79,12134,Further studies on the antiviral activity of alloferon and its analogues,HSV-1,1439
HGVSGHGQHGTHG,654,4,12135,"ZL-2, a cathelicidin-derived antimicrobial peptide, has a broad antimicrobial activity against gram-positive bacteria and gram-negative bacteria in vitro and in vivo",Staphylococcusaureus,2127
GIMDTVKNAAKNLAGQLLDKLK,655,4,12185,"A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",Staphylococcusaureus,807
GIMDTVKNAAKNLAGQLLDKLKCSITAC,655,4,12186,"A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",Staphylococcusaureus,807
VQWLEQQVAKRRTKR,656,2,12188,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,903
QREPQVQWLEQQVAKRRTKR,657,2,12189,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics",Escherichiacoli,903
RHSRLQREPQVQWLEQQVAKRRTKR,656,2,12190,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,903
SPHRPRHSRLQREPQVQWLEQQVAKRRTKR,656,2,12191,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,903
TKRSLSPHRPRHSRLQREPQVQWLEQQVAKRRTKR,656,2,12192,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,903
QKVFTNTWAVRIPGGPAVANSVARKHGFLNLQGIF,656,2,12193,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,904
RKHGFLNLQGIFGDYYHFWHRGV,656,2,12194,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,905
YYHFWHRGVTKRSLSPHRPRHSRLQR,656,4,12195,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Staphylococcusaureus,2128
GLPVCGETCVGGTCYTPGCTCSWPVCTRN,658,111,12200,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin,2129
GLPVCGETCVGGTCDTPGCTCSWPVCTRN,658,111,12201,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin,2129
YYHFWHRGVTKRSLSPHRPRHSR,656,4,12202,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Staphylococcusaureus,2128
YYHFWHRGVTKRSLSPHRPR,656,4,12203,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Staphylococcusaureus,2128
YYHFWHRGVTKRSLSPH,656,2,12204,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,2128
GLPVCGETCVGGTCNYPGCTCSWPVCTRN,658,111,12205,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin,2129
YYHFWHRGVTKRSL,656,2,12206,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,2128
YYHFWHRGVTKR,656,2,12207,"Cell-Selective Pore Forming Antimicrobial Peptides of the Prodomain of Human Furin: A Conserved Aromatic/Cationic Sequence Mapping, Membrane Disruption, and Atomic-Resolution Structure and Dynamics.",Escherichiacoli,2128
GLPVCGETCVGGTCNSPGCTCSWPVCTRN,658,112,12208,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humancervical,2129
GNFLRNGGSYYIVPAFRG,659,2,12209,"Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence.",Escherichiacoli,906
GLPVCGETCVGGTCNTPGCTCSYPVCTRN,658,111,12210,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin,2129
GLPVCGETCVGGTCNTPGCTCSWWPVCTRN,658,111,12211,Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting,Humanskin,2129
CPAIQRCC,660,4,12212,"Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII are synthetic antimicrobial peptides active against human pathogens by stimulating ROS generation and increasing plasma membrane permeability",Staphylococcusaureus,2130
NIQPPCRCC,660,4,12213,"Mo-CBP3-PepI, Mo-CBP3-PepII, and Mo-CBP3-PepIII are synthetic antimicrobial peptides active against human pathogens by stimulating ROS generation and increasing plasma membrane permeability",Staphylococcusaureus,2131
RKYVRFLHRWVKYFRAYL,659,2,12215,"Adevonin, a novel synthetic antimicrobial peptide designed from the Adenanthera pavonina trypsin inhibitor (ApTI) sequence.",Escherichiacoli,907
GLLSGILGAGKKIV,661,4,12221,"Modification Targeting the ""Rana Box"" Motif of a Novel Nigrocin Peptide From Hylarana latouchii Enhances and Broadens Its Potency Against Multiple Bacteria.",Staphylococcusaureus,2132
NNLRHIVAWCKNRNYSLAVCARFKPQ,662,4,12225,Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing.,Staphylococcusaureus,2133
NLLGFLQGAKDILKECEADNYQGWLCESYKPQ,662,4,12226,Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing.,Staphylococcusaureus,2134
KWKLFKKIHKVGQNIRKGIIKAGPAVAVVGQAAQIAK,663,2,12232,"Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity.",Escherichiacoli,2096
GFWSSVWDGAKNVGTAI,664,18,12237,Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain.,Micrococcusluteus,248
IKNAKVCVYAVCVSHK,664,18,12238,Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain.,Micrococcusluteus,248
TSVRQRWRWRQRVRTS,665,2,12240,The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.,Escherichiacoli,908
KRSKRKRRIHQRVRIS,665,2,12241,The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.,Escherichiacoli,909
TLSKEKERIVQRVRTS,665,2,12242,The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.,Escherichiacoli,910
VLLVTLTRLHQRGVIYRKWRHFSGRKYR,666,2,12244,The identification of a novel Sulfolobus islandicus CAMP-like peptide points to archaeal microorganisms as cell factories for the production of antimicrobial molecules.,Escherichiacoli,911
KRKKHRCRVYNNGMPTGMYRWC,667,4,12245,Structure-activity relationships of the bacteriocin bactofencin A and its interaction with bacterial membrane.,Staphylococcusaureus,2135
KRKKHRCRVYNNGLPTGLYRWC,667,4,12246,Structure-activity relationships of the bacteriocin bactofencin A and its interaction with bacterial membrane.,Staphylococcusaureus,2135
VWNQPVRGFKVYE,668,113,12251,Antimicrobial peptide KSL-W and analogues: Promising agents to control plant diseases.,Erwiniaamylovora,2136
KRKKHRCRVSNNGLPTGLYRWC,667,4,12261,Structure-activity relationships of the bacteriocin bactofencin A and its interaction with bacterial membrane.,Staphylococcusaureus,2135
RRLRPRRPRLPRPRPR,669,18,12308,Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action.,Micrococcusluteus,2710
DVIVVGAGIMGSSAAYQLAKRGQKTLL,670,4,12311,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus,2137
VLVPQGFAVVKKANFVAFYT,670,4,12312,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus,2138
AGDKKIKIGINGFGRIGRL,670,4,12313,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus,2139
GKVKIGINGFGRIGRLVA,670,4,12314,Discovery and identification of antimicrobial peptides in Sichuan pepper (Zanthoxylum bungeanum Maxim) seeds by peptidomics and bioinformatics.,Staphylococcusaureus,1081
HARIKPTFRRLKWKYKGKFW,671,31,12315,The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells.,Humanlung,912
PMPVSQECFETLRGHERILSILRHQNLLKELQDLALQGAKERAHQQ,672,114,12329,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata,913
ERILSILRHQNLLKE,672,114,12330,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata,913
LQDLALQGAKERAHQQ,672,114,12331,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata,913
GGLRKLGRKILRAWKKYGPIIVPIIRI,673,59,12333,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii,1005
KGLRKLGRKILRAWKKYGPIIVPIIRI,673,59,12334,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii,1005
GGLRSLGRKILRAWKKGGPIIVPIIRI,673,59,12335,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii,1005
KGLRKLGRKILRAWKKGGPIIVPIIRI,673,59,12336,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii,1005
RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFP,674,2,12342,"Copy number variation of PR-39 cathelicidin, and identification of PR-35, a natural variant of PR-39 with reduced mammalian cytotoxicity.",Escherichiacoli,1006
ALQGAKERAHQQ,672,114,12356,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata,914
GAKERAHQ,672,114,12357,"Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46.",Candidaglabrata,915
ACFLTRLGTYVC,675,2,12358,"Host-defense peptides AC12, DK16 and RC11 with immunomodulatory activity isolated from Hypsiboas raniceps skin secretion.",Escherichiacoli,916
DKERPICSNTFRGRKC,675,2,12359,"Host-defense peptides AC12, DK16 and RC11 with immunomodulatory activity isolated from Hypsiboas raniceps skin secretion.",Escherichiacoli,917
RCFRRRGKLTC,675,2,12360,"Host-defense peptides AC12, DK16 and RC11 with immunomodulatory activity isolated from Hypsiboas raniceps skin secretion.",Escherichiacoli,918
KKLIKVWAKGFKKAKKLFKGIG,676,2,12363,Antimicrobial activity of a porphyrin binding peptide.,Escherichiacoli,2140
KKLIKVFAKGWKKAKKLFKGIG,676,112,12364,Antimicrobial activity of a porphyrin binding peptide.,Humancervical,2140
KKLIKVFAKGFKKAKKLWKGIG,676,112,12365,Antimicrobial activity of a porphyrin binding peptide.,Humancervical,2140
KKAAKAWAKGAKKAKKLAKGAG,676,112,12367,Antimicrobial activity of a porphyrin binding peptide.,Humancervical,2141
NNNPRPPYLPRPRPP,677,2,12368,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli,1006
KKKPRPPYLPRPRPP,677,2,12369,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli,1006
RRRPRPPYLPPRRPP,677,2,12370,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli,1006
RRRPRPPYWPRPRPP,677,2,12371,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli,1006
RRRPRPPYLRPRPPP,677,2,12372,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli,1006
RRRPRPPYLNRPRPP,677,2,12373,Anti-microbial activity and cell binding are controlled by sequence determinants in the anti-microbial peptide PR-39.,Escherichiacoli,1006
RVKRFKKFFRKIKKGFRKIFKKTKIFIG,678,2,12374,Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Escherichiacoli,1694
HRVKRNGFRKFMRRLKKFFAGG,678,2,12375,Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Escherichiacoli,234
TRSRWRRFIRGAGRFARRYGWRIA,678,2,12376,Genomewide Analysis of the Antimicrobial Peptides in Python bivittatus and Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity.,Escherichiacoli,236
LVQIGTKIVGVGRNYAAH,679,2,12379,Phytohormone treatment induces generation of cryptic peptides with antimicrobial activity in the Moss Physcomitrella patens.,Escherichiacoli,919
INIINAPLQGFKIA,679,2,12380,Phytohormone treatment induces generation of cryptic peptides with antimicrobial activity in the Moss Physcomitrella patens.,Escherichiacoli,920
GACHRQGFGFACFCYKKC,680,24,12383,Plant defensin peptides have antifungal and antibacterial activity against human and plant pathogens.,Fusariumoxysporum,921
GSCNYVFPAHKCICYFP,680,24,12384,Plant defensin peptides have antifungal and antibacterial activity against human and plant pathogens.,Fusariumoxysporum,293
GDCKGIRRRCMCSKPL,680,24,12385,Plant defensin peptides have antifungal and antibacterial activity against human and plant pathogens.,Fusariumoxysporum,292
SFIKRSLKLIKSLVLIK,682,2,12397,A New Synthetic Peptide with In vitro Antibacterial Potential Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Escherichiacoli,1900
KIFGAIWPLALGALKNLIK,683,115,12405,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri,2142
KLLKFVTKVGKAIFKALIKAI,683,115,12406,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri,2143
IETFLKQLRSAANKIVGL,683,115,12407,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri,2144
LESLASSAVRTANKARAKL,683,115,12408,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri,2145
GFAWNVCVYRNGVRVCHRRAN,684,2,12415,Deleting the first disulphide bond in an arenicin derivative enhances its expression in Pichia pastoris,Escherichiacoli,174
QSVACTSYYCSKFCGSAG,685,2,12439,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,865
YCSKFCGSAGCSLYGCYLLH,685,2,12440,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,865
CSLYGCYLLHPGKICYCLHCSR,685,2,12441,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,865
CSLYGSYLLHPGKISYSLHCSR,685,2,12442,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,865
GCYLLHPGKICY,685,2,12444,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,1901
PGKICYCLHCSR,685,2,12446,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,1902
DKPKKKPPPPAGPPPPPPPPPG,686,2,12451,"The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action.",Escherichiacoli,1518
DKPKKKPPPPAGP,686,2,12452,"The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action.",Escherichiacoli,1903
KLLKHKLLVTLA,687,2,12453,"HJH-1, a Broad-Spectrum Antimicrobial Activity and Low Cytotoxicity Antimicrobial Peptide.",Escherichiacoli,1904
FKLLSHSLLVTLASHLP,688,116,12485,Purification and characterization of Hb 98-114: a novel hemoglobin-derived antimicrobial peptide from the midgut of Rhipicephalus (Boophilus) microplus.,Candidaparapsilosis,1938
FLPFFAACAITRKC,690,4,12497,"Effects of C-terminal amidation and heptapeptide ring on the biological activities and advanced structure of amurin-9KY, a novel antimicrobial peptide identified from the brown frog, Rana kunyuensis.",Staphylococcusaureus,2146
YGRKKRRQRRR,692,4,12522,DNA/Lysozyme-binding affinity study of novel peptides from TAT (47-57) and BRCA1 (782-786) in vitro by spectroscopic analysis.,Staphylococcusaureus,2148
SISLLYGRKKRRQRRR,692,4,12523,DNA/Lysozyme-binding affinity study of novel peptides from TAT (47-57) and BRCA1 (782-786) in vitro by spectroscopic analysis.,Staphylococcusaureus,2147
YGRKKRRQRRRSISLL,692,4,12524,DNA/Lysozyme-binding affinity study of novel peptides from TAT (47-57) and BRCA1 (782-786) in vitro by spectroscopic analysis.,Staphylococcusaureus,2148
GLPLLISWIKRKRQQAGPGSKKPVPIIYCNRRTGKCQRM,693,2,12528,Design and activity study of a melittin-thanatin hybrid peptide.,Escherichiacoli,1905
GLLRASSKWGRKYYVDLAGCAKA,694,4,12529,Selection and redesign for high selectivity of membrane-active antimicrobial peptides from a dedicated sequence/function database.,Staphylococcusaureus,2149
RFRPPIRRPPIRPPFYPPFRPPIRP,695,2,12531,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
GGGGLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLA,696,2,12533,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,875
GGGGLRKRLRKFRNKCKEKLKKCGQKIQGLLPKLA,696,2,12534,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,875
GGGRGLRRLGRKIAHGVKKYGPTVLRIIRIAG,696,2,12535,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,1906
GGGCGLRRLGCKIAHGVKKYGPTVLRIIRIAG,696,2,12536,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,1906
GGGGRFKRFRKKFKKLFKKLSPVIPLLHLG,696,2,12537,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,1907
GGGGRFKRFRKKCKKLFKKCSPVIPLLHLG,696,2,12538,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,1907
GGGGKKCKKLFKKCSPVIPLLHLG,696,2,12539,Antibody-Bactericidal Macrocyclic Peptide Conjugates To Target Gram-Negative Bacteria.,Escherichiacoli,1907
RRRGRSPRRRTPSPRRRRSQSPRRRRS,697,4,12540,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus,2174
RRRGRSPRRRTPSPRRRRSQSPRRRRSC,697,4,12541,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus,2174
RRRGRSPRRRTPSPRRRRSQSPRRRRSQ,697,4,12542,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus,2174
RRRGRSPRRRTPSPRRRRSC,697,4,12543,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus,2174
RRRTPSPRRRRSQSPRRRRSC,697,4,12544,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus,2174
RRRRSQSPRRRRSC,697,4,12545,Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides.,Staphylococcusaureus,2174
EVSLNSGYY,698,2,12558,Antimicrobial activity of antihypertensive food-derived peptides and selected alanine analogues.,Escherichiacoli,1908
FLFSLIRKAIGGLISAFK,699,4,12573,"A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.",Staphylococcusaureus,2150
RFRPPIRRPPIRPPFYPPFRPPI,695,2,12574,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
RFRPPIRRPPIRPPFYPPFRP,695,2,12575,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
RFRPPIRRPPIRPPFYPPF,695,2,12576,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
RFRPPIRRPPIRPPFYP,695,2,12577,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
RFRPPIRRPPIRPPF,695,2,12578,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
RPPIRRPPIRPPFYPPFRPPIRP,695,2,12579,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
PIRRPPIRPPFYPPFRPPIRP,695,2,12580,Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1-25) That Retain Antimicrobial Activity by Blocking Protein Synthesis.,Escherichiacoli,1941
KYYGNGVTCGKHSCSVDWGKATTCIINNGAMAWATGGHQGNHKC,700,117,12581,"Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.",Listeriaivanovii,649
KYYGNGVTAGKHSASVDWGKATTAIINNGAMAWATGGHQGNHKA,700,117,12586,"Synthesis, antimicrobial activity and conformational analysis of the class IIa bacteriocin pediocin PA-1 and analogs thereof.",Listeriaivanovii,649
KKWRWWLKALAKK,701,2,12609,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli,1909
KKWRKWLKALAKK,701,2,12610,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli,1909
KKWRAWLKWLAKK,701,2,12611,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli,1909
KKWRKWLKWLAKK,701,2,12612,Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.,Escherichiacoli,1910
RQCKAESNTFTGICIAKPPCRKACIREKFTDGHCSKVLRRCLCTKRC,702,112,12617,Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.,Humancervical,297
RQCKRESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,702,112,12618,Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.,Humancervical,297
HHHHHHCETPSKHFDGLCIRSSDCASVCHGEHFTDGRCEGVRRRCMCLKPC,703,17,12622,"Recombinant expression, purification and antimicrobial activity of a novel antimicrobial peptide PaDef in Pichia pastoris.",Listeriamonocytogenes,292
LRCMCIKWWSGKHPK,704,8,12623,Synthetic antimicrobial peptides delocalize membrane bound proteins thereby inducing a cell envelope stress response.,Bacillussubtilis,1594
LRAMCIKWWSGKHPK,704,8,12624,Synthetic antimicrobial peptides delocalize membrane bound proteins thereby inducing a cell envelope stress response.,Bacillussubtilis,1594
GKWKLFKKAFKKFLKILAC,704,8,12625,Synthetic antimicrobial peptides delocalize membrane bound proteins thereby inducing a cell envelope stress response.,Bacillussubtilis,2151
WFGKLYRGKTKVVKKVKGLLKG,705,2,12632,Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens.,Escherichiacoli,1911
FIFHIIRFFNFRVFRI,706,52,12633,Design of antimicrobial peptides from a cuttlefish database.,Enterococcusfaecalis,1912
KIFDAEILLNGKRKGLG,706,17,12634,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2152
FIKIFHHIFKGNPKFSIIK,706,17,12635,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2153
KIRFTRTVSRLLKAALAST,706,17,12636,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2154
AKAFKKAFEKLAAVVPFGGT,706,17,12637,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2155
GKSNKPALTLIQARILKHKT,706,17,12638,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2156
VILTRFRFLNRIVEPLLKKA,706,17,12639,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2157
GSTSFHLIYNKWFAVKRRRKR,706,17,12640,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2158
FFHHIFDPQIKSGLLVSMYD,706,17,12641,Design of antimicrobial peptides from a cuttlefish database.,Listeriamonocytogenes,2159
SLSGCWTKSFPRKPCLRNR,707,2,12642,Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles.,Escherichiacoli,2286
NPSNLRALEELVKEECSEIPVERCKKLIYGYRK,707,2,12643,Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles.,Escherichiacoli,1913
GGVGKIIEYFIGGGVGYYG,708,2,12668,Discovery and structure of the antimicrobial lasso peptide citrocin.,Escherichiacoli,1914
SNCWARCPGYPNGDSLCCRQYGACCSTSYPVPYKG,709,2,12672,The New Antimicrobial Peptide SpHyastatin from the Mud Crab Scylla paramamosain with Multiple Antimicrobial Mechanisms and High Effect on Bacterial Infection.,Escherichiacoli,1915
QLGKKKHRRRPSKKKRHW,710,2,12674,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Escherichiacoli,1917
QLGRRRHRRRPSRRRRHW,710,118,12675,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Humanbreast,1917
RQIKIWFQNRRWGGQLGKKKHRRRPSKKKRHW,710,2,12676,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Escherichiacoli,1916
RQIKIWFQNRRWGGQLGRRRHRRRPSRRRRHW,710,2,12677,HEXIM1 Peptide Exhibits Antimicrobial Activity Against Antibiotic Resistant Bacteria Through Guidance of Cell Penetrating Peptide.,Escherichiacoli,1916
AAVALLPAVLLALLAPMPFSTGKRIMLGE,711,62,12678,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Acutemyeloid,1917
AAVALLPAVLLALLAPQLGKKKHRRRPSKKKRHW,711,62,12679,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Acutemyeloid,1917
LTVSPWYGCGQLGKKKHRRRPSKKKRHW,711,118,12680,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast,1918
LTVSPWYGCGQLGRRRHRRRPSRRRRHW,711,118,12681,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast,1918
MPFSTGKRIMLGE,711,118,12682,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast,1919
LTVSPWYGCGMPFSTGKRIMLGE,711,118,12683,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanbreast,1919
LTVSPWYGCGKLAKLAKKLAKLAK,711,119,12684,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humanmultiple,1150
AAVALLPAVLLALLAPQLGRRRHRRRPSRRRRHW,711,120,12685,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humancolon,1917
AAVALLPAVLLALLAPQLGKKILAARPSKKKRHW,711,120,12686,Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy.,Humancolon,1917
QSCPTRRGLCFTSGLAACRAHCRGCHLGSNGRDCVRCPNGAQCTGVIGQTCTCLNPCPVC,712,8,12689,Induction of antibacterial proteins and peptides in the coprophilous mushroom Coprinopsis cinerea in response to bacteria.,Bacillussubtilis,2160
GIGAVLKVLTTGLPALIKRKRQQ,713,4,12691,"Action mechanism of melittin-derived antimicrobial peptides, MDP1 and MDP2, de novo designed against multidrug resistant bacteria.",Staphylococcusaureus,2501
GIGAVLKWLPALIKRKRQQ,713,4,12697,"Action mechanism of melittin-derived antimicrobial peptides, MDP1 and MDP2, de novo designed against multidrug resistant bacteria.",Staphylococcusaureus,2161
LEHGSCVTTMAKDKPTL,714,121,12753,In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,Aedesalbopictus,2162
DRGWGNGCGLFG,714,121,12754,In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,Aedesalbopictus,1429
GQGKAHNGRLITANP,714,121,12755,In vitro analysis of synthetic peptides in blocking the entry of dengue virus.,Aedesalbopictus,2163
GLLDLLKLLLKAAG,715,4,12756,Simulation-Guided Rational de Novo Design of a Small Pore-Forming Antimicrobial Peptide.,Staphylococcusaureus,2164
HLGHHALDHLLK,716,4,12769,Immune mediators of sea-cucumber Holothuria tubulosa (Echinodermata) as source of novel antimicrobial and anti-staphylococcal biofilm agents.,Staphylococcusaureus,2165
ASHLGHHALDHLLK,716,4,12770,Immune mediators of sea-cucumber Holothuria tubulosa (Echinodermata) as source of novel antimicrobial and anti-staphylococcal biofilm agents.,Staphylococcusaureus,825
MRGSHHHHHHGSSGENLYFQSL,718,17,12802,A Synthetic Derivative of Antimicrobial Peptide Holothuroidin 2 from Mediterranean Sea Cucumber (Holothuria tubulosa) in the Control of Listeria monocytogenes.,Listeriamonocytogenes,825
MRGSHHHHHHGSSGENLYFQSLASHLGHHALDHLLK,718,17,12803,A Synthetic Derivative of Antimicrobial Peptide Holothuroidin 2 from Mediterranean Sea Cucumber (Holothuria tubulosa) in the Control of Listeria monocytogenes.,Listeriamonocytogenes,825
AFCWNVCVYRNAVRVCHRRCN,719,2,12811,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli,174
GFCKAVCVYRNGVRVCHRRCN,719,2,12812,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli,174
WGFCWNVCVYRNGVRVCHRRCN,719,2,12813,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli,174
GFWNVVYRNGVRVHRRN,719,2,12814,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli,1920
GFCWNVAVYRNGVRVAHRRCN,719,2,12815,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli,174
GFAWNVAVYRNGVRVAHRRAN,719,2,12816,Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.,Escherichiacoli,174
HLNKRVQRLLIRWLDWLK,720,51,12819,Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Porphyromonasgingivalis,1862
HLLKRVQRLLIGWLDWLK,720,51,12820,Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Porphyromonasgingivalis,1862
HLLKRVQRELIRWLDWLK,720,51,12821,Antimicrobial activity against Porphyromonas gingivalis and mechanism of action of the cationic octadecapeptide AmyI-1-18 and its amino acid-substituted analogs.,Porphyromonasgingivalis,1862
HWRRFWHR,721,2,12822,Antimicrobial activity and membrane interaction mechanism of the antimicrobial peptides derived from Rana chensinensis with short sequences,Escherichiacoli,1921
RWRRFWRR,721,2,12823,Antimicrobial activity and membrane interaction mechanism of the antimicrobial peptides derived from Rana chensinensis with short sequences,Escherichiacoli,1922
KKLLPIVKNLLKSLL,722,2,12830,Effect of Acylation on the Antimicrobial Activity of Temporin B Analogues.,Escherichiacoli,413
PMARNKKLLKKLRLKIAFK,723,3,12842,Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria.,Pseudomonasaeruginosa,826
MKKLFAALALAAVVAPVW,724,2,12853,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1923
PMKKKLAARILAKIVAPVW,724,2,12854,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1924
PMKKLFAAKILARVVAKIW,724,2,12855,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1925
KKINNTILSGLDSVASFS,724,2,12856,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1926
PKKINKLLLRILDKIASFS,724,2,12857,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1927
PKKINNTILKLLDRVASKI,724,2,12858,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1928
MARNKPLGKKLRLAAAFK,724,2,12859,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,901
PMKLLKRLGKKIRLAAAFK,724,2,12860,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1929
PMARNKILGKILRKIAAFK,724,2,12861,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,901
MNAINFTCTVHKKVAISV,724,2,12863,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1930
PKLAIRITCKIHKKVAISV,724,2,12864,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1931
PMNAIKLLCRVHKKIAISV,724,2,12865,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1931
NRESQFYQSRRKKLSSQV,724,2,12866,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1932
PNRESQFYKILRKILSKIV,724,2,12867,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1933
PNRESQFYQKLLKKLSSKI,724,2,12868,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1934
MSAEVVVKKVDGDALELG,724,2,12869,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1935
PMKLLVRVKKKIGDALELG,724,2,12870,Joker: An algorithm to insert patterns into sequences for designing antimicrobial peptides.,Escherichiacoli,1936
LPKPPKPVSKMRMATPLLMQALPM,725,2,12882,Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.,Escherichiacoli,1937
GWRTLLKKAEVKTVGKLALKHYL,726,4,12887,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus,827
GIWKKWIKKWLKKLLKKLWKKG,727,4,12894,"Antimicrobial and antibiofilm activity of designed and synthesized antimicrobial peptide, KABT-AMP.",Staphylococcusaureus,828
GWKTLLKKAEVKTVGKLALKHYL,726,4,12898,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus,827
GYRTLLKKAEVKTVGKLALKHWL,726,4,12899,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus,827
KKAEVKTVGKLALKHWL,726,4,12900,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus,827
KTVGKLALKHWL,726,4,12901,Characterization and Antimicrobial Activity of Amphiphilic Peptide AP3 and Derivative Sequences.,Staphylococcusaureus,829
AKKKLSRWWLRWWVK,728,41,12905,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AKKKLVRWWLRWWSK,728,41,12906,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
ASKKLVRWWLRWWKK,728,41,12907,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
ALKKLSRWWKRWWVK,728,41,12908,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AVKKLSRWWLRWWKK,728,41,12909,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
ALKKLVRWWKRWWSK,728,41,12910,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AVKKLLRWWSRWWKK,728,41,12911,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AKKKLSAWWLAWWVK,728,41,12912,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AAAALSRWWLRWWVA,728,41,12913,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AKKKLSRAALRAAVK,728,41,12914,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,831
AKKKLSAAALAAAVK,728,41,12915,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,832
AAAALSRAALRAAVA,728,41,12916,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,833
AVKKLLAWWSAWWKK,728,41,12917,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AVAALLRWWSRWWAA,728,41,12918,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,830
AVKKLLRAASRAAKK,728,41,12919,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,834
AVKKLLAAASAAAKK,728,41,12920,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,835
AVAALLRAASRAAAA,728,41,12921,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,836
WSKWKRKAWVRLWLK,728,41,12922,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,837
RRERIEGDRRKEVA,728,41,12929,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,838
RRLDRKDYLRRVMP,728,41,12930,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,839
IEWGNVSRQPKPKATYI,728,41,12931,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,840
AAHRAGRPIHDAGVVKQ,728,41,12932,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,841
ARNVSEENVDRLAKRWIK,728,41,12933,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,2605
KREMKRPGKGNRNNWKKEY,728,41,12934,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,846
RPPGFYFEFRANIIPYLGRR,728,41,12935,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,842
ARRLGMNPWKTPPAKPKGSK,728,41,12936,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,843
RKPRTTKPKPAPKQEPATEE,728,41,12937,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,844
ARRRELRARRKRPPERHPGRR,728,41,12938,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,845
RNRIREMKRPGKGNRNNWKKEH,728,41,12939,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,846
RLFGLSIRQHEVMTGHTVKVKSQ,728,41,12940,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,847
RRMTFDADFELKVAQLNALIAIAELLKEKN,728,41,12941,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,848
RLIRVERDSVEALMRPIGK,728,41,12942,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,849
MLLKKLLKKM,728,41,12943,A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities.,Mycobacteriumtuberculosis,850
MQFITDLIGKAVDFFKGLFGNK,729,122,12948,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,1465
MQFITDLIGKAVDFFKGLFDNK,729,122,12949,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,1465
MNGFILGKFFDVAKKILDTIFQK,729,122,12950,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,851
MQTFQDILGKVIEVIKAIVDAK,729,122,12952,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,852
MAGVIAKIVEIVKGLIDQFTQK,729,122,12953,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
VNFKLLSHSLLVTLASHL,730,2,12966,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli,1938
KLLSHSLLVTLA,730,2,12967,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli,1939
MADVIAKIVEIVKKLIDQFTQK,729,122,13018,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
MAGVIAKIVEIVKKLIDQFTQK,729,122,13019,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
MADFIAKIVEIVKGLIDQFTQK,729,122,13020,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
MADVIAKIFEIVKGLIDQFTQK,729,122,13021,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
MADVIAKFVEIVKGLIDQFTQK,729,122,13022,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
MADVIAKFFEIVKGLIDQFTQK,729,122,13023,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
MQFITDLIKKAVDFFKGLVGNK,729,122,13024,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,1465
MQFITDLIKKAVDFIKGLFGNK,729,122,13025,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,1465
MQFITDLIKKAVDVIKGLFGNK,729,122,13026,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,1465
KLLRHRLLVTLA,730,2,13042,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli,1904
VRFKLLSHSLLVTLASHL,730,2,13043,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli,1938
RRFKLLSHSLLVTLASHL,730,2,13044,Potential of novel antimicrobial peptide P3 from bovine erythrocytes and its analogs to disrupt bacterial membranes in vitro and display activity against drug-resistant bacteria in a mouse model.,Escherichiacoli,1938
LKKWWKTSKGLLGGLLGKVTSVIK,732,3,13047,"Antibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, ?4-Short, in a Murine Model of Respiratory Infection.",Pseudomonasaeruginosa,854
VDFPNKGGKCDRKECRKTCKKLNYRGKCFNNYCRCFPG,733,4,13049,Loop Replacement Enhances the Ancestral Antibacterial Function of a Bifunctional Scorpion Toxin.,Staphylococcusaureus,855
VDFPNKGGKCDRKECRKTCKKLNYRGKCKFGGICRCFPG,733,4,13050,Loop Replacement Enhances the Ancestral Antibacterial Function of a Bifunctional Scorpion Toxin.,Staphylococcusaureus,855
KETWWETWWTEWSQPKKKRKV,734,2,13074,Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.,Escherichiacoli,1219
GLRKRDRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13075,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRRRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13076,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFLNKIKEKLKKIGQKIQGLLPKLAPRTDY,735,94,13077,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Salmonellaenterica,875
GLRKRLRKFRNKNKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13078,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKQKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13079,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKSKEKLKKIGQKIQGLLPKLAPRTDY,735,32,13080,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEFLKKIGQKIQGLLPKLAPRTDY,735,32,13081,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEILKKIGQKIQGLLPKLAPRTDY,735,32,13082,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKELLKKIGQKIQGLLPKLAPRTDY,735,32,13083,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEMLKKIGQKIQGLLPKLAPRTDY,735,32,13084,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEYLKKIGQKIQGLLPKLAPRTDY,735,32,13085,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKCKKIGQKIQGLLPKLAPRTDY,735,32,13086,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKHKKIGQKIQGLLPKLAPRTDY,735,32,13087,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKHGQKIQGLLPKLAPRTDY,735,32,13088,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKQGQKIQGLLPKLAPRTDY,735,32,13089,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKRGQKIQGLLPKLAPRTDY,735,32,13090,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKICQKIQGLLPKLAPRTDY,735,32,13091,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIIQKIQGLLPKLAPRTDY,735,32,13092,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKILQKIQGLLPKLAPRTDY,735,32,13093,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKCQGLLPKLAPRTDY,735,32,13094,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKEQGLLPKLAPRTDY,735,32,13095,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKHQGLLPKLAPRTDY,735,32,13096,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKSQGLLPKLAPRTDY,735,32,13097,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKCAPRTDY,735,32,13098,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRHDY,735,32,13099,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDD,735,32,13100,Dissection of the antimicrobial and hemolytic activity of Cap18: Generation of Cap18 derivatives with enhanced specificity.,Lactococcuslactis,875
KLCKIVVIKVCK,736,2,13161,A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Escherichiacoli,546
RLCRIWWIRWCR,736,2,13162,A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin.,Escherichiacoli,1940
ATCYCRTGR,737,59,13173,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,856
ATCYCRTGRCATR,737,59,13174,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,1788
ATCYCRTGRCATRESLSGVCEISGRLYR,737,59,13175,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,1788
TGRCATRESLSGVCEISGRLYRLCCR,737,59,13176,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,1788
CATRESLSGVCEISGRLYRLCCR,737,59,13177,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,1788
ESLSGVCEISGRLYRLCCR,737,59,13178,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,1788
CATRESLSGVCEISGRLY,737,59,13179,Paneth cell ?-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments.,Acinetobacterbaumannii,1788
RFRPPIRRPPIRPPFRPPFRPPVRP,738,2,13181,Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.,Escherichiacoli,1941
RFRPPIRRPPIRPPFNPPFRPPVRP,738,2,13182,Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.,Escherichiacoli,1941
RFRPPIRRPPIRPPFYPPFRPPIRPPIFPPI,738,2,13183,Fragments of the Nonlytic Proline-Rich Antimicrobial Peptide Bac5 Kill Escherichia coli Cells by Inhibiting Protein Synthesis.,Escherichiacoli,1941
YLARAIRRTLARLLL,739,2,13184,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1942
SWKKFFKKARSLPKLF,739,2,13189,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1943
KFKKLFKKLSPVFKRIVQRIKDFLR,740,4,13190,Design and characterization of a new hybrid peptide from LL-37 and BMAP-27.,Staphylococcusaureus,635
CGIYRSLKLIKSLVLIK,741,2,13191,New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Escherichiacoli,1944
CALKLTKAKRLVRKIGF,741,2,13192,New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).,Escherichiacoli,1945
EWRVARRAVQRLRHLARRYH,739,2,13193,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1946
ALKKMLRLAKRLS,739,2,13194,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1947
VLSAFHKVIKIIHHISHF,739,2,13195,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1948
RKFRKILHRARKWI,739,2,13196,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1949
RRWGRWHRMRRRGR,739,2,13205,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1950
FWKGLVKAAFKIVHAGS,739,2,13213,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1951
GWKAIHKAAKGIHTYVN,739,2,13245,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1952
YKRWKKWRSKAKKIL,739,2,13246,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1953
KWKCLAKVGIAAH,739,2,13247,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1954
KRSWDIVKKYVGVVVGTIH,739,2,13248,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1955
AGEKRIIKKIDEAFQ,739,2,13249,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1956
AIARTRRRLLLYLLA,739,2,13250,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1957
AAARLRLLLYLITRR,739,2,13251,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1958
RKLAFKPLKKFFSWKS,739,2,13252,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1959
SKFLSKKPKKLFWFRA,739,2,13253,Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.,Escherichiacoli,1960
FAKKFAKKFKKFAKKFAKFAFAF,742,3,13330,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,2018
FKLRAKIKVRLRAKIKL,742,3,13331,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,2016
FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK,743,123,13332,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1961
FLAAARIAKRVAKKARKLAKRAARKRK,743,123,13333,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1962
FRFKIKFRLKFRFKARFKFRAKFRA,743,123,13334,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1963
KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF,743,123,13335,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1964
FAVGLRAIKRALKKLRRGVRKVAKDL,743,123,13336,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1965
GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK,743,123,13337,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1966
KKKKFVKKVAKKVKKVAKKVAKVAVAV,743,123,13338,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1967
FLFAFRIFKRVFKKFRKLFKRAF,743,123,13339,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,2020
KRKRAVKRVGRRLKKKLARKIARLGVAF,743,123,13340,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1964
KRKRFAKKFLRFLRKVIRFLKRFIRRF,743,123,13341,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1968
FAIAIKAIKKAIKKIKKAIKKAI,743,123,13342,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1961
FKVKAKVKAKVKAKVKAKKKK,743,123,13344,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1969
AVKRVGRRLKKLARKIARLGVAF,743,123,13345,Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.,Felineimmunodeficiency,1964
KFAKKFAK,742,3,13352,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,857
KFAKKFAKKFAK,742,3,13353,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,858
KFAKKFAKKFAKKFAK,742,3,13354,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
KFAKKFAKKFAKKFAKKFAK,742,3,13355,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
KFAKKFAKKFAKKFAKKFAKKFAK,742,3,13356,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
KFAKKFAKKFAKKFAKKFAKKFAKKFAK,742,3,13357,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK,742,3,13358,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
KFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAKKFAK,742,3,13359,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
RFARRFARRFARRFARRFARRFAR,742,3,13361,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
RFARRFARRFARRFARRFARRFARRFAR,742,3,13362,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
RFARRFARRFARRFARRFARRFARRFARRFAR,742,3,13363,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
FAKKFAKKFAKKFAKKFAKKFAKK,742,3,13364,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
AKKFAKKFAKKFAKKFAKKFAKKF,742,3,13365,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
KKFAKKFAKKFAKKFAKKFAKKFA,742,3,13366,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
LKKLLKKLLKKLLKKLLKKL,742,3,13367,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,860
LKKLLKKLLKKLLKKLLKKLLKKL,742,3,13368,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,860
LKKLLKKLLKKLLKKLLKKLLKKLLKKL,742,3,13369,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,860
LKKLLKKLLKKLLKKLLKKLLKKLLKKLLKKL,742,3,13370,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,860
KFAFKFAFKFAFKFAFKFAFKFAFKFAF,742,3,13371,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,861
KFFKKFFKKFFKKFFKKFFKKFFKKFFK,742,3,13372,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,862
KAAKKAAKKAAKKAAKKAAKKAAKKAAK,742,3,13373,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,863
KKAKKKAKKKAKKKAKKKAKKKAKKKAK,742,3,13374,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,864
KFKKFKKFKKFKKFKKFK,742,3,13375,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
KFKKFKKFKKFKKFKKFKKFK,742,3,13376,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
KFKKFKKFKKFKKFKKFKKFKKFK,742,3,13377,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
KFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13378,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
KFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13379,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13380,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
KFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFKKFK,742,3,13381,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1760
FKAFKAFKAFKA,742,3,13384,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1761
FKAFKAFKAFKAFKAFKA,742,3,13385,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1762
FKAFKAFKAFKAFKAFKAFKA,742,3,13386,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1762
FKAFKAFKAFKAFKAFKAFKAFKA,742,3,13387,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1762
FKAFKAFKAFKAFKAFKAFKAFKAFKA,742,3,13388,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1762
FKAFKAFKAFKAFKAFKAFKAFKAFKAFKA,742,3,13389,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1762
FKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKAFKA,742,3,13390,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1762
LKLKLKLKLK,742,3,13393,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1763
LKLKLKLKLKLKLK,742,3,13394,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1764
LKLKLKLKLKLKLKLK,742,3,13395,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LKLKLKLKLKLKLKLKLK,742,3,13396,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LKLKLKLKLKLKLKLKLKLK,742,3,13397,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LKLKLKLKLKLKLKLKLKLKLK,742,3,13398,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LKLKLKLKLKLKLKLKLKLKLKLK,742,3,13399,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLK,742,3,13400,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLKLK,742,3,13401,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LRLRLRLRLRLRLR,742,3,13402,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1764
LRLRLRLRLRLRLRLRLR,742,3,13403,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1765
LALALALALALALALALALALA,742,3,13404,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1766
KFKKFKKFK,742,3,13406,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1767
KFKKFKKFKKFK,742,3,13407,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1768
KGKKGKKGKKGKKGKKGKKGK,742,3,13408,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1769
KGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGK,742,3,13409,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1769
KGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGKKGK,742,3,13410,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1769
KTKKTKKTKKTKKTKKTKKTK,742,3,13411,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1770
KFAKKFAKKFAKKAAK,742,3,13412,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1771
KFAKKFAKKAAKKAAK,742,3,13413,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,1771
KFAKKAAKKFAKKAAK,742,3,13414,Periodic antimicrobial peptides.,Pseudomonasaeruginosa,859
AMAYLAKDNLGEKITEVITILLNRLTDRLEKYAG,744,2,13415,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli,1970
MDKYIRKEDLGMKMLDVAKILGRRIEKRMEYIAKK,744,2,13416,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli,1971
IDTYSRKDDLDKKLLEVAKIIGRRLEKRHEYLAMK,744,2,13417,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli,1971
IRKYLEEDNLGEKLAAVVSIYVKRLNKRLDMR,744,2,13423,"Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.",Escherichiacoli,1972
ITEVITILLNRLTDRLEK,745,3,13425,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa,1970
ITKVITKLLNRLTKILSK,745,3,13426,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa,1772
ITKQITKQLNRQTKIQSK,745,3,13427,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa,1773
IQKVIQKLLNRLQKILQK,745,3,13428,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa,1774
ITKVIAKLLNRLTKILSK,745,3,13429,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa,1772
ITKVITKLLNRLSKILSK,745,3,13430,Helminth Defense Molecules as Design Templates for Membrane Active Antibiotics.,Pseudomonasaeruginosa,1772
VRLPPPVRLPPPVRLPPP,746,2,13488,Membrane-active peptides and the clustering of anionic lipids.,Escherichiacoli,1973
GWTLNSAGYLLGKINLKALAALAKKIL,746,2,13489,Membrane-active peptides and the clustering of anionic lipids.,Escherichiacoli,1974
PMNAIKLLCR,747,3,13491,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1775
MNAIKLLCRV,747,3,13492,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1776
NAIKLLCRVH,747,3,13493,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1777
AIKLLCRVHK,747,3,13494,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1778
IKLLCRVHKK,747,3,13495,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1779
KLLCRVHKKI,747,3,13496,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1780
LLCRVHKKIA,747,3,13497,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1781
LCRVHKKIAI,747,3,13498,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1782
CRVHKKIAIS,747,3,13499,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1783
RVHKKIAISV,747,3,13500,A short peptide with selective antibiofilm activity against Pseudomonas aeruginosa and Klebsiella pneumoniae carbapenemase-producing bacteria.,Pseudomonasaeruginosa,1784
RWCRRYRVRVRGVLVYAYVCW,748,2,13505,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli,1975
RRWCVYAYVRVRGVRVYAYVCW,748,2,13506,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli,1976
WCRRYRVLVRGVLVRYRRCW,748,2,13507,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli,1975
RWCVYAYVRV,748,1,13509,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",None_target,1785
WCRRYRVLV,748,1,13512,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",None_target,1786
RFCVYAYVRVRGVLVRYRRCF,748,2,13515,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli,1976
RWCVYAYVRVRGVLVRYRRCW,748,2,13517,"Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization.",Escherichiacoli,1976
CKGKGAKCSRLMYDCCTGSCRSGKCGS,749,2,13518,Macrocyclic Antimicrobial Peptides Engineered from ?-Conotoxin.,Escherichiacoli,1977
AKGKGAKASRLMYDAATGSARSGKAGS,749,2,13528,Macrocyclic Antimicrobial Peptides Engineered from ?-Conotoxin.,Escherichiacoli,1977
GNNKPVYKPQPRPPHPRL,750,2,13539,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNKPVYRPQPRPPHPRL,750,2,13541,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNKPVYIPQPRPPRPRL,750,2,13542,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNRPVYKPQPRPPRPRL,750,2,13543,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNRPVYRPQPRPPRPRL,750,2,13545,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNKPVYKPQPRPPRPRL,750,2,13546,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNKPVYRPQPRPPRPRL,750,2,13547,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
VDKGSYKPRPTPPKPIYNRN,750,2,13549,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,565
VDKGSYRPRPTPPKPIYNRN,750,2,13550,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,565
RRIKKRPPRLPRPRPR,750,2,13551,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIKPRPPRLPRPRPK,750,2,13552,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIRKRPPRLPRPRPK,750,2,13553,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIKKRPPRLPRPRPK,750,2,13554,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
GNNKPVYIPQPRPPHPRL,750,2,13555,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNRPVYKPQPRPPHPRL,750,2,13556,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNRPVYRPQPRPPHPRL,750,2,13557,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
GNNRPVYIPQPRPPRPRL,750,2,13558,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2542
VDKGSYKPRPTPPRPIYNRN,750,2,13559,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,565
VDKGSYRPRPTPPRPIYNRN,750,2,13560,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,565
VDKGSYLPRPTPPKPIYNRN,750,2,13561,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,565
KRIRPRPPRLPRPRPR,750,2,13562,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RKIRPRPPRLPRPRPR,750,2,13563,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRKRPRPPRLPRPRPR,750,2,13564,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRRRPRPPRLPRPRPR,750,2,13565,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIKPRPPRLPRPRPR,750,2,13566,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIRKRPPRLPRPRPR,750,2,13567,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIRPRKPRLPRPRPR,750,2,13568,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIRPRRPRLPRPRPR,750,2,13569,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
RRIRPRPPRLPRPRPK,750,2,13570,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,2710
VPKPPYLPRPRPPRRIYNRG,751,3,13599,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VRKPPYLPRPRPPRRIYNRG,751,3,13600,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKKPYLPRPRPPRRIYNRG,751,3,13601,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRFPRRIYNRG,751,3,13602,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRGPRRIYNRG,751,3,13603,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRKPRRIYNRG,751,3,13604,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRLPRRIYNRG,751,3,13605,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRMPRRIYNRG,751,3,13606,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRQPRRIYNRG,751,3,13607,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRRPRRIYNRG,751,3,13608,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRSPRRIYNRG,751,3,13609,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRWPRRIYNRG,751,3,13610,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRYPRRIYNRG,751,3,13611,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPRRRIYNRG,751,3,13612,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPKRIYNRG,751,3,13613,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRCYNRG,751,3,13614,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRFYNRG,751,3,13615,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRKYNRG,751,3,13616,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRIYCRG,751,3,13617,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRIYKRG,751,3,13618,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRIYWRG,751,3,13619,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRIYYRG,751,3,13620,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRIYNHG,751,3,13621,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
VDKPPYLPRPRPPRRIYNKG,751,3,13622,Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus.,Pseudomonasaeruginosa,1787
SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC,752,2,13625,Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues.,Escherichiacoli,1803
EVAKKLLASALKLALAI,753,2,13630,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design,Escherichiacoli,1978
EDWNHLGAAVHTLKHVYK,754,2,13637,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1979
AIVEQLRKRC,754,2,13638,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1980
KLSASLKHVAHRARHLS,754,2,13639,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1981
ESRAGKLAAKAAFKAAKR,754,2,13640,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1982
EWAAARQVIIHATRKY,754,2,13641,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1983
EILSKALSALSPLAN,754,2,13642,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1984
EKAILSALKLLRLAL,754,2,13643,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1985
ETAKGVAKHLPPAIA,754,2,13644,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1986
KVYARLHAVIKRLHRRLH,754,2,13645,A Uniform In Vitro Efficacy Dataset to Guide Antimicrobial Peptide Design.,Escherichiacoli,1987
SRSSRAGLQFPVGRIHRLLRK,755,25,13663,"A histone H2A derived antimicrobial peptide, Fi-Histin from the Indian White shrimp, Fenneropenaeus indicus: Molecular and functional characterization.",Bacilluscereus,882
ATCYCRTGRCATRESLSGVCEISGRLYRLCCR,756,2,13695,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli,1788
ATCYCRTGRCATRESLSAVCEISGRLYRLCCR,756,2,13696,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli,1788
ATCYCATGRCATRESLSGVCEISGRLYRLCCR,756,2,13697,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli,1788
ATAYARTGRAATRESLSGVAEISGRLYRLAAR,756,2,13698,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli,1788
ATCYCKTGKCATKESLSGVCEISGKLYKLCCK,756,2,13699,Roles of the Conserved Amino Acid Residues in Reduced Human Defensin 5: Cysteine and Arginine Are Indispensable for Its Antibacterial Action and LPS Neutralization.,Escherichiacoli,1788
ATCYARTGRAATRESLSGVAEISGRLYRLACR,757,59,13704,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii,1788
ATAYCRTGRAATRESLSGVCEISGRLYRLAAR,757,59,13705,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii,1788
ATAYARTGRCATRESLSGVAEISGRLYRLCAR,757,59,13706,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii,1788
ARARCRRGRAARRRRLRGVCRIRGRLRRLAAR,757,59,13707,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii,1789
AKAKCRKGRAAKRKKLKGVCRIKGRLKRLAAR,757,59,13708,A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii.,Acinetobacterbaumannii,1789
ATCYCRRGRCATRESLSGVCEISGRLYRLCCR,758,2,13709,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli,1788
ATCYCRTGRCATRESLSGVCRISGRLYRLCCR,758,2,13710,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli,1788
ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR,758,2,13711,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli,1788
ATCYCRTGRCATRESLSGVCEISRRLYRLCCR,758,2,13712,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli,1788
ATCYCRRGRCATRESLSGVCRISGRLYRLCCR,758,2,13713,Design of a potent antibiotic peptide based on the active region of human defensin 5.,Escherichiacoli,1788
IKIVAPKKIKL,759,2,13714,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1988
WKKLVPYKIHAGI,759,2,13715,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1989
FRIMRILRVLKL,759,2,13716,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1990
WKIFKLKLRMLW,759,2,13717,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1991
LRWLGTKVGILK,759,2,13718,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1992
KFKKVIWKSFL,759,2,13719,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1993
LIVLTCRKKKKPF,759,2,13720,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1994
RPILIRVRRIRVI,759,2,13721,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1995
RWRLVCFLCRRKKV,759,2,13722,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1996
GFIVKRFKILV,759,2,13723,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1997
CLIMKVRRKK,759,2,13724,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1998
ISRACLIMKVRRKK,759,2,13725,Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.,Escherichiacoli,1999
KKCWNGGRCRKKCKENEKPIGYCRNGKKCCVN,760,41,13731,Antimicrobial activity and structure of a consensus human ?-defensin and its comparison to a novel putative hBD10.,Mycobacteriumtuberculosis,1790
KWKSFIKKLTSVLKKVVTTALPALIS,761,2,13734,Antimicrobial Cationic Peptides,Escherichiacoli,2502
KWKSFIKNLTKVLKKVVTTALPALIS,761,2,13737,Antimicrobial Cationic Peptides,Escherichiacoli,2502
KWKLFKKKGTGAVLTVLTTGLPALIS,761,2,13738,Antimicrobial Cationic Peptides,Escherichiacoli,2501
KKWWRRVLSGLKTAGPAIQSVLNK,761,2,13739,Antimicrobial Cationic Peptides,Escherichiacoli,2000
KKWWRRALQGLKTAGPAIQSVLNK,761,2,13740,Antimicrobial Cationic Peptides,Escherichiacoli,2000
KKSFFKKLTSVASSVLS,761,2,13741,Antimicrobial Cationic Peptides,Escherichiacoli,2001
KWKSFIKNLEKVLKPGGLLSNIVTSL,761,2,13742,Antimicrobial Cationic Peptides,Escherichiacoli,2002
KWKSFIKNLEKVLKKGPILANLVSIV,761,2,13743,Antimicrobial Cationic Peptides,Escherichiacoli,2502
KWKEFIKKLTTAVKKVLTTGLPALIS,761,2,13744,Antimicrobial Cationic Peptides,Escherichiacoli,2502
KWKKFIKELQKVLAPGGLLSNIVTSL,761,2,13745,Antimicrobial Cationic Peptides,Escherichiacoli,2002
KWKLFKKIGIGAVLTTGLPALIS,761,4,13747,Antimicrobial Cationic Peptides,Staphylococcusaureus,2501
GLFDVIRRVASVIGGL,762,4,13760,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus,2459
GLFDVIRKVASVIGGL,762,4,13761,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus,2459
GLFDVIKKGVASVIGGL,762,4,13762,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus,1791
GLFEVIKKVASVIGGL,762,4,13763,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus,2459
GLWDVIKKVASVIGGL,762,4,13764,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus,2459
GLWRVIRKVASVIGGL,762,4,13765,Understanding interactions of Citropin 1.1 analogues with model membranes and their influence on biological activity.,Staphylococcusaureus,2459
KVEIVAINDPFIDL,763,48,13786,Identification of A Novel Antibacterial Peptide from Atlantic Mackerel belonging to the GAPDH-Related Antimicrobial Family and Its In Vitro Digestibility.,Bacillusmegaterium,1792
LRRLLRWLRRLLRR,764,2,13787,Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms.,Escherichiacoli,2003
LRRAARWARRLLRR,764,2,13788,Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms.,Escherichiacoli,2004
LRRPPRWPRRLLRR,764,2,13790,Design and characterization of short antimicrobial peptides using leucine zipper templates with selectivity towards microorganisms.,Escherichiacoli,2005
RKKRRQRRR,765,4,13834,Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor.,Staphylococcusaureus,1793
RKKRRQRRRCWTKSIPPKPC,765,4,13836,Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor.,Staphylococcusaureus,1794
RVKRVWYLVIRTVIAGYNLPRAIKKK,766,2,13888,Improving Cell Selectivity of Fowlicidin-1 by Swapping Residues between Pro-7 and Tyr-20,Escherichiacoli,95
KWCFRVCYRGICYRRCRG,767,2,13889,Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.,Escherichiacoli,1257
RWCFRVCYRGICYRKCRG,767,2,13890,Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.,Escherichiacoli,1257
KWCFRVCYRGICYRKCRG,767,2,13891,Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.,Escherichiacoli,1257
RVKRVWPLVIRTVIAGYNL,768,2,13892,The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.,Escherichiacoli,95
KRVWPLVIRTVIAGYNLYR,768,2,13893,The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.,Escherichiacoli,95
VWPLVIRTVIAGYNLYRAI,768,2,13894,The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.,Escherichiacoli,95
NLCASLRARHTIPQCRKFGRR,769,2,13896,"Structural and Functional Assessment of mBjAMP1, an Antimicrobial Peptide from Branchiostoma japonicum, Revealed a Novel ?-Hairpinin-like Scaffold with Membrane Permeable and DNA Binding Activity.",Escherichiacoli,2006
NLSASLRARHTIPQSRKFGRR,769,2,13898,"Structural and Functional Assessment of mBjAMP1, an Antimicrobial Peptide from Branchiostoma japonicum, Revealed a Novel ?-Hairpinin-like Scaffold with Membrane Permeable and DNA Binding Activity.",Escherichiacoli,2006
NLASLRARHTIPQRKFGRR,769,2,13899,"Structural and Functional Assessment of mBjAMP1, an Antimicrobial Peptide from Branchiostoma japonicum, Revealed a Novel ?-Hairpinin-like Scaffold with Membrane Permeable and DNA Binding Activity.",Escherichiacoli,2006
FLPAIAGLAAKFLPKIFCAITKKC,770,2,13908,Identification and molecular cloning of novel antimicrobial peptides from skin secretions of the Chinese bamboo leaf odorous frog (Odorrana versabilis) and the North American pickerel frog (Rana palustris),Escherichiacoli,1296
FLPAIAGVAAKFLPKIFCAITKKC,770,2,13909,Identification and molecular cloning of novel antimicrobial peptides from skin secretions of the Chinese bamboo leaf odorous frog (Odorrana versabilis) and the North American pickerel frog (Rana palustris),Escherichiacoli,1296
KKLRLKIAFK,771,2,13929,Short Cationic Peptide Derived from Archaea with Dual Antibacterial Properties and Anti-Infective Potential.,Escherichiacoli,2007
GWLKKIGKKIERVGQNTRDATIQAIGVAQQAANVAATLKG,772,59,13933,Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.,Acinetobacterbaumannii,1795
GWVKKIGKKIERVGQNTRDATIQVIGVAQQAANVAATLKG,772,59,13935,Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.,Acinetobacterbaumannii,1795
FLGALWKALSKLL,773,2,13991,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Escherichiacoli,2008
FLGALWHALSKLL,773,2,13992,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Escherichiacoli,1796
FLGALWKALSHLL,773,2,13994,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Escherichiacoli,1796
FLGALWHALSHLL,773,124,13995,Activity and selectivity of histidine-containing lytic peptides to antibiotic-resistant bacteria.,Humanpancreatic,1796
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGRCRGFRRRCYCYYRHCY,774,24,14008,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum,2009
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACHVRNGKHMCYCYYRHCY,774,24,14009,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum,2009
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACAAARHSKHYGCYCYYRHCY,774,24,14010,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum,2009
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNAAAKHYGCYCYYRHCY,774,24,14011,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum,2009
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNRHSAAAACYCYYRHCY,774,24,14012,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumoxysporum,2009
HTLCMDGGATY,775,125,14013,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Acinetobacteranitratus,2010
HTLCMGKATY,775,125,14014,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Acinetobacteranitratus,2011
HTLCMDKKATY,775,47,14015,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Streptococcuspyogenes,1797
HTLCMDRRATY,775,56,14016,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Staphylococcusepidermidis,1797
HTLCMDPPATY,775,56,14017,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Staphylococcusepidermidis,1798
HTLCMGGATY,775,56,14018,"M-Brucin, an antibacterial peptide against Staphylococcus epidermidis and Streptococcus pyogenes",Staphylococcusepidermidis,1799
GLLSRLRDFLSDIGRRLGEKIERIGQKIKDLSEFFQS,776,4,14020,Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity.,Staphylococcusaureus,1800
GLLSRLRDFLSDRGRRLGEIIERIGQIIKDLSEFFQS,776,4,14021,Enhancing the antibacterial activity of PMAP-37 by increasing its hydrophobicity.,Staphylococcusaureus,1800
MGIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK,777,2,14029,Bacterial expression and antibiotic activities of recombinant variants of human ?-defensins on pathogenic bacteria and M. tuberculosis.,Escherichiacoli,2012
CRKPTFRRLKWKIKFKFKC,778,2,14040,Synergistic antibiotic effect of looped antimicrobial peptide CLP-19 with bactericidal and bacteriostatic agents.,Escherichiacoli,2013
GIIKKIIKKIIKKI,779,2,14044,Hydrophobic Control of the Bioactivity and Cytotoxicity of de Novo-Designed Antimicrobial Peptides.,Escherichiacoli,2014
GFGCPGSEKKCHNHCKSVKGYKGGYCDGPYIPFVGRPRCKCY,780,4,14052,Invasive fungi-derived defensins kill drug-resistant bacterial pathogens.,Staphylococcusaureus,2323
GFGCPGNEKKCHNHCKSVKGYKGGYCDGPYIPFVGRPRCKCY,780,4,14053,Invasive fungi-derived defensins kill drug-resistant bacterial pathogens.,Staphylococcusaureus,2323
GFGCPGSEKKCHNHCKTIKGYKGGYCDGPYIPFVGRPRCKCY,780,4,14054,Invasive fungi-derived defensins kill drug-resistant bacterial pathogens.,Staphylococcusaureus,2323
VAIALKAAHYATHKE,781,52,14071,Bioinorganic chemistry of calcitermin - the picklock of its antimicrobial activity.,Enterococcusfaecalis,811
KKHRKHRKHRKHGGG,782,1,14074,Design and activity of a 'dual-targeted' antimicrobial peptide.,None_target,2166
DAANEAGGG,782,1,14076,Design and activity of a 'dual-targeted' antimicrobial peptide.,None_target,2167
FKARRWQWRMKKLGA,783,2,14093,"Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains",Escherichiacoli,114
GRFRRLRKKTRKRLKKIGKVLKWIWWIVGSIPLGCG,784,50,14099,Antimicrobial activity of the antibacterial peptide PMAP-36 and its analogues.,Enterococcusfaecium,2015
GRFRRLRKKTRKRLKKIGKVLKWIKKIVGSIPLGCG,784,50,14100,Antimicrobial activity of the antibacterial peptide PMAP-36 and its analogues.,Enterococcusfaecium,2015
MGFKLRAKIKVRLRAKIKL,785,50,14105,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2016
GRFKRFRKKLKKLFKKLSPVIPLLHLG,786,126,14106,Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.,Enterobactercloacae,1907
FRKKLKKLFKKLSPVIPLLKLG,786,126,14107,Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.,Enterobactercloacae,1907
CKLRFRGPGRIKVRLC,785,50,14113,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2017
CPGFAKKFAKKFKKFAKKFAKFAFAF,785,50,14114,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2018
KIRAKLCLGRFCIRAKLR,785,50,14115,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2019
KKKPKPPYLPKPKPPPFFPPKLPPKI,785,50,14116,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,1006
FAFAFKAFKKAFKKFKKAFKKAFGPC,785,50,14117,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2020
FAFAFAFKKAFKKFKKAFKKAF,785,50,14118,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2020
FAKKFAKKFKKFAKKFAFAFAF,785,50,14121,Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.,Enterococcusfaecium,2018
VAEARQGSFSY,787,3,14134,Antimicrobial activity and mechanism of action of a novel peptide present in the ecdysis process of centipede Scolopendra subspinipes subspinipes.,Pseudomonasaeruginosa,2168
RPFTRAQWFAIQHISPRTIAMRAINNYRWR,788,3,14140,"A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.",Pseudomonasaeruginosa,1884
RPFIRAQWFAIQHISPRTIAMRAINNYRWR,789,3,14141,Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.,Pseudomonasaeruginosa,1884
RPFTRAQIFAIQHISPRTIAMRAINNYRWR,789,3,14142,Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.,Pseudomonasaeruginosa,1884
RPFTRAQWFAIIHISPRTIAMRAINNYRWR,789,3,14143,Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.,Pseudomonasaeruginosa,1884
ACYCRIPACIAGERRYATCIYQGRLWAFCC,790,2,14144,"Invariant gly residue is important for ?-defensin folding, dimerization, and function: a case study of the human neutrophil ?-defensin HNP1.",Escherichiacoli,425
LKLSPKTKKTLKKVLKGAIKGAIAIASMA,791,4,14145,"Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa.",Staphylococcusaureus,2169
GIGKWLHSAKKFGKAFVGEIMNS,793,8,14162,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis,13
RRRRRRRRRGGGGIGKWLHSAKKFGKAFVGEIMNS,793,8,14163,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis,13
KWKKLLKKLLKLLKK,793,8,14164,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis,2170
RRRRRRRRRGGGKWKKLLKKPLKLLKK,793,8,14165,Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.,Bacillussubtilis,2171
KRKARKKGRFSKK,794,51,14180,Identification of cationic peptides derived from low protein rice by-products and evaluation of their multifunctional activities.,Porphyromonasgingivalis,2172
FKRIVQRIKDFLRNLV,795,3,14181,Cathelicidin-Derived Synthetic Peptide Improves Therapeutic Potential of Vancomycin Against Pseudomonas aeruginosa.,Pseudomonasaeruginosa,635
KIAGKIAKIAGKIAKIAGKIA,796,2,14201,Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides,Escherichiacoli,2021
KLALKLALKALKAALKLA,796,2,14202,Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides,Escherichiacoli,2022
GLKRIFKSGLGKLVKGISAHVAS,798,4,14272,Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria.,Staphylococcusaureus,2173
TIVRRRGGSRATRSPRRRTPSPRRRRSQSPRRRRSQSPASSNC,799,3,14276,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa,2174
TVIRRRGGARASRSPRRRTPSPRRRRSQSPRRRRSQSPSANC,799,3,14277,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa,2174
RKPRGLEPRRRKVKTTVVYGRRRSKSRERRAPTPQR,799,3,14278,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa,2175
RKPRGLEPRRRKVKTTVVYGRRRSKSRGRRSSPSQR,799,3,14279,Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement.,Pseudomonasaeruginosa,2175
ATKKCGLFKILKGVGKI,800,2,14392,"Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).",Escherichiacoli,2023
SQRKLAAKLTSK,801,3,14393,Development of a Novel Hybrid Antimicrobial Peptide for Targeted Killing of Pseudomonas Aeruginosa.,Pseudomonasaeruginosa,2176
SQRKLAAKLTSKGGGRLLRPLLQLLKQKLR,801,3,14394,Development of a Novel Hybrid Antimicrobial Peptide for Targeted Killing of Pseudomonas Aeruginosa.,Pseudomonasaeruginosa,2177
AKLIPTIAL,802,2,14396,"RcAlb-PepII, a Synthetic Small Peptide Bioinspired in the 2S Albumin From the Seed Cake of Ricinus Communis, Is a Potent Antimicrobial Agent Against Klebsiella Pneumoniae and Candida Parapsilosis.",Escherichiacoli,2024
GLRRLLRKIRGRWK,803,18,14398,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus,2437
NIKISGKWKAQKRFLK,803,18,14400,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus,2177
GLRRLLRKIRGRWKGGGRLLRPLLQLLKQKLR,803,18,14401,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus,2437
RKVRGPPGGGRLLRPLLQLLKQKLR,803,18,14403,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus,2177
NIKISGKWKAQKRFLKGGGRLLRPLLQLLKQKLR,803,18,14404,Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide.,Micrococcusluteus,2177
KAVKKRKKKLAKAKK,804,51,14405,Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins.,Porphyromonasgingivalis,2178
LPLRTRLLKVL,804,51,14406,Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins.,Porphyromonasgingivalis,2179
FRAPYIASLLR,804,51,14407,Identification and characterization of multifunctional cationic peptides from enzymatic hydrolysates of soybean proteins.,Porphyromonasgingivalis,2180
RKSREWRSKKTQPRRPR,805,51,14408,Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins.,Porphyromonasgingivalis,2181
KNQYGRIRVLQRFNQR,805,51,14409,Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins.,Porphyromonasgingivalis,2182
RIRLLQRFNKR,805,51,14410,Identification and characterization of multifunctional cationic and amphipathic peptides from soybean proteins.,Porphyromonasgingivalis,2183
RDNIQGITKPAIRRLARRGGVKRISGLIY,806,2,14426,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli,2025
VYPKTKTYFPHFDLHHGSAQVRTHGKKVLNALG,806,2,14427,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli,2534
VDKPPYLPRPPPPRRIYN,806,2,14428,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli,1787
VDKPPYLPRPTPPRRIYN,806,2,14429,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli,1787
VDKPPYLPRPHPPRRIYN,806,2,14430,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli,1787
VDKPPYLPRPKPPRRIYN,806,2,14431,Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.,Escherichiacoli,1787
RWRPPIRRPPIRPPFYP,808,2,14453,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RFRGPIRRPPIRPPFYP,808,2,14454,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRRPIRRPPIRPPFYP,808,2,14455,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRFPIRRPPIRPPFYP,808,2,14456,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRWPIRRPPIRPPFYP,808,2,14457,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRPPWRRPPIRPPFYP,808,2,14458,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRPPIRRRPIRPPFYP,808,2,14459,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRPPIRRPPIRPPWYP,808,2,14460,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRPPIRRPPIRPPFWP,808,2,14461,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2027
RFRPPIRRPPIRPPFYR,808,2,14462,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRPPIRRPPIRPPFYW,808,2,14463,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRRPIRRRPIRPPFYP,808,2,14464,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRRPIRRPPIRPPFYR,808,2,14465,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRWPIRRPPIRPPWYP,808,2,14466,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRWPIRRPPIRPPFYP,808,2,14467,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRWPIRRPPIRPPWYP,808,2,14468,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRWPIRRRPIRPPFYP,808,2,14469,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRWPIRRPPIRPPFYR,808,2,14470,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRRPIRRPPIRPPFYP,808,2,14471,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRRPIRRPPIRPPFYR,808,2,14472,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRRPIRRPPIRPPWYP,808,2,14473,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRRPIRRRPIRPPFYP,808,2,14474,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRWPIRRPPIRPPFYR,808,2,14475,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RFRWPIRRRPIRPPFYR,808,2,14476,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRWPIRRRPIRPPFYW,808,2,14477,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRRPIRRRPIRPPFYW,808,2,14478,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRRPIRRRPIRPPFYR,808,2,14479,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRRPIRRRPIRPPWYP,808,2,14480,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRWPIRRRPIRPPWYR,808,2,14481,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRRPIRRRPIRPPFWR,808,2,14482,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2027
RFRWPIRRRPIRPPFWR,808,2,14483,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2027
RFRRPIRRRPIRPPWYR,808,2,14484,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RRRRPIRRRPIRPPWYP,808,2,14485,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRRPIRRRPIRPPWYR,808,2,14486,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRRPIRRRPIRPPFWR,808,2,14487,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRRPWRRRPIRPPFYR,808,2,14488,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RWRWPIRRRPIRPPWYR,808,2,14489,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRWPIRRRPIRPPFWR,808,2,14490,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2027
RRRRPWRRRPIRPPFYW,808,2,14491,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRRPIRRRPIRPPFYR,808,2,14492,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RWRPPIRRPPIRPPWYP,808,2,14493,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RFRRPIRRPPIRPPWYP,808,2,14494,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,1941
RRRRPIRRRPIRPPFYR,808,2,14495,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
RRRRPIRRRPIRPPWYR,808,2,14496,"Proline-Rich Peptides With Improved Antimicrobial Activity Against E. Coli, K. Pneumoniae, and A. Baumannii.",Escherichiacoli,2026
KGIRGYKGGY,809,8,14575,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,1866
IRGYKGGYCK,809,8,14576,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,2184
GYKGGYCKGA,809,8,14577,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,2185
KGGYCKGAFK,809,8,14578,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,2186
GYCKGAFKQT,809,8,14579,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,2187
CKGAFKQTCK,809,8,14580,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,1467
GAFKQTCKCY,809,8,14581,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,2188
CKGAFKQTCKCY,809,8,14582,Antimicrobial Function of Short Amidated Peptide Fragments From the Tick-Derived OsDef2 Defensin.,Bacillussubtilis,1467
GLSRLFTALK,810,4,14616,Targeted separation of antibacterial peptide from protein hydrolysate of anchovy cooking wastewater by equilibrium dialysis.,Staphylococcusaureus,2189
WDPYFAGVKKLTKAILAVRA,811,2,14620,Rational Design of Membrane-Pore-Forming Peptides.,Escherichiacoli,2028
TKCFQWQWRMKKLGAPSITCVRRAF,812,2,14653,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2029
FKCRRWQRNMRKVRGPPVSCIKRDS,812,2,14654,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2324
FKCRRWQWNMRKVRGPPVSCIKRDS,812,2,14655,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2324
FKCRRWQWRMRKVRGPPVSCIKRDS,812,2,14656,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2324
GGFKCRRWQWRMKKLGAPSITCVRRAFLPETGG,812,2,14661,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2029
GGFKCRRWQWRMKKLGAPSITCVRRAFLPET,812,2,14662,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2029
GGRRWQWRMKKLGAPSITLPETGG,812,2,14663,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2029
GGRRWQWRMKKLGAPSITLPET,812,2,14664,Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.,Escherichiacoli,2029
GEFAQFEQEAQSLEQELSQLEQQLESL,813,2,14676,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli,2030
KWKVLKKKIKMLRNRINGLVKAGPALKVKLQALAL,813,2,14678,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli,2031
EAQNLEKEIAALEQAIQGLEKEIPALAQQIQALEL,813,2,14679,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli,2032
SRSELIVHQRLFK,814,1,14693,"Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 With Improved Antifungal Activity.",None_target,2190
GKSLVKWIVKSVRKA,815,2,14705,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2033
KVFTLFQARAQGKLMRI,815,2,14707,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2034
KVWTLFRAAGKLMAK,815,2,14708,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2035
AILRKATRRLVQLIVSG,815,2,14710,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2036
RILAKATRRLVKLIVSG,815,2,14711,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2037
LRKATRRLVQLIVSG,815,2,14714,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2036
ATAILRKATRRLVQLI,815,2,14715,In Silico Design of Polycationic Antimicrobial Peptides Active Against Pseudomonas Aeruginosa and Staphylococcus Aureus,Escherichiacoli,2038
PMKKLKLALRLAAKIAPVW,816,59,14716,A Computationally Designed Peptide Derived From Escherichia Coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies,Acinetobacterbaumannii,2191
GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLAKTC,817,18,14718,Biophysical Studies on the Antimicrobial Activity of Linearized Esculentin 2EM.,Micrococcusluteus,2192
GWWRRTVDKVRNAGRK,818,66,14719,Structure-activity Relationship Studies of Shortened Analogues of the Antimicrobial Peptide EeCentrocin 1 From the Sea Urchin Echinus Esculentus.,Corynebacteriumglutamicum,485
LLKLFFPFLETGE,819,7,14760,"A Novel Non-Cytotoxic Synthetic Peptide, Pug-1, Exhibited an Antibiofilm Effect on Streptococcus Mutans Adhesion.",Streptococcusmutans,2193
FPSFLVGR,819,7,14763,"A Novel Non-Cytotoxic Synthetic Peptide, Pug-1, Exhibited an Antibiofilm Effect on Streptococcus Mutans Adhesion.",Streptococcusmutans,2194
KSAFELPHYGL,820,52,14765,Human Salivary MUC7 Mucin Fragment and Its Analogues. Coordination and Biological Studies.,Enterococcusfaecalis,2039
KSHFELPAYGL,820,52,14766,Human Salivary MUC7 Mucin Fragment and Its Analogues. Coordination and Biological Studies.,Enterococcusfaecalis,2040
KSHFELPHYGL,820,52,14767,Human Salivary MUC7 Mucin Fragment and Its Analogues. Coordination and Biological Studies.,Enterococcusfaecalis,2039
GLLSRLRDRLSDRGRRLGEKIERIGQKIKDLSEFFQS,822,4,14867,Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37.,Staphylococcusaureus,1800
GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSERFQS,822,4,14868,Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37.,Staphylococcusaureus,1800
GLLSRLRDRLSDRGRRLGEKIERIGQKIKDLSERFQS,822,4,14869,Antimicrobial Peptide PMAP-37 Analogs: Increasing the Positive Charge to Enhance the Antibacterial Activity of PMAP-37.,Staphylococcusaureus,1800
LLKKLLKK,823,1,14951,Branched and 4-arm Starlike ?-Helical Peptide Structures With Enhanced Antimicrobial Potency and Selectivity,None_target,2195
LLKKLLKKKC,823,1,14955,Branched and 4-arm Starlike ?-Helical Peptide Structures With Enhanced Antimicrobial Potency and Selectivity,None_target,2196
ALWKKLLKKLLKSAKKLG,824,2,14963,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli,1168
AFWKKFFKKFFKSAKKFG,824,2,14964,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli,2041
AIWKKIIKKIIKSAKKIG,824,2,14965,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli,2042
AVWKKVVKKVVKSAKKVG,824,2,14966,Effects of Hydrophobic Amino Acid Substitutions on Antimicrobial Peptide Behavior,Escherichiacoli,2042
IRIRPIRIRP,825,2,14972,Simplified Head-to-Tail Cyclic Polypeptides as Biomaterial-Associated Antimicrobials With Endotoxin Neutralizing and Anti-Inflammatory Capabilities,Escherichiacoli,2043
IRIRIRPIRIRIRP,825,2,14973,Simplified Head-to-Tail Cyclic Polypeptides as Biomaterial-Associated Antimicrobials With Endotoxin Neutralizing and Anti-Inflammatory Capabilities,Escherichiacoli,2044
SKVWRHWRRFWHRAHRKL,826,2,14980,Antimicrobial Activity and Self-Assembly Behavior of Antimicrobial Peptide chensinin-1b With Lipophilic Alkyl Tails,Escherichiacoli,515
VKRTKRGARRGLTKVLKKIFGSIVKKAVSKGV,827,2,14984,Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus,Escherichiacoli,2045
VRRSKRGIKVPSFVKKVLKDVVSESIS,827,2,14986,Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus,Escherichiacoli,2046
ARIVQRIKDFLR,828,2,15032,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KAIVQRIKDFLR,828,2,15033,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2047
KRAVQRIKDFLR,828,2,15034,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2498
KRIAQRIKDFLR,828,2,15035,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
RLFDKIRQVIRK,829,2,15036,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AGGKRIVQRIKDFLRGAGGRLFDKIRQVIRKG,829,2,15037,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AGKRIVQRIKDFLRGAGRLFDKIRQVIRKG,829,2,15038,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AKRIVQRIKDFLRGARLFDKIRQVIRKG,829,2,15039,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,829,2,15040,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AGKRIVQRIKDFLRGAGKRIVQRIKDFLRG,829,2,15041,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AKRIVQRIKDFLRGAKRIVQRIKDFLRG,829,2,15042,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG,829,2,15043,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
CGGRLFDKIRQVIRKGAGGRLFDKIRQVIRKG,829,2,15044,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
CGGKRIVQRIKDFLRGAGGRLFDKIRQVIRKG,829,2,15045,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
CGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,829,2,15046,Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability.,Escherichiacoli,2048
KRIVARIKDFLR,828,2,15049,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2049
KRIVQAIKDFLR,828,2,15050,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2050
KRIVQRAKDFLR,828,2,15051,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2051
KRIVQRIADFLR,828,2,15052,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2052
KRIVQRIKAFLR,828,2,15053,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2053
KRIVQRIKDALR,828,2,15054,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2054
KRIVQRIKDFAR,828,2,15055,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KRIVQRIKDFLA,828,2,15056,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KKIVQRIKDFLR,828,2,15057,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2055
KRKVQRIKDFLR,828,2,15058,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2498
KRIKQRIKDFLR,828,2,15059,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KRIVKRIKDFLR,828,2,15060,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2056
KRIVQKIKDFLR,828,2,15061,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KRIVQRKKDFLR,828,2,15062,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2057
KRIVQRIKKFLR,828,2,15063,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2058
KRIVQRIKDKLR,828,2,15064,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2059
KRIVQRIKDFKR,828,2,15065,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KRIVQRIKDFLK,828,2,15066,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,1861
KRIVARIKAFLR,828,127,15067,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Humanhistiocytic,2060
KRIVKRIKKFLR,828,127,15068,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Humanhistiocytic,2058
KRIVKRIKAFLR,828,2,15069,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2061
KRKVKRIKKFLR,828,2,15070,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,127
KRIVARIKAALR,828,2,15071,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,128
KRIAQRIKAFLR,828,2,15072,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,129
KRAAQRIKAFLR,828,2,15073,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,130
KRIVQRKKDKKR,828,2,15074,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,131
KRIVQRKKDFKR,828,2,15075,Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.,Escherichiacoli,2057
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,830,128,15076,"Synthesis, biological activity and conformational analysis of head-to-tail cyclic analogues of LL37 and histatin 5",Rhodococcusequi,635
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESC,831,1,15077,Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.,None_target,635
CLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,831,1,15078,Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37.,None_target,635
QQCRRPLYCRRR,832,52,15086,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,132
QQCRRPLYCRRRWSHPQFEK,832,52,15087,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,132
RPLNFKMLRFWGQQQCRRPLYCRRR,832,52,15088,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,132
RPLNFKMLRFWGQQQCRRPLYCRRRWSHPQFEK,832,52,15089,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,132
QQCRRPLYCRRRKALAALAKKIL,832,52,15090,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,132
QQCRRPLYCRRRKALAALAKKILWSHPQFEK,832,52,15091,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,132
KALAALAKKILQQCRRPLYCRRR,832,52,15092,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,133
KALAALAKKIL,832,52,15093,Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.,Enterococcusfaecalis,134
GFGCNGPWSEDDIQCHNHCKSIKGYKGGYCARGGFVCKCY,833,41,15094,A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis.,Mycobacteriumtuberculosis,1467
RKGSRMGKKCECP,834,2,15104,Design of Bioactive Peptides Derived From CART Sequence Isolated From the Toadfish Thalassophryne nattereri.,Escherichiacoli,135
RKGSQMGKKCECP,834,2,15105,Design of Bioactive Peptides Derived From CART Sequence Isolated From the Toadfish Thalassophryne nattereri.,Escherichiacoli,135
ILPWKWRWWKWWR,835,129,15107,Antimicrobial peptides against drug resistant Mycobacterium abscessus.,Mycobacteriumabscessus,136
WWWLRRRW,836,4,15113,Membrane Activity of Two Short Trp-rich Amphipathic Peptides.,Staphylococcusaureus,2197
RRRWWWWL,836,4,15114,Membrane Activity of Two Short Trp-rich Amphipathic Peptides.,Staphylococcusaureus,2198
KYEITTIHNLFRKLTHRLFRRNFGYTLR,837,73,15115,Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control,Cryptococcusneoformans,2199
KYEITTIHNLARKLTHRLARRNAGATLR,837,73,15116,Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control,Cryptococcusneoformans,2199
VGGTICGPACAVAGAHYLPI,838,3,15117,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2200
GWFKTYKDWPVIISNVPGVI,838,3,15118,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2201
IKKIGKKAAKKVIVKAIQAI,838,3,15119,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2202
KKIGKKAAKKVIVKAIQAIV,838,3,15120,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2202
FLGEWLFVTRKAKRKHKHAA,838,3,15121,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2203
VKFAIKKIGKKAAKKVIVKA,838,3,15122,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2202
SFLGEWLFVTRKAKRKHKHA,838,3,15123,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2203
QAAKKMSNKEKAAKRWIAMR,838,3,15124,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2204
AKAIVRTIEQAPKTAKAKKS,838,3,15125,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2205
EVVPKVKKHFKDKENKKKLF,838,3,15126,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2206
KKIAIITKNLKNFFIMLNII,838,3,15127,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2207
KKSINSLHLAMLKKQRLNRD,838,3,15128,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2208
LLLGIKYKKIGANNFREVKK,838,3,15129,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2209
FMKKIVKIGKIARYSHKAKK,838,3,15130,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2210
LFRKKRHHWFVRTKNSLSKN,838,3,15131,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2211
VNHGYRKVTLTKTVRIKKFM,838,3,15132,Novel Antimicrobial Peptide Discovery Using Machine Learning and Biophysical Selection of Minimal Bacteriocin Domains.,Pseudomonasaeruginosa,2212
KAAKKWAKAAKKWAKAWKKAA,839,46,15133,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,137
KAAKKWAKAWKKAAKAWKKAA,839,46,15134,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,137
KAAKKAWKAWKKAAKAWKKAA,839,46,15135,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,138
KAAKKAWKAAKKAAKWWKKAA,839,46,15136,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,139
KAAKKAWKWAKKAAKWAKKAA,839,46,15137,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,139
KWWKKAAKAAKKAAKAAKKWA,839,46,15138,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,140
KAAKKAWKAAKKAWKAWKKAA,839,46,15139,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,139
KWAKKAAKWAKKAAKWAKKAA,839,46,15140,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,139
KAWKKAWKAAKKAWKAAKKAA,839,46,15141,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,139
AAKKWAKAKKWAKAKKWAKAA,839,46,15142,Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity.,Murinefibrosarcoma,141
WKWKWKNGKWKWKW,840,52,15144,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,142
LVTLVFVGGGWKWKWKNGKWKWKW,840,52,15145,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,143
WKWKWKNGKWKWKWGGGLVTLVFV,840,52,15146,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,144
WKWKWENGKWKWKW,840,52,15147,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,145
LVTLVFVGGGWKWKWENGKWKWKW,840,52,15148,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,143
WKWKWENGKWKWQW,840,52,15149,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,146
LVTLVFVGGGWKWKWENGKWKWQW,840,52,15150,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,143
YSTCFIMGGGWKWKWENGKWKWKW,840,52,15151,Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.,Enterococcusfaecalis,143
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL,841,130,15152,Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.,SARS-CoV,2213
LKVLLYEEFKLLESLIMEILEYQKDSDIKENAEDTK,841,131,15162,Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.,SARS-CoV-2,147
ANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ,842,130,15163,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,1297
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,842,130,15164,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,1322
AASFNKAMTNIVDAFTGVNDAITQTSQALQTVATALNKIQDVVNQQGNSLNHLTSQ,842,130,15165,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2214
VVEQYNQTILNLTSEISTLENKSAELNYTVQKLQTLIDNINSTLVDLKWL,842,130,15166,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2215
ANKFNQALGAMQTGFTTTNEAFRKVQDAVNNNAQALSKLASE,842,130,15167,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2216
SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL,842,130,15168,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2217
AASFNKAINNIVASFSSVNDAITQTAEAIHTVTIALNKIQDVVNQQGSALNHLTSQ,842,130,15169,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2214
DLTPFNLTYLNLSSELKQLEAKTASLFQTTVELQGLIDQINSTYVDLKLL,842,130,15170,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2215
ANAFNNALDAIQEGFDATNSALVKIQAVVNADAEALNNLLQQ,842,130,15171,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2218
SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDI,842,130,15172,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2213
SLDYINVTFLDLQDEMKKLEEAIKKLEQSYINLKDI,842,130,15173,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,SARS-CoV,2213
SLDYINVTFLDLEDEMKKLEEAIKKLEESYINLKEI,842,132,15174,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,MERS-CoV,2213
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEI,842,132,15175,A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.,MERS-CoV,2213
RGRKVVRRKKK,843,1,15176,Synthetic multivalent antifungal peptides effective against fungi.,None_target,2219
RGRKVVRRK,843,1,15178,Synthetic multivalent antifungal peptides effective against fungi.,None_target,2220
GPNFAEISKINTTLLDLSDEMAMLQEVVKQLNDSYI,844,132,15181,Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4.,MERS-CoV,148
EISKINTTLLDLSDEMAMLQEVVKQLNDSYIDLKEL,844,132,15182,Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4.,MERS-CoV,2217
LDLSDEMAMLQEVVKQLNDSYIDLKELGNYTYYNKW,844,132,15183,Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4.,MERS-CoV,149
SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL,845,132,15196,De Novo Design of alpha-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.,MERS-CoV,2213
GINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,846,132,15198,Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.,MERS-CoV,1322
MWKTPTLKYFGGFNFSQIL,847,130,15199,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV,2221
ATAGWTFGAGAALQIPFAMQMAY,847,130,15200,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV,2222
GYHLMSFPQAAPHGVVFLHVTW,847,130,15201,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV,2223
GVFVFNGTSWFITQRNFFS,847,130,15202,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV,2224
NEVAKNLNESLIDLQELGKYEQYIKWPWYVW,847,130,15203,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV,1322
AACEVAKNLNESLIDLQELGKYEQYIKW,847,130,15204,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,SARS-CoV,1322
GNHILSLVQNAPYGLYFIHFSW,847,133,15205,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,MurineHepatitis,2225
GYFVQDDGEWKFTGSSYYY,847,133,15206,Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.,MurineHepatitis,2226
GINASVVNIQKEIDRLNEVAKNLNESLIDL,848,130,15207,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV,1322
GINASVVNIQKEIDRLNEVAKNL,848,130,15208,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV,1322
QKQIANQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQ,848,130,15209,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV,1297
QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE,848,130,15210,Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.,SARS-CoV,1297
KKKKYRNIRRPG,849,130,15212,"Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV.",SARS-CoV,1298
LTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL,850,134,15213,Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.,MERS-CoVPsV,2217
SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL,851,132,15214,Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.,MERS-CoV,2217
NGAICWGPCPTAFRQIGNCGHFKVRCCKIR,852,135,15216,A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.,HumanInfluenza,362
KGSVVIVGRIILSGRK,853,49,15239,Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing.,HepatitisC,1299
AKDLEVVCSTYVLVEA,854,49,15241,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1300
ADLEVVAATYVDVA,854,49,15242,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1301
ADLEVVAATHVLVA,854,49,15243,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1302
AKDLEVVTSTYVLVEA,854,49,15244,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1300
KKKKVAAATYVLV,854,49,15245,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1303
DDSVVSAAMSYSYA,854,49,15246,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1304
KKKKVTAATYVLV,854,49,15247,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1303
ADLEVVAATFVLVA,854,49,15248,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1305
ADLEVVAATYVLVA,854,49,15249,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1305
KKKKVVKATYVLV,854,49,15250,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1306
AECVVSCSMSYTKA,854,49,15251,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1307
KKKKVVLPFLFFF,854,49,15252,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1308
KKKKFVAATYVLV,854,49,15253,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1309
ADLEVVAATYVLDD,854,49,15254,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1310
KKKKVVLATYVLV,854,49,15255,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1311
KKKKLLAAFLFFF,854,49,15256,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1312
KKKKLVLPFLFVF,854,49,15257,Peptide inhibitors of hepatitis C virus NS3 protease.,HepatitisC,1313
PLDVFNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVET,855,136,15258,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic,150
FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVE,855,136,15259,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic,150
FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDL,855,136,15260,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic,150
LKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWL,855,136,15261,Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.,Porcineepidemic,150
ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,856,130,15262,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,SARS-CoV,1322
ISGINASVVNIQEEIKKLNEEAKKLNESLIDLQEL,856,130,15263,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,SARS-CoV,1322
IEEINKKVEEIQKKIEELNKKAEELNKKLEELQKK,856,130,15264,Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.,SARS-CoV,1314
TLKPIFKLPLGINITNFR,857,137,15280,Identification of a New Region of SARS-CoV S Protein Critical for Viral Entry,SARS-CoVPsV,151
YENQKQIANQFNKAISQIQESLTTTSTA,858,137,15282,Fusion Core Structure of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): In Search of Potent SARS-CoV Entry Inhibitors.,SARS-CoVPsV,1297
IQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSS,858,137,15283,Fusion Core Structure of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): In Search of Potent SARS-CoV Entry Inhibitors.,SARS-CoVPsV,1297
DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI,858,137,15284,Fusion Core Structure of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): In Search of Potent SARS-CoV Entry Inhibitors.,SARS-CoVPsV,1322
FKLPLGINITNFRAILTAFS,859,130,15285,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1315
PTTFMLKYDENGTITDAVDC,859,130,15286,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1316
VLYNSTFFSTFKCYGVSATK,859,130,15287,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1317
PALNCYWPLNDYGFYTTTGI,859,130,15288,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1269
RDVSDFTDSVRDPKTSEILD,859,130,15289,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1318
YQDVNCTDVSTAIHADQLTP,859,130,15290,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1319
SNNTIAIPTNFSISITTEVM,859,130,15291,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1320
QYGSFCTQLNRALSGIAAEQ,859,130,15292,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1321
GIGVTQNVLYENQKQIANQF,859,130,15293,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1331
IQKEIDRLNEVAKNLNESLI,859,130,15294,Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof,SARS-CoV,1322
NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA,860,130,15305,Suppression of SARS-CoV Entry by Peptides Corresponding to Heptad Regions on Spike Glycoprotein,SARS-CoV,1331
IQKEIDRLNEVAKNLNESLIDLQELGK,860,130,15306,Suppression of SARS-CoV Entry by Peptides Corresponding to Heptad Regions on Spike Glycoprotein,SARS-CoV,1322
PKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,861,130,15308,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV,1322
LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,861,130,15309,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV,1322
DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE,861,130,15310,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV,1322
ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL,861,130,15312,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV,1322
DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE,861,130,15313,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV,1323
NQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLIT,861,130,15314,Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection Inhibition Using Spike Protein Heptad Repeat-Derived Peptides,SARS-CoV,1324
EEQAKTFLDK,862,137,15315,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV,152
DKFNHEAED,862,137,15316,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV,153
NHEAEDLFY,862,137,15317,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV,154
EEQAKTFLDKFNHEAEDLFYQSS,862,137,15318,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV,155
EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE,862,137,15319,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV,155
EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR,862,137,15320,Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor.,SARS-CoVPsV,155
SWLRDIWDWICEVLSD,863,49,15322,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWICEVL,863,49,15323,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWICEV,863,49,15324,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
LRDIWDWICEVLSDFK,863,49,15325,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SGSWLRDIWDWICEVLSDFK,863,49,15326,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
GSWLRDIWDWICEVLSDFK,863,49,15327,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWICEVLSDFKT,863,49,15328,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWICEVLSDFKTW,863,49,15329,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWRLIDWDWICEVLSDFK,863,49,15330,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWRLDIWDWICESVLDFK,863,49,15331,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
VLDLIYSLHKQINRGLKKIVL,863,49,15332,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1326
KFDSLVECIWDWIDRLWS,863,49,15333,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1327
KWLCRIWSWISDVLDDFE,863,49,15335,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1328
SIWRDWVDLICEFLSDWK,863,49,15336,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1329
SWLRDVWDWICTVLTDFK,863,49,15337,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDVWDWVCTILTDFK,863,49,15338,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
DWLRIIWDWVCSVVSDFK,863,49,15339,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLWEVWDWVLHVLSDFK,863,49,15340,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1330
TWLRAIWDWVCTALTDFK,863,49,15341,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDVWDWVCTVLSDFK,863,49,15342,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWISEVLSDFK,863,49,15343,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWIREVLSDFK,863,49,15344,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWIEEVLSDFK,863,49,15345,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLDDIWDWICEVLSDFE,863,49,15346,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRDIWDWICKVLSDFK,863,49,15347,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLDRIWRWICKVLSRFE,863,49,15348,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1328
SWLRDIWRWICKVLSRFK,863,49,15349,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
SWLRRIWRWICKVLSRFK,863,49,15350,A Virocidal Amphipathic {Alpha}-Helical Peptide That Inhibits Hepatitis C Virus Infection in Vitro,HepatitisC,1325
GVTQNVLYENQKQIANQFNKAISQIQESLTTTSTALGKLQ,864,130,15351,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV,1331
LTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFG,864,130,15352,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV,1297
KQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITG,864,130,15353,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV,1324
GRLQSLQTYVTQQLIRAAEIRASANLAATKMSEC,864,130,15354,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV,1332
KEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYVW,864,130,15355,Interaction Between Heptad Repeat 1 and 2 Regions in Spike Protein of SARS-associated Coronavirus: Implications for Virus Fusogenic Mechanism and Identification of Fusion Inhibitors.,SARS-CoV,1322
SFAIKWEYVLLLFLL,865,49,15358,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
FAIKWEYVLLLFLL,865,49,15359,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
AIKWEYVLLLFLL,865,49,15360,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
LLFLLLVYEWKIA,865,49,15362,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1333
IKWEYVLLLFLL,865,49,15364,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1334
KWEYVLLLFLL,865,49,15365,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1335
WEYVLLLFLL,865,49,15366,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1336
VSFAIKWEYVLLLFL,865,49,15367,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
VSFAIKWEYVLLLF,865,49,15368,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
VSFAIKWEYVLLL,865,49,15369,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
VSFAIKWEYVLL,865,49,15370,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
VSFAIKWEYVL,865,49,15371,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
LKLFEVYLILWLA,865,49,15372,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1337
VSFAIKWEYVLLLFLL,865,49,15373,A Peptide Derived From Hepatitis C Virus E2 Envelope Protein Inhibits a Post-Binding Step in HCV Entry,HepatitisC,1338
WEEWDKKIEEYTKKIEELIKKSQNQQ,866,30,15375,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
MTWEEWDKKIEEYTKKIEELIKKSQNQQ,866,30,15376,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQSM,866,30,15377,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQSW,866,30,15378,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQSY,866,30,15379,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQSDLD,866,30,15380,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQLDL,866,30,15381,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQIDI,866,30,15382,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQLDI,866,30,15383,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
WEEWDKKIEEYTKKIEELIKKSQNQQIDL,866,30,15384,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL,866,30,15385,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1617
EEQKTQLKNKIEIDWTKMELEQDWSKIYKEI,866,30,15386,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,HIV-1IIIB,1406
TTLLDLTYEMLSLQQVVKALNESYIDLKEL,866,132,15387,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,MERS-CoV,2217
EANTTLLDLTYEMLSLQQVVKALNESYIDLKEL,866,132,15388,Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.,MERS-CoV,2217
CEELRVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15390,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
EELRVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15391,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CEEIRARLSTHLRKMRKRLMRDADDLQKRLAVY,867,49,15392,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CEEQAQQIRLQAEAFQARLKSWFEPLVEDM,867,49,15393,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CVRLASHLRKLRKRLLRDADDL,867,49,15394,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CIRLQAEAFQARLKSWFEPLV,867,49,15395,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
VRLASHLRKLRKRLLRDADDLIRLQAEAFQARLKSWFEPLV,867,49,15396,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
LRVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15397,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
EELRVRLASHLRKLRKRLLRDADDL,867,49,15398,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
VRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15399,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CVRLASHLRKLRKRLLRDADDLQKRLAVY,867,49,15400,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CLRVRLASHLRKLRKRLLRDADDL,867,49,15401,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1407
CLRKLRKRLLRC,867,49,15402,Human Apolipoprotein E Peptides Inhibit Hepatitis C Virus Entry by Blocking Virus Binding,HepatitisC,1408
GELDELVYLLDGPGYDPIHSRQIKIWFQNRRMKWKK,868,49,15403,High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants,HepatitisC,1409
RQIKIWFQNRRMKWKKGELDELVYLLDGPGYDPIHS,868,49,15404,High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants,HepatitisC,1410
AKGSRAIWFMWLGARFLE,869,49,15405,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1411
KREKKLGEFGKAKGSRAI,869,49,15406,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1412
WVLNNPHMKDKTTVKEWR,869,49,15407,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1413
LLDWCVRLGRYLLRRLKT,869,49,15408,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
IWQYVCNFFVICFNVLKA,869,49,15409,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1414
LWEWIMRQVRMVMSRLRA,869,49,15410,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1415
VLDLIYSLHKQINRGLKK,869,49,15411,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1326
ILELLYKFRDNIKSSVRE,869,49,15412,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1416
LLDCWVRLGRYLLRRLKT,869,49,15413,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
LLDCWVRLGRYLLRRLKTPFTRL,869,49,15414,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
LLDCWVRLGRYLLRRLKTPFT,869,49,15415,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
LLDCWVRLGRYLLRRLKTP,869,49,15416,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
LLDCWVRLGRYLLRRLK,869,49,15417,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
LDCWVRLGRYLLRRLKTPFTRL,869,49,15418,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYLLRRLKTPFTRL,869,49,15419,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
LDCWVRLGRYLLRRLKTP,869,49,15420,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
DCWVRLGRYLLRRLKTPF,869,49,15421,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYLLRRLKTPFT,869,49,15422,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
WVRLGRYLLRRLKTPFTR,869,49,15423,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
VRLGRYLLRRLKTPFTRL,869,49,15424,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYKLRRLKTPFT,869,49,15434,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYSLRRLKTPFT,869,49,15435,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYALRRLKTPFT,869,49,15436,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYVLRRLKTPFT,869,49,15437,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLARYLLRRLKTPFT,869,49,15438,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLVRYLLRRLKTPFT,869,49,15439,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLLRYLLRRLKTPFT,869,49,15440,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLLRYLLRRLKTLFT,869,49,15441,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYLLRRLKTLFT,869,49,15442,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYILRRLKTPFT,869,49,15443,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRLGRYILRRIKTPFT,869,49,15444,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
CWVRIGRYILRRIKTPFT,869,49,15445,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
KWVRLGRKLLRRLKKPFK,869,49,15446,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1418
CWVRLGRKLLRRLKTPFT,869,49,15447,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
EWVRLGRELLRRLKEPFE,869,49,15448,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1418
CWVRLGRELLRRLKTPFT,869,49,15449,Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived From GB Virus A NS5A,HepatitisC,1417
QGSWFGCTWMNSTGF,870,49,15450,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC,1419
FGCTWMNSTGFTKTC,870,49,15451,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC,1420
GLLHLHQNIVDVQYM,870,49,15452,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC,1421
LHQNIVDVQYMYGLS,870,49,15453,A screen for inhibitory peptides of hepatitis C virus identifies a novel entry inhibitor targeting E1 and E2.,HepatitisC,1422
MTWEEWDKKIEEYTKKIEELIKKS,871,30,15454,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB,1617
MTWEEWDKKIEEYTKKIEELIKKSDCAWHLGELVWCT,871,30,15455,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB,1423
DCAWHLGELVWCTMTWEEWDKKIEEYTKKIEELIKKS,871,30,15456,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB,1424
DCAWHLGELVWCT,871,30,15457,IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.,HIV-1IIIB,1423
FNATYLNLTGEIDDLEFRSEKL,872,138,15458,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV,150
FNATYLNLTGEIDDLEFRSEKLHNTTVEL,872,138,15459,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV,150
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNI,872,138,15460,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV,150
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNL,872,138,15461,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV,150
FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIE,872,138,15462,Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.,FCoV,150
PWLKPGDLDL,873,139,15503,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,DENV-2,1425
AGVKDGKLDF,873,139,15504,Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.,DENV-2,1426
AWLVHTQWFLDLPLPWLPGADTQGSNWI,874,139,15505,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2,1427
RWMVWRHWFHRLRLPYNPGKNKQNQQWP,874,139,15506,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2,1428
MVDRGWGNHAGLFGKGSIV,874,139,15507,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2,1429
AWLVHRQWFLDLPLPWLPG,874,139,15508,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2,1427
RQMRAWGQDYQHGGMGYSC,874,139,15509,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2,1430
FWFTLIKTQAKQPARYRRFC,874,139,15510,Structural optimization and de novo design of dengue virus entry inhibitory peptides.,DENV-2,1431
MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY,875,139,15511,Release of dengue virus genome induced by a peptide inhibitor.,DENV-2,160
MVDRGWGNGCGLF,876,139,15512,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2,1429
CKIPFEIMDLEKRHV,876,139,15513,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2,1432
VEPGQLKLNWFKK,876,139,15514,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2,1433
WDFGSLGGV,876,139,15516,Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with ?3 integrin.,DENV-2,1434
LCLRNWDQGHRP,877,79,15517,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,HSV-1,156
KKVTMTCSAS,877,79,15518,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,HSV-1,157
NQVSATCSVK,877,140,15519,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,VesicularStomatitis,1435
SEETKENEGFTVTAEGK,877,141,15520,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Adenovirus,158
KKLVAASQAALGL,877,142,15521,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Coxsackievirus,1436
DSGEGDFLAEGGGVR,877,142,15522,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Coxsackievirus,247
GLEEELQFSLGSKINVK,877,142,15523,Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins.,Coxsackievirus,1437
STLGKAFSTTLKGAQRLAALGDTAWDFG,878,143,15524,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis,159
SIGGVFNSIGRAVHQVFGGAFRTL,878,143,15525,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis,160
AALGDTAWDFGSIGGVFNSIGRAVHQVFGGAFRTL,878,143,15526,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis,160
AWDFGSIGGVFNSIGRAVHQVFGGAFRTL,878,143,15527,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis,160
AWDFGSIGGVFNSIGRAVHQVF,878,143,15528,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Japaneseencephalitis,160
AWDFGSVGGVFNSLGKGIHQIFGAAFKSL,878,144,15529,Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.,Zikavirus,160
VSGHGQHGVHG,879,145,15530,New alloferon analogues: synthesis and antiviral properties.,Humanepidermoid,161
SGHGQHGVHG,879,145,15531,New alloferon analogues: synthesis and antiviral properties.,Humanepidermoid,162
GHGQHGVHG,879,79,15532,New alloferon analogues: synthesis and antiviral properties.,HSV-1,163
HGQHGVHG,879,145,15533,New alloferon analogues: synthesis and antiviral properties.,Humanepidermoid,164
HGVSGHGQHGV,879,146,15538,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre,2127
HGVSGHGQHG,879,146,15539,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre,2127
HGVSGHGQ,879,146,15540,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre,1438
FGVSGHGQHGVHG,879,79,15542,New alloferon analogues: synthesis and antiviral properties.,HSV-1,1439
YGVSGHGQHGVHG,879,146,15548,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre,1439
WGVSGHGQHGVHG,879,146,15554,New alloferon analogues: synthesis and antiviral properties.,HSV-1McIntyre,1439
DLTTKLWSSWGYYLGKKARWNLKHPYVQF,880,56,15570,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1440
SVPTSVYTLGIKILWSAYKHRKTIEKSFNKGFYH,880,56,15571,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1441
SWGYYLGKKARWNLKHPYVQF,880,56,15572,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1440
SWGYYLGKKARWNL,880,56,15573,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1440
DLTTKLWSSWGYYLGKKARWNL,880,56,15574,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1440
DLTTKLWSSWGYYLG,880,56,15576,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1440
YTLGIKILWSAYKHRKTIEKSFNKGFYH,880,56,15577,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1441
YTLGIKILWSAYKH,880,56,15578,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1441
SVPTSVYTLGIKILWSAYKH,880,56,15579,Plantaricin NC8 alpha beta Exerts Potent Antimicrobial Activity Against Staphylococcus Spp. And Enhances the Effects of Antibiotics.,Staphylococcusepidermidis,1441
LLKKVLKAAAKAALNAVLVGANA,881,147,15594,Dermaseptins as Potential Antirabies Compounds,Rabiesvirus,33
KTAATLADTLADTAATLAKAAAA,882,79,15595,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1,165
LKAALTAAKTALTAALTALKAALTAAKT,882,79,15596,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1,166
LAAALTAKATALTAKLTALAAALTAKAT,882,79,15597,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1,166
LAAKLTKAAKLTAALTKLAAALTAAAT,882,79,15598,Linear Antimicrobial Peptides With Activity Against Herpes Simplex Virus 1 and Aichi Virus,HSV-1,167
VCSCRLVFCRR,883,148,15599,The Human ?-Defensin-Derived Peptide HD5(1-9) Inhibits Cellular Attachment and Entry of Human Cytomegalovirus,Humancytomegalovirus,275
EMTWEEWEKKIEEYTKKIEEILKKSQNQQIDL,884,30,15603,A Peptide-Based HIV-1 Fusion Inhibitor With Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.,HIV-1IIIB,1442
EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDL,884,30,15604,A Peptide-Based HIV-1 Fusion Inhibitor With Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.,HIV-1IIIB,1442
GFLKKIGKKLEGAVQRTRDATIQTIAVAQAAANVAATAKQG,885,4,15606,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus,1261
GWLRDFGKRIERTGQNIRDATIQTIGIAQEAANVAATLKG,885,4,15608,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus,1795
GFLKKVGKKLEGASDLTRDATIQTIAVAQAAANVAATAKQG,885,4,15621,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus,1261
AACSLGSLLNVGCNSCACAAHCLATRGKNGACNSQRRCVCNK,885,4,15624,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus,1262
ATCDLLSFLNVKDAACAAHCLAKGYRGGYCDGRKVCNCRK,885,4,15625,Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria.,Staphylococcusaureus,1468
SSRRKPCKGWLCKLKLRGGYTLIGSATNLNRP,886,4,15627,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcusaureus,364
SSRRKPCKGWLCKLKLRGGYTL,886,149,15628,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus,364
SSRRKPCKGWLCKLKLR,886,149,15629,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus,364
KPCKGWLCKLKLRGGYTLIGSATNLNRPTYVRA,886,149,15630,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus,364
KPCKGWLCKLKLRGGYTLIGSATNLNRP,886,149,15631,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus,364
KPCKGWLCKLKLR,886,149,15632,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus,364
HVTTTFAPPPPR,887,150,15636,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,Transmissiblegastroenteritis,168
SVVPSKATWGFA,887,150,15637,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,Transmissiblegastroenteritis,169
FKPSSPPSITLW,887,150,15638,Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro.,Transmissiblegastroenteritis,170
FKLPLGIKITNFRAILTAFL,888,130,15639,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1315
PTKFMLKYDENGTITDAVDC,888,130,15640,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1316
VLYNSTSFSTFKCYGVSATK,888,130,15641,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1317
PALNCYWPLKDYGFYTTSGI,888,130,15642,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1269
RDVSDITDSVRDPKTSEILD,888,130,15643,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1318
YQDVNCTDVPTAIHADQLTP,888,130,15644,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1319
SNNTIAIPTNFLISITTEVM,888,130,15645,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1320
QYGSFCAQLNRALSGIAVEQ,888,130,15646,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1321
GIGVAQNVLYENQKQIANQF,888,130,15647,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1331
IQEEIDRLNEVAKNLNESLI,888,130,15648,Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus.,SARS-CoV,1322
ANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQ,889,131,15659,Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.,SARS-CoV-2,1297
VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK,890,151,15660,Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins.,NewcastleDisease,1314
EKINQSLAFIRKSDELLHNV,891,152,15678,A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,Respiratorysyncytial,171
FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST,891,152,15702,A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.,Respiratorysyncytial,171
MANAGLQLLGFILAFLGW,892,49,15777,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
GLQLLGFILAFLGWIGAI,892,49,15778,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
LLGFILAFLGWIGAIVST,892,49,15779,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
FILAFLGWIGAIVSTALP,892,49,15780,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1263
AFLGWIGAIVSTALPQWR,892,49,15781,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1263
GWIGAIVSTALPQWRIYS,892,49,15782,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1263
GAIVSTALPQWRIYSYAG,892,49,15783,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1264
VSTALPQWRIYSYAGDNI,892,49,15784,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1264
ALPQWRIYSYAGDNIVTA,892,49,15785,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1264
MANAGLQLLGFILA,892,49,15786,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
MANAGLQLLGFILAFL,892,49,15787,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
MANAGLQLLGFILAFLGWIG,892,49,15788,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
MANAGLQLLGFILAFLGWIGAI,892,49,15789,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
MANAGLQLLGFILAFLGWIGAIVS,892,49,15790,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
AGALMFAWLLLGLQGIFN,892,49,15792,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1266
MASAGMQILGVVLTLLGW,892,49,15794,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1267
MANSGLQLLGFSMALLGW,892,49,15795,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1265
MASTGLELLGMTLAVLGW,892,49,15796,A human claudin-1-derived peptide inhibits hepatitis C virus entry.,HepatitisC,1268
ALNCYWPLNDYGFYTTTGIGYQPYRVVVLSFEL,893,130,15803,Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.,SARS-CoV,1269
TDVSTAIHADQLTPAWRIYSTG,893,130,15804,Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library.,SARS-CoV,1270
LMGGIGKTMMQSGGTFGTFMAIGMGIRC,894,3,15807,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
GGIGKTMMQSGGTFGTFMAIGMGIRC,894,3,15808,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
IGKTMMQSGGTFGTFMAIGMGIRC,894,3,15809,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
GKTMMQSGGTFGTFMAIGMGIRC,894,3,15810,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
KTMMQSGGTFGTFMAIGMGIRC,894,3,15811,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
MMQSGGTFGTFMAIGMGIRC,894,3,15812,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
LMGGIGKTMMQSGGTFGTFMAIGMGIR,894,3,15813,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
GGIGKTMMQSGGTFGTFMAIGMGIR,894,3,15814,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
IGKTMMQSGGTFGTFMAIGMGIR,894,3,15815,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
GKTMMQSGGTFGTFMAIGMGIR,894,3,15816,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
KTMMQSGGTFGTFMAIGMGIR,894,3,15817,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
MMQSGGTFGTFMAIGMGIR,894,3,15818,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
KTMMQSGGTFGTFMAIGMGI,894,3,15819,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
KTMMQSGGTFGTFMAIGMG,894,3,15820,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
KTMMQSGGTFGTFMAIGM,894,3,15821,Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent Against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.,Pseudomonasaeruginosa,1271
PRPISYLKGSSGGPL,895,49,15822,Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy.,HepatitisC,1272
CLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP,896,4,15841,Antibacterial Activity of Rationally Designed Antimicrobial Peptides.,Staphylococcusaureus,2088
WNPFKELEKAGQRVRDAIISAKPAVDVVGQATAIIK,896,4,15842,Antibacterial Activity of Rationally Designed Antimicrobial Peptides.,Staphylococcusaureus,1466
AWDFGSLGGVFTSIGKALHQVFGAIYGAA,897,153,15858,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1,160
AWDFGSVGGVLNSLGKMVHQIFGSAYTAL,897,153,15859,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1,160
AWDFGSVGGLFTSLGKAVHQVFGSVYTTM,897,153,15860,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1,160
AWDFGSIGGVFTSVGKLVHQVFGTAYGVL,897,153,15861,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-1,160
AWDFGSLGGVFTSIGKALHQVFGGAFGAA,897,139,15862,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-2,160
AWDFGSVGGVFTSVGKAVHQVFGGAFRSL,897,139,15863,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-2,160
AWDFGSVGGVFTSVGKAVHQVFGWWWRSL,897,139,15864,Peptide inhibitors of flavivirus entry derived from the E protein stem.,DENV-2,160
NKVKEWIKYLKSLFK,898,87,15867,"Design and Engineering of Antimicrobial Peptides Based on LPcin-YK3, an Antimicrobial Peptide Derivative from Bovine Milk.",Listeriainnocua,1480
NKVKEWIKYLKSKFK,898,87,15868,"Design and Engineering of Antimicrobial Peptides Based on LPcin-YK3, an Antimicrobial Peptide Derivative from Bovine Milk.",Listeriainnocua,1480
NKVKEWWKWLKKL,898,87,15869,"Design and Engineering of Antimicrobial Peptides Based on LPcin-YK3, an Antimicrobial Peptide Derivative from Bovine Milk.",Listeriainnocua,1273
RPQFFEAVGDFVENVGEGVGDFFEGVGDFFSNVFSGSSR,899,4,15907,Maturation of an Antimicrobial Peptide Inhibits Aeromonas hydrophila Infection in Crayfish.,Staphylococcusaureus,1274
WFGHLYRGITSVVKHVHGLLSG,900,77,15908,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae,1911
WFGHLYRGITKVVKHVHGLLKG,900,77,15909,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae,1911
WFGKLYRGITSVVKKVKGLLSG,900,77,15910,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae,1911
WFGKLYRGITKVVKKVKGLLKG,900,77,15911,Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens,Klebsiellapneumoniae,1911
ATCYCRTGRCATRESRSGVCEISGRLYRLCCR,901,154,15912,Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.,HSV-2,1788
FALALKALKKALKKLKKALKKAL,902,4,15913,Short bioactive peptides,Staphylococcusaureus,1275
MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,902,4,15915,Short bioactive peptides,Staphylococcusaureus,2096
FAKKLAKKLKKLAKKLAKLALAL,902,4,15918,Short bioactive peptides,Staphylococcusaureus,1276
FALALKALKKLKKALKKAL,902,2,15919,Short bioactive peptides,Escherichiacoli,2425
FAKKLAKKLKKLAKLALAL,902,2,15920,Short bioactive peptides,Escherichiacoli,172
GGHKWKLFKKIGAVLKVL,903,2,15932,Antimicrobial and Antibiofilm Activities of Helical Antimicrobial Peptide Sequences Incorporating Metal-Binding Motifs.,Escherichiacoli,500
VIHKWKLFKKIGAVLKVL,903,2,15933,Antimicrobial and Antibiofilm Activities of Helical Antimicrobial Peptide Sequences Incorporating Metal-Binding Motifs.,Escherichiacoli,500
KKIRVRLSA,904,1,15934,A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.,None_target,1277
KKIRVRLSAK,904,1,15935,A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo.,None_target,1278
FAKKLAKLAKKLAKLAL,902,2,15951,Short bioactive peptides,Escherichiacoli,1276
FAKKLAKKLKKLAKKLAKKWKL,902,2,15956,Short bioactive peptides,Escherichiacoli,1276
KTKLFKKFAKKLAKKLKKLAKKL,902,4,15963,Short bioactive peptides,Staphylococcusaureus,1279
KWKLFKKKTKLFKKFAKKLAKKL,902,4,15964,Short bioactive peptides,Staphylococcusaureus,1280
FAKKLAKKLKKLAKKLIGAVLKV,902,4,15979,Short bioactive peptides,Staphylococcusaureus,1276
GAGIGPGHRRTWRRWPRRRWR,905,155,15996,Prediction and Characterization of Cationic Arginine-Rich Plant Antimicrobial Peptide SM-985 From Teosinte ( Zea mays ssp. mexicana),Clavibacterfangii,2427
MSLLERKLLMHFLRV,906,2,15997,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2428
GLMKLLRELLHMFSRVG,906,2,15998,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2429
MRIGLRFVLM,906,2,15999,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2430
SVAGRAMRIGLRFVLM,906,2,16000,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2431
GIAGLLRSFVRMLAKIMGG,906,2,16001,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2432
GSVLRAIMRMFAKLMG,906,2,16002,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2433
GIHGVVRSFMRMLGHLG,906,2,16003,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2434
GSVIRALMRMFARLVG,906,2,16004,Antimicrobial peptide selection from Lippia spp leaf transcriptomes,Escherichiacoli,2435
FFRKVLKLIRKIWR,908,59,16006,Studies on the Antibacterial Activity and Mechanism of Antimicrobial Peptides Against Drug-Resistant Bacteria.,Acinetobacterbaumannii,1281
EPRWKVFKKIEKMGRNIRDGIIKAGPAVAVLGDAKALGK,909,2,16020,"Identification and characteristics of a novel cecropin from the armyworm, Mythimna separata.",Escherichiacoli,2096
AIPAVDPFGRVKRSPWHGGTWGCKPIWACQNSPPYLG,910,4,16051,"Characterization and antimicrobial evaluation of a new Spgly-AMP, glycine-rich antimicrobial peptide from the mud crab Scylla paramamosain.",Staphylococcusaureus,1282
GRVKRSPWHGGTWGCKPIWACQNSPPYLG,910,4,16052,"Characterization and antimicrobial evaluation of a new Spgly-AMP, glycine-rich antimicrobial peptide from the mud crab Scylla paramamosain.",Staphylococcusaureus,1282
RYIYLSGTDRIIRAKLGK,911,156,16053,Development of a novel anti-biofilm peptide derived from profilin of Spodoptera frugiperda,Candidatropicalis,1283
ITRYLDKILRILRKYLKA,911,156,16054,Development of a novel anti-biofilm peptide derived from profilin of Spodoptera frugiperda,Candidatropicalis,1284
KCWDTWSRCTRFTSVFTGSVWNTCQKRCQCLGHATGSCVLRRSECPLTSQAYRCECS,912,2,16055,"The molecular characterization, expression analysis and antimicrobial activity of theromacin from Asian polychaeta (Perinereis linea)",Escherichiacoli,2436
GLRRLLRKIRGRWKGGGRGGRLCYCRRRFCVCVGR,913,2,16098,"The Addition of a Synthetic LPS-Targeting Domain Improves Serum Stability While Maintaining Antimicrobial, Antibiofilm, and Cell Stimulating Properties of an Antimicrobial Peptide.",Escherichiacoli,2437
FALGAVTCLIRTKCKVLPKLF,914,4,16102,"Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.",Staphylococcusaureus,1285
FALGAVTKVLYKLFCLITRKC,914,4,16103,"Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.",Staphylococcusaureus,1296
FLRNGGSYYIVPAFRGKG,915,2,16117,"Adepamycin: design, synthesis and biological properties of a new peptide with antimicrobial properties",Escherichiacoli,906
FQRYFHRYARFLAKIWKG,915,2,16118,"Adepamycin: design, synthesis and biological properties of a new peptide with antimicrobial properties",Escherichiacoli,2438
SNVMEERKIKVYLPRMKMEE,916,157,16119,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1286
RKIKVYLPRMK,916,157,16120,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1287
RKIKVYLRRMK,916,157,16121,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1288
RKIKRYLRRMK,916,157,16122,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1289
RKIKRYLRRMI,916,157,16123,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1292
RKIKRYLRRMW,916,157,16124,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1290
RLIKRYLRRMW,916,157,16125,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1291
RKIKRYLRRMIW,916,157,16126,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1292
RKIKRYLRRMIIW,916,157,16127,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1292
RKIKRYLRRMIIIW,916,157,16128,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1292
RKMKRVWKRFKL,916,157,16129,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1293
RKLKRFWKRVKM,916,157,16130,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1294
RKVKRLFKRWKM,916,157,16131,Antimicrobial activity and secondary structure of a novel peptide derived from ovalbumin,Streptococcusepidermidis,1295
WWLSRRRSSLFYWR,917,2,16138,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli,2439
SRRRFDFSRRRIYVARRRSLAFAHRRR,917,2,16139,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli,2440
TINKKFRWHGKRKWWLRFVKQ,917,2,16140,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli,2441
KGGKFLNFLKKAAKVGAKVGMAALG,917,2,16141,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli,2442
KLKTWPKNYWRKVWSKKNWRKFVKKFKHW,917,2,16142,In silico identification and functional validation of linear cationic ?-helical antimicrobial peptides in the ascidian Ciona intestinalis,Escherichiacoli,2443
KLDLKLDLKLDL,918,2,16144,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli,2444
RKLDLKLDLKLDL,918,2,16145,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli,2445
RRKLDLKLDLKLDL,918,2,16146,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli,2446
RRRKLDLKLDLKLDL,918,2,16147,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli,2447
RRRRKLDLKLDLKLDL,918,2,16148,"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties.",Escherichiacoli,2447
FLPLIAGLAAKFLPKIFCAITKKC,919,4,16153,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,1296
FLPLIAGLAAKCAITKKC,919,4,16154,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,1296
FLPKIFCAITKKC,919,4,16155,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,1296
KFLPKIFCAITKKC,919,4,16156,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,1296
KKFLPKIFCAITKKC,919,4,16157,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,1296
KFLPWKIFCAITKKC,919,4,16158,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,2227
KKFLPWKIFCAITKKC,919,4,16159,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,2227
KFWPWKIFCAITKKC,919,4,16160,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,2227
KFLPWKWFCAITKKC,919,4,16161,Modification and Targeted Design of N-Terminal Truncates Derived from Brevinin with Improved Therapeutic Efficacy,Staphylococcusaureus,2227
GFGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16164,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus,2323
GYGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16165,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus,2323
GAGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16166,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus,2323
GLFNIIKKTIGKLR,921,8,16196,Alignment-based design and synthesis of new antimicrobial Aurein-derived peptides with improved activity against Gram-negative bacteria and evaluation of their toxicity on human cells.,Bacillussubtilis,2228
GLFWIIKKTIGKLR,921,8,16197,Alignment-based design and synthesis of new antimicrobial Aurein-derived peptides with improved activity against Gram-negative bacteria and evaluation of their toxicity on human cells.,Bacillussubtilis,2228
IGRHFKRRNSIWGICWF,922,2,16198,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli,2448
VLIRGLIHMLRGG,922,2,16199,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli,2449
FVKILAKLVNYAKN,922,2,16200,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli,2450
FLIGKAIKRKFCLRSVWNA,922,2,16201,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli,2451
KKGKSFKQLHIIVHLVKSWLRTILTHI,922,2,16202,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli,2452
IVKRFFRISYKLQSLKIIKGKRTFT,922,2,16203,The Hirudo Medicinalis Microbiome Is a Source of New Antimicrobial Peptides.,Escherichiacoli,2453
LRCDYGRFFASKSLYDPLKKRR,923,4,16204,Anti-Acne Action of Peptides Isolated from Burdock Root-Preliminary Studies and Pilot Testing.,Staphylococcusaureus,2229
ILPWKWPWWPWRR,924,2,16253,Indolicidin analogs with broad-spectrum antimicrobial activity and low hemolytic activity,Escherichiacoli,1522
RRIPFWPPNLPGPRRPPWFLPDFRIPRIPRKR,926,2,16331,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli,618
RRIPFWPIPLRWQWPPPWFPPSFPIPRISRKR,926,2,16332,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli,619
RRIRFPFPPFPWQWPPAGFPTFHIPRIPRKQ,926,2,16333,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli,2454
RRIRFRPPRLPRPRPRPWIPPRFPFPRIPGKR,926,2,16354,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli,2710
RRIRIRPPRLPRPRPRPWFPPRFPIPRIPGKR,926,2,16355,Characterization of Cetacean Proline-Rich Antimicrobial Peptides Displaying Activity against ESKAPE Pathogens.,Escherichiacoli,2710
WIKIWKKIIKKWKK,928,2,16406,Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure - Activity Relationships to Enhance Bactericidal Efficiency.,Escherichiacoli,2455
QKRPRVRLSA,928,2,16411,Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure - Activity Relationships to Enhance Bactericidal Efficiency.,Escherichiacoli,2456
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGVGSCQSQCRGCR,929,158,16439,Genes Encoding Hevein-Like Antimicrobial Peptides from Elytrigia repens (L.) Desv. ex Nevski.,Bipolarissorokiniana,2230
AQRCGDQARGAKC,930,158,16440,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana,2230
IAAERRYATIYQARLWAF,931,2,16441,Inhibition and eradication activity of truncated alpha-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm,Escherichiacoli,2457
GVVDILKGAAKDLAGH,932,2,16442,Novel Ocellatin Peptides Mitigate LPS-induced ROS Formation and NF-kB Activation in Microglia and Hippocampal Neurons.,Escherichiacoli,645
GVVDILKGAAKDLAGHLASKV,932,2,16443,Novel Ocellatin Peptides Mitigate LPS-induced ROS Formation and NF-kB Activation in Microglia and Hippocampal Neurons.,Escherichiacoli,645
KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ,933,3,16444,"New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927).",Pseudomonasaeruginosa,2231
KEIERAGQRIRDAIISAAPAVETLAQAQKIIKGG,933,3,16445,"New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927).",Pseudomonasaeruginosa,1466
LCCGKYGFCGSG,930,158,16450,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana,2230
CCGKYGFCGSGDAYC,930,158,16451,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana,2230
GKGSCQSQCRGCR,930,158,16452,Hevein-Like Antimicrobial Peptides Wamps: Structure-Function Relationship in Antifungal Activity and Sensitization of Plant Pathogenic Fungi to Tebuconazole by WAMP-2-Derived Peptides.,Bipolarissorokiniana,2232
RIIDRLWRVRRPQKPKFVTVWVR,934,4,16453,Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.,Staphylococcusaureus,2233
RIIDLLWRVRRPQKPKFVIVWVR,934,4,16454,Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.,Staphylococcusaureus,2233
RIIDRLWRVRRPQKPKFVIVWVR,934,4,16455,Analogs of the Cathelicidin-Derived Antimicrobial Peptide PMAP-23 Exhibit Improved Stability and Antibacterial Activity.,Staphylococcusaureus,2233
GILDTLKQFAKGVGKWLVKGAAQGVLSTVSCKLAKTC,935,18,16456,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus,2192
GILDTLKQFAKGVGKDLVKGAAQ,935,18,16457,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus,2192
GILDTLKQFAKGVGKWLVKGAAQ,935,18,16458,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus,2192
GILDTLKQFAKGVGKFLVKGAAQ,935,18,16459,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus,2192
GILDTLKQFAKGVGWDLVKGAAQ,935,18,16460,Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4.,Micrococcusluteus,2192
FLPGILKVAANVVPGVI,936,4,16463,Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri.,Staphylococcusaureus,1296
GIKKFLHIIWKFIKAFVGEIMNS,937,2,16469,Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.,Escherichiacoli,14
IIKKFLHSIWKFGKAFVGEIMNI,937,2,16470,Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.,Escherichiacoli,14
GLARCLAGTL,938,2,16489,New cationic antimicrobial peptide screened from boiled-dried anchovies by immobilized bacterial membrane liposome chromatography.,Escherichiacoli,2458
GLFDVIKKVASVIGPLG,939,159,16496,The design and anticancer activity of a citropin1.1 hybrid peptide with selective activity against highly invasive metastatic cell lines.,Humanprostate,2459
GLFDVIKKVASVIGPLGIAGQGGD,939,159,16497,The design and anticancer activity of a citropin1.1 hybrid peptide with selective activity against highly invasive metastatic cell lines.,Humanprostate,2459
PFWRIRIRRPFWRIRIRR,940,160,16503,Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.,Humanmelanoma,2234
FLFKLIKHAIKGLIKAFK,941,118,16518,In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide.,Humanbreast,2460
GITDLRGMLKRLKKMK,942,2,16520,Antibacterial Activity and Potential Application in Food Packaging of Peptides Derived from Turbot Viscera Hydrolysate.,Escherichiacoli,2461
ATLTAKDLTFLQDYKKTKKRVK,942,2,16521,Antibacterial Activity and Potential Application in Food Packaging of Peptides Derived from Turbot Viscera Hydrolysate.,Escherichiacoli,2462
HTMWRCVRLSACLFSVRRR,942,2,16522,Antibacterial Activity and Potential Application in Food Packaging of Peptides Derived from Turbot Viscera Hydrolysate.,Escherichiacoli,2463
PAWFKARRWAWRMLKKAA,943,2,16526,Short antibacterial peptides and erythromycin act synergically against Escherichia coli,Escherichiacoli,696
RRWQWRMKKLGA,943,2,16528,Short antibacterial peptides and erythromycin act synergically against Escherichia coli,Escherichiacoli,1206
LLKQLWTKMKGAGKAVLGKIKGLL,944,2,16531,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli,2464
LLKKLWTKMKGAGKAVLGKIKGLL,944,2,16532,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli,2464
LLRELWTRMRGAGRAVLGRIRGLL,944,2,16533,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli,2464
AFRPIPTHSC,946,2,16557,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2465
YNYSYIITRS,946,2,16558,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2466
PTTVHIIYRI,946,2,16559,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2467
ASVTWLLYAM,946,2,16560,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2468
LRCLMLKFPI,946,2,16561,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2469
CLRPSIISRA,946,2,16562,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2470
WRYQWTILFI,946,2,16563,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2471
FCIRLATYVI,946,2,16564,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2472
PGHRVSCWLS,946,2,16565,Discovery and characterization of New Delhi metallo-beta-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.,Escherichiacoli,2473
RRWQWRAFCWNVCVYRNAVRVCHRRCN,947,42,16573,Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin6/Tat11.,Salmonellatyphimurium,174
YGRKKRRQRRRAFCWNVCVYRNAVRVCHRRCN,947,42,16574,Improved antibacterial activity of a marine peptide-N2 against intracellular Salmonella typhimurium by conjugating with cell-penetrating peptides-bLFcin6/Tat11.,Salmonellatyphimurium,174
GKHKNKGKKNGKHNGWKWWW,948,4,16593,"Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability.",Staphylococcusaureus,2235
DGRCLLIIKLAKLAKKLAKLAK,949,118,16628,Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.,Humanbreast,2474
GLLDIIKTTGKDFAVKILDNLKCKLAGGCPP,950,4,16630,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,1151
FFPIIARLAAKVIPSLVCAVTKKC,950,4,16631,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2236
GLWETIKTTGKSIALNLLDKIKCKIAGGCPP,950,4,16632,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,1151
FLTFPGMTFGKLLGK,950,4,16633,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2237
GLLDIIKDTGKTTGILMDTLKCQMTGRCPPSS,950,4,16634,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2238
ATAWRIPPPGMQPIIPIRIRPLCGKQ,950,4,16635,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,261
FFPRVLPLANKFLPTIYCALPKSVGN,950,4,16636,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2239
FPAIICKVSKNC,950,4,16637,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2240
FYFPVSRKFGGK,950,4,16638,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2241
ALVAKIQKFPVFNTLKLCKLELEII,950,4,16639,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2242
SNRDFFKVNIFRLCG,950,4,16640,AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens,Staphylococcusaureus,2243
RFRLPFRRIHPPPFVRIHPPPFYRRFL,951,2,16646,Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.,Escherichiacoli,2475
RFRLPFRRPWPIRIHPPPFYPWPFRRFL,951,2,16648,Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.,Escherichiacoli,2476
VHISHREARGPSFRICVGFLGPRWARGCSTGN,952,2,16654,The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics.,Escherichiacoli,2477
GDVPPGIRNTICRMQQGICRLFFCHSGTGQQHRQRCG,952,2,16655,The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics.,Escherichiacoli,2478
PIMYKVPLIRKKSLRRTLSERGLLKD,953,2,16845,Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform.,Escherichiacoli,2479
PFLKKHNLNPARKYFPQWKAPTL,953,2,16846,Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform.,Escherichiacoli,2479
PIMYKVPLIRKKSLRRTLSERGLLKDPFLKKHNLNPARKYFPQWKAPTL,953,2,16847,Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational-Experimental Platform.,Escherichiacoli,2479
RLKWVRIWRR,954,2,16849,A Safe and Multitasking Antimicrobial Decapeptide: The Road from De Novo Design to Structural and Functional Characterization.,Escherichiacoli,2480
RLIVKVRIWRR,954,2,16850,A Safe and Multitasking Antimicrobial Decapeptide: The Road from De Novo Design to Structural and Functional Characterization.,Escherichiacoli,2481
FKCRRWQWRMKKLGAPSITGVRRAF,955,161,16854,Effect of intramolecular disulfide bond of bovine lactoferricin on its molecular structure and antibacterial activity against Trueperella pyogenes separated from cow milk with mastitis.,Trueperellapyogenes,114
ILIACLGLKLLRYRRIY,956,77,16863,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Klebsiellapneumoniae,2482
ILIACWGLKLLRYRRIY,956,2,16865,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
WRWACWGLKLLRYRRIY,956,2,16866,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
ILWACWGLKLLRYRRIY,956,2,16867,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
ILWACWGLKLLKYKKIY,956,2,16868,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
WRWACWGLKLLKYKKIY,956,2,16869,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
WRWAKWGLKLLKYKKIY,956,2,16870,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
ILWAKWGLKLLRYRRIY,956,2,16872,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKWGLKLLRYRRIY,956,2,16873,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKWGLKWLRYRRIY,956,2,16874,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKWGLKLLRYRRIW,956,2,16875,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKWGLKLLDYRRIW,956,2,16877,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKWGLDLLRYRRIW,956,2,16878,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
WRWAKWGLKLWKWKKIY,956,2,16879,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKWGLKLLRYRRWY,956,2,16880,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
IWWAKLGLKLLRYRRWY,956,2,16881,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
WWWAKLGLKLLRYRRWY,956,2,16882,Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae.,Escherichiacoli,2482
FTILKKLKSFIK,957,4,16906,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2244
KLVKKLLKKYITF,957,4,16907,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2245
LARFVLRILKYGFK,957,4,16908,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2246
IPLLRKGKKIIWW,957,4,16909,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2247
GLKKVIKLLRPLL,957,4,16910,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2248
ILKPKLWKLTVVARKIIK,957,4,16911,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2249
IVIKSLGKFLKNVGGFAG,957,4,16912,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2250
FKLVWKLLKKLALKL,957,3,16913,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Pseudomonasaeruginosa,2251
ITKWLLNAIKKGFKL,957,4,16914,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2252
IHKLVKLWLNLGKKF,957,3,16915,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Pseudomonasaeruginosa,2253
LFSIIWKLNRKLIKA,957,4,16916,"Design of antimicrobial and cytolytic peptides by computational analysis of bacterial, algal, and invertebrate proteomes.",Staphylococcusaureus,2254
ILGKIWKGIKSLF,958,8,16937,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis,2492
AGKETIRQYLKNEIKKKGRKAVIAW,959,77,16951,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae,616
AGKEKIRKKLKNEIKKKGRKAVIAW,959,77,16952,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae,616
AWKEKIRKKLKNEIKKKGRKAVIAW,959,77,16953,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae,616
AGKEKIRKKLKNEIKKKWRKAVIAW,959,77,16954,Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy.,Klebsiellapneumoniae,616
AFALIAGALYRIFHRR,960,78,16955,"LHH1, a novel antimicrobial peptide with anti-cancer cell activity identified from Lactobacillus casei HZ1.",Enterobacteraerogenes,2255
DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER,961,131,16962,De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.,SARS-CoV-2,2483
GDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELG,962,130,16964,Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.,SARS-CoV,1322
NGAICWGPCPTAFRQIGNCGRFRVRCCRIR,963,131,16965,A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2.,SARS-CoV-2,362
SRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGRKTMYA,964,2,16977,Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2.,Escherichiacoli,2062
FPVTWRWWKWWKG,965,2,16980,Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells.,Escherichiacoli,2063
FPVTWRWWKWWKGKFPVTWRWWKWWKG,965,2,16981,Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells.,Escherichiacoli,2064
AKLIPTIA,967,162,17029,Synthetic peptides against Trichophyton mentagrophytes and T. rubrum: Mechanisms of action and efficiency compared to griseofulvin and itraconazole.,Trichophytonmentagrophytes,2065
VQWRRIRVWVIR,968,52,17042,Host defense peptide IDR-1002 associated with ciprofloxacin as a new antimicrobial and immunomodulatory strategy for dental pulp revascularization therapy.,Enterococcusfaecalis,2066
AKKLLKLLKKLLKLAG,969,2,17049,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKALKLLKKLLKLAG,969,2,17050,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLAKLLKKLLKLAG,969,2,17051,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKALKKLLKLAG,969,2,17052,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2067
LKKLLKLAKKLLKLAG,969,2,17053,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLLKKALKLAG,969,2,17054,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLLKKLAKLAG,969,2,17055,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2068
LKKLLKLLKKLLKAAG,969,2,17056,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLGKKLLKLAG,969,2,17057,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLSKKLLKLAG,969,2,17058,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLPKKLLKLAG,969,2,17059,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLNKKLLKLAG,969,2,17060,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLQKKLLKLAG,969,2,17061,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLDKKLLKLAG,969,2,17062,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLEKKLLKLAG,969,2,17063,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLKKKLLKLAG,969,2,17064,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
LKKLLKLHKKLLKLAG,969,2,17065,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2654
AKRIVQRIKDFLR,969,2,17066,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2048
FKRAVQRIKDFLR,969,2,17067,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIAQRIKDFLR,969,2,17068,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRIVQRAKDFLR,969,2,17069,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRIVQRIKDALR,969,2,17070,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIVQRIKDFAR,969,2,17071,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRGVQRIKDFLR,969,2,17072,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRSVQRIKDFLR,969,2,17073,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRNVQRIKDFLR,969,2,17074,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRQVQRIKDFLR,969,2,17075,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRHVQRIKDFLR,969,2,17076,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIGQRIKDFLR,969,2,17077,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRISQRIKDFLR,969,2,17078,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRINQRIKDFLR,969,2,17079,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRIQQRIKDFLR,969,2,17080,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRIHQRIKDFLR,969,2,17081,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,1861
FKRIVQRIKDGLR,969,2,17082,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIVQRIKDSLR,969,2,17083,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIVQRIKDNLR,969,2,17084,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIVQRIKDQLR,969,2,17085,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
FKRIVQRIKDHLR,969,2,17086,Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.,Escherichiacoli,2498
KRLFKKLLKYLRKF,970,2,17119,D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.,Escherichiacoli,2069
KRLFKRLFKYLRRF,970,2,17120,D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.,Escherichiacoli,2070
RRIFKRLFKYLRRF,970,2,17121,D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.,Escherichiacoli,2070
AGRQTIKAYLRREIRKRGRKAVIAW,971,2,17135,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
WGTQRIKAYLRREIRKRGRKAVIAW,971,2,17136,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
WGTNRIAKELRRYIRKVGRIARKAW,971,2,17137,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AWRQTIAKYLRREIRKRGRKAVIAW,971,2,17138,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AWTQRIKAYLRREIRKRGRKAVIAW,971,2,17139,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQWIKAYLRREIRKRGRKAVIAW,971,2,17140,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQWIAKYLRREIRKRGRKAVIAW,971,2,17141,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGWQRIKAYLRREIRKRGRKAVIAW,971,2,17142,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQWIKAYLRREIRKVGRKARIAW,971,2,17143,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQTIAKYLRREIRKRGRKWVIAW,971,2,17144,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGTNRIAKELRRYIRKVGRIARKWW,971,2,17145,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AGTNRIAKELRRYIRKVKRIARKAW,971,2,17146,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AGTNRIAKELRRYIRKVGRIKRKAW,971,2,17147,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AGTNRIAKELRRYIRKVGRIARKKW,971,2,17148,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AKTNRIAKELRRYIRKVGRIARKAW,971,2,17149,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AGKETIRQFLKKKIQEKGKRATIAW,971,2,17150,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIFQRLKKKIQEKGKRAWIAW,971,2,17151,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGTEKIFQRLKKKIQEGKKIAKRAW,971,2,17152,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AWTEKIFQRLKKTIQEGKKIAKRAW,971,2,17153,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AWTEKIFNRLKKTINEGKKIAKRAW,971,2,17154,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIFQRLKKKIQEKWKRATIAW,971,2,17155,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIRQFLKKKIQEWKKRATIAW,971,2,17156,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGTEKIFNRLKKTINEWKKIAKRAW,971,2,17157,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIFQRLKKKIQEKGKRATIWW,971,2,17158,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIRQFLKKTIQEKGKRAKIWW,971,2,17159,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGTEKIFQRLKKTIQEGKKIAKRWW,971,2,17160,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGTEKIFNRLKKTINEGKKIAKRWW,971,2,17161,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKEKIFQRLKKTIQEGKKIAKRAW,971,2,17162,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIFQRLKKKIQEKGKRAKIAW,971,2,17163,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGKETIRQFLKKKIQEGKKRAKIAW,971,2,17164,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2072
AGRQALTLYLKEELRKRGKKAFIAW,971,2,17165,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGAQRLTKELLEYLRKFGKIARKAW,971,2,17166,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
WGRQALTKYLLEELRKRGKKAFIAW,971,2,17167,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
WGRQALTLYLKEELRKFGKKARIAW,971,2,17168,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
WGAQRLTKELLEYLRKFGKIARKAW,971,2,17169,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AGRQALTKYLLEELRKRWKKAFIAW,971,2,17170,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQALTLYLKEELRKRGKKAFIWW,971,2,17171,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQALTKYLLEELRKRGKKAFIWW,971,2,17172,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRQKLTLELKEYLRKRGKKAFIAW,971,2,17173,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AKRQALTKYLLEELRKRGKKAFIAW,971,2,17174,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AKANRLTKELLEYLRKFGKIARKAW,971,2,17175,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AGRESIKAYLKKEIKKKGKRAVIAW,971,2,17176,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGSERIWKELKKYIKKGKKVIRAAW,971,2,17177,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,2071
AWRESIKAYLKKEIKKKGKRIVAAW,971,2,17178,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRESIKAYLKKEIKKKWKRAVIAW,971,2,17179,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
AGRESIKAYLKKEIKKKWKRIVAAW,971,2,17180,Synthetic Peptide Libraries Designed From a Minimal Alpha-Helical Domain of AS-48-Bacteriocin Homologs Exhibit Potent Antibacterial Activity.,Escherichiacoli,616
CVRRFPWWWPFLRRC,972,8,17182,Cyclic Tritrpticin Analogs with Distinct Biological Activities.,Bacillussubtilis,2256
KWCFKVCYKGICYKKCKG,973,163,17195,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanmetastatic,1257
KSCFRVCYRGICYRRCRG,973,111,17196,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
KWCFRVCSRGSCYRRCRG,973,111,17197,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
KWCSRVCYRGICSRRCRG,973,111,17198,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
KWCFRVCYSGICYRRCRG,973,118,17199,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanbreast,1257
KWCFRVCYRGICYSRCRG,973,111,17200,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
KWCFRVCYRGICYRRCSG,973,111,17201,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
KWCFRVCYSGICYSRCSG,973,164,17202,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanmalignant,1257
KWCFRVCYRGICYRRCRK,973,111,17203,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
KWCFRVCYRGFCYRRCRK,973,111,17204,Cyclic Analogues of Horseshoe Crab Peptide Tachyplesin I with Anticancer and Cell Penetrating Properties.,Humanskin,1257
TFLDKFNHEAEDLFYQ,974,165,17208,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,SARS-CoV-2PsV,155
EDLFYQSSL,974,165,17209,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,SARS-CoV-2PsV,2257
QAKTFLDKFNHEA,974,165,17210,Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.,SARS-CoV-2PsV,155
LAREYKKIVEKLKRWLRQVLRTLR,975,59,17217,"Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.",Acinetobacterbaumannii,2258
GFCWYVCARRNGARVCYRRCN,976,2,17218,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWRVCASRNGLRVCYRRCN,976,2,17219,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWYACAKRNGLRVCYRRCN,976,2,17220,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWNVCVRRNGVRVCHRRCN,976,2,17221,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWYVCVKRNGVRSCYRRCN,976,2,17222,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWNVCVYRNGVRICHRRCN,976,2,17223,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWHVCARRNGVRVCYRRCN,976,2,17224,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWRACVYRNGVRACYRRCN,976,2,17225,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
GFCWRACVYRNGVRVCYRRCN,976,2,17226,An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria.,Escherichiacoli,174
KWCFRSCYRGICYRRCR,977,4,17227,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus,1257
KWCFRRCYRGICYRRCR,977,4,17228,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus,1257
KWCFRVCSRGICYRRCR,977,4,17229,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus,1257
KWCFRVCRRGICYRRCR,977,4,17230,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus,1257
KWCFRVCYRGSCYRRCR,977,4,17231,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus,1257
KWCFRVCYRGRCYRRCR,977,4,17232,Improved strategy for recombinant production and purification of antimicrobial peptide tachyplesin I and its analogs with high cell selectivity.,Staphylococcusaureus,1257
KFLNRFWHWLQLKPGQPMY,978,2,17233,Moonlighting peptides with emerging function.,Escherichiacoli,173
RRYGTCIYQGRLWAF,979,41,17234,Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1.,Mycobacteriumtuberculosis,425
RVQGRWKVRASFFK,981,2,17274,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
RVQGRWKVRASFFKEAAAKEAAAKGFAWNVCVYRNGVRVCHRRAN,981,2,17275,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
RVQGRWKVRASFFKGGGGSGFAWNVCVYRNGVRVCHRRAN,981,2,17276,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
RVQGRWKVRASFFKGFAWNVCVYRNGVRVCHRRAN,981,2,17277,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
VCVYRGFAWNCHRRANNGVRV,981,2,17278,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
RVQGRWKVRASFFKEAAAKEAAAKVCVYRGFAWNCHRRANNGVRV,981,2,17279,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
RVQGRWKVRASFFKGGGGSVCVYRGFAWNCHRRANNGVRV,981,2,17280,Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli.,Escherichiacoli,174
ATCDLLSPFKVGHAACAAHCIARGKRGGWCDGRAVCNCRK,982,4,17281,An Enhanced Variant Designed From DLP4 Cationic Peptide Against Staphylococcus aureus CVCC 546.,Staphylococcusaureus,1468
KKGWAKKLAFAFGKK,983,2,17306,"Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria.",Escherichiacoli,175
NIRPRPTARPPYINRPPNPFKPRW,984,48,17336,Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective.,Bacillusmegaterium,2259
FLPKLFAKITKKNMAHIRC,986,2,17349,A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria.,Escherichiacoli,176
CFLPKLFAKITKKNMAHIR,986,2,17350,A Peptide-Nanoparticle System with Improved Efficacy against Multidrug Resistant Bacteria.,Escherichiacoli,176
AAHHIIGGLFSAGKAIHRLIRRRRR,987,3,17361,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIAAIIGGLFSAGKAIHRLIRRRRR,987,3,17362,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHAAGGLFSAGKAIHRLIRRRRR,987,3,17363,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGAASAGKAIHRLIRRRRR,987,3,17364,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKAAHRLIRRRRR,987,3,17365,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKARHRLIRRRRR,987,3,17366,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKAEHRLIRRRRR,987,3,17367,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKAIHRHHRRRRR,987,3,17368,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
HHIIGGLFSAGKAIHRLIRRRRR,987,3,17369,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
IIGGLFSAGKAIHRLIRRRRR,987,3,17370,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKAIHRLIRRR,987,3,17371,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKAIHRLIR,987,3,17372,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSVGKHIHRLIRRRRR,987,3,17373,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSIGKIIHRLIRRRRR,987,3,17374,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSAGKAIHSLIHRRRR,987,3,17378,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
FIHHIIGGLFSVGKHIHSLIHRRRR,987,3,17379,"Hydrophobic residues are critical for the helix-forming, hemolytic and bactericidal activities of amphipathic antimicrobial peptide TP4.",Pseudomonasaeruginosa,1056
LNWKAILKHIIK,988,2,17392,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,177
VLPKVMAHMK,988,2,17393,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,178
LNWGAVLKHVVK,988,2,17394,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,179
LNWGAIKKHIIK,988,2,17395,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,179
LNWGAFLKHFFK,988,2,17396,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,180
VDLKNLLK,988,2,17397,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,181
LRRLRLRLLRLLRRLLRLL,988,2,17398,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,182
LNWGAWLKHWWK,988,2,17399,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,183
LVKRVKKVL,988,2,17400,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,184
VNLKNLLR,988,2,17401,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,181
KWKLWKKIEKWGQGIGAVLKWLTTWL,988,2,17402,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,185
FFFHIIKGLFHAGRMIHGLV,988,2,17403,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,1056
FFFKLLPKAIGALKKI,988,2,17404,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,186
FKIKASKKLLKKVGKGALGAVAKALAQQA,988,2,17405,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,187
KWKKFIKKLTSAAKKVLTTGLPALIS,988,2,17406,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,2502
KWKKFLKKLTSAAKKVLTTALKPISS,988,2,17407,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,2502
FFKKFIGGVAKIAGKAAPHGVGQLIPHVTP,988,2,17408,PepVAE3: variational autoencoder framework for antimicrobial peptide generation and activity prediction,Escherichiacoli,188
RVKRVWPLVIRTVIAGYNLYRAIKKK,32,94,11,"Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken",Salmonellaenterica,95
ENREVPPGFTALIKTLRKCKII,989,2,16,A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta,Escherichiacoli,189
NLVSGLIEARKYLEQLHRKLKNCKV,989,2,36,A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta,Escherichiacoli,1342
VRRFPWWWPFLRR,8,6,160,Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from a putative porcine precursor protein of a novel family of antibacterial peptides,Aspergillusfumigatus,2256
GIGKFLHSAKKFGKAFVGEIMNS,15,8,360,Helix stability confers salt resistance upon helical antimicrobial peptides,Bacillussubtilis,13
DCLSGRYKGPCAVWDNETCRRVCKEEGRSSGHCSPSLKCWCEGC,990,28,461,Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides,Neurosporacrassa,2260
ISDYSIAMDKIRQQDFVNWLLAQKGKKSDWKHNITQ,991,48,462,"Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910",Bacillusmegaterium,2261
KTCENLADTY,992,65,500,"Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase.",Botrytiscinerea,190
SMWSGMWRRKLKKLRNALKKKLKGE,993,95,535,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis,191
GLFGKLIKKFGRKAISYAVKKARGKH,993,95,536,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis,540
QAFQTFKPDWNKIRYDAMKMQTSLGQMKKRFNL,993,95,567,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis,192
GETFDKLKEKLKTFYQKLVEKAEDLKGDLKAKLS,993,95,568,"Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.",Arthrobacterglobiformis,193
SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,994,2,569,"he structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR.",Escherichiacoli,1069
KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGTTCPSDYPK,22,12,595,Structural dissection of a highly knotted peptide reveals minimal motif with antimicrobial activity,Clavibactermichiganensis,2517
ALWMTLLKKVLKAAAKAALNAVLVGANA,23,2,606,Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity,Escherichiacoli,33
FLGALFKVASKVLPSVKCAITKKC,24,8,626,Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5,Bacillussubtilis,1296
NPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCRKK,997,2,659,"Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.",Escherichiacoli,677
ALWKNMLKGIGKLAGQAALGAVKTLVGA,998,4,660,"Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.",Staphylococcusaureus,435
RSVCRQIKICRRRGGCYYKCTNRPY,999,18,694,Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood.,Micrococcusluteus,2262
YVPLPNVPQPGRRPFPTFPGQGPFNPKIKWPQGY,1000,103,698,"Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera).",Agrobacteriumtumefaciens,2263
GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG,1001,2,707,Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA.,Escherichiacoli,2015
GLLSRLRDFLSDRGRRLGEKIERIGQKIKDLSEFFQS,1002,2,708,"PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity.",Escherichiacoli,1800
GIPCGESCVWIPCISAALGCSCKNKVCYRN,1003,2,755,An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.,Escherichiacoli,2082
SIPCGESCVFIPCTVTALLGCSCKSKVCYKN,1003,2,756,An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.,Escherichiacoli,2082
GVIPCGESCVFIPCISTLLGCSCKNKVCYRN,1003,2,757,An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.,Escherichiacoli,2082
VTCFCRRRGCASRERHIGYCRFGNTIYRLCCRR,1006,4,768,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus,422
CFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ,1006,4,769,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus,422
VTCFCRRRGCASRERLIGYCRFGNTIYGLCCRR,1006,4,770,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus,422
VTCFCKRPVCDSGETQIGYCRLGNTFYRLCCRQ,1006,4,771,"Isolation, antimicrobial activities, and primary structures of hamster neutrophil defensins",Staphylococcusaureus,422
KTCEHLADTYRGVCFTNASCDDHCKNKAHLISGTCHNWKCFCTQNC,1007,166,782,Characterization of two novel defense peptides from pea (Pisum sativum) seeds,Aspergillusniger,423
KTCENLSGTFKGPCIPDGNCNKHCRNNEHLLSGRCRDDFRCWCTNRC,1007,166,813,Characterization of two novel defense peptides from pea (Pisum sativum) seeds,Aspergillusniger,423
SDEKASPDKHHRFSLSRYAKLANRLANPKLLETFLSKWIGDRGNRSVK,33,2,818,Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin.,Escherichiacoli,194
FRGLAKLLKIGLKSFARVLKKVLPKAAKAGKALAKSMADENAIRQQNQ,1008,2,822,"Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.",Escherichiacoli,195
GFCRCLCRRGVCRCICTR,1009,4,823,Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins.,Staphylococcusaureus,97
GVCRCLCRRGVCRCLCRR,1009,4,824,Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins.,Staphylococcusaureus,1645
GFCRCICTRGFCRCICTR,1009,4,825,Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins.,Staphylococcusaureus,97
GVLSNVIGYLKKLGTGALNAVLKQ,1010,2,826,Antimicrobial peptides in the stomach of Xenopus laevis.,Escherichiacoli,196
YSLQMGATAIKQVKKLFKKWGW,1011,167,828,"Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.",Pediococcuspentosaceus,2281
GIGGKILSGLKTALKGAAKELASTYLH,1012,2,835,Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,Escherichiacoli,197
SIGAKILGGVKTFFKGALKELASTYLQ,1012,2,843,Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.,Escherichiacoli,197
GLLNTFKDWAISIAKGAGKGVLTTLSCKLDKSC,1013,4,845,"Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.",Staphylococcusaureus,820
SLFSLIKAGAKFLGKNLLKQGAQYAACKVSKEC,1013,4,846,"Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa.",Staphylococcusaureus,1813
SLGGVISGAKKVAKVAIPIGKAVLPVVAKLVG,1014,2,848,"Molecular characterization of ceratotoxin C, a novel antibacterial female-specific peptide of the ceratotoxin family from the medfly Ceratitis capitata.",Escherichiacoli,198
HRHQGPIFDTRPSPFNPNQPRPGPIY,1015,18,849,"Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties.",Micrococcusluteus,424
ACYCRIGACVSGERLTGACGLNGRIYRLCCR,1016,4,871,Purification and antimicrobial properties of three defensins from rat neutrophils.,Staphylococcusaureus,425
TRSSRAGLQFPVGRVHRLLRK,37,8,872,"Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II.",Bacillussubtilis,882
FLPKTLRKFFCRIRGGRCAVLNCLGKEEQIGRCSNSGRKCCRKKK,1018,4,917,"Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3.",Staphylococcusaureus,2012
FLGALFKVASKVLPSVFCAITKKC,1019,8,918,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Bacillussubtilis,1296
GKVWDWIKSAAKKIWSSEPVSQLKGQVLNAAKNYVAEKIGATPT,1020,3,947,Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.,Pseudomonasaeruginosa,426
FWGALAKGALKLIPSLFSSFSKKD,1020,3,948,Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.,Pseudomonasaeruginosa,121
ATRSYGNGVYCNNSKCWVNWGEAKENIAGIVISGWASGLAGMGH,1021,168,949,"Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum.",Lactobacilluscurvatus,649
FKLGSFLKKAWKSKLAKKLRAKGKEMLKDYAKGLLEGGSEEVPGQ,1022,2,964,"Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.",Escherichiacoli,242
KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK,192,52,965,Induction of bacteriocin production in Lactobacillus sake by a secreted peptide.,Enterococcusfaecalis,649
GKVWDWIKSTAKKLWNSEPVKELKNTALNAAKNLVAEKIGATPS,1023,2,966,"ntibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa.",Escherichiacoli,426
GLVTSLIKGAGKLLGGLFGSVTGGQS,1024,2,988,Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain.,Escherichiacoli,199
FLPIIAGIAAKVFPKIFCAISKKC,1025,2,990,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.",Escherichiacoli,1296
ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ,1026,169,991,Isolation and structure of novel defensive peptides from frog skin.,Microsporumcanis,200
GWGSFFKKAAHVGKHVGKAALTHYL,1027,2,1003,"Characterization of a fish antimicrobial peptide: gene expression, subcellular localization, and spectrum of activity.",Escherichiacoli,1560
GFGALFKFLAKKVAKTVAKQAAKQGAKYVVNKQME,1028,2,1006,"Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae)",Escherichiacoli,201
GFGSLFKFLAKKVAKTVAKQAAKQGAKYVANKHME,1029,2,1008,"Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae).",Escherichiacoli,201
FLPVVAGLAAKVLPSIICAVTKKC,1030,4,1009,"Induction of synthesis of an antimicrobial peptide in the skin of the freeze-tolerant frog, Rana sylvatica, in response to environmental stimuli.",Staphylococcusaureus,1296
SMLSVLKNLGKVGLGFVACKINKQC,1031,4,1010,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,427
GLFLDTLKGAAKDVAGKLEGLKCKITGCKLP,1031,4,1011,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,428
GFLDIINKLGKTFAGHMLDKIKCTIGTCPPSP,1031,4,1012,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,429
FLPFIARLAAKVFPSIICSVTKKC,1031,4,1013,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,1296
FLPIASLLGKYL,1031,4,1014,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,430
FISAIASMLGKFL,1031,4,1015,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,431
FLSAIASMLGKFL,1031,4,1016,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,431
FISAIASFLGKFL,1031,4,1017,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,432
FLFPLITSFLSKVL,1031,4,1018,"Ranatuerins: antimicrobial peptides isolated from the skin of the American bullfrog, Rana catesbeiana",Staphylococcusaureus,433
SMLSVLKNLGKVGLGLVACKINKQC,1032,4,1019,Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,Staphylococcusaureus,427
FLGGLMKAFPALICAVTKKC,1032,4,1020,Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,Staphylococcusaureus,526
GLFLDTLKGLAGKLLQGLKCIKAGCKP,1032,4,1021,Purification and characterization of antimicrobial peptides from the skin of the North American green frog Rana clamitans.,Staphylococcusaureus,434
IAPIIVAGLGYLVKDAWDHSDQIISGFKKGWNGGRRK,1033,52,1028,"Enterocin X, a novel two-peptide bacteriocin from Enterococcus faecium KU-B5, has an antibacterial spectrum entirely different from those of its component peptides.",Enterococcusfaecalis,202
SNDSLWYGVGQFMGKQANCITNHPVKHMIIPGYCLSKILG,1033,52,1029,"Enterocin X, a novel two-peptide bacteriocin from Enterococcus faecium KU-B5, has an antibacterial spectrum entirely different from those of its component peptides.",Enterococcusfaecalis,203
GLRKRLRKFRNKIKEKLKKIGQKIQGLLPKLAPRTDY,44,3,1058,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,875
GIMDTLKNLAKTAGKGALQSLLNKASCKLSGQC,1034,2,1069,Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.,Escherichiacoli,868
GLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ,44,3,1071,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,1571
GLVRKGGEKFGEKLRKIGQKIKEFFQKLALEIEQ,44,3,1072,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,1571
RGLRRLGRKIAHGVKKYGPTVLRIIRIAG,44,3,1073,Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.,Pseudomonasaeruginosa,1906
FLPLLAGLAANFLPKIFCKITRKC,1035,2,1077,Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta,Escherichiacoli,1296
GIFSKLGRKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,1034,2,1078,Novel antimicrobial peptides from skin secretion of the European frog Rana esculenta.,Escherichiacoli,1750
ALWKNMLKGIGKLAGKAALGAVKKLVGAES,1036,43,1098,Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis,Plasmodiumfalciparum,435
ATCDLLSGFGVGDSACAAHCIARGNRGGYCNSKKVCVCRN,1037,48,1099,Full sequence and characterization of two insect defensins: immune peptides from the mosquito Aedes aegypti.,Bacillusmegaterium,1468
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP,1038,2,1121,Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.,Escherichiacoli,2088
QQCGRQAGNRRCANNLCCSQYGYCGRTNEYCCTSQGCQSQCRRCG,1039,36,1134,Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.).,Alternariabrassicicola,204
VGECVRGRCPSGMCCSQFGYCGKGPKYCGR,1039,36,1135,Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.).,Alternariabrassicicola,2326
FDITKLNIKKLTKATCKVISKGASMCKVLFDKKKQE,1040,170,1143,"Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.",Lactococcusgarvieae,436
GNNRPIYIPQPRPPHPRL,1042,103,1159,Apidaecins: antibacterial peptides from honeybees.,Agrobacteriumtumefaciens,2542
GNNRPVYIPQPRPPHPRL,1042,103,1160,Apidaecins: antibacterial peptides from honeybees.,Agrobacteriumtumefaciens,2542
GNNRPVYIPQPRPPHPR,1042,103,1161,Apidaecins: antibacterial peptides from honeybees.,Agrobacteriumtumefaciens,2542
VQETQKLAKTVGANLEETNKKLAPQIKSAYDDFVKQAQEVQKKLHEAASKQ,1043,18,1213,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph,Micrococcusluteus,437
DIQIPGIKKPTHRDIIIPNWNPNVRTQPWQRFGGNKS,1043,18,1214,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph,Micrococcusluteus,438
EIRLPEPFRFPSPTVPKPIDIDPILPHPWSPRQTYPIIARRS,1044,18,1215,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus,439
RQRVEELSKFSKKGAAARRRK,55,21,1231,Antimicrobial peptides protect coho salmon from Vibrio anguillarum infections.,Vibrioanguillarum,440
DKLIGSCVWGATNYTSDCNAECKRRGYKGGHCGSFWNVNCWCEE,1044,18,1234,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus,115
EADEPLWLYKGDNIERAPTTADHPILPSIIDDVKLDPNRRYA,1044,18,1236,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus,1136
ETESTPDYLKNIQQQLEEYTKNFNTQVQNAFDSDKIKSEVNNFIESLGKILNTEKKEAPK,1044,18,1237,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus,441
ENFFKEIERAGQRIRDAIISAAPAVETLAQAQKIIKGGD,1044,18,1238,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus,1466
DTLIGSCVWGATNYTSDCNAECKRRGYKGGHCGSFLNVNCWCE,1044,18,1239,Purification and characterization of eight peptides from Galleria mellonella immune hemolymph.,Micrococcusluteus,115
GLMSSIGKALGGLIVDVLKPKTPAS,1045,25,1262,The antibiotic and anticancer active aurein peptides from the Australian Bell Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2.,Bacilluscereus,443
GILSLVKGVAKLAGKGLAKEGGKFGLELIACKIAKQC,1046,2,1272,Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,Escherichiacoli,445
FLGGLIKIVPAMICAVTKKC,61,4,1273,"Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",Staphylococcusaureus,526
GLFDVIKKVASVIGLASP,1048,25,1325,Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,Bacilluscereus,442
SIWGDIGQGVGKAAYWVGKAMGNMSDVNQASRINRKKKH,1049,32,1333,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis,989
KKWGWLAWVEPAGEFLKGFGKGAIKEGNKDKWKNI,1049,32,1334,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis,988
GLIGSIGKALGGLLVDVLKPKL,1048,25,1335,Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,Bacilluscereus,443
GTWDDIGQGIGRVAYWVGKAMGNMSDVNQASRINRKKKH,1049,32,1336,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis,989
GLIGSIGKALGGLLVDVLKPKLQAAS,1048,25,1337,Host defence peptides from the skin glands of the Australian blue mountains tree-frog Litoria citropa. Solution structure of the antibacterial peptide citropin 1.1.,Bacilluscereus,443
HVDKKVADKVLLLKQLRIMRLLTRL,1050,8,1339,Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect.,Bacillussubtilis,444
KKWGWLAWVDPAYEFIKGFGKGAIKEGNKDKWKNI,1049,32,1347,"Lactococcin Q, a novel two-peptide bacteriocin produced by Lactococcus lactis QU 4.",Lactococcuslactis,988
GLFTLIKGAVKMIGKTVAKEAGKTGLELMACKVTNQC,1051,4,1353,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus,445
GLFSKFAGKGIKNMIIKGIKGIGKEVGMDVIRTGIDVAGCKIKGEC,1051,4,1354,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus,1750
GIFSKFAGKGIKDLIIKGVKGIAKEAGMDVIRTGIDIAGCKIKGEC,1051,4,1355,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus,1750
GIFTLFKGAAKLLGKTLAKEAGKTGLELMACKVTNQC,1051,4,1356,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus,445
GIFSKLAGKKIKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,1051,4,1357,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus,1750
GIFSLIKGAAKVVAKGLGKEVGKFGLDLMACKVTNQC,1051,4,1358,Cloning from tissue surrogates: antimicrobial peptide (esculentin) cDNAs from the defensive skin secretions of Chinese ranid frogs.,Staphylococcusaureus,445
GRKSDCFRKSGFCAFLKCPSLTLISGKCSRFYLCCKRIR,1052,2,1359,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli,877
GKREKCLRRNGFCAFLKCPTLSVISGTCSRFQVCC,1052,2,1360,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli,877
LFCKRGTCHFGRCPSHLIKVGSCFGFRSCCKWPWDA,1052,2,1374,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli,124
LSCKRGTCHFGRCPSHLIKGSCSGG,1052,2,1375,Isolation of antimicrobial peptides from avian heterophils.,Escherichiacoli,124
KRFGRLAKSFLRMRILLPRRKILLAS,67,2,1430,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli,205
KRRHWFPLSFQEFLEQLRRFRDQLPFP,67,2,1431,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli,206
KRFHSVGSLIQRHQQMIRDKSEATRHGIRIITRPKLLLAS,67,2,1432,Structural and functional analysis of horse cathelicidin peptides.,Escherichiacoli,2412
GLLDAIKDTAQNLFANVLDKIKCKFTKC,1053,2,1459,Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,Escherichiacoli,1004
GLFNVFKKVGKNVLKNVAGSLMDNLKCKVSGEC,1053,2,1462,Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,Escherichiacoli,807
GLFSAFKKVGKNVLKNVAGSLMDNLKCKVSGEC,1053,2,1463,Expression of genes encoding antimicrobial and bradykinin-related peptides in skin of the stream brown frog Rana sakuraii.,Escherichiacoli,807
GIFSKLAGKKLKNLLISGLKNVGKEVGMDVVRTGIDIAGCKIKGEC,1046,2,1467,Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.,Escherichiacoli,1750
FLSLALAALPKFLCLVFKKC,1054,2,1468,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli,1693
FLSLALAALPKLFCLIFKKC,1054,2,1469,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli,2320
FLPLLLAGLPKLLCLFFKKC,1054,2,1470,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli,2320
GLFDVVKGVLKGAGKNVAGSLLEQLKCKLSGGC,1054,2,1471,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli,447
GLFSVVTGVLKAVGKNVAKNVGGSLLEQLKCKISGGC,1054,2,1472,"Cytolytic peptides belonging to the brevinin-1 and brevinin-2 families isolated from the skin of the Japanese brown frog, Rana dybowskii.",Escherichiacoli,807
FLIGMTHGLICLISRKC,1055,18,1476,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus,446
FLIGMTQGLICLITRKC,1055,18,1477,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus,446
GLFDVVKGVLKGVGKNVAGSLLEQLKCKLSGGC,1055,18,1478,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus,447
VWPLGLVICKALKIC,1055,18,1479,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus,448
FLPLLLAGLPLKLCFLFKKC,1055,18,1480,Purification and characterization of antimicrobial peptides from the skin secretion of Rana dybowskii.,Micrococcusluteus,1693
GIINTIQRYFCRVRGGRCAALTCLPRETQIGRCSVKGRKCCRTRK,1056,171,1481,Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway.,Haemophilusinfluenzae,2012
VVKCSYRLGSPDSRCN,1057,2,1482,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,207
AALKGCWTKSIPPKPCFGKR,1057,2,1483,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,2286
GVLGAVKDLLIGAGKSAAQSVLKTLSCKLSNDC,1057,2,1484,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,820
GFLDTFKNLALNAAKSAGVSVLNSLSCKLFKTC,1057,2,1491,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,208
GLGGAKKNFIIAANKTAPQSVKKTFSCKLYNG,1057,2,1492,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,209
GFMDTAKNAAKNVAVTLLDNLKCKITKAC,1057,2,1493,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,807
FMPILSCSRFKRC,1057,2,1494,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,210
GIFGKILGVGKKVLCGLSGVC,1057,2,1495,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,264
GFFTLIKAANKLINKTVNKEAGKGGLEIMA,1057,2,1497,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,257
GLFTLIKCAYQLIAPTVACN,1057,2,1499,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,258
GLFTLIKGAAKLIGKTVPKKQARLGMNLWLVKLPTNVKT,1057,2,1501,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,259
VEVQVRDKGKGIYGLSPLRQPAP,1057,2,1502,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,260
ATAWDFGPHGLLPIRPIRIRPLCGKDKS,1057,2,1503,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,261
DEKGPKWKR,1057,2,1504,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,262
AVPLIYNRPGIYVTKRPKGK,1057,2,1505,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,263
VIPFVASVAAEMMQHVYCAASKKC,1057,2,1506,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,1061
GLLSGILGAGKHIVCGLSGPCQSLNRKSSDVEYHLAKC,1057,2,1507,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,264
APFCLGYLSPKLKDMEPKPRG,1057,2,1517,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,265
GFSPNLPGKGLRIS,1057,2,1518,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,266
FLPPSPWKETFRTS,1057,2,1519,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,821
TSRCYIGYRRKVVCS,1057,2,1520,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,267
GCSRWIIGIHGQICRD,1057,2,1521,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,461
GLLSGTSVRGSI,1057,2,1522,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,268
GLFGKSSVWGRKYYVDLAGCAKA,1057,2,1523,Anti-infection peptidomics of amphibian skin.,Escherichiacoli,2149
GLLSGILGAGKHIVCGLSGLC,1058,2,1524,Anti-infection peptidomics of amphibian skin,Escherichiacoli,264
GLLSGVLGVGKKVLCGLSGLC,1058,2,1525,Anti-infection peptidomics of amphibian skin,Escherichiacoli,264
GLLSGILGAGKHIVCGLSGLR,1058,2,1526,Anti-infection peptidomics of amphibian skin,Escherichiacoli,264
KRGPNCVGNFLGGLFAGAAAGVPLGPAGIVGGANLGMVGGALTCL,1059,87,1527,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P,Listeriainnocua,1565
KNGYGGSGNRWVHCGAGIVGGALIGAIGGPWSAVAGGISGGFASCH,1059,87,1528,Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P,Listeriainnocua,1566
GLLSGILGAGKHIICGLSGLC,1058,2,1542,Anti-infection peptidomics of amphibian skin,Escherichiacoli,264
GLLSGILGAGKQKVCGLSGLC,1058,2,1543,Anti-infection peptidomics of amphibian skin,Escherichiacoli,264
GLLGKILGVEKKVLCGLSGMC,1058,2,1544,Anti-infection peptidomics of amphibian skin,Escherichiacoli,264
CLMARPNYRCKIFKQC,1060,4,1548,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,449
GLHKVMREVLGYERNSYKKFFLR,1061,4,1562,"A novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis",Staphylococcusaureus,450
SNDIYFNFQR,1062,172,1568,An antifungal protein from flageolet beans,Mycosphaerellaarachidicola,451
FLPLAVSLAANFLPKLFCKITKKC,1063,4,1569,"Two families of antimicrobial peptides with multiple functions from skin of rufous-spotted torrent frog, Amolops loloensis",Staphylococcusaureus,1296
FLPIVGKLLSGLSGLL,958,8,1570,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis,452
AMRLTYNKPCLYGT,71,2,1571,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2414
SIITMTKEAKLPQLWKQIACRLYNTC,71,2,1578,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2416
AGETHTVMINHAGRGAPKLVVGGKKLS,1064,65,1586,"Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum",Botrytiscinerea,269
GFSSLFKAGAKYLLKSVGKAGAQQLACKAANNCA,1065,4,1588,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus,453
GVITDALKGAAKTVAAELLRKAHCKLTNSC,1065,4,1589,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus,454
FLGGLLASLLGKI,71,2,1590,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,270
YPELQQDLIARLL,71,2,1591,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,271
FLSGILKLAFKIPSVLCAVLKNC,71,2,1592,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2417
FRSGILKLASKIPSVLCAVLKNC,71,2,1594,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2417
SIWEGIKNAGKGFLVSILDKVRCKVAGGCNP,1065,4,1595,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus,1151
AKAWGIPPHVIPQIVPVRIRPLCGNV,71,2,1596,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,261
GFWDSVKEGLKNAAVTILNKIKCKISECPPA,71,2,1601,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2419
FIPGLRRLFATVVPTVVCAINKLPPG,71,2,1605,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2420
DDPDKGMLKWKNDFFQEF,71,2,1610,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2421
GLLDSVKEGLKKVAGQLLDTLKCKISGCTPA,71,2,1614,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,807
GFFDRIKALTKNVTLELLNTITCKLPVTPP,71,2,1619,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2422
SFGAKNAVKNGLQKLRNQCQANNYQGPFCDIFKKNP,71,2,1620,Antioxidant peptidomics reveals novel skin antioxidant system,Escherichiacoli,2423
VIDDLKKVAKKVRRELLCKKHHKKLN,1065,4,1631,Purification and characterization of novel antimicrobial peptides from the skin secretion of Hylarana guentheri,Staphylococcusaureus,455
EWEPVQNGGSSYYMVPRIWA,1066,173,1637,"Psc-AFP, an antifungal protein with trypsin inhibitor activity from Psoralea corylifolia seeds",Alternariabrassicae,456
SIITMTKEAKLPQSWKQIACRLYNTC,1067,2,1638,A new family of antimicrobial peptides from skin secretions of Rana pleuraden.,Escherichiacoli,2416
GLLRASSVWGRKYYVDLAGCAKA,1068,2,1639,An antimicrobial peptide with antimicrobial activity against Helicobacter pylori.,Escherichiacoli,2149
CIGNGGRCNENVGPPYCCSGFCLRQPNQGYGVCRNR,1069,36,1643,Isolation and characterization of a novel class of plant antimicrobial peptides form Mirabilis jalapa L. seeds,Alternariabrassicicola,1086
FFPIGVFCKIFKTC,1070,2,1644,Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica,Escherichiacoli,272
FGLPMLSILPKALCILLKRKC,1070,2,1645,Antimicrobial peptides with atypical structural features from the skin of the Japanese brown frog Rana japonica,Escherichiacoli,273
NEYHGFVDKANNENKRKKQQGRDDFVVKPNNFANRRRKDDYNENYYDDVDAADVV,1071,65,1647,"Isolation of cicadin, a novel and potent antifungal peptide from dried juvenile cicadas",Botrytiscinerea,274
VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV,1072,2,1648,"Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family.",Escherichiacoli,275
KTCENLADDY,1073,24,1650,"Gymnin, a potent defensin-like antifungal peptide from the Yunnan bean (Gymnocladus chinensis Baill)",Fusariumoxysporum,276
DNGEAGRAAR,1074,24,1655,"A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroom Pleurotus sajor-caju",Fusariumoxysporum,277
KQTENLADTY,1075,172,1665,"Coccinin, an antifungal peptide with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from large scarlet runner beans",Mycosphaerellaarachidicola,457
ANDPQCLYGNVAAKF,1076,172,1666,"Agrocybin, an antifungal peptide from the edible mushroom Agrocybe cylindracea",Mycosphaerellaarachidicola,458
CVISAGWNHKIRCKLTGNC,1077,4,1667,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,215
FKTWKRPPFQTSCWGIIKE,1077,4,1668,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,459
CVHWQTNTARTSCIGP,1077,4,1669,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,460
DCTRWIIGINGRICRD,1077,4,1670,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,461
SLWETIKNAGKGFIQNILDKIR,1077,4,1671,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,1151
SLWETIKNAGKGFILNILDKIRCKVAGGCKT,1077,4,1672,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,1151
FIGPVLKIAAGILPTAICKIFKKC,1077,4,1673,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,462
FVGPVLKIAAGILPTAICKIYKKC,1077,4,1674,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,462
FLGPIIKIATGILPTAICKFLKKC,1077,4,1675,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,462
SIRDKIKTIAIDLAKSAGTGVLKTLICKLDKSC,1077,4,1676,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,820
SIRDKIKTIAIDLAKSAGMGILKTLICKLDKSC,1077,4,1677,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,820
SIRDKIKTIAIDLAKSAGTGVLKTLICKLNKSC,1077,4,1678,"Peptidomics and genomics analysis of novel antimicrobial peptides from the frog, Rana nigrovittata",Staphylococcusaureus,820
DDFLCAGGCL,1078,172,1681,"Isolation of alliumin, a novel protein with antimicrobial and antiproliferative activities from multiple-cloved garlic bulbs",Mycosphaerellaarachidicola,463
DKLIGSCVWGAVNYTSDCNGECKRRGYKGGHCGSFANVNCWCET,1079,2,1686,Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity,Escherichiacoli,115
KGRGKQGGKVRAKAKTRSS,1081,16,1718,Cathepsin D produces antimicrobial peptide parasin I from histone H2A in the skin mucosa of fish.,Aeromonassalmonicida,882
KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF,74,8,1737,Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics.,Bacillussubtilis,1694
GIPCGESCVWIPCISSAIGCSCKSKVCYRN,1083,174,1740,Cyclotides: a novel type of cytotoxic agents,HumanMyeloma,2082
GLPVCGETCVGGTCNTPGCSCSWPVCTRN,1084,174,1770,Cyclotides: a novel type of cytotoxic agents.,HumanMyeloma,2129
GVPICGETCTLGTCYTAGCSCSWPVCTRN,1084,174,1771,Cyclotides: a novel type of cytotoxic agents.,HumanMyeloma,993
AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL,1080,2,1772,"Crystal structures of human alpha-defensins HNP4, HD5, and HD6",Escherichiacoli,278
RLGNFFRKAKKKIGRGLKKIGQKIKDFLGNLVPRTES,1085,2,1775,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli,635
RLGDILQKAREKIEGGLKKLVQKIKDFFGKFAPRTES,1085,2,1776,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli,279
LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES,1085,2,1777,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli,635
RLGNFFRKVKEKIGGGLKKVGQKIKDFLGNLVPRTAS,1085,2,1778,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity,Escherichiacoli,635
GIGKFLHSAGKFGKAFVGEIMKS,1087,2,1781,Synthetic magainin analogues with improved antimicrobial activity,Escherichiacoli,13
ATCDLLSAFGVGHAACAAHCIGHGYRGGYCNSKAVCTCRR,1088,4,1799,Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major,Staphylococcusaureus,1468
HSHACTSYWCGKFCGTASCTHYLCRVLHPGKMCACVHCSR,1089,18,1800,"Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis",Micrococcusluteus,865
HPHVCTSYYCSKFCGTAGCTRYGCRNLHRGKLCFCLHCSR,1089,18,1801,"Myticin, a novel cysteine-rich antimicrobial peptide isolated from haemocytes and plasma of the mussel Mytilus galloprovincialis",Micrococcusluteus,865
FLPMLAGLAASMVPKFVCLITKKC,1090,4,1802,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,866
GILSLFTGGIKALGKTLFKMAGKAGAEHLACKATNQC,1090,4,1803,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,445
GILDSFKGVAKGVAKDLAGKLLDKLKCKITGC,1090,4,1804,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,807
GILSSIKGVAKGVAKNVAAQLLDTLKCKITGC,1090,4,1805,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,807
FLPFIAGMAAKFLPKIFCAISKKC,1090,4,1809,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPAIAGMAAKFLPKIFCAISKKC,1090,4,1810,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPFIAGVAAKFLPKIFCAISKKC,1090,4,1811,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPAIAGVAAKFLPKIFCAISKKC,1090,4,1812,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPAIVGAAAKFLPKIFCVISKKC,1090,4,1813,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPFIAGMAANFLPKIFCAISKKC,1090,4,1814,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
GLFSILRGAAKFASKGLGKDLTKLGVDLVACKISKQC,1090,4,1815,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,110
GLLDTIKGVAKTVAASMLDKLKCKISGC,1090,4,1816,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,807
FLPIIAGVAAKVFPKIFCAISKKC,1090,4,1817,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPIIASVAAKVFSKIFCAISKKC,1090,4,1818,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
FLPIIASVAANVFSKIFCAISKKC,1090,4,1819,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Staphylococcusaureus,1296
GFSSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC,1090,2,1820,"Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens",Escherichiacoli,110
YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRY,1093,2,1849,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins",Escherichiacoli,280
YVSCLFRGARCRVYSGRSCCFGYYCRRDFPGSIFGTCSRRNF,1093,2,1850,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins",Escherichiacoli,281
DYDWSLRGPPKCATYGQKCRTWSPPNCCWNLRCKAFRCRPR,1093,2,1851,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins",Escherichiacoli,282
VFIDILDKVENAIHNAAQVGIGFAKPFEKLINPK,1095,2,1853,"The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster",Escherichiacoli,283
SFGLCRLRRGFCARGRCRFPSIPIGRCSRFVQCCRRVW,1096,18,1854,"Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin, Aptenodytes patagonicus",Micrococcusluteus,867
GIFALIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC,1097,4,1857,"Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis",Staphylococcusaureus,445
GIFSLIKTAAKFVGKNLLKQAGKAGVEHLACKANNQC,1097,4,1858,"Five novel antimicrobial peptides from skin secretions of the frog, Amolops loloensis",Staphylococcusaureus,445
GIFSKFAGKGIKNLLVKGVKNIGKEVGMDVIRTGIDIAGCKIKGEC,1098,2,1872,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,1750
RIFSKIGGKAIKNLILKGIKNIGKEVGMDVIRTGIDVAGCKIKGEC,1098,2,1873,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,1750
GIFSLIKGAAKLITKTVAKEAGKTGLELMACKVTNQC,1098,2,1874,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,445
GFMDTAKNVAKNVAVTLLDKLKCKITGGC,1098,2,1875,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,807
SLLDTFKNLAVNAAKSAGVSVLNALSCKISRTC,1098,2,1876,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,208
SFLTTFKDLAIKAAKSAGQSVLSTLSCKLSNTC,1098,2,1877,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,820
SVLGTVKDLLIGAGKSAAQSVLTTLSCKLSNSC,1098,2,1878,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,820
GIFSTVFKAGKGIVCGLTGLC,1098,2,1879,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,264
GILGTVFKAGKGIVCGLTGLC,1098,2,1880,Identification and characterization of antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae,Escherichiacoli,264
SLFSIFKTAAKFVGKNLLKQAGKAGLETLACKAKNEC,1099,175,1886,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,445
GLWNTIKEAGKKFAINVLDKIRCGIAGGCKT,1099,175,1887,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,1151
FLSTALKVAANVVPTLFCKITKKC,1099,175,1888,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,1296
FLPIVAGLAANFLPKIVCKITKKC,1099,175,1889,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,1296
FLSTLLNVASNVVPTLICKITKKC,1099,175,1890,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,462
FLSTLLNVASKVVPTLFCKITKKC,1099,175,1891,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,1296
FLPMLAGLAANFLPKIVCKITKKC,1099,175,1892,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,1296
GILDKLKEFGISAARGVAQSLLNTASCKLAKTC,1099,175,1893,Characterization of diverse antimicrobial peptides in skin secretions of Chungan torrent frog Amolops chunganensis,Rhodococcusrhodochrous,868
GFMDTAKNVAKNVAATLLDKLKCKITGGC,1101,2,1895,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,807
GFMSTASNVLTNVAGTVMDKLKCKFTGAC,1101,2,1896,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,807
GILSTVFKAGKGIVCGLSGLC,1101,2,1897,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,264
FLPGVLRLVTKVGPAVVCAITRNC,1101,2,1898,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,284
ATAWNLGPHGLRPIRPIRIRPLCGKDKS,1101,2,1899,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,261
AAGYPFGIKV,1101,2,1900,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,285
AAIYPFGIKIRCKAAFC,1101,2,1901,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,286
NFYEIFRNRNRGGLIKDAATPWLPCEILRPC,1101,2,1902,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,287
NIFEIFRNRNRGGLIKDAATPWLPCEILRPC,1101,2,1903,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,287
SPYRCGSPDSRGSENTRCLIKK,1101,2,1904,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,288
RLMKCYKPNSRGFQLCE,1101,2,1905,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,289
CGYRHGRLNCGRG,1101,2,1906,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,290
GIFSVLNEVCKKNDYKPEICAHFSQNKP,1101,2,1907,Characterization of novel antimicrobial peptides from the skin of the endangered frog Odorrana ishikawae by shotgun cDNA cloning,Escherichiacoli,291
GIFSSRKCKTPSKTFKGYCTRDSNCDTSCRYEGYPAGD,1102,12,1908,Novel defensin subfamily from spinach (Spinacia oleracea).,Clavibactermichiganensis,292
GIFSSRKCKTPSKTFKGICTRDSNCDTSCRYEGYPAGDCKGIRRRCMCSKPC,1102,12,1909,Novel defensin subfamily from spinach (Spinacia oleracea).,Clavibactermichiganensis,292
ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKAVCVCRN,1104,4,1911,"Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.",Staphylococcusaureus,1468
LCNERPSQTWSGNCGNTAHCDKQCQDWEKASHGACHKRENHWKCFCYFNC,1105,65,1920,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae.",Botrytiscinerea,293
NLCERASLTWTGNCGNTGHCDTQCRNWESAKHGACHKRGNWKCFCYFNC,1106,65,1921,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea,293
ELCEKASKTWSGNCGNTGHCDNQCKSWEGAAHGACHVRNGKHMCFCYFNC,1106,65,1922,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea,293
DGVKLCDVPSGTWSGHCGSSSKCSQQCKDREHFAYGGACHYQFPSVKCFCKRQC,1106,65,1924,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea,293
RVCMGKSQHHSFPCISDRLCSNECVKEEGGWTAGYCHLRYCRCQKAC,1106,65,1925,"Isolation and characterisation of plant defensins from seeds of Asteraceae, Fabaceae, Hippocastanaceae and Saxifragaceae",Botrytiscinerea,294
ATYNGKCYKKDNICKYKAQSGKTAICKCYVKKCPRDGAKCEFDSYKGKCYC,1107,176,1943,The antifungal protein from Aspergillus giganteus causes membrane permeabilization.,Fusariumsporotrichioides,804
FMPIIGRLMSGSL,1108,2,1947,Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.,Escherichiacoli,295
INMKASAAVAKKLL,1108,2,1948,Antimicrobial peptides from the venoms of Vespa bicolor Fabricius.,Escherichiacoli,296
GTCKAECPTWEGICINKAPCVKCCKAQPEKFTDGHCSKILRRCLCTKPC,1109,24,1953,Isolation and properties of floral defensins from ornamental tobacco and petunia.,Fusariumoxysporum,297
ATCKAECPTWDSVCINKKPCVACCKKAKFSDGHCSKILRRCLCTKEC,1109,24,1954,Isolation and properties of floral defensins from ornamental tobacco and petunia.,Fusariumoxysporum,297
RECKTESNTFPGICITKPPCRKACISEKFTDGHCSKILRRCLCTKPC,1109,24,1955,Isolation and properties of floral defensins from ornamental tobacco and petunia.,Fusariumoxysporum,297
YSRCQLQGFNCVVRSYGLPTIPCCRGLTCRSYFPGSTYGRCQRF,1110,2,1956,"Horseshoe crab hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence similarity to spider neurotoxins.",Escherichiacoli,280
QLINSPVTCMSYGGSCQRSCNGGFRLGGHCGHPKIRCCRRK,1111,2,1957,"A novel mouse beta-defensin, mBD-6, predominantly expressed in skeletal muscle.",Escherichiacoli,298
KTCMTKKEGWGRCLIDTTCAHSCRKYGYMGGKCQGITRRCYCLLNC,1112,4,1964,Identification of a cowpea gamma-thionin with bactericidal activity.,Staphylococcusaureus,869
KLCERSSGTWSGVCGNNNACKNQCIRLEGAQHGSCNYVFPAHKCICYFPC,1113,36,1966,Small cysteine-rich antifungal proteins from radish: their role in host defense.,Alternariabrassicicola,293
KSCCPSTTARNIYNTCRLTGASRSVCASLSGCKIISGSTCDSGWNH,1114,127,1967,"Ligatoxin B, a new cytotoxic protein with a novel helix-turn-helix DNA-binding domain from the mistletoe Phoradendron liga.",Humanhistiocytic,299
GAFGDLLKGVAKEAGMKLLNMAQCKLSGKC,1115,4,1970,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii",Staphylococcusaureus,870
SILDKIKNVALGVARGAGTGILKALLCKLDKSC,1115,4,1971,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii",Staphylococcusaureus,820
GVLDTFKDVAIGVAKGAGTGVLKALLCKLDKSC,1115,4,1974,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii",Staphylococcusaureus,820
RISFKKGKGSWIKNGLIKGIKGLGKEISLDVIRTGIDIAGCKIKGEC,1116,4,1975,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",Staphylococcusaureus,1750
GIFSLFKAGAKFFGKHLLKQAGKAGAEHLACKATNQC,1116,4,1976,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",Staphylococcusaureus,445
SLWENFKNAGKQFILNILDKIRCRVAGGCRT,1116,4,1977,"Molecular cloning and characterization of antimicrobial peptides from skin of the broad-folded frog, Hylarana latouchii.",Staphylococcusaureus,1151
FLPLLAGVVANFLPQIICKIARKC,1117,4,1979,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus,871
FLGSLLGLVGKVVPTLFCKISKKC,1117,4,1980,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus,1296
GLMSTLKDFGKTAAKEIAQSLLSTASCKLAKTC,1117,4,1981,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus,868
GILDTLKEFGKTAAKGIAQSLLSTASCKLAKTC,1117,4,1982,Identification and characterization of antimicrobial peptides from skin of Amolops ricketti (Anura: Ranidae).,Staphylococcusaureus,868
LVQRGRFGRFLRKIRRFRPKVTITIQGSARFG,1118,2,1983,Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity.,Escherichiacoli,1027
GLVSSIGRALGGLLADVVKSKEQPA,1119,25,1992,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea",Bacilluscereus,443
GLVSSIGKVLGGLLADVVKSKGQPA,1119,25,1993,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea",Bacilluscereus,443
AEILFGDVRPPWMPPPIFPEMP,1119,25,1997,"Host-defence peptide profiles of the skin secretions of interspecific hybrid tree frogs and their parents, female Litoria splendida and male Litoria caerulea",Bacilluscereus,872
VFQFLGKIIHHVGNFVHGFSHVF,1120,4,2003,Effects of pH and salinity on the antimicrobial properties of clavanins,Staphylococcusaureus,1570
PIRNWWIRIWEWLNGIRKRLRQRSPFYVRGHLNVTSTPQP,1121,2,2005,"Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway",Escherichiacoli,300
GYGGHGGHGGHGGHGGHGGHGHGGGGHG,1123,26,2009,"Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris",Erwiniaherbicola,873
GYHGGHGGHGGGYNGGGGHGGHGGGYNGGGHHGGGGHG,1123,26,2010,"Characterization and cDNA cloning of two glycine- and histidine-rich antimicrobial peptides from the roots of shepherd's purse, Capsella bursa-pastoris",Erwiniaherbicola,874
GFGCPGNQLKCNNHCKSISCRAGYCDAATLWLRCTCTDCNGKK,1125,34,2017,"Characterization of a defensin from the oyster Crassostrea gigas. Recombinant production, folding, solution structure, antimicrobial activities, and gene expression",Micrococcuslysodeikticus,2323
ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,1126,2,2028,"Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse",Escherichiacoli,1571
ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQ,81,3,2031,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,875
FALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,81,3,2033,Bactericidal activity of mammalian cathelicidin-derived peptides.,Pseudomonasaeruginosa,635
DTHFPICIFCCGCCHRSKCGMCCKT,1127,8,2042,"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.",Bacillussubtilis,876
ICIFCCGCCHRSKCGMCCKT,1128,2,2043,"Hepcidin, a urinary antimicrobial peptide synthesized in the liver.",Escherichiacoli,876
APGNKAECEREKGYCGFLKCSFPFVVSGKCSRFFFCCKNIW,1129,4,2045,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Staphylococcusaureus,877
LFCRKGTCHFGGCPAHLVKVGSCFGFRACCKWPWDV,1129,2,2046,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Escherichiacoli,124
IPRPLDPCIAQNGRCFTGICRYPYFWIGTCRNGKSCCRRR,1129,2,2047,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Escherichiacoli,1464
LPVNEAQCRQVGGYCGLRICNFPSRFLGLCTRNHPCCSRVWV,1129,2,2048,Identification of three novel ostricacins: an update on the phylogenetic perspective of beta-defensins.,Escherichiacoli,301
GNNRPVYIPQPRPPHPRI,86,2,2090,Antibiotic Peptides,Escherichiacoli,2542
GGAGHVPEYFVGIGTPISFYG,1131,2,2121,"Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.",Escherichiacoli,302
INLLKIAKGIIKSL,85,4,2123,Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom.,Staphylococcusaureus,878
LNLKGLIKKVASLLN,1132,4,2126,Chemical and biological characterization of four new linear cationic a-helical peptides from the venoms of two solitary eumenine wasps.,Staphylococcusaureus,879
LNLKGLFKKVASLLT,1132,4,2127,Chemical and biological characterization of four new linear cationic a-helical peptides from the venoms of two solitary eumenine wasps.,Staphylococcusaureus,880
AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH,1133,2,2135,"Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori.",Escherichiacoli,307
WFYQGMNIAIYANIGGVANIIGYTEAAVATLLGAVVAVAPVVP,1134,178,2136,"Molecular and genetic characterization of propionicin F, a bacteriocin from Propionibacterium freudenreichii.",Propionibacteriumacidipropionici,881
VIEPKCYKYEGKKCPPDINPVCGTDKRTYYNECALCVFIRQSTKKADKAIKIKKWGKC,1135,2,2137,A Kazal prolyl endopeptidase inhibitor isolated from the skin of Phyllomedusa sauvagii.,Escherichiacoli,303
GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKAL,1136,2,2138,"Antimicrobial activity spectrum, cDNA cloning, and mRNA expression of a newly isolated member of the cecropin family from the mosquito vector Aedes aegypti.",Escherichiacoli,1209
RPEIKKKNVFSKPGYCPEYRVPCPFVLIPKCRRDKGCKDALKCCFFYCQMRCVDPWESPE,1137,2,2139,Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif.,Escherichiacoli,304
DLHIPPPDNKINWPQLSGGGGGSPKTGYDININAQQK,1138,2,2141,Purification and characterization of a diptericin homologue from Sarcophaga peregrina (flesh fly).,Escherichiacoli,305
FFGHLFKLATKIIPSLFQ,1139,179,2144,Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides.,Bacillussp.,239
KVNVNAIKKGGKAIGKGFKVISAASTAHDVYEHIKNRRH,87,2,2148,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,306
GKIPVKAIKKGGQIIGKALRGINIASTAHDIISQFKPKKKKNH,87,2,2149,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,307
KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRH,87,2,2150,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,356
KVPIGAIKKGGKIIKKGLGVLGAAGTAHEVYNHVRNRQ,87,2,2151,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,356
KVPIGAIKKGGKIIKKGLGVIGAAGTAHEVYSHVKNRQ,87,2,2152,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,356
KVPVGAIKKGGKAIKTGLGVVGAAGTAHEVYSHIRNRH,87,2,2153,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,356
KGIGSALKKGGKIIKGGLGALGAIGTGQQVYEHVQNRQ,87,2,2154,The discovery and analysis of a diverged family of novel antifungal moricin-like peptides in the wax moth Galleria mellonella.,Escherichiacoli,308
AGRGKQGGKVRAKAKTRSSRAGLQFPVGRVHRLLRKGNY,1141,8,2158,A novel antimicrobial peptide from Bufo bufo gargarizans.,Bacillussubtilis,882
FLPLIAGLAANFLPKIFCAITKKC,1142,2,2168,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,1296
FLPVIAGVAAKFLPKIFCAITKKC,1142,2,2169,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,1296
GLFSILKGVGKIALKGLAKNMGKMGLDLVSCKISKEC,1142,2,2170,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,445
GIMDTVKNVAKNLAGQLLDKLKCKITAC,1142,2,2171,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,807
GIMDTVKNAAKDLAGQLLDKLKCRITGC,1142,2,2172,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,807
GLLDTIKNTAKNLAVGLLDKIKCKMTGC,1142,2,2173,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,807
GIMDSVKNVAKNIAGQLLDKLKCKITGC,1142,2,2174,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,807
GIMDSVKNAAKNLAGQLLDTIKCKITAC,1142,2,2175,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,807
GIMDTVKNAAKDLAGQLDKLKCRITGC,1142,2,2176,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,807
GLFPKINKKKAKTGVFNIIKTVGKEAGMDLIRTGIDTIGCKIKGEC,1142,2,2177,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,1750
GIFTKINKKKAKTGVFNIIKTIGKEAGMDVIRAGIDTISCKIKGEC,1142,2,2178,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,1750
ALFSILRGLKKLGNMGQAFVNCKIYKKC,1142,2,2180,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,309
ALSILKGLEKLAKMGIALTNCKATKKC,1142,2,2181,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,310
GFFSTVKNLATNVAGTVIDTLKCKVTGGCRS,1142,2,2182,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,1803
GFLSTVKNLATNVAGTVIDTLKCKVTGGCRS,1142,2,2183,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,1803
GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLNNIGNTGCNEDEC,1142,2,2184,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,311
GIFPKIIGKGIKTGIVNGIKSLVKGVGMKVFKAGLSNIGNTGCNEDEC,1142,2,2185,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,311
ALSILRGLEKLAKMGIALTNCKATKKC,1142,2,2186,"Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.",Escherichiacoli,310
GSNTGFNFKTLDKE,1143,4,2188,"Maximins S, a novel group of antimicrobial peptides from toad Bombina maxima.",Staphylococcusaureus,883
QGYKSGHTGPYPRPLYGSRPIGLRPITRPDPSCAGCRILTLDDAIACCRRLGRCCSALKG,1144,4,2191,Characterization and expression of a new subfamily member of penaeidin antimicrobial peptides (penaeidin 5) from Fenneropenaeus chinensis.,Staphylococcusaureus,884
SRWPSPGRPRPFPGRPKPIFRPRPCNCYAPPCPCDRW,1145,180,2192,"Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus.",Listonellaanguillarum,885
GLFSKFAGKGIKNLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,1146,2,2193,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli,1750
GLLDTFKNLALNAAKSAGVSVLNSLSCKLSKTC,1146,2,2194,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli,208
FLPLLAGLAANFLPKIFCKITKKC,1146,2,2195,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli,1296
GLFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC,1146,4,2196,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Staphylococcusaureus,259
GLLSGILGAGKNIVCGLSGLC,1146,2,2197,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli,264
GLFGKILGVGKKVLCGLSGMC,1146,2,2198,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli,264
GVLGTVKNLLIGAGKSAAQSVLKTLSCKLSNDC,1146,2,2199,"Antimicrobial peptides from diverse families isolated from the skin of the Asian frog, Rana grahami.",Escherichiacoli,820
GILSSFKGVAKGVAKDLAGKLLETLKCKITGC,1147,2,2200,Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,Escherichiacoli,807
FLPILAGLAAKIVPKLFCLATKKC,1147,2,2201,Peptide defenses of the Cascades frog Rana cascadae: implications for the evolutionary history of frogs of the Amerana species group.,Escherichiacoli,1296
GIMSLFKGVLKTAGKHVAGSLVDQLKCKITGGC,1148,2,2210,Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis.,Escherichiacoli,807
GFLDSFKNAMIGVAKSVGKTALSTLACKIDKSC,1149,2,2213,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,312
GLLDSLKNLAINAAKGAGQSVLNTLSCKLSKTC,1149,2,2214,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,820
GIFSKFGGKAIKNLFIKGAKNIGKEVGMDVIRTGIDVAGCKIKGEC,1149,2,2215,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,1750
GIFSLIKGAAQLIGKTVAKEAGKTGLELMACKVTKQC,1149,2,2216,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,445
FLPAVLRVAAKIVPTVFCAISKKC,1149,2,2217,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,1296
FLPAVLRVAAQVVPTVFCAISKKC,1149,2,2218,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,1296
GLLGSLFGAGKKVACALSGLC,1149,2,2219,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,264
GLLGSIFGAGKKIACALSGLC,1149,2,2220,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,264
FMGGLIKAATKIVPAAYCAITKKC,1149,2,2221,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,1296
GAIKDALKGAAKTVAVELLKKAQCKLEKTC,1149,2,2222,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,454
GFKGAFKNVMFGIAKSAGKSALNALACKIDKSC,1149,2,2223,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,312
GLLDSFKNAMIGIAKSAGKTALNKIACKIDKTC,1149,2,2224,"Characterization of antimicrobial peptides from the skin secretions of the Malaysian frogs, Odorrana hosii and Hylarana picturata (Anura:Ranidae).",Escherichiacoli,312
VDKPDYRPRPRPPNM,89,30,2249,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,1787
FLPKMSTKLRVPYRRGTKDYH,1151,2,2251,Two novel antimicrobial peptides from centipede venoms.,Escherichiacoli,313
GILKKFMLHRGTKVYKMRTLSKRSH,1151,2,2252,Two novel antimicrobial peptides from centipede venoms.,Escherichiacoli,314
FRPALIVRTKGTRL,89,30,2254,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,886
KWCFRVCYRGICYRRCR,88,29,2261,Leishmanicidal activity of synthetic antimicrobial peptides in an infection model with human dendritic cells.,Leishmaniapanamensis,1257
GLASFLGKALKAGLKIGSHLLGGAPQQ,1152,2,2270,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli,315
GFGSFLGKALKAALKIGANVLGGAPQQ,1152,2,2271,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli,315
GFGSFLGKALKAALKIGANVLGGAPEQ,1152,2,2272,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli,315
GFGSFLGKALKAALKIGADVLGGAPQQ,1152,2,2273,"Host-defense peptides from skin secretions of the tetraploid frogs Xenopus petersii and Xenopus pygmaeus, and the octoploid frog Xenopus lenduensis (Pipidae).",Escherichiacoli,315
GVIIDTLKGAAKTVAAELLRKAHCKLTNSC,1153,181,2281,Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.,Propionibacteriumacnes,454
GLKEVLHSTKKFAKGFITGLTGQ,1154,2,2284,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,27
GLFLDTLKKFAKAGMEAVTNPK,1154,2,2287,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,2266
GLASTIGSLLGKFAKGGAQAFLQPK,1154,2,2288,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,316
GFWTTAAEGLKKFAKAGLASILNPK,1154,2,2289,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,2266
GVWTTILGGLKKFAKGGLEALTNPK,1154,2,2290,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,2266
GFLGPLLKLGLKGVAKVIPHLIPSRQQ,1154,2,2291,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,2265
GFLGPLLKLGLKGAAKLLPQLLPSRQQ,1154,2,2292,Host-defense peptides in skin secretions of the tetraploid frog Silurana epitropicalis with potent activity against methicillin-resistant Staphylococcus aureus (MRSA).,Escherichiacoli,2265
KIKWFKTMKSIAKFIAKEQMKKHLGGE,1155,2,2297,"Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinensis.",Escherichiacoli,317
GAWKNFWSSLRKGFYDGEAGRAIRR,89,30,2299,Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.,HIV-1IIIB,887
GFKDLLKGAAKALVKTVLF,1156,2,2302,"The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",Escherichiacoli,318
GFRDVLKGAAKAFVKTVAGHIAN,1156,2,2303,"The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",Escherichiacoli,318
GIKDWIKGAAKKLIKTVASHIANQ,1156,2,2305,"The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei.",Escherichiacoli,319
RPKHPIKHQGLPQEVLNENLLRF,1157,2,2307,"Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",Escherichiacoli,2360
YQEPVLGPVRGPFPI,1157,2,2308,"Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",Escherichiacoli,320
YQEPVLGPVRGPFPIIV,1157,2,2309,"Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.",Escherichiacoli,320
GILSTIKDFAIKAGKGAAKGLLEMASCKLSGQC,1158,2,2310,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli,321
GIFLDKLKNFAKGVAQSLLNKASCKLSGQC,1158,2,2311,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli,868
GLGSILGKILNVAGKVGKTIGKVADAVGNKE,1158,2,2313,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli,322
GLGSFLKNAIKIAGKVGSTIGKVADAIGNKE,1158,2,2314,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli,322
GLGSFFKNAIKIAGKVGSTIGKVADAIGNKE,1158,2,2315,Characterization of novel antimicrobial peptides from the skins of frogs of the Rana esculenta complex.,Escherichiacoli,322
GWKDWAKKAGGWLKKKGPGMAKAALKAAMQ,91,32,2316,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Lactococcuslactis,323
FLPLLAGLAANFLPTIICKISYKC,90,31,2318,In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.,Humanlung,1296
WLGSALKIGAKLLPSVVGLFKKKKQ,91,32,2334,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Lactococcuslactis,2490
VFQFLGRIIHHVGNFVHGFSHVF,1159,4,2364,Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.,Staphylococcusaureus,1570
IWLTALKFLGKHAAKHLAKQQLSKL,1159,4,2367,Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.,Staphylococcusaureus,888
INLKAIAALAKKLL,1160,4,2368,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,889
GLNTLKKVFQGLHEAIKLINNHVQ,1159,4,2372,Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.,Staphylococcusaureus,890
KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPNANS,93,4,2374,Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice.,Staphylococcusaureus,891
GIFNVFKGALKTAGKHVAGSLLNQLKCKVSGEC,1162,182,2424,"Activity of antimicrobial skin peptides from ranid frogs against Batrachochytrium dendrobatidis, the chytrid fungus associated with global amphibian declines.",Batrachochytriumdendrobatidis,807
FLPVIAGIAANVLPKLFCKLTKRC,1163,182,2430,"Antimicrobial peptide defenses of the Tarahumara frog, Rana tarahumarae.",Batrachochytriumdendrobatidis,1296
GIMDSIKGAAKEIAGHLLDNLKCKITGC,1163,182,2431,"Antimicrobial peptide defenses of the Tarahumara frog, Rana tarahumarae.",Batrachochytriumdendrobatidis,807
TTLTLHNLCPYPVWWLVTPNNGGFPIIDNTPVVLG,1164,24,2432,"Dendrocin, a distinctive antifungal protein from bamboo shoots.",Fusariumoxysporum,324
QWGRRCCGWGPGRRYCRRWC,1165,54,2434,Bactericidal properties of the antimicrobial peptide Ib-AMP4 from Impatiens balsamina produced as a recombinant fusion-protein in Escherichia coli.,Acinetobactercalcoaceticus,325
SCIPKHEECTNDKHNCCRKGLFKLKCQCSTFDDESGQPTERCACGRPMGHQAIETGLNIF,1166,2,2441,"A venom-derived neurotoxin, CsTx-1, from the spider Cupiennius salei exhibits cytolytic activities.",Escherichiacoli,326
RESPSSRMECYEQAERYGYGGYGGGRYGGGYGSGRGQPVGQGVERSHDDNRNQPR,1167,2,2445,Identification of a novel storage glycine-rich peptide from guava (Psidium guajava) seeds with activity against Gram-negative bacteria.,Escherichiacoli,327
GLPICGETCVGGTCNTPGCSCSWPVCTRN,1168,183,2451,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2129
GIPCGESCVWIPCITSAIGCSCKSKVCYRN,1168,183,2452,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2082
GLPVCGETCFGGTCNTPGCSCETWPVCSRN,1168,183,2453,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2129
GLPICGETCVGGSCNTPGCSCSWPVCTRN,1168,183,2454,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2129
GYPICGESCVGGICNIPGCSCSWPVCTTN,1168,183,2493,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2129
GLPICGETCVGGTCNTPGCFCTWPVCTRN,1168,183,2494,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2129
GLPVCGETCFTGSCYTPGCSCNWPVCNRN,1168,183,2495,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,993
GLPVCGETCVGGTCNTPGCSCSWPVCFRN,1168,183,2496,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2129
GTLPCGESCVWIPCISSVVGCACKSKVCYKD,1168,183,2497,Isolation and characterization of cytotoxic cyclotides from Viola tricolor.,Humanglioblastoma,2082
GFMKYIGPLIPHAVKAISDLI,98,2,2511,"Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.",Escherichiacoli,2533
GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD,1169,61,2536,"Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif.",HIV-1,993
SISCGESCAMISFCFTEVIGCSCKNKVCYLN,1170,5,2537,"Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide.",HIV,2082
GFGCPNNYQCHRHCKSIPGRCGGYCGGWHRLRCTCYRC,1171,18,2538,A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis),Micrococcusluteus,2323
KTCENLADTFRGPCFATSNCDDHCKNKEHLLSGRCRDDFRCWCTRNC,1172,65,2570,A mitogenic defensin from white cloud beans (Phaseolus vulgaris).,Botrytiscinerea,423
ATCENLANTYRGPCFGGCDFHCKTKEHLLSGRCRDDFRCWCTRNC,1173,65,2571,"Peptides from pinto bean and red bean with sequence homology to cowpea 10-kDa protein precursor exhibit antifungal, mitogenic, and HIV-1 reverse transcriptase-inhibitory activities.",Botrytiscinerea,423
GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC,1174,18,2594,"Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis.",Micrococcusluteus,892
QDDESDVPHVRVRRGFGCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK,102,2,2595,Babesial vector tick defensin against Babesia sp. parasites.,Escherichiacoli,2331
ATCDILSFQSQWVTPNHAGCALHCVIKGYKGGQCKITVCHCRR,1175,18,2609,"Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus.",Micrococcusluteus,1468
VTCDLLSFEAKGFAANHSLCAAHCLAIGRRGGSCERGVCICRR,1176,4,2628,Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide.,Staphylococcusaureus,1468
ATCDLLSGTGINHSACAAHCLLRGNRGGYCNGKGVCVCRN,1177,2,2629,Insect immunity. Isolation from the lepidopteran Heliothis virescens of a novel insect defensin with potent antifungal activity.,Escherichiacoli,1468
ATCDLASGFGVGSSLCAAHCIARRYRGGYCNSKAVCVCRN,1178,4,2630,Characterization of a defensin from the sand fly Phlebotomus duboscqi induced by challenge with bacteria or the protozoan parasite Leishmania major.,Staphylococcusaureus,1468
FTCDVLSVEAKGVKLNHAACGIHCLFRRRTGGYCNKKRVCICR,1180,25,2632,"Purification and cDNA cloning of an insect defensin from larvae of the longicorn beetle, Acalolepta luxuriosa.",Bacilluscereus,1468
DFGCGQGMIFMCQRRCMRLYPGSTGFCRGFRCMCDTHIPLRPPFMVG,1181,2,2646,"A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis. ",Escherichiacoli,793
FFGTALKIAANVLPTAICKILKKC,1182,4,2732,"The novel antimicrobial peptides from skin of Chinese broad-folded frog, Hylarana latouchii (Anura:Ranidae).",Staphylococcusaureus,462
KSCCRSTQARNIYNAPRFAGGSRPLCALGSGCKIVDDKKTPPND,1183,184,2733,"Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens). ",Erwiniacarotovora,299
KSCCRSTTARTARVPCAKKSNIYNGCRVPGGCKIQEAKKCEPPYD,1184,184,2734,"Amino acid sequence and antimicrobial activity of chitin-binding peptides, Pp-AMP 1 and Pp-AMP 2, from Japanese bamboo shoots (Phyllostachys pubescens).",Erwiniacarotovora,328
KSCCRNTVARNCYNVCRIPGTPRPVCAATCDCKLITGTKCPPGYEK,1185,184,2736,"Purification, characterization, and sequencing of novel antimicrobial peptides,Tu-AMP 1 and Tu-AMP 2, from bulbs of ulip (Tulipa gesneriana L.).",Erwiniacarotovora,2517
AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCK,1186,184,2737,"Purification, characterization, and sequencing of a novel type of antimicrobial peptides,Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).",Erwiniacarotovora,2230
AQCGAQGGGATCPGGLCCSQWGWCGSTPKYCGAGCQSNCR,1186,184,2738,"Purification, characterization, and sequencing of a novel type of antimicrobial peptides,Fa-AMP1 and Fa-AMP2, from seeds of buckwheat (Fagopyrum esculentum Moench.).",Erwiniacarotovora,2230
DPQTDCQQCQRRCRQQESGPRQQQYCQRRCKEICEEEEEYN,1187,185,2740, A family of antimicrobial peptides is produced by processing of a 7Sglobulin protein in Macadamia integrifolia kernels. ,Leptosphaeriamaculans,893
KRDPQQREYEDCRRRCEQQEPRQQYQCQRRCREQQ,1188,185,2741,A family of antimicrobial peptides is produced by processing of a 7Sglobulin protein in Macadamia integrifolia kernels.,Leptosphaeriamaculans,894
RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQ,1188,177,2742,A family of antimicrobial peptides is produced by processing of a 7Sglobulin protein in Macadamia integrifolia kernels.,Alternariahelianthi,895
RQRDPQQQYEQCQERCQRHETEPRHMQTCQQRCERRYEKEKRKQQKR,1189,177,2743,A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels.,Alternariahelianthi,895
INWLKLGKKMMSAL,1190,2,2796,New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs,Escherichiacoli,329
AANIPFKVHFRCKAAFC,107,2,2824,"Inhibitory and antimicrobial activities of OGTI and HV-BBI peptides, fragments and analogs derived from amphibian skin",Escherichiacoli,2539
GFGCPLDQMQCHRHCQTITGRSGGYCSGPLKLTCTCYR,1192,18,2852,"A novel insect defensin mediates the inducible antibacterial activity in larvae of the dragonfly Aeschna cyanea (Paleoptera, Odonata)",Micrococcusluteus,1467
FTCDVLGFEIAGTKLNSAACGAHCLALGRTGGYCNSKSVCVCR,1193,18,2868,Insect immunity. Isolation from a coleopteran insect of a novel inducible antibacterial peptide and of new members of the insect defensin family,Micrococcusluteus,1468
GLLNGLALRLGKRALKKIIKRLCR,1194,8,2967,"Isolation and functional analysis of a 24-residue linear alpha-helical antimicrobial peptide from Korean blackish cicada, Cryptotympana dubia (Homoptera)",Bacillussubtilis,896
GLPVCGETCFGGRCNTPGCTCSYPICTRN,1195,127,2970,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic,2129
GIPCAESCVWIPCTVTALIGCGCSNKVCYN,1195,127,2971,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic,2082
GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN,1195,127,2972,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic,2082
GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN,1195,127,2973,"The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity",Humanhistiocytic,2082
FLPAIVGAAGQFLPKIFCAISKKC,1196,2,2974,"Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala",Escherichiacoli,1296
PGMGIYLPM,1197,186,2980,Two cyclopeptides from the seeds of Annona cherimola,Humannasopharyngeal,330
GDPTFCGETCRVIPVCTYSAALGCTCDDRSDGLCKRN,1198,187,2981,A novel anti-HIV macrocyclic peptide from Palicourea condensata,HIV-1RF,897
GIPCGESCVFIPCITSVAGCSCKSKVCYRN,1199,30,2982,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1IIIB,2082
KIPCGESCVWIPCVTSIFNCKCENKVCYHD,1199,61,2983,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1,2082
KIPCGESCVWIPCLTSVFNCKCENKVCYHD,1199,61,2984,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1,2082
AIPCGESCVWIPCISAAIGCSCKNKVCYR,1199,61,2985,New circulin macrocyclic polypeptides from Chassalia parvifolia,HIV-1,2082
GLLSFLPKVIGVIGHLIHPPS,1200,25,2990,The fallaxidin peptides from the skin secretion of the Eastern Dwarf Tree Frog Litoria fallax. Sequence determination by positive and negative ion electrospray mass spectrometry: antimicrobial activity and cDNA cloning of the fallaxidins,Bacilluscereus,2264
KRFKKFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,1201,2,3001,Identification and characterization of novel reptile cathelicidins from elapid snakes,Escherichiacoli,1694
FHPSLWVLIPQYIQLIRKILKSG,1202,2,3006,Conolysin-Mt: a conus peptide that disrupts cellular membranes,Escherichiacoli,331
ALWKTIIKGAGKMIGSLAKNLLGSQAQPES,1203,27,3007,"Synthesis, antimicrobial activity and gene structure of a novel member of the dermaseptin B family",Acholeplasmalaidlawii,332
FLPVLAGIAAKVVPALFCKITKKC,1204,8,3008,"Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa",Bacillussubtilis,2236
GLLDSLKGFAATAGKGVLQSLLSTASCKLAKTC,1204,8,3009,"Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa",Bacillussubtilis,868
FFGLHNLVPSMLCVVRKKC,1205,2,3106,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana).",Escherichiacoli,526
FLGGLFKLVPSVICAVTKKC,1205,2,3107,"Purification and characterization of antimicrobial peptides from the skin secretions of the carpenter frog Rana virgatipes (Ranidae, Aquarana).",Escherichiacoli,526
GFGCNGPWDEDDMQCHNHCKSIKGYKGGYCAKGGFVCKCY,1206,100,3114,Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.,Streptococcuspneumoniae,1467
GFLGPLLKLAAKGVAKVIPHLIPSRQQ,1207,4,3154,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Staphylococcusaureus,2265
GVWSTVLGGLKKFAKGGLEAIVNPK,1207,4,3155,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Staphylococcusaureus,2266
GVFLDALKKFAKGGMNAVLNPK,1207,4,3156,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Staphylococcusaureus,2266
GLLGPLLKIAAKVGSNLL,1207,2,3159,"Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae).",Escherichiacoli,333
CIKNGNGCQPDGSQGNCCSRYCHKEPGWVAGYCR,1208,114,3160,Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.,Candidaglabrata,334
CIANRNGCQPDGSQGNCCSGYCHKEPGWVAGYCR,1208,114,3161,Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.,Candidaglabrata,334
CIKNGNGCQPNGSQGNCCSGYCHKQPGWVAGYCRRK,1208,114,3162,Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus.,Candidaglabrata,334
AGECVQGRCPSGMCCSQFGYCGRGPKYCGR,1209,188,3163,An antimicrobial peptide Ar-AMP from amaranth (Amaranthus retroflexus L.) seeds.,Helminthosporiumsativum,2326
KKINNPVSCLRKGGRCWNRCIGNTRQIGSCGVPFLKCCKRK,1210,3,3166,Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs.,Pseudomonasaeruginosa,2088
NNEAQCEQAGGICSKDHCFHLHTRAFGHCQRGVPCCRTVYD,117,2,3167,Modification of chicken avian beta-defensin-8 at positively selected amino acid sites enhances specific antimicrobial activity.,Escherichiacoli,2546
LVAYGIAQGTAEKVVSLINAGLTVGSIISILGGVTVGLSGVFTAVKAAIAKQGIKKAIQL,1211,2,3172,"Isolation and characterization of carnocyclin a, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307.",Escherichiacoli,335
SLLSLIRKLIT,1212,4,3176,"Decoralin, a novel linear cationic alpha-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus.",Staphylococcusaureus,2267
RRICRCRIGRCLGLEVYFGVCFLHGRLARRCCR,1213,2,3186,alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,Escherichiacoli,336
RICRCRIGRCLGLEVYFGVCFLHGRLARRCCR,1213,2,3187,alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,Escherichiacoli,336
RTCRCRLGRCSRRESYSGSCNINGRIYSLCCR,1213,2,3188,alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.,Escherichiacoli,2487
RTCQSQSHKFKGACFSDTNCDSVCRTENFPRGQCNQHHVERKCYCERDC,1214,189,3189,Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.,Alternariaconsortiale,805
RECQSQSHRYKGACVHDTNCASVCQTEGFSGGKCVGFRGRCFCTKHC,1214,24,3190,Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.,Fusariumoxysporum,805
RECQSQSHRYKGACVHDTNCASVCQTEGFSGGKCVGFRGRCFCTKAC,1214,89,3191,Seed defensins of barnyard grass Echinochloa crusgalli (L.) Beauv.,Fusariumgraminearum,805
ALWKTLLKNVGKAAGKAALNAVTDMVNQ,1215,52,3193,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis,770
ALWKTMLKKLGTMALHAGKAAFGAAADTISQ,1215,52,3194,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis,200
ALWKNMLKGIGKLAGQAALGAVKTLVGAES,1215,52,3195,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis,435
GLWSKIKEAAKTAGLMAMGFVNDMV,1215,52,3196,Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta.,Enterococcusfaecalis,770
SLGSFLKGVGTTLASVGKVVSDQFGKLLQAGQ,1216,27,3197,"Isolation of dermatoxin from frog skin, an antibacterial peptide encoded by a novel member of the dermaseptin genes family.",Acholeplasmalaidlawii,337
SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSVL,1217,2,3198,Dermcidin: a novel human antibiotic peptide secreted by sweat glands.,Escherichiacoli,338
YDPEAASAPGSGNPCHEASAAQKENAGEDP,1217,2,3199,Dermcidin: a novel human antibiotic peptide secreted by sweat glands.,Escherichiacoli,339
SHQDCYEALHKCMASHSKPFSCSMKFHMCLQQQ,1218,2,3222,A novel antimicrobial peptide from the sea hare Dolabella auricularia.,Escherichiacoli,340
YCSYTMEA,1219,2,3224,Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,Escherichiacoli,341
SVAGRAQGM,1219,2,3225,Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,Escherichiacoli,342
TESYFVFSVGM,1219,2,3226,Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.,Escherichiacoli,343
RCVCTRGFCRCVCRRGVC,1220,4,3233,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus,1645
RCVCRRGVCRCVCRRGVC,1220,4,3234,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus,1645
RCVCTRGFCRCVCTRGFC,1220,4,3235,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus,97
RCVCTRGFCRCICLLGIC,1220,4,3236,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus,2268
RCVCTRGFCRCFCRRGVC,1220,4,3237,"Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes.",Staphylococcusaureus,1645
AWKLFDDGV,1221,56,3238,Identification and characterization of a bactericidal and proapoptotic peptide from Cycas revoluta seeds with DNA binding properties.,Staphylococcusepidermidis,2269
IIIQYEGHKH,1222,18,3240,Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph.,Micrococcusluteus,2270
FLPGLLAGLL,1223,2,3241,Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli,344
RAGLKFPVGRVHRLLR,1223,2,3242,Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli,882
FLNALKNFAKTAGKRLKSLLN,1223,2,3243,Identification and characterization of novel antibacterial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli,233
IFGAIWNGIKS,1224,8,3246,"Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis.",Bacillussubtilis,2271
ILGKIWEGIKS,1224,8,3248,"Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis.",Bacillussubtilis,2492
IGGIISFFKRLF,1225,8,3330,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2272
FIGGIISFFKRLF,1225,8,3331,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2272
FIGGIISFIKKLF,1225,8,3332,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2273
LFGFLIKLIPSLFGALSNIGRNRNQ,1225,8,3333,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2274
LFGFLIPLLPHIIGAIPQVIGAIR,1225,8,3334,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2275
WWRELLKKLAFTAAGHLGSVLAAKQSGW,1225,8,3335,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2276
NWRKILGKIAKVAAGLLGSMLAGYQV,1225,8,3336,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2277
NWRKILGQIASVGAGLLGSLLAGYE,1225,8,3337,Further isolation and characterization of grammistins from the skin secretion of the soapfish Grammistes sexlineatus.,Bacillussubtilis,2277
FFPLALLCKVFKKC,1226,2,3345,"Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",Escherichiacoli,345
IIPLPLGYFAKKT,1226,2,3347,"Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",Escherichiacoli,2607
SAVGRHGRRFGLRKHRKH,1226,2,3348,"Characterization of antimicrobial peptides isolated from the skin of the Chinese frog, Rana dybowskii.",Escherichiacoli,711
GLMSVLGHAVGNVLGGLFKPKS,1227,25,3351,The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,Bacilluscereus,2278
GFLDKLKKGASDFANALVNSIKGT,1227,25,3352,The structures of the frenatin peptides from the skin secretion of the giant tree frog Litoria infrafrenata.,Bacilluscereus,1695
GLNALKKVFQGIHEAIKLINNHVQ,1228,2,3357,Pseudin-2: an antimicrobial peptide with low hemolytic activity from the skin of the paradoxical frog.,Escherichiacoli,890
LDVKKIICVACKIKPNPACKKICPK,1229,18,3383,"Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).",Micrococcusluteus,2279
LDVKKIICVACKIRPNPACKKICPK,1229,18,3385,"Panurgines, novel antimicrobial peptides from the venom of communal bee Panurgus calcaratus (Hymenoptera: Andrenidae).",Micrococcusluteus,2279
GIHDILKYGKPS,1230,2,3389,"Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L.",Escherichiacoli,1240
GLMSLFKGVLKTAGKHIFKNVGGSLLDQAKCKITGEC,1231,2,3396,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli,807
GLMSLFRGVLKTAGKHIFKNVGGSLLDQAKCKITGEC,1231,2,3397,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli,807
GLMSVTKGVLKTAGKHIFKNVGGSLLDQAKCKISGQC,1231,2,3398,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli,807
GLMSVLKGVLKTAGKHIFKNVGGSLLDQAKCKITGQC,1231,2,3399,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli,807
GLLSVLKGVLKTTGKHIFKNVGGSLLDQAKCKISGQC,1231,2,3400,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli,807
GLMDVFKGAAKNLLASALDKIRCKVTKC,1231,2,3401,"A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.",Escherichiacoli,1004
VNWKKILGKIIKVVK,1232,8,3420,Lasioglossins: three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).,Bacillussubtilis,2280
FLPLFLPKIICVITKKC,1234,2,3486,"Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.",Escherichiacoli,824
FLPIVENCSLVCWENNQKC,1234,2,3487,"Antimicrobial peptide diversity in the skin of the torrent frog, Amolops jingdongensis.",Escherichiacoli,2608
KSSAYSLQMGATAIKQVKKLFKKWGW,1011,167,3488,"Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A.",Pediococcuspentosaceus,2281
RRSRKNGIGYAIGYAFGAVERAVLGGSRDYNK,1235,1,3492,None_article5,None_target,2282
FNRGGYNFGKSVRHVVDAIGSVAGIRGILKSIR,1236,1,3494,None_article6,None_target,2283
VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG,1237,1,3495,None_article7,None_target,2284
ESVFSKIGNAVGPAAYWILKGLGNMSDVNQADRINRKKH,1238,1,3497,None_article8,None_target,989
GPGKWLPWLQPAYDFVTGLAKGIGKEGNKNKWKNV,1239,1,3498,None_article9,None_target,988
SMISVLKNLGKVGLGFVACKVNKQC,1241,4,3558,Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,Staphylococcusaureus,427
FLGGLMKIIPAAFCAVTKKC,1241,4,3559,Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,Staphylococcusaureus,526
GLLLDTLKGAAKDIAGIALEKLKCKITGCKP,1241,4,3560,Purification and characterization of antimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio.,Staphylococcusaureus,428
FLPLIASLAANFVPKIFCKITKKC,1242,50,3563,"Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",Enterococcusfaecium,1296
FLPLIASVAANLVPKIFCKITKKC,1242,50,3564,"Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",Enterococcusfaecium,1296
SLLGTVKDLLIGAGKSAAQSVLKGLSCKLSKDC,1242,50,3565,"Novel antimicrobial peptides isolated from the skin secretions of Hainan odorous frog, Odorrana hainanensis.",Enterococcusfaecium,820
GVFSFLKTGAKLLGSTLLKMAGKAGAEHLACKATNQC,1243,2,3566,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,445
GIFSALAAGVKLLGNTLFKMAGKAGAEHLACKATNQC,1243,2,3567,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,445
GILDTFKGVAKGVAKDLAVHMLENLKCKMTGC,1243,2,3568,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,807
GIMNTVKDVATGVATHLLNMVKCKITGC,1243,2,3581,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,807
FLPVLTGLTPSIVPKLVCLLTKKC,1243,2,3582,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,866
FLPVLAGLTPSIVPKLVCLLTKKC,1243,2,3583,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,866
FFPMLAGVAARVVPKVICLITKKC,1243,2,3584,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,1296
FLPMLAGLAASMVPKLVCLITKKC,1243,2,3585,Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.,Escherichiacoli,866
LNLKGIFKKVASLLT,1244,4,3644,"Eumenitin, a novel antimicrobial peptide from the venom of the solitary eumenine wasp Eumenes rubronotatus.",Staphylococcusaureus,880
VIVFVASVAAEMMQHVYCAASKKC,128,2,3645,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
FIFPKKNIINSLFGR,128,2,3646,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,346
TSRCIFYRRKKCS,128,2,3647,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,347
KEKLKLKCKAPKCYNDKLACT,128,2,3648,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,348
VAIYGRDDRSDVCRQVQHNWLVCDTY,128,2,3649,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,349
ENMFNIKSSVESDSFWG,128,2,3650,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,350
EMLKKKKEVKMERKT,128,2,3651,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,351
FLPAVIRVAANVLPTAFCAISKKC,128,2,3652,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1296
LPFVAGVAAEMMQHVYCAASKKC,128,2,3653,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
ILPFVAGVAAEMMQHVYCAASKKC,128,2,3654,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
IDPFVAGVAAEMMQHVYCAASKKC,128,2,3655,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
INPFVAGVAAEMMQHVYCAASKKC,128,2,3656,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
ILPFVAGVAAEMMKHVYCAASKKC,128,2,3657,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
IIPFVAGVAAEMMEHVYCAASKKC,128,2,3658,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
QLPFVAGVACEMCQCVYCAASKKC,128,2,3659,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
ILPFVAGVAAEMMEHVYCAASKKC,128,2,3660,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
ILPFVAGVAAMEMEHVYCAASKKC,128,2,3668,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,352
FLPAVLLVATHVLPTVFCAITRKC,128,2,3669,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1296
LAFVAGVAAEMMQHVYCAASKKC,128,2,3670,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1061
GILDTFKNMALNAAKSAGVSVLNALSCKLSKTC,128,2,3671,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GLLDTFKNMALNAAKSAGVSVLNALSCKLSKTC,128,2,3672,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GLLDTFKNMAINAAHGAGVSVLNALSCKLKKTC,128,2,3673,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GLLDTFKNLALNAAESAGVSVLNSLSCKLSKTC,128,2,3674,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GLLDGILNANFNAAKSAGTSVLNALSCKLSKTC,128,2,3675,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GVLATVKNLLIGTGDGAAQSVLKTLSCKLSNDC,128,2,3676,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
GVLGTVKDLLIGAGKSAAQSTLKTLSCKISNDC,128,2,3677,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
GVLATVKNLLNGTGDGAAQSVLKTLSCKLSNDC,128,2,3678,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SVLGTVKDLLIGAGKSAAQSVLTALSCKLSNSC,128,2,3679,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
GLLDTIKNMALNAAKSAGVSVLNSLSCKLSKTC,128,2,3680,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GLIDTIKNMALNAAKSAGVSVLNTLSCKLSKTC,128,2,3681,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
SVLGTVKDLLIGAGKSAAQSVLTANSCKLSNSC,128,2,3682,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SFLDTLKNLAISAAKGAGQSVLSTLSCKLSETC,128,2,3683,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
GLLDTIKNMALNAAKSAGVSVLNSLSCKDSKTC,128,2,3684,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
GLLDTIKNMALNAAKSAGVSVLNTLSCKLSKTC,128,2,3685,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,208
SFLDTLKNLAISAAKGAGQSVLSTLSCKLSKTC,128,2,3686,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SFLSTFKELAINAAKNAGQSILHTLSCKLDKTC,128,2,3687,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SFLSTFKELAINAAKNAGQSLLHTLSCKLDKTC,128,2,3688,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SVMGTVKDLLIGAGKSAAQSVLKSLSCKISNDC,128,2,3689,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SVMGTVKDLLIGAGKSAAQSVLKSLSCKLSNDC,128,2,3690,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
SVMGTVKDLLIGAGKSAAQSVLKALSCKLSKDC,128,2,3691,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,820
GLFSKFVGKGIKNFLIKGVKHIGKEVGMDVIRVGIDVAGCKIKGVC,128,2,3692,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GLFSKFSGKGIKNFLIKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3693,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GLFSKFAGKGIKDLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3694,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GLFTKFAGKGIKDLIFKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3695,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GLFSKFAGKGIKNFLIKGVKHIGKEVGMDVIRTGIDVAGCKIKGEC,128,2,3696,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GIFSKISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC,128,2,3698,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
KISGKAIKNLFIKGAKNVGKEVGMDVVRTGIDVVGCKIKGEC,128,2,3699,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GIFSKISGKAIKNLFIKGAKNVGKRVGMDVVRTGMDVVGCKIKGEC,128,2,3700,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GIFSKISGKAIKNLFIKGAENVGKHVGMDVVRTGIDVVGCKIKGEC,128,2,3701,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GIFSKISGKAIKNLFIKGAKNVGKEVGMDVVRTGMDVVGCKIKGEC,128,2,3702,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
GIFTLIKGAAKLIGKTVAKEAGKTGLELMACKITNQC,128,2,3703,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
GLFTLIKGAAKLIGKTTAKEAGKTGKLEMACKITNQC,128,2,3704,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,259
GVFTLIKGATQLIGKTLGKELGKTGLELMACKITNQC,128,2,3705,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
GVFTLIKGATQLIGKTLGKEVGKTGLELMACKITKQC,128,2,3706,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
GVFTLLKGATQLIGKTLGKELGKTGLELMACKITNQC,128,2,3707,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
GVFTLIKGATQLIGKTLGKELGKTGLELMACKITEQC,128,2,3708,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
GVFTLIKGATQLIGKTLGKELGKTGLEIMACKITKQC,128,2,3709,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,445
GLLSGVLGVGKKIVCGLSGLC,128,2,3711,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GIFGKILGVGKKTLCELSGMC,128,2,3712,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GIFLKVLGVGKKVLCGVSGLC,128,2,3713,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILSGILGVGKKLVCGLSGLC,128,2,3714,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILSGILGVGKMLVCGLSGLC,128,2,3715,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILSGLLGVGKMLVCGLSGLC,128,2,3716,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILSGVLGMGKKIVCGLSGLC,128,2,3717,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILGNIVGMGKKIVCGLSGLC,128,2,3718,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILGNIVGMGKKVVCGLSGLC,128,2,3719,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILSGVLGMGKKIVCGLRGLC,128,2,3720,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
GILGNIVGMGKQVVCGLSGLC,128,2,3721,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,264
VVKCSYRLGSPDSQCN,128,2,3722,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,207
GFMDTAKNVAKNMAGNLLDNLKCKITKAC,128,2,3723,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,746
GFMDTAKNVAKNMAVTLLDNLKCKITKAC,128,2,3724,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,807
GFMDTAKNVAKNEAGNLLDNLKCKITKAC,128,2,3725,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,746
GFMATAKNVAKNMDVTLLDNLKCKITKAC,128,2,3726,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,807
GFMNTAKNVAKNVAVTLLDNLKCKITGGC,128,2,3727,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,807
GLFTLIKGAYKLDAPTVACN,128,2,3728,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,258
GLFTLIKGAYKNDAPTVACN,128,2,3729,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,258
ATNIPFKVHFRCKAAFC,128,2,3730,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,2539
AVNIPFKVHFRCKAAFC,128,2,3731,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,2539
GLFSKFAGKGIVNFLIEGVE,128,2,3732,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,1750
FLPKLFAKITKKNMAHIR,128,2,3733,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,176
FLPKLFAGIISKNF,128,2,3734,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,747
VVKCSYRQGSPDSR,128,2,3735,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,207
VVKFSYRKGSPAPQKN,128,2,3736,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,748
ENAEEDIVLMENLFCSYIVGSADSFWT,128,2,3737,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,749
DANVENGEDAEDLTDKFIGLMG,128,2,3738,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,750
RFIYMKGFGKPRFGKR,128,2,3739,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,751
SADQTGMNKAALSPIRFISKSV,128,2,3740,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,752
IPWKLPATFRPVERPFSKPFCRKD,128,2,3741,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,753
KNNFCQVLYVWLLRLGKQCFVKFSKDVET,128,2,3742,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,754
FLPGLECVW,128,2,3743,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,755
VTPPWARIYYGCAKA,128,2,3744,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,756
FFSTSCRSGC,128,2,3745,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,757
AAPRGGKGFFCKLFKDC,128,2,3746,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,758
LLPPWLRPRNG,128,2,3747,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,759
APDRPRKFCGILG,128,2,3748,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,760
VFLGNIVSMGKKI,128,2,3749,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,761
DAAVEPELYHWGKVWLPN,128,2,3750,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,762
CVDIGFSPTGKRPPFCPYPG,128,2,3751,Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs.,Escherichiacoli,763
FKVQNQHGQVVKIFHH,129,39,3755,Processing of an antibacterial peptide from hemocyanin of the freshwater crayfish Pacifastacus leniusculus.,Shigellaflexneri,764
SFPFFPPGICKRLKRC,1245,2,3760,Limnonectins: a new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,Escherichiacoli,765
SFHVFPPWMCKSLKKC,1245,2,3761,Limnonectins: a new class of antimicrobial peptides from the skin secretion of the Fujian large-headed frog (Limnonectes fujianensis).,Escherichiacoli,765
PSCVCSGFETSGIHFC,1246,56,3762,Purification and structural characterization of a novel antibacterial peptide from Bellamya bengalensis: activity against ampicillin and chloramphenicol resistant Staphylococcus epidermidis.,Staphylococcusepidermidis,2285
YVPPVQKPHPNGPKFPTFP,1247,2,3763,Characterization of an abaecin-like antimicrobial peptide identified from a Pteromalus puparum cDNA clone.,Escherichiacoli,415
GKFLHSAGKFGKAFLGEVMIG,1248,2,3764,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli,13
GIGKFLHSAGKFGKAFLGEVMKS,1248,2,3765,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli,13
GLGSLLGKAFKIGLKTVGKMMGGAPREQ,1248,2,3767,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli,766
GWASKIGTQLGKMAKVGLKEFVQS,1248,2,3768,Antimicrobial peptides with therapeutic potential from skin secretions of the Marsabit clawed frog Xenopus borealis (Pipidae).,Escherichiacoli,767
GVGKFLHSAKKFGQALASEIMKS,1249,2,3769,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli,13
GVGKFLHSAKKFGQALVSEIMKS,1249,2,3770,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli,13
GWASKIGQALGKVAKVGLQQFIQPK,1249,2,3771,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli,767
GLGSLLGKALKFGLKAAGKFMGGEPQQ,1249,2,3773,Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae),Escherichiacoli,766
GFLGPLLKLGLKGVAKVLPHLIPSRQQ,1250,2,3774,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli,2265
GFWSSALEGLKKFAKGGLEALTNPK,1250,2,3775,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli,2266
GVSKILHSAGKFGKAFLGEIMKS,1250,2,3776,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli,13
GWASKIGQTLGKMAKVGLQELIQPK,1250,2,3777,Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.,Escherichiacoli,767
GIGKFLHSAGKFGKAFIGEIMKS,1251,2,3779,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli,13
GLGSLLGKAFKFGLKTVGKMMAGAPREQ,1251,2,3780,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli,766
GLGSLLGKAFKFGLKTVGKMMGGAPREQ,1251,2,3783,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli,766
GLGSLLGKAFKFGLKTVGKMMGGAPREE,1251,2,3784,Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific.,Escherichiacoli,766
LKIPGFVKDTLKKVAKGIFSAVAGAMTPS,1252,2,3786,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
IKIPAVVKDTLKKVAKGVLSAVAGALTQ,1252,2,3787,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
IKIPAFVKDTLKKVAKGVISAVAGALTQ,1252,2,3788,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
IKIPPIVKDTLKKVAKGVLSTIAGALST,1252,2,3789,The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
GFGSFLGSLFKTGLKIIPKLLPSIQQ,1253,2,3791,Hybridization between the African clawed frogs Xenopus laevis and Xenopus muelleri (Pipidae) increases the multiplicity of antimicrobial peptides in skin secretions of female offspring.,Escherichiacoli,769
RWCVYAYVRIRGVLVRYRRCW,1254,2,3792,"Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina.",Escherichiacoli,1976
SALVGCWTKSYPPKPCFGR,1255,4,3802,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus,2286
SALVGCGTKSYPPKPCFGR,1255,4,3803,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus,2286
SALVGCWTKSWPPKPCFGRG,1255,4,3805,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus,2286
SALVGCWTKSWPPKPCFGR,1255,4,3806,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Staphylococcusaureus,2286
GIKEFAHSLGKFGKAFVGGILNQ,1256,2,3817,"Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae).",Escherichiacoli,13
GWASKIGQTLGKMAKVGLQEIIQPK,1257,2,3818,Host-defense peptides from skin secretions of Fraser's clawed frog Xenopus fraseri (Pipidae): Further insight into the evolutionary history of the Xenopodinae.,Escherichiacoli,767
FMGSALRIAAKVLPAALCQIFKKC,1258,4,3835,"Isolation, characterization and molecular cloning of new antimicrobial peptides belonging to the brevinin-1 and temporin families from the skin of Hylarana latouchii (Anura: Ranidae).",Staphylococcusaureus,462
GFLSALKKYLPIVLKHV,1259,18,3837,Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (Hymenoptera: Megachilidae).,Micrococcusluteus,2287
FIGPVLKMATSILPTAICKGFKKC,1260,4,3846,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus,462
FLGPIIKMATGILPTAICKGLKKC,1260,4,3848,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus,462
SIRDKIKTMAIDLAKSAGTGVLKTLICKLDKSC,1260,4,3849,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus,820
SIRDKGKTIAIDLAKSAGTGVLKTLMCKLDKSC,1260,4,3850,"Five novel antimicrobial peptides from the Kuhl's wart frog skin secretions, Limnonectes kuhlii.",Staphylococcusaureus,820
NALSMPRNKCNRALMCFG,1262,4,3887,Novel family of antimicrobial peptides from the skin of Rana shuchinae.,Staphylococcusaureus,2288
NALSSPRNKCDRASSCFG,1262,4,3888,Novel family of antimicrobial peptides from the skin of Rana shuchinae.,Staphylococcusaureus,2288
ACYCRIPACFAGERRYGTCFYLGRVWAFCC,135,2,3890,De novo sequencing of two new cyclic theta-defensins from baboon (Papio hamadryas) leukocytes by matrix-assisted laser desorption/ionization mass spectrometry.,Escherichiacoli,425
GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS,1263,2,3894,Peptides with differential cytolytic activity from skin secretions of the lemur leaf frog Hylomantis lemur (Hylidae: Phyllomedusinae).,Escherichiacoli,770
GLVSSIGRALGGLLADVVKSKGQPA,1264,25,3918,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,443
GLWEKIKEKASELVSGIVEGVK,1264,25,3919,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2289
GLLSSLGLNL,1264,25,3923,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2290
GLLDVVGNLLGGLGL,1264,25,3924,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2291
AGGLDDLLEPVLNSADNLVHGL,1264,25,3926,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2292
EGPVGLADPDGPASAPLGAP,1265,190,3927,Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,Phytophthoracapsici,771
GPVGLLSSPGSLPPVGGAP,1265,191,3928,Two novel antimicrobial peptides purified from the symbiotic bacteria Xenorhabdus budapestensis NMC-10.,Verticilliumdahliae,2293
FALGAVTKLLPSLLCMITRKC,1266,4,3929,"Hainanenins: a novel family of antimicrobial peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.",Staphylococcusaureus,2294
FALGAVTKRLPSLFCLITRKC,1266,4,3930,"Hainanenins: a novel family of antimicrobial peptides with strong activity from Hainan cascade-frog, Amolops hainanensis.",Staphylococcusaureus,2294
GIKCRFCCGCCTPGICGVCCRF,1267,17,3936,"Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions.",Listeriamonocytogenes,2295
QSHLSLCRWCCNCCRSNKGC,1267,17,3937,"Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions.",Listeriamonocytogenes,1597
GIKCCFCCGCCNSGVCELCCRF,1267,17,3938,"Three different hepcidins from tilapia, Oreochromis mossambicus: analysis of their expressions and biological functions.",Listeriamonocytogenes,2295
CRFCCRCCPRMRGCGLCCRF,1268,21,3939,The antimicrobial peptide hepcidin exerts an important role in the innate immunity against bacteria in the bony fish gilthead seabream.,Vibrioanguillarum,105
GKLNLFLSRLEILKLFVGAL,1269,2,3940,"Isolation and identification of pelteobagrin, a novel antimicrobial peptide from the skin mucus of yellow catfish (Pelteobagrus fulvidraco)",Escherichiacoli,772
KSLRPRCWIKIKFRCKSLKF,1270,4,3943,Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,Staphylococcusaureus,2296
RPRCWIKIKFRCKSLKF,1270,4,3944,Two antimicrobial and nematicidal peptides derived from sequences encoded Picea sitchensis.,Staphylococcusaureus,2296
FLGAIAAALPHVINAVTNAL,1271,2,3945,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli,773
FFGAIAAALPHVISAIKNAL,1271,2,3946,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli,773
FVGAIAAALPHVISAIKNAL,1271,2,3947,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli,773
IIGAIAAALPHVINAIKNTF,1271,2,3948,"A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata.",Escherichiacoli,773
GLVPNLLNNLGL,1264,25,4078,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2297
GLVSNLGI,1264,25,4079,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2298
GLISNLGI,1264,25,4080,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2298
GAVSGLLTNL,1264,25,4081,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2299
GAVSGLLTNLGL,1264,25,4082,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2300
AGPVSKLVSGIGL,1264,25,4083,"Host-defence peptides of Australian anurans: structure, mechanism of action and evolutionary significance.",Bacilluscereus,2301
GLVSSIGKALGGLLADVVKSKGQPA,1272,25,4085,"Differences in the skin peptides of the male and female Australian tree frog Litoria splendida. The discovery of the aquatic male sex pheromone splendipherin, together with phe8 caerulein and a new antibiotic peptide caerin 1.10.",Bacilluscereus,443
KIKIPWGKVKDFLVGGMKAV,1273,4,4108,Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum.,Staphylococcusaureus,2302
LFKEILEKIKAKL,1273,4,4110,Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum.,Staphylococcusaureus,2303
FLLFPLMCKIQGKC,1274,4,4111,"Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",Staphylococcusaureus,2304
FVLPLVMCKILRKC,1274,4,4112,"Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",Staphylococcusaureus,2305
GWANTLKNVAGGLCKITGAA,1274,4,4113,"Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri.",Staphylococcusaureus,2306
FLPAVIRVAANVLPTVFCAISKKC,1275,2,4116,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli,1296
GIFGKILGAGKKVLCGLSGLC,1275,2,4117,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli,264
GIFGKILGVGKKVLCGLSGMC,1275,2,4118,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli,264
FLPAVLRVAAKVVPTVFCLISKKC,1275,2,4119,"Antimicrobial peptides from the skin of the Asian frog, Odorrana jingdongensis: de novo sequencing and analysis of tandem mass spectrometry data.",Escherichiacoli,1296
GLLSKVLGVGKKVLCGVSGLC,1278,18,4122,"Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",Micrococcusluteus,264
GLLDSIKGMAISAGKGALQNLLKVASCKLDKTC,1278,18,4123,"Structural study of novel antimicrobial peptides, nigrocins, isolated from Rana nigromaculata.",Micrococcusluteus,868
FLHHIVGLIHHGLSLFGDRAD,1279,34,4133,Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,Micrococcuslysodeikticus,2307
FIHHIIGWISHGVRAIHRAIHG,1279,34,4134,Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,Micrococcuslysodeikticus,2308
FLHHIVGLIHHGKLDMYRSNN,1279,34,4135,Differential expression and biological activity of two piscidin paralogues and a novel splice variant in Atlantic cod (Gadus morhua L.).,Micrococcuslysodeikticus,2309
GILSGILGMGKKLVCGLSGLC,1280,4,4136,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus,264
GILSGILGAGKSLVCGLSGLC,1280,4,4137,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus,264
GILSNVLGMGKKIVCGLSGLC,1280,4,4138,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus,264
SILSGNFGVGKKIVCGLSGLC,1280,4,4139,Nigrocin-2 peptides from Chinese Odorrana frogs--integration of UPLC/MS/MS with molecular cloning in amphibian skin peptidome analysis.,Staphylococcusaureus,264
GLLGGLLGPLLGGGGGGGGGLL,1281,3,4141,Leptoglycin: a new Glycine/Leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog Leptodactylus pentadactylus (Leptodactylidae).,Pseudomonasaeruginosa,2310
DSIRDVSPTFNKIRRWFDGLFK,146,87,4142,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Listeriainnocua,2311
KRKCPKTPFDNTPGAWFAHLILGC,146,87,4143,Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 334.,Listeriainnocua,106
MQFITDLIKKAVDFFKGLFGNK,1282,48,4146,Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.,Bacillusmegaterium,1465
MAADIISTIGDLVKLIINTVKKFQK,1282,48,4147,Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri.,Bacillusmegaterium,2312
KRGFGKKLRKRLKKFRNSIKKRLKNFNVVIPIPLPG,147,2,4172,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli,875
KRGLWESLKRKATKLGDDIRNTLRNFKIKFPVPRQG,147,2,4173,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli,360
RTKRRIKLIKNGVKKVKDILKNNNIIILPGSNEK,147,2,4174,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli,2073
RPWAGNGSVHRYTVLSPRLKTQ,147,2,4175,Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options.,Escherichiacoli,2074
FFGHLYRGITSVVKHVHGLLSG,1283,192,4179,"A piscidin-like antimicrobial peptide from the icefish Chionodraco hamatus (Perciformes: Channichthyidae): molecular characterization, localization and bactericidal activity.",Psychrobactersp.,1911
RIGVLLARLPKLFSLFKLMGKKV,1284,2,4189,"Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species.",Escherichiacoli,2075
GLLSGILGAGKHIVCGLTGCAKA,1285,2,4192,A novel antimicrobial peptide from amphibian skin secretions of Odorrana grahami.,Escherichiacoli,264
DSMGAVKLAKLLIDKMKCEVTKAC,1286,4,4194,"Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",Staphylococcusaureus,2313
GFMDTAKNVAKNVAVTLIDKLRCKVTGGC,1286,4,4195,"Two novel families of antimicrobial peptides from skin secretions of the Chinese torrent frog, Amolops jingdongensis.",Staphylococcusaureus,807
VIPFVASVAAEMMHHVYCAASKRC,1287,18,4204,Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.,Micrococcusluteus,1061
GIFSKLAGKKIKNLLISGLKNIGKEVGMDVVRTGIDIAGCKIKGEC,1287,18,4205,Structure-activity relationships of antimicrobial peptides from the skin of Rana esculenta inhabiting in Korea.,Micrococcusluteus,1750
SPAGCRFCCGCCPNMRGCGVCCRF,1288,4,4206,Molecular characterization of hepcidin AS-hepc2 and AS-hepc6 in black porgy (Acanthopagrus schlegelii): expression pattern responded to bacterial challenge and in vitro antimicrobial activity.,Staphylococcusaureus,105
GRGREFMSNLKEKLSGVKEKMKNS,1289,48,4207,Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.,Bacillusmegaterium,1062
VKLIQIRIWIQYVTVLQMFSMKTKQ,1289,48,4208,Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus.,Bacillusmegaterium,1063
FFPIIAGMAAKLIPSLFCKITKKC,1290,2,4209,Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,Escherichiacoli,2236
FLPIIAGMAAKVICAITKKC,1290,2,4210,Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).,Escherichiacoli,1296
FFPIIAGMAAKVICAITKKC,1291,2,4211,Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis),Escherichiacoli,1296
FLPAIVGAAAKFLPKIFCAISKKC,1292,2,4213,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli,1296
FLPVIAGVAANFLPKLFCAISKKC,1292,2,4215,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli,1296
FLPIIAGAAAKVVQKIFCAISKKC,1292,2,4216,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli,1296
FLPIIAGAAAKVVEKIFCAISKKC,1292,2,4217,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli,1296
GLMDTIKGVAKTVAASWLDKLKCKITGC,1292,2,4218,"Peptides with potent cytolytic activity from the skin secretions of the North American leopard frogs, Lithobates blairi and Lithobates yavapaiensis.",Escherichiacoli,807
GILSSFKGVAKGVAKNLAGKLLDELKCKITGC,1293,2,4219,Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,Escherichiacoli,807
FLPILAGLAAKLVPKVFCSITKKC,1294,2,4220,Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora,Escherichiacoli,1296
FLPILAGLAANILPKVFCSITKKC,1293,2,4221,Host-defense peptides isolated from the skin secretions of the Northern red-legged frog Rana aurora aurora.,Escherichiacoli,1296
FLPIIAGVAAKVLPKLFCAITKKC,1295,2,4226,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,1296
FLPVIAGLAAKVLPKLFCAITKKC,1295,2,4227,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,1296
FFPTIAGLTKLFCAITKKC,1295,2,4228,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,2076
GFSSIFRGVAKFASKGLGKDLAKLGVDLVACKISKQC,1295,2,4229,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,110
GLMDTVKNAAKNLAGQLLDRLKCKITGC,1295,2,4230,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,807
GLMDTIKGVAKNVAASLLEKLKCKVTGC,1295,2,4231,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,447
GLLSTFKNLATNVAGTVIDTLKCKVTGGCRT,1295,2,4232,Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona.,Escherichiacoli,1803
SVSNIPESIGF,1296,25,4244,The host-defence skin peptide profiles of Peron's Tree Frog Litoria peronii in winter and summer. Sequence determination by electrospray mass spectrometry and activities of the peptides.,Bacilluscereus,1064
DVIKKVASVIGGL,150,2,4248,Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.,Escherichiacoli,2077
GWKDWLNKGKEWLKKKGPGIMKAALKAATQ,91,166,4268,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Aspergillusniger,1065
DFKDWMKTAGEWLKKKGPGILKAAMAAAT,91,117,4269,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Listeriaivanovii,1065
GIWGTALKWGVKLLPKLVGMAQTKKQ,91,193,4271,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Proteusmirabilis,1066
FWGALIKGAAKLIPSVVGLFKKKQ,91,193,4272,"Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii.",Proteusmirabilis,2490
KPPPWVPV,1297,159,4274,"PsT-1: a new tryptophyllin peptide from the skin secretion of Waxy Monkey Leaf Frog, Phyllomedusa sauvagei.",Humanprostate,2078
GEFLKCGESCVQGECYTPGCSCDWPICKKN,1298,4,4275,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus,993
GIPCGESCVFIPCITGAIGCSCKSKVCYRN,1298,4,4276,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus,2082
GLPTCGETCTLGTCYVPDCSCSWPICMKN,1298,4,4277,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus,2129
GIPCGESCVFIPCITAAIGCSCKSKVCYRN,1298,4,4278,Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family.,Staphylococcusaureus,2082
GIPCGESCVFIPCTVTALLGCSCKDKVCYKN,1299,31,4279,Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells.,Humanlung,2082
GVPCAESCVWIPCTVTALLGCSCKDKVCYLN,1299,31,4280,Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells.,Humanlung,2082
GIPCGESCVYIPCTVTALLGCSCKDKVCYKN,1299,31,4281,Chemosensitizing activities of cyclotides from Clitoria ternatea in paclitaxel-resistant lung cancer cells.,Humanlung,2082
GDACGETCFTGICFTAGCSCNPWPTCTRN,1300,4,4282,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Staphylococcusaureus,2129
GIPCAESCVWIPCTITALMGCSCKNNVCYNN,1300,4,4283,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Staphylococcusaureus,2082
GASCGETCFTGICFTAGCSCNPWPTCTRN,1300,4,4285,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Staphylococcusaureus,2129
IPCGESCVWIPCITAIAGCSCKNKVCYT,1300,2,4286,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli,2082
AIPCGESCVWIPCISTVIGCSCSNKVCYR,1300,2,4287,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli,2082
GEYCGESCYLIPCFTPGCYCVSRQCVNKN,1300,2,4288,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli,2079
IPCGESCVWIPCISGMFGCSCKDKVCYS,1300,2,4289,Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities.,Escherichiacoli,2082
GSGRGSCRSQCMRRHEDEPWRVQECVSQCRRRRGGGD,1301,194,4291,Disulfide-stabilized helical hairpin structure and activity of a novel antifungal peptide EcAMP1 from seeds of barnyard grass (Echinochloa crus-galli).,Alternariaalternata,2080
DRCSQQCQHHRDPDRKQQCMRECRRHQGRSD,1302,33,4292,Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.,Pseudomonassyringae,1067
DRCSQQCQHHRDPDRKQQCMRECRRH,1302,33,4293,Defense peptides from barnyard grass (Echinochloa crusgalli L.) seeds.,Pseudomonassyringae,1067
RKGWFKAMKSIAKFIAKEKLKEHL,1303,2,4294,"Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis.",Escherichiacoli,317
FLSLIPSLVGGSISAFK,152,4,4297,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus,1068
FLGMIPGLIGGLISAFK,152,4,4298,"Two peptides, TsAP-1 and TsAP-2, from the venom of the Brazilian yellow scorpion, Tityus serrulatus: evaluation of their antimicrobial and anticancer activities.",Staphylococcusaureus,1068
RLGDGCTR,1304,118,4301,Identification and structural characterization of a new pro-apoptotic cyclic octapeptide cyclosaplin from somatic seedlings of Santalum album L.,Humanbreast,2081
GIACGESCVFLGCFIPGCSCKSKVCYFN,1305,127,4302,"Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",Humanhistiocytic,2079
GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,1305,127,4303,"Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",Humanhistiocytic,2082
KLCGETCFKFKCYTPGCSCSYPFCK,1305,127,4304,"Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.",Humanhistiocytic,993
GLWNSIKIAGKKLFVNVLDKIRCKVAGGCKTSPDVE,154,2,4309,Identification and structure–activity relationship of an antimicrobial peptide of the palustrin-2 family isolated from the skin of the endangered frog Odorrana ishikawae.,Escherichiacoli,1151
SWLSKTYKKLENSAKKRISEGIAIAIQGGPR,1306,4,4324,Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.,Staphylococcusaureus,1069
AANFGPSVFTPEVHETWQKFLNVVVAALGKQYH,1307,195,4338,"Antimicrobial peptides derived from hemoglobin are expressed in epithelium of channel catfish (Ictalurus punctatus, Rafinesque).",Vibrioalginolyticus,1070
GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD,1308,2,4343,Identification and structural characterization of novel cyclotide with activity against an insect pest of sugar cane.,Escherichiacoli,2082
FSFKRLKGFAKKLWNSKLARKIRTKGLKYVKNFAKDMLSEGEEAPPAAEPPVEAPQ,1310,2,4348,A novel amphipathic linear peptide with both insect toxicity and antimicrobial activity from the venom of the scorpion Isometrus maculatus.,Escherichiacoli,2083
GLRSKIWLWVLLMIWQESNKFKKM,1311,2,4349,"Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.",Escherichiacoli,680
RSGRGECRRQCLRRHEGQPWETQECMRRCRRRG,1312,2,4350,Purification and characterization of a novel antimicrobial peptide from maize (Zea mays L.) kernels.,Escherichiacoli,2080
QGVRNSQSCRRNKGICVPIRCPGSMRQIGTCLGAQVKCCRRK,1313,2,4351,Epithelial antibiotics induced at sites of inflammation.,Escherichiacoli,677
RTCMIKKEGWGKCLIDTTCAHSCKNRGYIGGNCKGMTRTCYCLVNC,262,2,4352,Cloning and functional expression of a mungbean defensin VrD1 in Pichia pastoris.,Escherichiacoli,869
FLGLIFHGLVHAGKLIHGLIHRNRG,1314,4,4353,"Identification, synthesis and characterization of a novel antimicrobial peptide HKPLP derived from Hippocampus kuda Bleeker.",Staphylococcusaureus,1071
GILDSFKDVAKGVATHLLNMAKCKMTGC,1315,182,4381,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis,807
GILDTFKGVAKGVAKDLAVHMLEKLKCKMTGC,1315,182,4382,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis,807
GILSSFKDVAKGVAKNVAAQLLDKLKCKITGC,1315,182,4383,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis,807
GILDTVKGVAKDVAAHLLNMVKCKITGC,1315,182,4384,Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.,Batrachochytriumdendrobatidis,807
GLMDTVKNAAKNLAGQMLDKLKCKITGSC,1316,2,4395,"Primary structures of skin antimicrobial peptides indicate a close, but not conspecific, phylogenetic relationship between the leopard frogs Lithobates onca and Lithobates yavapaiensis (Ranidae).",Escherichiacoli,807
ITIPPIVKDTLKKFFKGGIAGVMGKSQ,1317,4,4398,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,768
FKIPPIVKDTLKKFFKGGIAGVMGQ,1317,4,4399,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,768
ITIPPIIKDTLKKFFKGGIAGVMGKSQ,1317,4,4400,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,768
ITIPPIVKDTLKKFFKGGIAGVMGQ,1317,4,4401,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,768
ITIPPIVKNTLKKFIKGAVSALMS,1317,4,4404,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,768
IKIPSFFRNILKKVGKEAVSLIAGALKQS,1317,4,4405,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,1072
GIFPIFAKLLGKVIKVASSLISKGRTE,1317,4,4406,Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae.,Staphylococcusaureus,1073
APAHRSSTFPKWVTKTERGRQPLRS,1318,4,4439,"Alarin but not its alternative-splicing form, GALP (Galanin-like peptide) has antimicrobial activity.",Staphylococcusaureus,1074
FFGSLLSLGSKLLPSVFKLFQRKKE,1319,2,4451,Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics.,Escherichiacoli,2490
FWGHIWNAVKRVGANALHGAVTGALS,1320,18,4452,"Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.",Micrococcusluteus,1075
GFWKKVGSAAWGGVKAAAKGAAVGGLNALAKHIQ,1320,18,4453,"Halocyntin and papillosin, two new antimicrobial peptides isolated from hemocytes of the solitary tunicate, Halocynthia papillosa.",Micrococcusluteus,1076
RCLPAGKTCVRGPMRVPCCGSCSQNKCT,1321,2,4466,Isolation and characterization of Psalmopeotoxin I and II: two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei.,Escherichiacoli,2084
AWLDKLKSLGKVVGKVALGVAQNYLNPQQ,163,2,4469,Post-secretory events alter the peptide content of the skin secretion of Hypsiboas raniceps.,Escherichiacoli,2085
VGECVRGRCPSGMCCSQFGYCGKGPKYCG,1322,36,4476,Antimicrobial peptides from Amaranthus caudatus seeds with sequence homology to the cysteine/glycine-rich domain of chitin-binding proteins.,Alternariabrassicicola,2326
RVRRFWPLVPVAINTVAAGINLYKAIRRK,1323,4,4477,"Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix.",Staphylococcusaureus,1077
LVQRGRFGRFLKKVRRFIPKVIIAAQIGSRFG,1323,4,4478,"Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix.",Staphylococcusaureus,1078
GIRCPKSWKCKAFKQRVLKRLLAMLRQHAF,1324,8,4480,Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.,Bacillussubtilis,1079
SPRVSRRYGRPFGGRPFVGGQFGGRPGCVCIRSPCPCANYG,1325,149,4481,"Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.",Staphylococcushaemolyticus,1080
IPAMEPAARVKRSPGYGGCSPRWACGGYG,1325,149,4482,"Two novel antimicrobial peptides, arasin-likeSp and GRPSp, from the mud crab Scylla paramamosain, exhibit the activity against some crustacean pathogenic bacteria.",Staphylococcushaemolyticus,1282
GLPVCGETCVGGTCNTPGCACSWPVCTRN,1326,111,4484,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2129
GLPVCGETCVGGTCNTPGCGCSWPVCTRN,1326,111,4485,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2129
GIPCGESCVFIPCLTSAIGCSCKSKVCYRN,1326,111,4486,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2082
GSIPCGESCVFIPCISSVIGCACKSKVCYKN,1326,111,4487,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2082
GIPCGESCVFIPCISSVIGCSCSSKVCYRN,1326,111,4488,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2082
GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,1326,111,4489,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2082
GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,1326,111,4490,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2082
GSIPCGESCVFIPCISAIIGCSCSNKVCYKN,1326,111,4491,Isolation and characterization of cytotoxic cyclotides from Viola philippica.,Humanskin,2082
KRFWPLVPVAINTVAAGINLYKAIRRK,1327,2,4492,Fowlicidin-3 is an alpha-helical cationic host defense peptide with potent antibacterial and lipopolysaccharide-neutralizing activities.,Escherichiacoli,1077
GLWDTIKQAGKKFFLNVLDKIRCKVAGGCRT,165,2,4497,Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli.,Escherichiacoli,1151
RKCNFLCKLKEKLRTVITSHIDKVLRPQG,1328,2,4536,Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide.,Escherichiacoli,2086
QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY,1329,2,4555,"Purification and cloning of a novel antimicrobial peptide from salivary glands of the hard tick, Ixodes sinensis.",Escherichiacoli,2087
KNIGNSVSCLRNKGVCMPGKCAPKMKQIGTCGMPQVKCCKRK,1330,196,4570,The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets.,Bordetellapertussis,2088
VKVGINGFGRIGRLVTRAAFHGKKVEVVAIND,1331,8,4577,"Purification and characterization of YFGAP, a GAPDH-related novel antimicrobial peptide, from the skin of yellowfin tuna, Thunnus albacares.",Bacillussubtilis,1081
FRFGSFLKKVWKSKLAKKLRSKGKQLLKDYANKVLNGPEEEAAAPAE,1332,2,4592,"Characterization of BmKbpp, a multifunctional peptide from the Chinese scorpion Mesobuthus martensii Karsch: gaining insight into a new mechanism for the functional diversification of scorpion venom peptides.",Escherichiacoli,242
ACQFWSCNSSCISRGYRQGYCWGIQYKYCQCQ,1333,2,4611,Antimicrobial peptide induction in the haemolymph of the Mexican scorpion Centruroides limpidus limpidus in response to septic injury.,Escherichiacoli,2089
GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE,1334,2,4612,Specific antimicrobial and hemolytic activities of 18-residue peptides derived from the amino terminal region of the toxin pardaxin.,Escherichiacoli,2090
FFGWLIKGAIHAGKAIHGLIHRRRH,1335,7,4652,Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms,Streptococcusmutans,991
INLKGLIKKVASLLT,1336,2,4684,Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae.,Escherichiacoli,879
VHVPPICSHRECRK,1336,2,4691,Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae.,Escherichiacoli,2091
FGPVIGLLSGILKSLL,1336,2,4692,Venom peptides from solitary hunting wasps induce feeding disorder in lepidopteran larvae.,Escherichiacoli,2092
GTRCGETCFVLPCWSAKFGCYCQKGFCYRN,1337,4,4696,Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.,Staphylococcusaureus,1082
IQCGESCVWIPCISSAWGCSCKNKICSS,1337,4,4697,Discovery of a linear cyclotide from the bracelet subfamily and its disulfide mapping by top-down mass spectrometry.,Staphylococcusaureus,2082
GIWSSIKNLASKAWNSDIGQSLRNKAAGAINKFVADKIGVTPSQAAS,1338,2,4724,"Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus.",Escherichiacoli,2093
RIKRFWPVVIRTVVAGYNLYRAIKKK,1339,4,4725,Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus.,Staphylococcusaureus,95
NAGSLLSGWG,1340,56,4727,Characterization of the novel antibacterial peptide Leucrocin from crocodile (Crocodylus siamensis) white blood cell extracts.,Staphylococcusepidermidis,1083
RWKIFKKIEKVGRNVRDGIIKAGPAVAVVGQAATVVKG,1341,2,4743,"Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, papiliocin, from the swallowtail butterfly, Papilio xuthus.",Escherichiacoli,2096
GMWSKIKNAGKAAKAAAKAAGKAALGAVSEAM,1342,2,4749,"Dermaseptin DA4, although closely related to dermaseptin B2, presents chemotactic and Gram-negative selective bactericidal activities.",Escherichiacoli,2094
RGGGLCYCRRRFCVCVGR,26,2,4756,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
RGGRLCYCRGWICFCVGR,26,2,4757,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2095
RGGRLCYCRPRFCVCVGR,26,2,4758,Protegrin structure-activity relationships: using homology models of synthetic sequences to determine structural characteristics important for activity.,Escherichiacoli,2437
FFHHIFRGIVHVGKTIHRLVTG,186,2,4867,Solution structure and cell selectivity of piscidin 1 and its analogues.,Escherichiacoli,2690
RWKPFKKELKVGRNIRDGIIKAGPAVAVIGQATSIARPTGK,1344,2,4871,"Production, purification, and characterization of the cecropin from Plutella xylostella, pxCECA1, using an intein-induced self-cleavable system in Escherichia coli.",Escherichiacoli,2096
LRVRRTLQCSCRRVCRNTCSCIRLSRSTYAS,1345,2,4888,"Rattusin, an intestinal ?-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities.",Escherichiacoli,2097
GLFNVFKGALKTAGKHVAGSLLNQLKCKVSGGC,1346,2,4933,"Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.",Escherichiacoli,807
VGKTWIKVIRGIGKSKIKWQ,1347,197,4955,Bactrocerin-1: a novel inducible antimicrobial peptide from pupae of oriental fruit fly Bactrocera dorsalis Hendel.,Sarcinalutea,2098
CIAKGNGCQPSGVQGNCCSGHCHKEPGWVAGYCK,1348,50,4997,"Isolation and characterization of Psacotheasin, a novel Knottin-type antimicrobial peptide, from Psacothea hilaris.",Enterococcusfaecium,334
LFCKGGSCHFGGCPSHLIKVGSCFGFRSCCKWPWNA,1349,8,5002,Primary structure and antibacterial activity of chicken bone marrow-derived beta-defensins.,Bacillussubtilis,124
GRLKKLGKKIEGAGKRVFKAAEKALPVVAGVKALG,1350,64,5077,"Cloning and analysis of a cecropin gene from the malaria vector mosquito, Anopheles gambiae.",Alcaligenesfaecalis,1209
ELPKLPDDKVLIRSRSNCPKGKVWNGFDCKSPFAFS,1351,198,5086,"Scarabaecin, a novel cysteine-containing antifungal peptide from the rhinoceros beetle, Oryctes rhinoceros.",Pyriculariaoryzae,1084
DHYLCVKNEGICLYSSCPSYTKIEGTCYGGKAKCCK,1352,4,5088,"A beta-defensin 1-like antimicrobial peptide from the tree shrew, Tupaia belangeri.",Staphylococcusaureus,2724
GGYYCPFFQDKCHRHCRSFGRKAGYCGGFLKKTCICV,1353,8,5100,Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.,Bacillussubtilis,2327
GGYYCPFRQDKCHRHCRSFGRKAGYCGGFLKKTCICV,1353,8,5102,Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.,Bacillussubtilis,2327
QLGELIQQGGQKIVEKIQKIGQRIRDFFSNLRPRQEA,1354,2,5105,Expression and activity of a novel cathelicidin from domestic cats.,Escherichiacoli,875
FTCAISCDIKVNGKPCKGSGEKKCSGGWSCKFNVCVKV,1355,18,5106,"Juruin: an antifungal peptide from the venom of the Amazonian Pink Toe spider, Avicularia juruensis, which contains the inhibitory cystine knot motif.",Micrococcusluteus,1085
AGCIKNGGRCNASAGPPYCCSSYCFQIAGQSYGVCKNR,1356,48,5107,"Purification, characterization, and molecular cloning of the gene of a seed-specific antimicrobial protein from pokeweed.",Bacillusmegaterium,1086
ILENLLARSTNEDREGSIFDTGPIRRPKPRPRPRPEG,200,34,5109,Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin.,Micrococcuslysodeikticus,1087
RWKVFKKIEKVGRNVRDGIIKAGPAIGVLGQAKALG,1357,2,5114,"Antibacterial properties and partial cDNA sequences of cecropin-like antibacterial peptides from the common cutworm, Spodoptera litura.",Escherichiacoli,2096
RWKVFKKIEKMGRNIRDGIVKAGPAIEVLGSAKALGK,1357,2,5115,"Antibacterial properties and partial cDNA sequences of cecropin-like antibacterial peptides from the common cutworm, Spodoptera litura.",Escherichiacoli,2096
VAKCTEESGGKYFVFCCYKPTRICYMNEQKCESTCIGK,1358,24,5116,Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.,Fusariumoxysporum,2099
GGKCTVDWGGQGGGRRLPSPLFCCYKPTRICYLNQETCETETCP,1358,24,5117,Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.,Fusariumoxysporum,2099
ANKCIIDCMKVKTTCGDECKGAGFKTGGCALPPDIMKCCHNC,1358,24,5118,Discovery of novel antimicrobial peptides with unusual cysteine motifs in dandelion Taraxacum officinale Wigg. flowers.,Fusariumoxysporum,2100
GFGCPFNENECHAHCLSIGRKFGFCAGPLRATCTCGKQ,1359,48,5119,Dermatophytic defensin with antiinfective potential.,Bacillusmegaterium,2323
FPWSCPTLSGVCRKVCLPTEMFFGPLGCGKEFQCCVSHFF,1360,18,5123,A novel beta-defensin antimicrobial peptide in Atlantic cod with stimulatory effect on phagocytic activity.,Micrococcusluteus,1040
PICTRNGLPVCGETCFGGTCNTPGCTCTW,1361,1,5131,Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties.,None_target,1088
PVCTRNGLPVCGETCVGGTCNTPGCTCSW,1361,1,5132,Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties.,None_target,1088
PICKRNGLPVCGETCTLGTCYTQGCTCSW,1361,1,5133,Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties.,None_target,1088
TTKNYGNGVCNSVNWCQCGNVWASCNLATGCAAWLCKLA,1362,55,5134,Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin.,Campylobacterjejuni,2101
QQCGRQAGNRRCPNNLCCSQFGYCGRTNEYCCTGFGCQSNCRRCG,1363,36,5144,Synergistic antifungal activity of two chitin-binding proteins from spindle tree (Euonymus europaeus L.).,Alternariabrassicicola,204
GWLKKIGKKIERVGQHTRDATIQGLGIAQQAANVAATARG,1104,4,5153,"Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina.",Staphylococcusaureus,1795
ATCDLLSGIGVQHSACALHCVFRGNRGGYCTGKGICVCRN,1364,2,5157,"Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.",Escherichiacoli,1468
LTCEIDRSLCLLHCRLKGYLRAYCSQQKVCRCVQ,1364,2,5158,"Purification, sequence and antibacterial activity of two novel sapecin homologues from Sarcophaga embryonic cells: similarity of sapecin B to charybdotoxin.",Escherichiacoli,2102
YDLSKNCRLRGGICYIGKCPRRFFRSGSCSRGNVCCLRFG,1365,2,5161,"Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.",Escherichiacoli,2103
AACSDRAHGHICESFKSFCKDSGRNGVKLRANCKKTCGLC,1366,2,5171,"Aurelin, a novel antimicrobial peptide from jellyfish Aurelia aurita with structural features of defensins and channel-blocking toxins.",Escherichiacoli,2104
GFGCPGDAYQCSEHCRALGGGRTGGYCAGPWYLGHPTCTCSF,1367,4,5172,"Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action.",Staphylococcusaureus,2323
ADTLACRQSHQSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS,1368,2,5173,"Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.",Escherichiacoli,2706
VLLFLFQAAPGSADAPFADTAACRSQGNFCRAGACPPTFAASGSCHGGLLNCCAK,1368,2,5174,"Two novel duck antibacterial peptides, avian beta-defensins 9 and 10, with antimicrobial activity.",Escherichiacoli,2105
CLAGRLDKQCTCRRSQPSRRSGHEVGRPSPHCGPSRQCGCHMD,1369,6,5175,"Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.",Aspergillusfumigatus,2106
YENPYGCPTDEGKCFDRCNDSEFEGGYCGGSYRATCVCYRT,1370,2,5176,"Two novel non-cationic defensin-like antimicrobial peptides from haemolymph of the female tick, Amblyomma hebraeum.",Escherichiacoli,2107
GILDTIKSIASKVWNSKTVQDLKRKGINWVANKLGVSPQAA,1371,2,5177,"Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus.",Escherichiacoli,2108
DTLACRQSHGSCSFVACRAPSVDIGTCRGGKLKCCKWAPSS,207,55,5178,The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens.,Campylobacterjejuni,2706
DDTPSSRCGSGGWGPCLPIVDLLCIVHVTVGCSGGFGCCRIG,1372,3,5186,"Structure, self-assembly, and dual role of a beta-defensin-like peptide from the Chinese soft-shelled turtle eggshell matrix.",Pseudomonasaeruginosa,1089
FSCDVLSFQSKWVSPNHSACAVRCLAQRRKGGKCKNGDCVCR,1373,18,5188,Identification and characterization of the parasitic wasp Nasonia defensins: positive selection targeting the functional region?,Micrococcusluteus,1468
GTPCGESCVYIPCISGVIGCSCTDKVCYLN,1374,1,5235,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,None_target,2082
GLPVCGETCFGGTCNTPGCSCTWPICTRD,1374,2,5236,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Escherichiacoli,2129
GLPTCGETCFGGTCNTPGCSCSSWPICTRN,1374,199,5237,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Haemonchuscontortus,2129
GLPVCGETCTLGTCYTQGCTCSWPICKRN,1374,2,5238,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Escherichiacoli,993
GIPCAESCVYIPCTVTALLGCSCSNRVCYN,1374,199,5239,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Haemonchuscontortus,2082
GLPVCGETCFGGTCNTPGCICDPWPVCTRN,1374,199,5240,Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.,Haemonchuscontortus,2129
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPL,1375,2,5242,"Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils.",Escherichiacoli,2710
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGC,1376,158,5256,A novel antifungal hevein-type peptide from Triticum kiharae seeds with a unique 10-cysteine motif.,Bipolarissorokiniana,2230
KGAPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,1377,12,5257,"Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",Clavibactermichiganensis,0
KGGPCAKKPCCGPLGHYKVDCSTIPDYPCCSKYGFCGSGPQYCG,1377,12,5258,"Purification, characterization, and sequencing of antimicrobial peptides, Cy-AMP1, Cy-AMP2, and Cy-AMP3, from the Cycad (Cycas revoluta) seeds.",Clavibactermichiganensis,0
TKYYGNGVYCNSKKCWVDWGTAQGCIDVVIGQLGGGIPGKGKC,1378,32,5260,"Purification, characterization and amino acid sequencing of divergicin M35: a novel class IIa bacteriocin produced by Carnobacterium divergens M35.",Lactococcuslactis,649
ATYYGNGVYCNKQKCWVDWSRARSEIIDRGVKAYVNGFTKVLGGIGGR,1379,8,5261,"Isolation and characterization of enterocin SE-K4 produced by thermophilic enterococci, Enterococcus faecalis K-4.",Bacillussubtilis,1090
AQEPVKGPVSTKPGSCPIILIRCAMLNPPNRCLKDTDCPGIKKCCEGSCGMACFVPQ,1380,2,5269,Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes.,Escherichiacoli,2711
KYYGNGVSCNKKGCSVDWGKAIGIIGNNSAANLATGGAAGWKS,1381,2,5277,"Biochemical and genetic characterization of mundticin KS, an antilisterial peptide produced by Enterococcus mundtii NFRI 7393.",Escherichiacoli,649
MLAKIKAMIKKFPNPYTLAAKLTTYEINWYKQQYGRYPWERPVA,1382,200,5278,"Isolation and characterization of enterocin EJ97, a bacteriocin produced by Enterococcus faecalis EJ97.",Bacilluscirculans,2712
GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC,1383,4,5281,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus,311
GIFSKINKKKAKTGLFNIIKTVGKEAGMDVIRAGIDTISCKIKGEC,1383,4,5282,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus,1750
GLFPKFNKKKVKTGIFDIIKTVGKEAGMDVLRTGIDVIGCKIKGEC,1383,4,5283,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus,1750
GLMDTVKNAAKNLAGQLLDTIKCKMTGC,1383,4,5284,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus,807
GILDTIKNAAKTVAVGLLEKIKCKMTGC,1383,4,5285,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus,807
GFISTVKNLATNVAGTVIDTIKCKVTGGC,1383,4,5286,"Antimicrobial peptides and protease inhibitors in the skin secretions of the crawfish frog, Rana areolata.",Staphylococcusaureus,1803
SIGSALKKALPVAKKIGKIALPIAKAALPVAAGLVG,215,2,5299,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli,2713
SIGTAVKKAVPIAKKVGKVAIPIAKAVLSVVGQLVG,215,2,5306,Antibacterial activity and pore-forming properties of ceratotoxins: a mechanism of action based on the barrel stave model.,Escherichiacoli,2713
RIIDLLWRVRRPQKPKFVTVWVR,217,2,5317,Effects of tryptophan residues of porcine myeloid antibacterial peptide PMAP-23 on antibiotic activity.,Escherichiacoli,2233
MGIIAGIIKVIKSLIEQFTGK,222,56,5352,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis,1091
MAIVGTIIKIIKAIIDIFAK,222,56,5354,Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry.,Staphylococcusepidermidis,1092
FAVWGCADYRGYCRAACFAFEYSLGPKGCTEGYVCCVPNTF,1384,4,5356,The first salamander defensin antimicrobial peptide.,Staphylococcusaureus,1093
FFRHLFRGAKAIFRGARQGWRAHKVVSRYRNRDVPETDNNQEEP,1385,201,5359,"Piscidin 4, a novel member of the piscidin family of antimicrobial peptides.",Streptococcusiniae,1048
GLVGTLLGHIGKAILG,1386,4,5371,A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae),Staphylococcusaureus,1740
MVALLKSLERRRLMITISTMLQFGLFLIALIGLVIKLIELSNKK,1387,4,5372,Dual toxic-peptide-coding Staphylococcus aureus RNA under antisense regulation targets host cells and bacterial rivals unequally.,Staphylococcusaureus,1094
MITISTMLQFGLFLIALIGLVIKLIELSNKK,1387,4,5373,Dual toxic-peptide-coding Staphylococcus aureus RNA under antisense regulation targets host cells and bacterial rivals unequally.,Staphylococcusaureus,1094
KTKQQFLIKAQTQLFKVFGYTL,1388,18,5375,"Purification and Characterization of Plantaricin ZJ5, a New Bacteriocin Produced by Lactobacillus plantarum ZJ5.",Micrococcusluteus,1095
KTCENLSDSFKGPCIPDGNCNKHCKEKEHLLSGRCRDDFRCWCTRNC,1389,103,5393,Heterologous expression and solution structure of defensin from lentil Lens culinaris.,Agrobacteriumtumefaciens,423
FCKSLPLPLSVK,1390,4,5394,Isolation and identification of a new intracellular antimicrobial peptide produced by Paenibacillus alvei AN5.,Staphylococcusaureus,1096
KRFKKFFKKLKNSVKKRAKKFFKKPKVIGVTFPF,1392,202,5396,"Antimicrobial and antibiofilm activity of cathelicidins and short, synthetic peptides against Francisella.",Francisellanovicida,1694
CYCRIPACIAGERRYGTCIYQGRLWAFCC,227,30,5401,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,HIV-1IIIB,425
QWGYGGYGRGYGGYGGYGRGYGGYGGYGRGYGGYGRGMYGGYGRPYGGYGWGK,1393,18,5408,"TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM.",Micrococcusluteus,1097
GIGAVLKVLTTGLPALISWIKRKRQQ,227,2,5417,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,Escherichiacoli,2501
AIFIFIRWLLKLGHHGRAPP,228,8,5418,"Salusin-beta, an antimicrobially active peptide against Gram-positive bacteria.",Bacillussubtilis,1098
SDYLNNNPLFPRYDIGNVELSTAYRSFANQKAPGRLNQNWALTADYTYR,1394,2,5427,Cationic Bioactive Peptide from the Seeds of Benincasa hispida.,Escherichiacoli,2714
DVNDLKNLCAKTHNLLPMCAMFGKK,1395,4,5440,"Cloning and expression of genes enocoding antimicrobial peptides and bradykinin from the skin and brain of Oki Tago's brown frog, Rana tagoi okiensis.",Staphylococcusaureus,1099
GIGAVLKVLSTGLPALISWIKRKRQQ,1396,1,5455,Identification of a novel melittin isoform from Africanized Apis mellifera venom.,None_target,2501
GLGSVFGRLARILGRVIPKVAKKLGPKVAKVLPKVMKEAIPMAVEMAKSQEEQQPQ,1397,1,5490,"Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula.",None_target,1100
GYGCPFNQYQCHSHCSGIRGYKGGYCKGTFKQTCKCY,1398,25,5515,Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria.,Bacilluscereus,2331
LTCDLLSFEAKGFAANHSLCAAHCLAIGRKGGACQNGVCVCRR,1398,18,5516,Antibacterial activity and mechanism of action of tick defensin against Gram-positive bacteria.,Micrococcusluteus,1468
ALWFTMLKKLGTMALHAGKAALGAAANTISQGTQ,1399,203,5530,The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.,Aeromonascaviae,200
ALWMTLLKKVLKAAAKALNAVLVGANA,1399,203,5531,The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.,Aeromonascaviae,33
GLWSKIKTAGKSVAKAAAKAAVKAVTNAV,1399,203,5532,The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms.,Aeromonascaviae,2094
KSTVGQKLKKKLNQAVDKVKEVLNKSEYMCPVVSSFCKQHCARLGKSGQCDLLECIC,1400,8,5540,Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms.,Bacillussubtilis,774
KDRPKKPGLCPPRPQKPCVKECKNDDSCPGQQKCCNYGCKDECRDPIFVG,1401,48,5542,"Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins.",Bacillusmegaterium,775
GVVKVSRLKGESLRARL,239,8,5545,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis,776
IIKVPLKKFKSMREVMRDHGIKAPVVDPATKY,239,8,5546,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis,777
SGRGKQGGKVRAKAKTRSSRAGLQFPVGRVHRLLRKGNY,239,8,5547,"Antimicrobial peptides derived from pepsinogens in the stomach of the bullfrog, Rana catesbeiana.",Bacillussubtilis,882
SLFSLIKAGAKFLGKNLLKQGACYAACKASKQC,1019,18,5556,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus,1813
GIMSIVKDVAKNAAKEAAKGALSTLSCKLAKTC,1019,18,5557,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus,820
GIMSIVKDVAKTAAKEAAKGALSTLSCKLAKTC,1019,18,5558,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus,820
GILDTLKQFAKGVGKDLVKGAAQGVLSTVSCKLALTC,1019,18,5559,"Antimicrobial peptides from the skin of a Korean frog, Rana rugosa.",Micrococcusluteus,2192
ATYYGNGLYCNKEKCWVDWNQAKGEIGKIIVNGWVNHGPWAPRR,1402,204,5568,"Bacteriocin T8, a novel class IIa sec-dependent bacteriocin produced by Enterococcus faecium T8, isolated from vaginal secretions of children infected with human immunodeficiency virus.",Lactobacillusacidophilus,1090
FIHHIFRGIVHAGRSIGRFLTG,1403,201,5569,Peptide antibiotics in mast cells of fish.,Streptococcusiniae,2715
ADDRCERMCQRYHDRREKKQCMKGCRYG,1404,89,5579,"Genes encoding 4-Cys antimicrobial peptides in wheat Triticum kiharae Dorof. et Migush.: multimodular structural organization, instraspecific variability, distribution and role in defence.",Fusariumgraminearum,2716
TDDRCERMCQHYHDRREKKQCMKGCRYGESD,1404,89,5580,"Genes encoding 4-Cys antimicrobial peptides in wheat Triticum kiharae Dorof. et Migush.: multimodular structural organization, instraspecific variability, distribution and role in defence.",Fusariumgraminearum,2716
IGGALGNALNGLGTWANMMNGGGFVNQWQVYANKGKINQYRPY,1405,196,5581,"Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains.",Bordetellapertussis,2717
NLKAIAALAKKLL,1160,4,5603,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,778
INLKAITALAKKLL,1160,4,5604,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,889
INLKAIAPLAKKLL,1160,4,5605,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,779
VIVKAIATLASKLL,1160,126,5606,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Enterobactercloacae,2718
INLKAIAALVKKLL,1160,4,5607,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,780
INLKAIAALARNY,1160,4,5608,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,781
FLPIIGKLLSGLL,1160,4,5609,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,452
FLPIIGKLLSG,1160,4,5610,Antimicrobial peptides from the venom gland of the social wasp Vespa tropica.,Staphylococcusaureus,452
SPIHACRYQRGVCIPGPCRWPYYRVGSCGSGLKSCCVRNRWA,242,42,5620,Expression in Pichia Pastoris and biological activity of Avian ?-defensin 6 and its mutant peptide without cysteines.,Salmonellatyphimurium,1464
FIHHIIGGLFSVGKHIHGLIHGH,1406,4,5622,Cloning and functional characterization of three novel antimicrobial peptides from tilapia (Oreochromis niloticus).,Staphylococcusaureus,1056
FIHHIIGGLFSAGKAIHRLIRRRRR,1406,4,5623,Cloning and functional characterization of three novel antimicrobial peptides from tilapia (Oreochromis niloticus).,Staphylococcusaureus,1056
IWDAIFHGAKHFLHRLVNPGGKDAVKDVQQKQ,1406,4,5624,Cloning and functional characterization of three novel antimicrobial peptides from tilapia (Oreochromis niloticus).,Staphylococcusaureus,782
NPVSCVRNKGICVPIRCPGNMKQIGTCVGRAVKCCRKK,1407,23,5626,Bactericidal activity of tracheal antimicrobial peptide against respiratory pathogens of cattle.,Mannheimiahaemolytica,677
GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,243,2,5627,"A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus.",Escherichiacoli,2090
GCRFCCNCCPNMSGCGVCCRF,1408,52,5651,"Bass hepcidin synthesis, solution structure, antimicrobial activities and synergism, and in vivo hepatic response to bacterial infections.",Enterococcusfaecalis,105
GKFSVFGKILRSIAKVFKGVGKVRKQFKTASDLDKNQ,1008,4,5652,"Oxyopinins, large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins.",Staphylococcusaureus,783
FLSLIPHIVSGVAALAKHLG,1409,2,5656,"Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.",Escherichiacoli,2719
RRSKARGGSRGSKMGRKDSKGGSRGRPGSGSRPGGGSSIAGASRGDRGGTRNA,1410,4,5668,"Structural and functional characterization of CATH_BRALE, the defense molecule in the ancient salmonoid, Brachymystax lenok.",Staphylococcusaureus,784
DRCTKRYGRCKRDCLESEKQIDICSLPRKICCTEKLYEEDDMF,1411,2,5669,The novel human ?-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss.,Escherichiacoli,2720
YSKSLPLSVLNP,1412,4,5670,Detection of secreted antimicrobial peptides isolated from cell-free culture supernatant of Paenibacillus alvei AN5.,Staphylococcusaureus,785
NRWCFAGDD,1413,205,5672,Characterization of an antimicrobial peptide produced by Bacillus subtilis subsp. spizezinii showing inhibitory activity towards Haemophilus parasuis.,Haemophilusparasuis,786
GLLLDTVKGAAKNVAGILLNKLKCKMTGDC,1414,2,5683,Different expression profiles of bioactive peptides in Pelophylax nigromaculatus from distinct regions.,Escherichiacoli,428
AATAKKGAKKADAPAKPKKATKPKSPKKAAKKAGAKKGVKRAGKKGAKKTTKAKK,1416,8,5685,"cgMolluscidin, a novel dibasic residue repeat rich antimicrobial peptide, purified from the gill of the Pacific oyster, Crassostrea gigas.",Bacillussubtilis,787
GYGDGCYSEDDLSVCCKKKFKVIGKCFKSVRECQNSGCKYH,1417,194,5686,A novel cysteine-rich antifungal peptide ToAMP4 from Taraxacum officinale Wigg. flowers.,Alternariaalternata,2721
AMPWRPATGLLPIKPTHIKPLCGDD,1418,4,5691,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,788
GFLNTAMNTVTNLAGTLMDKAKCKIRGC,1418,4,5692,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,807
GIFSLFKAGAKFFGKNLLKEAGKAGAEHLACKAANQC,1418,4,5693,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,1813
FLPAVLKVAAHILPTAICAISRRC,1418,4,5694,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,1489
FMGTALKIAANVLPAAFCKIFKKC,1418,4,5695,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,1296
GLRDKIKNVAIDVAKGAGTGVLKALLCQLDKSC,1418,4,5696,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,820
GVLDTLKNVAIGVAKGAGTGVLKALLCQLDKSC,1418,4,5697,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,820
GAFGNLLKGVAKKAGLKILSIAQCKLSGTC,1418,4,5698,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,870
GAFGDLLKGVAKEAGLKLLNMAQCKLSGNC,1418,4,5699,"Identification of multiple antimicrobial peptides from the skin of fine-spined frog, Hylarana spinulosa (Ranidae).",Staphylococcusaureus,870
GLFGVLAKVAAHVVPAIAEHF,1419,25,5708,"Maculatin 1.1, an anti-microbial peptide from the Australian tree frog, Litoria genimaculata solution structure and biological activity.",Bacilluscereus,789
GWASSIGSILGKFAKGGAQAFLQPK,248,2,5714,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,316
GLLSNVAGLLKQFAKGGVNAVLNPK,248,2,5717,Origin and functional diversification of an amphibian defense peptide arsenal.,Escherichiacoli,2722
PPCRGIFCRRVGSSSAIARPGKTLSTFITV,1420,4,5729,"Identification and polymorphism discovery of the cathelicidins, Lf-CATHs in ranid amphibian (Limnonectes fragilis).",Staphylococcusaureus,790
GKCNVLCQLKQKLRSIGSGSHIGSVVLPRG,1420,4,5730,"Identification and polymorphism discovery of the cathelicidins, Lf-CATHs in ranid amphibian (Limnonectes fragilis).",Staphylococcusaureus,791
LLPIVGNLLKSLL,251,4,5732,"Design, structural and functional characterization of a Temporin-1b analog active against Gram-negative bacteria.",Staphylococcusaureus,411
EYHLMNGANGYLTRVNGKYVYRVTKDPVSAVFGVISNGWGSAGAGFGPQH,1422,206,5736,"Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578.",Bacilluscoagulans,2723
ACQCPDAISGWTHTDYQCHGLENKMYRHVYAICMNGTQVYCRTEWGSSC,1423,8,5743,"Identification, purification and characterization of laterosporulin, a novel bacteriocin produced by Brevibacillus sp. strain GI-9.",Bacillussubtilis,2346
DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR,1426,2,5782,"Molecular cloning, expression and characterization of the porcine beta defensin 2 in E. coli.",Escherichiacoli,2724
GFGCPNDYSCSNHCRDSIGCRGGYCKYQLICTCYGCKKRRSIQE,1429,8,5794,"Cloning and localization of MCdef, a defensin from Manila clams (Ruditapes philippinarum).",Bacillussubtilis,2323
GAFGNFLKGVAKKAGLKILSIAQCKLSGTC,1431,4,5805,"Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.",Staphylococcusaureus,870
GAFGNFLKGVAKKAGLKILSIAQCKLFGTC,1431,4,5806,"Two novel antimicrobial peptides from skin secretions of the frog, Rana nigrovittata.",Staphylococcusaureus,870
KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKPPAHRCICYYEC,1432,166,5807,Novel antifungal defensins from Nigella sativa L. seeds.,Aspergillusniger,293
KFCEKPSGTWSGVCGNSGACKDQCIRLEGAKHGSCNYKLPAHRCICYYEC,1432,166,5808,Novel antifungal defensins from Nigella sativa L. seeds.,Aspergillusniger,293
KICERASGTWKGICIHSNDCNNQCVKWENAGSGSCHYQFPNYMCFCYFDC,1436,158,5812,"Isolation, molecular cloning and antimicrobial activity of novel defensins from common chickweed (Stellaria media L.) seeds.",Bipolarissorokiniana,293
KICERASGTWKGICIHSNDCNNQCVKWENAGSGSCHYQFPNYMCFCYFNC,1436,158,5813,"Isolation, molecular cloning and antimicrobial activity of novel defensins from common chickweed (Stellaria media L.) seeds.",Bipolarissorokiniana,293
GLPVCGETCAGGTCNTPGCSCSWPICTRN,1437,127,5814,Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands.,Humanhistiocytic,2129
GLPVCGETCFGGTCNTPGCTCDPWPVCTRN,1437,127,5815,Cyclotides from an extreme habitat: characterization of cyclic peptides from Viola abyssinica of the Ethiopian highlands.,Humanhistiocytic,2129
LMCTHPLDCSN,1438,156,5816,Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation.,Candidatropicalis,792
DFGCARGMIFVCMRRCARMYPGSTGYCQGFRCMCDTHIPIRRPPFIMG,1439,4,5817,Cloning and characterization of a male-specific defensin-like antimicrobial peptide from the tick Haemaphysalis longicornis.,Staphylococcusaureus,793
RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRPLPFPRPGPRPIPRP,256,2,5818,Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.,Escherichiacoli,2710
RYCERSSGTWSGVCGNSGKCSNQCQRLEGAAHGSCNYVFPAHKCICYYPC,1440,65,5828,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea,293
QKLCERPSGTWSGVCGNNNACRNQCINLEKARHGSCNYVFPAHKCICYFPC,1440,65,5832,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea,293
RYCERSSGTWSGVCGNTDKCSSQCQRLEGAAHGSCNYVFPAHKCICYYPC,1440,65,5833,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea,293
QKLCERPSGTWSGVCGNNGACRNQCIRLERARHGSCNYVFPAHKCICYFPC,1440,65,5834,Four plant defensins from an indigenous South African Brassicaceae species display divergent activities against two test pathogens despite high sequence similarity in the encoding genes.,Botrytiscinerea,293
RRSRRGRGGGRRGGSGGRGGRGGGGRSGAGSSIAGVGSRGGGGGRHYA,1441,4,5835,Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate.,Staphylococcusaureus,794
MLCKLSMFGAVLGVPACAIDCLPMGKTGGSCEGGVCGCRKLTFKILWDKKFG,1442,4,5837,"A defensin-like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana.",Staphylococcusaureus,795
RMCKTPSGKFKGYCVNNTNCKNVCRTEGFPTGSCDFHVAGRKCYCYKPCP,1443,104,5838,"Recombinant expression, affinity purification and functional characterization of Scots pine defensin 1.",Fusariumsolani,292
TNYGNGVGVPDAIMAGIIKLIFIFNIRQGYNFGKKAT,1444,35,5839,"Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum.",Salmonellaenteritidis,2725
GFLDIIKDTGKEFAVKILNNLKCKLAGGCPP,1445,208,5841,Effects of Two Novel Peptides from Skin of Lithobates Catesbeianus on Tumor Cell Morphology and Proliferation,ListeriaATCC,1151
RTCESQSHRFKGTCVRQSNCAAVCQTEGFHGGNCRGFRRRCFCTKHC,1446,24,5851,"v-AMP1, a ripening induced peptide from Vitis vinifera shows strong antifungal activity.",Fusariumoxysporum,805
GFGCPWNRYQCHSHCRSIGRLGGYCAGSLRLTCTCYRS,1447,32,5858,"Purification of a novel arthropod defensin from the American oyster, Crassostrea virginica.",Lactococcuslactis,2331
IFGSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPQT,1448,21,5867,"Strongylocins, novel antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",Vibrioanguillarum,796
IFNSIYHRKCVVKNRCETVSGHKTCKDLTCCRAVIFRHERPEVCRPST,1449,21,5869,"Two recombinant peptides, SpStrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against Gram-positive and Gram-negative bacteria.",Vibrioanguillarum,796
WNPFRKLYRKECNDVTSCDTVSGVKTCTKKNCCHRKFFGKTILKAPECTVIS,1449,21,5870,"Two recombinant peptides, SpStrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against Gram-positive and Gram-negative bacteria.",Vibrioanguillarum,797
GKIPVKAIKKAGAAIGKGLRAINIASTAHDVYSFFKPKHKKK,1450,2,5874,"Isolation, gene expression and solution structure of a novel moricin analogue, antibacterial peptide from a lepidopteran insect, Spodoptera litura.",Escherichiacoli,307
KTCMTKKEGWGRCLIDTTCAHSCRKQGYKGGNCKGMRRTCYCLLDC,1451,24,5877,Cloning and characterization of a plant defensin VaD1 from azuki bean.,Fusariumoxysporum,869
RSMRLSFRARGYGFR,263,18,5882,New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.,Micrococcusluteus,418
SWLSKTAKKLENSAKKRISEGIAIAIKGGSR,1306,4,5883,Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.,Staphylococcusaureus,1069
SWLSKTYKKLENSAKKRISEGVAIAILGGLR,1306,4,5884,Cecropin P1 and novel nematode cecropins: a bacteria-inducible antimicrobial peptide family in the nematode Ascaris suum.,Staphylococcusaureus,1069
MRKEFHNVLSSGQLLADKRPARDYNRK,267,62,5888,Functional and structural characteristics of anticancer peptide Pep27 analogues.,Acutemyeloid,1204
SCTCRRAWICRWGERHSGKCIDQKGSTYRLCCRR,1452,2,5935,"A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.",Escherichiacoli,2726
LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF,272,5,5979,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV,2727
QRPRLSHKGPMPF,272,5,5982,Apelin peptides block the entry of human immunodeficiency virus (HIV).,HIV,2727
GLLNVIKDTAQNLFAAALDKLKCKVTKCN,1454,2,6008,Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.,Escherichiacoli,1004
GLLNVIKDTAQNLFAAALEKLKCKVTKCN,1454,2,6009,Evidence from the primary structures of dermal antimicrobial peptides that Rana tagoi okiensis and Rana tagoi tagoi (Ranidae) are not conspecific subspecies.,Escherichiacoli,1004
DDDKTEEEDDKENETTKVVE,1455,8,6075,Novel antimicrobial peptides isolated from skin secretions of the Mexican frog Hyla eximia.,Bacillussubtilis,798
KYYGNGVHCTKSGCSVNWGEAFSAGVHRLANGGNGFW,1456,50,6095,"Characterization of leucocin B-KM432Bz from Leuconostoc pseudomesenteroides isolated from boza, and comparison of its efficiency to pediocin PA-1.",Enterococcusfaecium,799
GIMDTIKGAAKDLAGQLLDKLKCKITKC,1457,2,6166,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli,807
FLGAIAGVAAKFLPKVFCFITKKC,1457,2,6167,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli,1296
FLPLIAGVAANFLPKIFCLISKKC,1457,2,6168,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli,111
FLPVIASVAAKVLPKVFCFITKKC,1457,2,6169,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli,1296
FLPLIAGVAASILPKIFCFITKKC,1457,2,6170,"Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).",Escherichiacoli,1296
AISYGNGVYCNKEKCWVNKAENKQAITGIVIGGWASSLAGMGH,1458,209,6216,Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells.,Carnobacteriumdivergens,649
VNYGNGVSCSKTKCSVNWGQAFQERYTAGINSFVSGVASGAGSIGRRP,1458,209,6227,Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells.,Carnobacteriumdivergens,799
GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,1459,2,6281,Bactericidal activity of Musca domestica cecropin (Mdc) on multidrug-resistant clinical isolate of Escherichia coli.,Escherichiacoli,1795
TVSAEESCPPGAVWSTCSNCHAYCKNKDLMCITACQEGCKCTTQGYKIHNNECIPAEKCP,1461,8,6464,Proteomic analysis of skin defensive factors of tree frog Hyla simplex.,Bacillussubtilis,800
FSRYARMRDSRPWSDRKNNYSGPQFTYPPEKAPPEKLIKWNNEGSPIFEMPAEGGHIEP,1462,4,6587,"A novel antimicrobial peptide from skin secretions of the earthworm, Pheretima guillelmi (Michaelsen).",Staphylococcusaureus,801
RECKAQGRHGTCFRDANCVQVCEKQAGWSHGDCRAQFKCKCIFEC,1463,210,6593,"NmDef02, a novel antimicrobial gene isolated from Nicotiana megalosiphon confers high-level pathogen resistance under greenhouse and field conditions.",Phytophthorainfestans,802
PDPGQPWQVKAGRPPCYSIPCRKHDECRVGSCSRCNNGLWGDRTCR,1464,25,6594,"Purification and characterization of a novel salivary antimicrobial peptide from the tick, Ixodes scapularis.",Bacilluscereus,803
ATYDGKCYKKDNICKYKAQSGKTAICKCYVKVCPRDGAKCEFDSYKGKCYC,1465,4,6595,A highly thermostable antimicrobial peptide from Aspergillus clavatus ES1: biochemical and molecular characterization.,Staphylococcusaureus,804
RYCLSQSHRFKGLCMSSSNCANVCQTENFPGGECKADGATRKCFCKKIC,1466,211,6596,Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.,Kocuriarhizophila,805
RHRHCFSQSHKFVGACLRESNCENVCKTEGFPSGECKWHGIVSKCHCKRIC,1466,211,6598,Evolutionary relationship between defensins in the Poaceae family strengthened by the characterization of new sugarcane defensins.,Kocuriarhizophila,805
ENDHRMPNELNRPNNLSKGGAKCGAAIAGGLFGIPKGPLAWAAGLANVYSKCN,1467,14,6622,"Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A.",Lactobacillussakei,1000
TTHSGKYYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGGAIPGKC,1467,14,6623,"Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A.",Lactobacillussakei,649
VTCELLMFGGVVGDSACAANCLSMGKAGGSCNGGLCDCRKTTFKELWDKRFG,1468,4,6644,A defensin antimicrobial peptide from the venoms of Nasonia vitripennis.,Staphylococcusaureus,795
FNKLKQGSSKRTCAKCFRKIMPSVHELDERRRGANRWAAGFRKCVSSICRY,1469,2,6645,"Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization.",Escherichiacoli,1001
LSKYGGECSVEHNTCTYLKGGKDHIVSCPSAANLRCKTERHHCEYDEHHKTVDCQTPV,1470,2,6646,Isolation and characterization of a novel antifungal peptide from Aspergillus niger.,Escherichiacoli,2115
TPGGIDFISGGPHVAQDVLNAIKNFFK,1471,206,6692,Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish.,Bacilluscoagulans,1002
YSSKDCLKDIGKGIGAGTVAGAAGGGLAAGLGAIPGAFVGAHFGVIGGSAACIGGLLGN,1471,206,6693,Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish.,Bacilluscoagulans,1003
FLPFLLSALPKVFCFFSKKC,1472,4,6702,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus,806
FLPLLLSALPSFLCLVFKKC,1472,4,6703,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus,1693
GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC,1472,4,6704,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus,807
GLADYWRTAFRANFANLGPGIRCKSARC,1472,4,6705,"Molecular cloning and functional characterization of novel antimicrobial peptides from the skin of brown frog, Rana zhenhaiensis.",Staphylococcusaureus,808
GADRCRERCERRHRGDWQGKQRCLMECRRREQEED,1473,33,6766,A novel hairpin-like antimicrobial peptide from barnyard grass (Echinochloa crusgalli L.) seeds: Structure-functional and molecular-genetics characterization.,Pseudomonassyringae,809
DCYCRIPACIAGERRYGTCIYQGRLWAFCC,1474,30,6785,Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.,HIV-1IIIB,425
RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAI,333,77,6851,Biological activities of cecropin B-thanatin hybrid peptides.,Klebsiellapneumoniae,2096
SFLNFFKGAAKNLLAAGLDKLKCKISGTQC,1476,2,7008,A family of acyclic brevinin-1 peptides from the skin of the Ryukyu brown frog Rana okinavana.,Escherichiacoli,1004
GGLRSLGRKILRAWKKYGPIIVPIIRIG,1477,2,7038,"Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific.",Escherichiacoli,1005
RFGRFLRKIRRFRPKVTITIQGSARF,1478,2,7129,Chicken cathelicidins display antimicrobial activity against multiresistant bacteria without inducing strong resistance.,Escherichiacoli,1078
RVKRFWPLVPVAINTVAAGINLYKAIRRK,1478,2,7130,Chicken cathelicidins display antimicrobial activity against multiresistant bacteria without inducing strong resistance.,Escherichiacoli,1077
GRPNPVNNKPTPHPRL,356,2,7178,Hydroxyproline substitutions stabilize non-glycosylated drosocin against serum proteases without challenging its antibacterial activity.,Escherichiacoli,687
GFFLNALKNFAKTAGKRLKSLLNHASCKLSGQC,1479,2,7211,Purification and modeling amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli,233
VIPFVASVAAEMMQHIFCAASRKC,1479,2,7212,Purification and modeling amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis.,Escherichiacoli,1061
FLPLIGRVLSGIL,363,8,7382,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,810
ILGPVLGLVSDTLDDVLGIL,363,8,7383,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,679
VAIALKAAHYHTHKE,363,8,7384,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,811
GLFDVIKKVASVIGGL,363,8,7386,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,2459
GWFDVVKHIASAV,363,8,7387,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,812
SKGKKANKDVELARG,363,8,7388,"Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis.",Bacillussubtilis,813
RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP,365,2,7468,Antimicrobial and immunomodulatory activities of PR-39 derived peptides.,Escherichiacoli,1006
GFCWYVCVYRNGVRVCYRRCN,1480,2,7486,Polypeptides having antimicrobial activity and polynucleotides encoding same.,Escherichiacoli,174
LLFGKIISRLLGN,1481,182,7658,"Development of antimicrobial peptide defenses of southern leopard frogs, Rana sphenocephala, against the pathogenic chytrid fungus, Batrachochytrium dendrobatidis.",Batrachochytriumdendrobatidis,814
KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF,381,2,7699,Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.,Escherichiacoli,1694
LRDLVCYCRTRGCKRRERMNGTCRKGHLMYTLCCR,1482,42,7701,Cryptdins: antimicrobial defensins of the murine small intestine.,Salmonellatyphimurium,1007
CVLIGQRCDNDRGPRCCSGQGNCVPLPFLGGVCAV,1483,4,7862,A Cactus-Derived Toxin-Like Cystine Knot Peptide with Selective Antimicrobial Activity.,Staphylococcusaureus,815
SLGNFFRKARKKIGEEFKRIVQRIKDFLQHLIPRTEA,1485,2,7987,Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity.,Escherichiacoli,635
DLRGACAAAHAL,395,180,7995,"Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",Listonellaanguillarum,816
DLRAICAGAHAL,395,1,7999,"Centrocins: isolation and characterization of novel dimeric antimicrobial peptides from the green sea urchin, Strongylocentrotus droebachiensis.",None_target,817
TLIWEFYHQILDEYNKENKG,1060,4,8032,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,818
FLPGLIKVAVGVGSTILCKITKKC,1060,4,8033,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,819
FLPGLIKAAVGIGSTIFCKISRKC,1060,4,8034,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,819
SILSTLKDVGISAIKSAGSGVLSTLLCKLNKNC,1060,4,8035,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,820
SILSTLKDVGISALKNAGSGVLKTLLCKLNKNCEK,1060,4,8036,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,820
FLPMLAGLAANFLPKIICKITKKC,1060,4,8039,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,1296
FLPIVASLAANFLPKIICKITKKC,1060,4,8040,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,1296
FLPPSPWKETFRTT,1060,4,8041,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,821
NILSSIANGINRALSFFG,1060,4,8042,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,822
GFMDTAKNVAKNVAKNVAVTLLDKLRCKVTGGC,1060,4,8043,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,807
SIMSTLKQFGISAIKGAAQNVLGVLSCKIAKTC,1060,4,8044,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,868
GIFSLIKTAAKFVGKNLLKQAGKAGLEHLACKANNQC,1060,4,8045,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,445
AVIPPLRCKAAFC,1060,4,8046,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,823
FLPLFLPKIICEITKKC,1060,4,8047,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,824
GLWNTIKEAGKKFALNLLDKIRCGIAGGCKG,1060,4,8048,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,1151
GFMDTAKNVFKNVAVTLLDKLKCKIAGGC,1060,4,8049,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,807
GILDTLKQLGKAAAQSLLSKAACKLAKTC,1060,4,8050,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,2314
QINWGSVVGHCIGGAIIGGAFSGGAAAGVGCLVGSGKAIINGL,1486,1,8059,"Thermophilin 13, a nontypical antilisterial poration complex bacteriocin, that functions without a receptor.",None_target,2315
LALERRSGWLRLFGLKPRRKH,1487,4,8062,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus,2316
NFAEIFAAVNKLIKQGVVKG,1487,4,8063,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus,2317
ILPIIGKILSTIFGK,1487,4,8064,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus,2318
GLLSVFKGVLKTAGKNVAKNVAGSLLDQLKCKISGGC,1487,4,8065,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus,807
GLWDSIKNFGKTIALNVMDKIKCKIGGGCPP,1487,4,8066,"Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis.",Staphylococcusaureus,1151
KRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV,1488,4,8072,AP-57/C10orf99 is a new type of mutifunctional antimicrobial peptide.,Staphylococcusaureus,2319
ATCDLLSGTGVGHSACAAHCLLRGNRGGYCNGKGVCVCRN,1489,4,8085,Molecular characterization and expression of the antimicrobial peptide defensin from the housefly (Musca domestica).,Staphylococcusaureus,1468
VTCDLLSFEAKGFAANHSICAAHCLAIGRKGGSCQNGVCVCRN,1490,48,8086,"Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.",Bacillusmegaterium,1468
VTCDLLSFEAKGFAANHSICAAHCLVIGRKGGACQNGVCVCRN,1490,48,8087,"Two novel insect defensins from larvae of the cupreous chafer, Anomala cuprea: purification, amino acid sequences and antibacterial activity.",Bacillusmegaterium,1468
VTCDLLSLQIKGIAINDSACAAHCLAMRRKGGSCKQGVCVCRN,1491,8,8088,"A sapecin homologue of Holotrichia diomphalia: purification, sequencing and determination of disulfide pairs.",Bacillussubtilis,1468
GFGCPFNQGACHRHCRSIGRRGGYCAGLFKQTCTCYSR,1492,4,8092,"Identification and characterization of antimicrobial peptide, defensin, in the taiga tick, Ixodes persulcatus.",Staphylococcusaureus,1467
LTCDILGSTPACAAHCIARGYRGGWCDGQSVCNCRR,1493,2,8093,"Isolation, characterization and chemical synthesis of a new insect defensin from Chironomus plumosus (Diptera).",Escherichiacoli,1468
LLSLALAALPKLFCLIFKKC,1494,4,8094,Identification and characterisation of a novel antimicrobial polypeptide from the skin secretion of a Chinese frog (Rana chensinensis).,Staphylococcusaureus,2320
ATCDLLSGFGVGDSACAAHCIARRNRGGYCNAKKVCVCRN,1037,18,8104,Full sequence and characterization of two insect defensins: immune peptides from the mosquito Aedes aegypti.,Micrococcusluteus,1468
APVPFSCTRGCLTHLV,1495,18,8106,A non-pediocin low molecular weight antimicrobial peptide produced by Pediococcus pentosaceus strain IE-3 shows increased activity under reducing environment.,Micrococcusluteus,2321
LRLKSIVSYAKKVL,1496,2,8128,Identification and biochemical characterization of a new antibacterial and antifungal peptide derived from the insect Sphodromantis viridis.,Escherichiacoli,1008
CWSCMGHSCWSCMGHSCWSCAGHSCWSCMGHSCWSCMGHSCWSCAGHCCGSCWHGGM,1497,17,8130,"Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93.",Listeriamonocytogenes,2322
GSCGASIAEFNSSQILAKRAPPCRRPRLQNSEDVTHTTLP,1498,36,8155,"ARACINs, Brassicaceae-specific peptides exhibiting antifungal activities against necrotrophic pathogens in Arabidopsis.",Alternariabrassicicola,1009
GSCGAPISKYDFQVLAKRPPPCRRPRLENTEDVTHTTRP,1498,36,8156,"ARACINs, Brassicaceae-specific peptides exhibiting antifungal activities against necrotrophic pathogens in Arabidopsis.",Alternariabrassicicola,1009
KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL,403,2,8157,"Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity, and Special Mechanism.",Escherichiacoli,723
GFGCPEDEYECHNHCKNSVGCRGGYCDAGTLRQRCTCYGCNQKGRSIQE,1499,4,8161,"A defensin from clam Venerupis philippinarum: Molecular characterization, localization, antibacterial activity, and mechanism of action.",Staphylococcusaureus,2323
FSTKTRNWFSEHFKKVKEKLKDTFA,404,2,8162,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,1010
KTRNWFSEHFKKVKEKLKDTFA,404,2,8163,Bioprospecting the American alligator (Alligator mississippiensis) host defense peptidome.,Escherichiacoli,1010
ATCDLLSPFKVGHAACAAHCIARGKRGGWCDKRAVCNCRK,1500,4,8170,Purification and characterization of a novel antibacterial peptide from black soldier fly (Hermetia illucens) larvae.,Staphylococcusaureus,1468
GRRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA,405,7,8171,Identification of multifunctional peptides from human milk.,Streptococcusmutans,2324
GWLRDFGKRIERVGQHTRDATIQAIGVAQQAANVAATVRG,1501,2,8173,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1795
GWLKKIGKKIERVGQHTRDATIQVLGVAQQAANVAATARG,1501,2,8174,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1795
GWLKKIGKKIERVGQHTRDASIQAIGIAQQAANVAATARG,1501,2,8175,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1795
GLVKKIGKKIERVGQHTRDASIQAIGIAQQAANVAATARG,1501,2,8176,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1795
GWLKKFGKKIERVGQHTRDATIQAIGVAQQAANVAATLKG,1501,2,8177,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1795
ATCDLLSATGFSGTACAAHCLLIGHRGGYCNTKSVCVCRD,1501,2,8178,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1468
ATCDLLSGTGVKHSACAAHCLLRGNRGGYCNGRAICVCRN,1501,2,8179,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1468
ATCDLLSGTGANHSACAAHCLLRGNRGGYCNSKAVCVCRN,1501,2,8180,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1468
LTCNIDRSFCLAHCLLRGYKRGFCTVKKICVCRH,1501,2,8181,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,2102
GTCSFSSALCVVHCRVRGYPDGYCSRKGICTCRR,1501,2,8182,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1011
FTCNSYACKAHCILQGHKSGSCARINLCKCQR,1501,2,8183,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1012
HHHHRFGKIGHELHKGVKKVEKVTHDVNKVTSGVKKVASSIEKAKNV,1501,2,8184,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1013
HHHFGRIGHELHKGVKKVEKVTSDVNKVTNGVKQVANGIAKAKTVIEAGSIAGAVAAAAA,1501,2,8185,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1013
HHHLFGHVGHEVERSLHKVGHKLEHACHEVHKTAKKVQK,1501,2,8187,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1014
AGFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,1501,2,8188,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1015
GFRKRFNKLVKKVKHTIKETANVSKDVAIVAGSGVAVGAAMG,1501,2,8189,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1015
EWRPHGSNGGSSLRPGRPQTLPPQRPIQPDFNGPRQRF,1501,2,8191,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1016
EWRPHGSIGGSGLRPGRPQTLPPQRPRRPDFNGPRHRF,1501,2,8192,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1016
SPFVDRPRRPIQHNGPKPRIITNPPFNPNARPAW,1501,2,8193,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1017
SWIKKDKFPSSTGPYNPNPPPPRF,1501,2,8194,Antimicrobial peptides expressed in medicinal maggots of the blow fly Lucilia sericata show combinatorial activity against bacteria.,Escherichiacoli,1018
KACPRNCDTDIAYMVCPSSGERIIRKVCTNCCAAQKGCKLFRSNGSIKCTGT,1503,37,8196,"Characterization of Peptides from Capsicum annuum Hybrid Seeds with Inhibitory Activity Against ?-Amylase, Serine Proteinases and Fungi.",Saccharomycescerevisiae,1019
FLPLILPSIVTALSSFLKQG,1504,4,8197,"Identification and characterization of an antimicrobial peptide of Hypsiboas semilineatus (Spix, 1824) (Amphibia, Hylidae). ",Staphylococcusaureus,2325
GASPALWGCDSFLGYCRIACFAHEASVGQKDCAEGMICCLPNVF,1505,2,8198,The first anionic defensin from amphibians.,Escherichiacoli,1020
GRADYNFGYGLGRGTRKFFNGIGRWVRKTF,1506,14,8200,"Purification and characterization of a novel plantaricin, KL-1Y, from Lactobacillus plantarum KL-1.",Lactobacillussakei,1021
SSRRPCRGRSCGPRLRGGYTLIGRPVKNQNRPKYMWV,406,2,8201,A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria.,Escherichiacoli,1022
FFPIVAGVAGQVLKKIYCTISKKC,1507,2,8204,"Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala.",Escherichiacoli,1296
MTPLWRVMGNKPFGAYCQDHVECSTGICKGGHCIYSQPIKS,1508,212,8205,"Molecular characterization of the liver-expressed antimicrobial peptide 2 (LEAP-2) in a teleost fish, Plecoglossus altivelis: antimicrobial activity and molecular mechanism.",Vibriovulnificus,1808
QSHISLCRWCCNCCKANKGCGFCCKF,1509,96,8206,Turbot (Scophthalmus maximus) hepcidin-1 and hepcidin-2 possess antimicrobial activity and promote resistance against bacterial and viral infection.,Edwardsiellatarda,1597
GMKCKFCCNCCNLNGCGVCCRF,1509,96,8207,Turbot (Scophthalmus maximus) hepcidin-1 and hepcidin-2 possess antimicrobial activity and promote resistance against bacterial and viral infection.,Edwardsiellatarda,105
KSCCRNTTARNCYNVCRIPG,1512,1,8274,"Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",None_target,2517
TPRPVCAATCDCKIITGTKCPPGYEK,1512,1,8275,"Purification, characterization, and sequencing of novel antimicrobial peptides, Tu-AMP 1 and Tu-AMP 2, from bulbs of tulip (Tulipa gesneriana L.).",None_target,2517
DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK,1513,2,8282,Human-?-defensins-1-3 and analogs do not require proton motive force for antibacterial activity against Escherichia coli.,Escherichiacoli,2724
GYGCPFNQYQCHSHCKGIRGYKGGYCKGAFKQTCKCY,414,8,8285,Structural and functional characterization of peptides derived from the carboxy-terminal region of a defensin from the tick Ornithodoros savignyi.,Bacillussubtilis,2323
GVFDIIKGAGKQLIAHAMEKIAEKVGLNKDGN,1514,2,8293,Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.,Escherichiacoli,1023
GVFDIIKGAGKQLIAHAMGKIAEKVGLNKDGN,1514,2,8294,Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.,Escherichiacoli,1023
GVFDIIKGAGKQLIARAMGKIAEKVGLNKDGN,1514,2,8295,Characterization and Biological Activities of Ocellatin Peptides from the Skin Secretion of the Frog Leptodactylus pustulatus.,Escherichiacoli,1023
SGPNGQCGPGWGGCRGGLCCSQYGYCGSGPKYCAH,1515,65,8296,A novel antifungal peptide from leaves of the weed Stellaria media L.,Botrytiscinerea,2326
VGPGGECGGRFGGCAGGQCCSRFGFCGSGPKYCAH,1515,166,8297,A novel antifungal peptide from leaves of the weed Stellaria media L.,Aspergillusniger,2326
GYYCPFRQDKCHRHCRSFGRKAGYCGNFLKRTCICVKK,415,17,8298,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2327
GYFCPYNGYCDHHCRKKLRWRGGYCGGRWKLTCICVRG,415,17,8300,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2328
GFFCPYNGYCDRHCRKKLRRRGGYCGGRWKLTCICIMN,415,17,8301,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2328
GFGCPLNQGACHNHCRSIKRRGGYCSGIIKQTCTCYRK,415,17,8302,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2331
GFGCPKSALSCSQQCRENNTHSGGYCNGPFNIVCSCY,415,17,8304,Ixodes ricinus defensins attack distantly-related pathogens.,Listeriamonocytogenes,2329
GFLSILKKVLPKVMAHMK,416,1,8307,Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity.,None_target,2330
VPAESEAAHLRVRRGFGCPLNQGACHNHCRSIRRRGGYCSGIIKQTCTCYRN,1516,101,8335,"Molecular characterization of a defensin gene from a hard tick, Dermacentor silvarum.",Bacilluspumilus,2331
LKGASKLIPHLLPSRQQ,1517,2,8338,Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.,Escherichiacoli,2265
IRPVPFFPPVHAKKVFPLH,1517,2,8340,Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis.,Escherichiacoli,1024
EWKLPDLIINHITLTRRNCFKYRCG,1518,213,8351,"Gene cloning, expression profiling and anti-microbial assay of Muscin, a new antimicrobial peptide in the housefly (Musca domestica)",Microbacteriumoxydans,1025
FLPGLIKAAVGVGSTILCKITKKC,1060,4,8373,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus.",Staphylococcusaureus,819
FLPGLIKAAVGIGSTIFCKISKKC,1519,4,8374,"Identification of multiple peptides with antioxidant and antimicrobial activities from skin and its secretions of Hylarana taipehensis, Amolops lifanensis, and Amolops granulosus",Staphylococcusaureus,819
PPIQNPSMAPPTQNPYGQPMTPPTQNPYGQPMAPP,1520,2,8416,Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus.,Escherichiacoli,1026
GLLSGILGAGKRIVCGLSGLC,1521,4,8425,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,264
GIFSKFAGRGLKNLFMKGAKKIGKEVGMDVLRTGIDIAGCKIRGEC,1521,4,8426,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,1750
FLPAVLRVAAKVGPAVFCAITQKC,1521,4,8427,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,462
RFCFKGTPCG,1521,4,8428,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,2332
FFPLIAGLAARFLPKIFCSITKRC,1521,4,8429,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,1296
GIFSKFAGKGLKNLFMKGAKTIGKEVGMDVLRTGIDIAGCKIKGEC,1521,4,8430,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,1750
GLLSGILGAGKKIVCGLSGLC,1521,4,8431,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,264
FLPGLECVSGKIVPTVFCAITRIC,1521,4,8432,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,2333
VIPFVASVAAEMMQHVYCAASKRC,1521,4,8433,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,1061
SFLSTFKKLAIDAAKNAGQSVLHTLTCKLDNQC,1521,4,8434,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,820
GIFSKFVGKGLKNLFMKGAKTIGREVGMDVLRTGIDIAGCKIKGEC,1521,4,8435,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,1750
FFPSIAGLAAKFLPKIFCSITKRC,1521,4,8436,Novel peptides from skins of amphibians showed broad-spectrum antimicrobial activities.,Staphylococcusaureus,1296
SPAIWGCDSFLGYCRLACFAHEASVGQKECAEGMLCCIPNVF,1522,2,8441,"A novel defensin-like antimicrobial peptide from the skin secretions of the tree frog, Theloderma kwangsiensis.",Escherichiacoli,1020
GLLSGLKKVGKHVAKNVAVSLMDSLKCKISGDC,1523,4,8579,"Ranatuerin 1T: an antimicrobial peptide isolated from the skin of the frog, Rana temporaria.",Staphylococcusaureus,807
NPFKKLERVGQHIRDGIIKAGPAVEVIGQANSIARPAGK,1524,4,8606,Cecropins from Plutella xylostella and Their Interaction with Metarhizium anisopliae.,Staphylococcusaureus,2096
KGFKKIEKLGRHIRDGVVKAGPAVGVVGQASSIMG,1524,4,8607,Cecropins from Plutella xylostella and Their Interaction with Metarhizium anisopliae.,Staphylococcusaureus,2096
LIQRGRFGRFLGRIRRFRPRINFDIRARGSIRLG,1525,2,8609,Novel Cathelicidins from Pigeon Highlights Evolutionary Convergence in Avain Cathelicidins and Functions in Modulation of Innate Immunity.,Escherichiacoli,1027
KRFWQLVPLAIKIYRAWKRR,1526,2,8610,Identification of a novel cathelicidin antimicrobial peptide from ducks and determination of its functional activity and antibacterial mechanism.,Escherichiacoli,1028
NLCASLRARHTIPQCKKFGRR,1527,2,8612,Identification of a novel antimicrobial peptide from amphioxus Branchiostoma japonicum by in silico and functional analyses.,Escherichiacoli,2006
GLPWILLRWLFFRG,1528,4,8613,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2334
AIPWIWIWRLLRKG,1528,4,8614,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2335
RIRFPWPWRWPWWRRVRG,1528,4,8615,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2336
RIRFPWPWRWPWWPRFRG,1528,4,8616,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2337
AIPWIWIWWLLRKG,1528,4,8617,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2335
AIPWSIWWRLLFKG,1528,4,8618,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2338
AIPWSIWWHLLFKG,1528,4,8619,"Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins.",Staphylococcusaureus,2338
GLRKKFRKTRKRIQKLGRKIGKTGRKVWKAWREYGQIPYPCRI,431,67,8645,Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.,Yersiniaruckeri,1029
ATCDLLSISTPWGSVNHAACAAHCLALNRGFRGGYCSSKAVCTCRK,1529,4,8704,"Purification and characterization of a novel defensin from the salivary glands of the black fly, Simulium bannaense.",Staphylococcusaureus,1468
ATCDLFSFQSKWVTPNHAACAAHCTARGNRGGRCKKAVCHCRK,1530,214,8705,Characterization of Cimex lectularius (bedbug) defensin peptide and its antimicrobial activity against human skin microflora.,Corynebacteriumrenale,1468
ACDFQQCWVTCQRQYSINFISARCNGDSCVCTFRT,1531,4,8706,Cloning and purification of the first termicin-like peptide from the cockroach Eupolyphaga sinensis.,Staphylococcusaureus,2339
QSHLSMCRYCCNCCRNNKGCGFCCKF,1532,4,8707,Two hepcidins from spotted scat (Scatophagus argus) possess antibacterial and antiviral functions in vitro.,Staphylococcusaureus,1597
NPAGCRFCCGCCPNMIGCGVCCRF,1532,4,8708,Two hepcidins from spotted scat (Scatophagus argus) possess antibacterial and antiviral functions in vitro.,Staphylococcusaureus,105
GLPLCGETCVGGTCNTPGCSCGWPVCVRN,1533,112,8715,Viola plant cyclotide vigno 5 induces mitochondria-mediated apoptosis via cytochrome C release and caspases activation in cervical cancer cells.,Humancervical,2129
AVAGEKLWLLPHLLKMLLTPTP,1534,129,8764,Antimycobacterial Activity of a New Peptide Polydim-I Isolated from Neotropical Social Wasp Polybia dimorpha.,Mycobacteriumabscessus,1030
GFGCPRDQYKCNSHCQSIGCRAGYCDAVTLWLRCTCTDCNGKK,1535,34,8789,Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.,Micrococcuslysodeikticus,2323
GFGCPGDQYECNRHCRSIGCRAGYCDAVTLWLRCTCTGCSGKK,1535,34,8790,Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.,Micrococcuslysodeikticus,2323
AGLQFPVGRIGRLLRK,1536,50,8808,"Scolopendin 2, a cationic antimicrobial peptide from centipede, and its membrane-active mechanism.",Enterococcusfaecium,882
FWQKMSFA,1537,25,8892,"Purification and Characterization of Plantaricin JLA-9: A Novel Bacteriocin against Bacillus spp. Produced by Lactobacillus plantarum JLA-9 from Suan-Tsai, a Traditional Chinese Fermented Cabbage.",Bacilluscereus,2340
AATKPKKAGAEAAPKKPAKKQTKKKPAKKAGGKKKPKRAGAKKAKK,1538,8,8926,"Antimicrobial peptide, hdMolluscidin, purified from the gill of the abalone, Haliotis discus.",Bacillussubtilis,2341
MPRRRRSSSRPVRRRRRPRVSRRRRRRGGRRR,449,2,8930,Rational design of artificial ?-strand-forming antimicrobial peptides with biocompatible properties.,Escherichiacoli,1031
GMASLLAKVLPHVVKLIK,450,18,8943,Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells.,Micrococcusluteus,494
GGLKKLGKKLEGAGKRVFKASEKALPVVVGIKAIGK,453,2,8974,Aedesin: structure and antimicrobial activity against multidrug resistant bacterial strains.,Escherichiacoli,1209
KYYGNGVHCTKSGCSVNWGEAFSAGVHRLA,1539,206,9000,Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.,Bacilluscoagulans,799
KGLGKLIGIDWLLGQAKDAVKQYKKDYKRWH,1539,206,9001,Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.,Bacilluscoagulans,1032
FIGRAIGDFVYFGAKGLRESGKLLNYYYKHKH,1539,206,9002,Identification and characterization of novel multiple bacteriocins produced by Leuconostoc pseudomesenteroides QU 15.,Bacilluscoagulans,1033
DTTPCGESCVWIPCVSSIVGCSCQNKVCYQN,1540,2,9050,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,2082
DTIPCGESCVWIPCISSILGCSCKDKVCYHN,1540,2,9051,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,2082
GLPICGETCFKTKCYTKGCSCSYPVCKRN,1540,2,9052,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,993
GSVIGCGETCLRGRCYTPGCTCDHGICKKN,1540,2,9053,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,993
GSVIKCGESCLLGKCYTPGCTCSRPICKKN,1540,2,9054,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,993
GSAIRCGESCLLGKCYTPGCTCDRPICKKN,1540,2,9055,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,993
DLQCAETCVHSPCIGPCYCKHGLICYRN,1540,2,9056,Immunostimulating and Gram-negative-specific Antibacterial Cyclotides from the Butterfly Pea Clitoria ternatea.,Escherichiacoli,1034
FFVLKFLLKWAGKVGLEHLACKFKNWC,1541,2,9058,Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor.,Escherichiacoli,1035
YPCKLNLKLGKVPFH,460,2,9125,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,1036
LRHKVYGYCVLGP,460,2,9130,De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus).,Escherichiacoli,1037
RGSALTHLP,1542,215,9190,"Cationic Antimicrobial Peptides Derived from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and Apoptotic Induction on Human Cervical Cancer Cells.",Vibriocholerae,1038
KKKKQSWYAAAGDAIVSFGEGFLNAW,464,1,9194,Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.,None_target,2342
RNKLAYNMGHYAGKATIFGLAAWALLA,464,1,9196,Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.,None_target,2343
IEFEKSTESHDIQKRGVTITVKPPFPGCVFYECIANCRSRGYKNGGYCTINGCQCLR,1543,8,9206,"Cloning and expression of gallerimycin, an antifungal peptide expressed in immune response of greater wax moth larvae, Galleria mellonella.",Bacillussubtilis,2344
MELRGCNNSGCDSVCRALGFNHGRCVSADTCRCYN,1544,2,9207,The potential of the Galleria mellonella innate immune system is maximized by the co-presentation of diverse antimicrobial peptides.,Escherichiacoli,1039
KWKIFKKIEKAGRNIRDGIIKAGPAVSVVGEAATIYKTG,1544,2,9208,The potential of the Galleria mellonella innate immune system is maximized by the co-presentation of diverse antimicrobial peptides.,Escherichiacoli,2096
RTCENLADKYRGPCFSGCDTHCTTKENAVSGRCRDDFRCWCTKRC,1545,89,9210,Differential antifungal and calcium channel-blocking activity among structurally related plant defensins.,Fusariumgraminearum,423
RTCESQSHKFKGPCASDHNCASVCQTERFSGGRCRGFRRRCFCTTHC,466,89,9212,Structure-activity determinants in antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium graminearum.,Fusariumgraminearum,805
VSFPWSCAALSGVCRQGACLPSELYFGPLGCGKGSLCCVSYFL,1546,2,9235,"Identification and characterization of a ?-defensin gene involved in the immune defense response of channel catfish, Ictalurus punctatus.",Escherichiacoli,1040
AAKIILNPKFRCKAAFC,474,2,9365,Kunitzins: Prototypes of a new class of protease inhibitor from the skin secretions of European and Asian frogs.,Escherichiacoli,2652
MGAIIKAGAKIVGKGVLGGGASWLGWNVGEKIWK,1547,32,9410,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1041
MGAIIKAGAKIIGKGLLGGAAGGATYGGLKKIFG,1547,32,9411,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1041
MGAIIKAGAKIVGKGALTGGGVWLAEKLFGGK,1547,32,9412,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1042
MGKLAIKAGKIIGGGIASALGWAAGEKAVGK,1547,32,9414,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1043
MGAVAKFLGKAALGGAAGGATYAGLKKIFG,1547,32,9415,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1041
MGALIKTGAKIIGSGAAGGLGTYIGHKILGK,1547,32,9416,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1042
MGAVIKVGAKVIGWGAASGAGLYGLEKIFKK,1547,32,9417,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1042
MGAVVKGGLKIIGGTAASWLGWEAGTRIWK,1547,32,9419,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1044
MGAAVKMLGKAFAGGVAGGATYGGLKKIFG,1547,32,9420,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1041
MGAVVKGALKIIGGGAASGGAVYGLERIFGR,1547,32,9421,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1045
MGKKIGKWIITGAAGWAGWEIGEGIWK,1547,32,9423,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1046
MKYLGTLIKGAAGGAGAYVGEKIYNWYKN,1547,32,9424,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1047
MGALFKAALKAAGGGAAGGATYGGLKHFFG,1547,32,9425,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1041
MAKIGKWVVKGAAGYLGWEIGEGIWK,1547,32,9428,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1046
MGALVKGGLKLIGGTAASWLGWEAGERVWK,1547,32,9429,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1044
MGAIIKGGLKLVGGGAAGGFTYGGLKKIFG,1547,32,9430,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1041
MGAIIKGAAKVLGKGAATGGVIYGLEKLFR,1547,32,9431,A novel group of leaderless and multi-peptide bacteriocins from Gram-positive bacteria.,Lactococcuslactis,1045
RYPAVGYT,1548,48,9491,Lacrain: the first antimicrobial peptide from the body extract of the Brazilian centipede Scolopendra viridicornis.,Bacillusmegaterium,2345
ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEWGGPCQL,1549,41,9529,Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens.,Mycobacteriumtuberculosis,2346
QSHLSLCRYCCNCCRNKGCGYCCKF,1550,44,9561,"Cloning and Characterization of Antimicrobial Peptide, Hepcidin in Medium Carp, Puntius sarana",Aeromonashydrophila,1597
FFHHIFRGIVHVGKTIHKLVTG,1551,201,9562,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae,2690
LIGSLFRGAKAIFRGARQGWRSHKAVSRYRARYVRRPVIYYHRVYP,1551,201,9563,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae,1048
LFGSVKAWFKGAKKGFQDYRYQKDMAKMNKRYGPNWQQRGGQEPPADAQANDQPP,1551,201,9564,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae,1049
FFGRLKSMWRGARGGLKAYKYQKDMAKMNKRYGPNWQQGGGQEPPADAQANDQPP,1551,201,9565,A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes,Streptococcusiniae,1049
IWSFLIKAATKLLPSLFGGGKKDS,488,90,9592,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis,2491
GVWDWIKKTAGKIWNSEPVKALKSQALNAAKNFVAEKIGATPS,488,90,9595,Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus.,Bacilussubtilis,426
RTCESKSHRFKGPCVSTHNCANVCHNEGFGGGKCRGFRRRCYCTRHC,1552,65,9596,The antifungal plant defensin AtPDF2.3 from Arabidopsis thaliana blocks potassium channels.,Botrytiscinerea,805
GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFHSGGGFHRGGGFHSGGSFGYR,1553,48,9673,"Armadillidin H, a Glycine-Rich Peptide from the Terrestrial Crustacean Armadillidium vulgare, Displays an Unexpected Wide Antimicrobial Spectrum with Membranolytic Activity.",Bacillusmegaterium,2347
GHLGRPYIGGGGGFNRGGGFHRGGGFHRGGGFQSGGGFHRGGGFHSGGSFGYR,1553,48,9674,"Armadillidin H, a Glycine-Rich Peptide from the Terrestrial Crustacean Armadillidium vulgare, Displays an Unexpected Wide Antimicrobial Spectrum with Membranolytic Activity.",Bacillusmegaterium,2347
KRMGIFHLFWAGLRKLGNLIKNKIQQGIENFLG,1554,2,9675,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli,1050
KRIGLIRLIGKILRGLRRLG,1554,2,9676,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli,1051
KRIRFFERIRDRLRDLGNRIKNRIRDFFS,1554,2,9677,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli,1052
TFKRKNGSRKNGHRPGGYSLIALGNKKVLKAPYMESI,1554,2,9678,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli,1053
KREDFLDQIIRDFRNFIYQKYRRLRDEFRKLRDILSG,1554,2,9679,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli,1054
GIKHILFMAKTKLPRATCTAEIKENCDRKK,1554,2,9680,Cathelicidins in the Tasmanian devil (Sarcophilus harrisii).,Escherichiacoli,1055
GPDSCNHDRGLCRVGNCNPGEYLAKYCFEPVILCCKPLSPTPTKT,1555,2,9704,Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.,Escherichiacoli,617
FIFHIIKGLFHAGKMIHGLVTRRRHGVEELQDLDQRAFEREKAFA,492,2,9705,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli,1056
FIFHIIKGLFHAGKMIHGLVTRRRH,492,2,9706,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli,1056
FFFHIIKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA,492,2,9708,"Two isoforms of piscidin from Malabar grouper, Epinephelus malabaricus: Expression and functional characterization.",Escherichiacoli,1056
LLGRCKVKSNRFNGPCLTDTHCSTVCRGEGYKGGDCHGLRRRCMCLC,493,92,9710,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis,292
KTCENLANTYRGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTRNC,493,92,9711,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis,423
IWGLIAHGVGHVGRLIHGLIRG,1556,8,9712,Characterization of a novel piscidin-like antimicrobial peptide from Pseudosciaena crocea and its immune response to Cryptocaryon irritans.,Bacillussubtilis,991
RDCESDSHKFHGACFSDTNCANVCQTEGFAGKCVGVQRHCHCTKDC,493,92,9718,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis,805
ACIKNGGRCVASGGPPYCCSNYCLQIAGQSYGVCKKH,493,92,9719,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis,1086
KVCRQRSAGFKGPCVSDKNCAQVCLQEGWGGGNCDGPFRRCKCIRQC,493,92,9726,Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria,Lactobacillusbrevis,2348
RIPCQYEDATEDTICQQHCLPKGYSYGICVSYRCSCV,1557,4,9743,An anionic defensin from Plutella xylostella with potential activity against Bacillus thuringiensis.,Staphylococcusaureus,2349
FFGRLKSVWSAVKHGWKAAKSR,1558,4,9755,Trichoplaxin - a new membrane-active antimicrobial peptide from placozoan cDNA.,Staphylococcusaureus,2350
DLWNSIKDMAAAAGRAALNAVTGMVNQ,1559,18,9758,Schistosoma mansoni dermaseptin-like peptide: structural and functional characterization.,Micrococcusluteus,770
APRMEIGKRREKLGRNVFKAAKKALPVIAGYKALG,1560,2,9759,Mitochondrial inactivation by Anopheles albimanus cecropin 3: molecular mechanisms.,Escherichiacoli,1057
GFGCPLNQGACHNHCRSIRRRGGYCSGIIKQTCTCYRN,1561,18,9760,Defensin from the ornate sheep tick Dermacentor marginatus and its effect on Lyme borreliosis spirochetes.,Micrococcusluteus,2331
ECIPTKHDCTNDRKNCCPGHECKCYNTQIGGSKKEQCGCKKSLLAKAKNFGGKVITIFKA,499,95,9762,Cysteine-rich toxins from Lachesana tarabaevi spider venom with amphiphilic C-terminal segments.,Arthrobacterglobiformis,1058
AFGCPFDQGTCHSHCRSIRRRGERCSGFAKRTCTCYQK,1562,88,9779,Defensins from the tick Ixodes scapularis are effective against phytopathogenic fungi and the human bacterial pathogen Listeria grayi.,Listeriafleischmannii,1467
GFGCPFDQGACHRHCQSIGRRGGYCAGFIKQTCTCYHN,1562,88,9780,Defensins from the tick Ixodes scapularis are effective against phytopathogenic fungi and the human bacterial pathogen Listeria grayi.,Listeriafleischmannii,2331
GLRKRLRKFRNKIKEKLKKIGQKIQGFVPKLAPRTDY,501,25,9792,Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?,Bacilluscereus,875
KKCKFFCKVKKKIKSIGFQIPIVSIPFK,1563,2,9847,Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.,Escherichiacoli,1817
KKCGFFCKLKNKLKSTGSRSNIAAGTHGGTFRV,1563,2,9848,Cathelicidins from the bullfrog Rana catesbeiana provides novel template for peptide antibiotic design.,Escherichiacoli,1817
SGYLPGKEYVYKYKGKVF,1564,4,9864,Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles.,Staphylococcusaureus,2351
NGNLLGGLLRPVLGVVKGLTGGLGKK,508,4,9916,Thaulin-1: The first antimicrobial peptide isolated from the skin of a Patagonian frog Pleurodema thaul (Anura: Leptodactylidae: Leiuperinae) with activity against Escherichia coli.,Staphylococcusaureus,1471
IWQWIVGGLGFLAGDAWSHSDQISSGIKKRKKKGYGY,1566,18,9920,Expression of a novel bacteriocin-the plantaricin Pln1-in Escherichia coli and its functional analysis.,Micrococcusluteus,2352
APKGVQGPNG,1567,64,9921,"Glycin-rich antimicrobial peptide YD1 from B. amyloliquefaciens, induced morphological alteration in and showed affinity for plasmid DNA of E. coli.",Alcaligenesfaecalis,1059
GSQLVYREWVGHSNVIKP,1568,8,9949,"Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171.",Bacillussubtilis,2353
GSQLVYREWVGHSNVIKGPP,1568,8,9950,"Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171.",Bacillussubtilis,2353
GLFKKLRRKIKKGFKKIFKRLPPIGVGVSIPLAGKR,514,59,9972,Cathelicidin antimicrobial peptide from Alligator mississippiensis has antibacterial activity against multi-drug resistant Acinetobacter baumanii and Klebsiella pneumoniae.,Acinetobacterbaumannii,996
QPFSLERW,1569,18,9975,Evidence of an Antimicrobial Peptide Signature Encrypted in HECT E3 Ubiquitin Ligases,Micrococcusluteus,2354
KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,1570,2,10049,Design of hybrid ?-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity.,Escherichiacoli,2096
RNGCIVDPRCPYQQCRRPLYCRRR,1571,94,10066,Comparative Analysis of the Bacterial Membrane Disruption Effect of Two Natural Plant Antimicrobial Peptides.,Salmonellaenterica,2355
GWLDVAKKIGKAAFNVAKNFL,525,2,10137,Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.,Escherichiacoli,1481
RWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK,1572,2,10182,"A potential food biopreservative, CecXJ-37N, non-covalently intercalates into the nucleotides of bacterial genomic DNA beyond membrane attack.",Escherichiacoli,2096
WGWKEVVQNGQTIFSAGQKLGNMVGKIVPLPFG,1573,209,10201,"Identification and three-dimensional structure of carnobacteriocin XY, a class IIb bacteriocin produced by Carnobacteria.",Carnobacteriumdivergens,2356
SAILAITLGIFATGYGMGVQKAINDRRKK,1573,209,10202,"Identification and three-dimensional structure of carnobacteriocin XY, a class IIb bacteriocin produced by Carnobacteria.",Carnobacteriumdivergens,2357
FLPLLAGLAANFLPTIICKIARKC,1574,4,10205,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,1296
GIMDTIKNAAKDVVQSLLNKASCKLAKTC,1574,4,10206,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,868
CGYKYGCMVKVDR,1574,4,10207,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,2358
FFGTKGIFSKVEPIFCKISHSC,1574,4,10208,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,2359
IVRPPIRCKAAFC,1574,4,10209,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,211
FLPAIIGMAAKVLPAFLCKITKKC,1574,4,10212,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,1296
GILMDTFKGAAKNVAGFLLDKLKCKISGGC,1574,4,10213,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,807
GAPKGCWTKSYPPQPCFGKK,1574,4,10214,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,2286
GLWTTIKEGLKKFSLGVLDKIRCKIAGGC,1574,4,10215,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,1151
QYRPGSFGPLNQK,1574,4,10218,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,212
DYSIRTRLHQESSRNVF,1574,4,10220,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,213
DNVYSRPPQRFGQNVIS,1574,4,10221,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,214
SFLDKFKDVAIGVAKGAGTGVLKALLCKLDNSC,1574,4,10222,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,820
CVVSSGWKWNYKIRCKLTGNC,1574,4,10223,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,215
FKTWKNRPILSSCSGIIKG,1574,4,10224,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,216
CQWQFISPSRAGCIGP,1574,4,10225,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,217
FFPLIPGVRCKILRTC,1574,4,10226,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,218
FFLLPIPNDVKCKVLGICKS,1574,4,10227,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,219
ILPSKLCRLLGNC,1574,4,10228,Identification and functional analyses of novel antioxidant peptides and antimicrobial peptides from skin secretions of four East Asian frog species.,Staphylococcusaureus,220
ASVVNKLTGGVAGLLK,1575,2,10229,Isolation and characterisation of a novel antibacterial peptide from a native swine intestinal tract-derived bacterium.,Escherichiacoli,1060
FFFHIVKGLFHAGRMIHGLVNRRRHRHGMEELDLDQRAFEREKAFA,529,2,10232,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli,1056
IFGLLLHGAIHVGKLIHGLVRRHGEEQLDDLEQLDKRALDYNPGRPGFD,529,2,10234,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli,991
FFRHIKSFWKGAKAIFRGARQGWREHRALSKQRKMDQGGGGNEVDNGTPPYWQK,529,2,10236,"Three new piscidins from orange-spotted grouper (Epinephelus coioides): Phylogeny, expression and functional characterization.",Escherichiacoli,992
NILSSIVNGINRALSFFG,1576,4,10258,A novel family of antimicrobial peptides from the skin of Amolops loloensis,Staphylococcusaureus,822
NVLSSVANGINRALSFFG,1576,4,10259,A novel family of antimicrobial peptides from the skin of Amolops loloensis,Staphylococcusaureus,822
GWLKKIGKKIERVGQHTRGLGIAQIAANVAATAR,1577,2,10344,A Novel Antimicrobial Peptide Derived from the Insect Paederus dermatitis,Escherichiacoli,1795
KWKFFKKIERVGQNIRDGIIKAGPAVAVVGQATNIAKG,1578,2,10351,"Characterization and functional study of a Cecropin-like peptide from the Chinese oak silkworm, Antheraea pernyi.",Escherichiacoli,2096
KRRGSVTTRYQFLMIHLLRPKKLFA,1579,4,10356,Novel cathelicidin-derived antimicrobial peptides from Equus asinus.,Staphylococcusaureus,221
RILTMTKRVKMPQLYKQIVCRLFKTC,1580,2,10357,A novel antimicrobial peptide from skin secretions of the tree frog Theloderma kwangsiensis.,Escherichiacoli,2416
GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKALRK,1581,3,10520,Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa,Pseudomonasaeruginosa,1209
NLLNDALGTVNGLLGRS,552,2,10525,"Dendropsophin 1, a novel antimicrobial peptide from the skin secretion of the endemic Colombian frog Dendropsophus columbianus.",Escherichiacoli,1238
GIPCGESCVWIPCLTSAIGCSCKSKVCYRN,553,2,10528,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,2082
GTLPCGESCVWIPCISSVVGCSCKSKVCYKD,553,2,10529,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,2082
GIPCAESCVWIPCTVTALLGCSCKDKVCYLD,553,2,10530,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,2082
GLPCGESCVFIPCITTVVGCSCKNKVCYNN,553,2,10531,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,2082
GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN,553,2,10532,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,993
GLPVCGETCFGGTCNTPGCACDPWPVCTRD,553,2,10533,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,2129
GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSD,553,2,10535,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,994
GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD,553,2,10536,Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra.,Escherichiacoli,994
GLPTCGETCTLGKCNTPKCTCNWPICYKD,1582,111,10537,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Humanskin,993
GVIPCGESCVFIPCINKKKCSCKNKVCYRD,1582,2,10538,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,2082
GLPTCGETCTLGKCNTPKCTCNWPICYKN,1582,111,10539,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Humanskin,993
GKYTCGETCFKGKCYTPGCTCSYPICKKD,1582,2,10540,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,993
GKPTCGETCFKGKCYTPGCTCSYPLCKKD,1582,2,10541,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,993
GKPICGETCFKGKCYTPGCTCSYPICKKD,1582,2,10542,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,993
GKPICGETCFKGKCYTPGCTCSYPICKKN,1582,2,10543,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,993
GLPTCGETCFKGKCYTPGCSCSYPICKKD,1582,2,10544,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,993
GLPTCGETCFKGKCYTPGCSCSYPICKKN,1582,2,10545,Lysine-rich Cyclotides: A New Subclass of Circular Knotted Proteins from Violaceae.,Escherichiacoli,993
IVPFLLGMVPKLVCLITKKC,1583,56,10585,Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae).,Staphylococcusepidermidis,526
SMATPHVAGAAALILSKHPTWTNAQVRDRLESTATYLGNSFYYGK,1584,25,10587,"Novel antimicrobial activities of a peptide derived from a Japanese soybean fermented food, Natto, against Streptococcus pneumoniae and Bacillus subtilis group strains.",Bacilluscereus,222
RPKKVQGRKAEKDNGDGTTAANASGKKKSSNVFK,1585,2,10588,Identification of the first cathelicidin gene from skin of Chinese giant salamanders Andrias davidianus with its potent antimicrobial activity.,Escherichiacoli,995
RRGLFKKLRRKIKKGFKKIFKRLPPVGVGVSIPLAGRR,1586,2,10590,"As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses.",Escherichiacoli,996
TRRKFWKKVLNGALKIAPFLLG,1586,2,10591,"As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses.",Escherichiacoli,997
TRWLWLLRGGLKAAGWGIRAHLNRNQ,1586,2,10592,"As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from Alligator sinensis, play pivotal roles in host antimicrobial immune responses.",Escherichiacoli,998
ASENGKCNLLCLVKKKLRAVGNVIKTVVGKIA,1587,2,10613,The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities.,Escherichiacoli,999
RTCESQSHRFKGPCARDSNCATVCLTEGFSGGDCRGFRRRCFCTRPC,1588,24,10684,Inhibition of cereal rust fungi by both class I and II defensins derived from the flowers of Nicotiana alata.,Fusariumoxysporum,292
MWGRILGTVAKYGPKAVSWAWQHKWELINMGDLAFRYIQRIWG,1589,32,10691,"Lactolisterin BU, a novel Class II broad spectrum bacteriocin from Lactococcus lactis subsp. lactis bv. diacetylactis BGBU1-4.",Lactococcuslactis,1728
MMRVMRRKTKVIWEKKDFIGLYSID,1590,4,10711,"Catesbeianin-1, a novel antimicrobial peptide isolated from the skin of Lithobates catesbeianus (American bullfrog).",Staphylococcusaureus,223
GLFDIVKKVVGAIGSL,1591,25,10737,The importance of bacterial membrane composition in the structure and function of aurein 2.2 and selected variants.,Bacilluscereus,224
FFGPLIKIATGVLPNLICKALGKC,1592,2,10742,Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,Escherichiacoli,1729
GIGSMLLGLAKNVGMSLLNKAQCKISGKC,1592,2,10743,Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,Escherichiacoli,870
GFMGDTLKGIARNAALALMNAAQCKLSGKC,1592,2,10744,Three novel antimicrobial peptides from the skin of the Indian bronzed frog Hylarana temporalis (Anura: Ranidae).,Escherichiacoli,870
MKFKFNPTGTIVKKLTQYEIAWFKNKHGYYPWEIPRC,1593,4,10757,"The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor.",Staphylococcusaureus,2712
MKTILRFVAGYDIASHKKKTGGYPWERGKA,1593,4,10758,"The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor.",Staphylococcusaureus,225
APKVNVNALRKGGRVIRKGLGVIGAAGTAHEVYNHVRNRNQG,1594,2,10759,"Cloning and functional identification of moricins from the diamondback moth, Plutella xylostella (L.).",Escherichiacoli,356
APKVNVNALKKGGHVIKKGLGVIGAAGTAHEVYNHVRNRNQG,1594,2,10760,"Cloning and functional identification of moricins from the diamondback moth, Plutella xylostella (L.).",Escherichiacoli,356
GLMDIFKVAVNKLLAAGMNKPRCKAAHC,571,4,10826,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus,226
IIPLPLGYFAKKP,571,4,10827,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus,2607
VLPLVGNLLNDLLGK,571,4,10829,"Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis.",Staphylococcusaureus,227
AIGHCLGATL,1595,8,10838,Antimicrobial peptide from mucus of Andrias davidianus: screening and purification by magnetic cell membrane separation technique.,Bacillussubtilis,228
GLTRLFSVIK,1596,8,10839,"Purification, characterization and application of a novel antimicrobial peptide from Andrias davidianus blood.",Bacillussubtilis,229
GVIPGQKQCIALKGVCRDKLCSTLDDTIGICNEGKKCCRRWWILEPYPTPVPKGKSP,1597,43,10850,Involvement of ?-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum.,Plasmodiumfalciparum,230
GFGCPFNQYECHAHCSGVPGYKGGYCKGLFKQTCNCY,574,4,10868,Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.,Staphylococcusaureus,2331
GYPWWDYRDLFGGHTFISP,1598,85,10894,"Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency.",Mycobacteriumsmegmatis,1730
GYPWWDYRDLFGGHTFI,1598,216,10895,"Novel propeptin analog, propeptin-2, missing two amino acid residues from the propeptin C-terminus loses antibiotic potency.",Mycobacteriumphlei,1730
LALRTAGWLRLLGFRDKKKN,1599,4,10911,Molecular Cloning and Functional Characterization of Antimicrobial Peptides Brevinin-1ULf and Ulmin-1ULa in the Skin of the Newly Classified Ryukyu Brown Frog Rana ulma.,Staphylococcusaureus,231
GFGSKPLDSFGLNFF,1600,4,10931,"Chaxapeptin, a Lasso Peptide from Extremotolerant Streptomyces leeuwenhoekii Strain C58 from the Hyperarid Atacama Desert.",Staphylococcusaureus,232
GFGSKPIDSFGLSWL,1601,31,10942,"Sungsanpin, a lasso peptide from a deep-sea streptomycete.",Humanlung,232
GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC,1602,4,11021,Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats.,Staphylococcusaureus,233
WQQPSCSSICDYSCGKSACISYSGRCGCCASCRRGPIY,1603,2,11022,"Paralithocins, Antimicrobial Peptides with Unusual Disulfide Connectivity from the Red King Crab, Paralithodes camtschaticus.",Escherichiacoli,1731
RSPPQCQYTNCAAVLCPAVYCANAYTPPCGCCDICPPQKYGGGYRPR,1603,2,11023,"Paralithocins, Antimicrobial Peptides with Unusual Disulfide Connectivity from the Red King Crab, Paralithodes camtschaticus.",Escherichiacoli,1732
RSQPGPTCPSSVQAILCDNRCGRSACSYYIERCACCAKCNRIPYYGASNHP,1603,2,11024,"Paralithocins, Antimicrobial Peptides with Unusual Disulfide Connectivity from the Red King Crab, Paralithodes camtschaticus.",Escherichiacoli,1733
FLPLLLAGLPSFLCLVFKKC,592,4,11075,"Identification of novel Amurin-2 variants from the skin secretion of Rana amurensis, and the design of cationicity-enhanced analogues.",Staphylococcusaureus,1693
KRFKKFFRKLKKSVKKRAKEFFKKPRVIGVSIPF,593,4,11084,The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.,Staphylococcusaureus,1694
KRFKKFFRKIKKGFRKIFKKTKIFIGGTIPI,1604,4,11165,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus,1694
KRNGFRKFMRRLKKFFAGGGSSIAHIKLH,1604,4,11166,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus,234
KRFQNFFRELEKKFREFFRVYRITIGATIRF,1604,4,11167,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus,235
TRSRWRRFIRGAGRFARRYGWRIALGLVG,1604,4,11168,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus,236
SPPQAMGFPPQVNVEHYIPASYSVAALTVTEEE,1604,4,11169,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus,237
RAAPQRRLRAMARLKKFAEAGGADPDSGGLRARFPER,1604,4,11170,Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality.,Staphylococcusaureus,238
FFGHLFKLATKIIPSLFQRKKE,1605,48,11208,Mesobuthus Venom-Derived Antimicrobial Peptides Possess Intrinsic Multifunctionality and Differential Potential as Drugs.,Bacillusmegaterium,239
FFGHLFKLATKIIPSFFRRKNQ,1605,48,11209,Mesobuthus Venom-Derived Antimicrobial Peptides Possess Intrinsic Multifunctionality and Differential Potential as Drugs.,Bacillusmegaterium,239
NLVSALIEGRKYLKNVLKKLNRLKEKNKAKNSKENN,597,4,11212,"Discovery of Distinctin-Like-Peptide-PH (DLP-PH) From the Skin Secretion of Phyllomedusa hypochondrialis, a Prototype of a Novel Family of Antimicrobial Peptide.",Staphylococcusaureus,240
GFLEKLKTGAKDFASAFVNSIKGT,598,4,11216,"A Combined Molecular Cloning and Mass Spectrometric Method to Identify, Characterize, and Design Frenatin Peptides from the Skin Secretion of Litoria infrafrenata.",Staphylococcusaureus,1695
VSGPAGPPGTH,1606,25,11318,"Purification, Characterization, and Mode of Action of Plantaricin GZ1-27, a Novel Bacteriocin against Bacillus cereus.",Bacilluscereus,241
FKFGSFIKRMWRSKLAKKLRAKGKELLRDYANRVLSPEEEAAAPAPVPA,605,25,11319,"Meucin-49, a multifunctional scorpion venom peptide with bactericidal synergy with neurotoxins.",Bacilluscereus,242
MGAIAKLVAKFGWPIVKKYYKQIMQFIGEGWAINKIIDWIKKHI,1607,1,11332,The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity.,None_target,243
MGAIAKLVAKFGWPFIKKFYKQIMQFIGQGWTIDQIEKWLKRH,1607,1,11333,The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity.,None_target,243
RRCICTTRTCRFPYRRLGTCIFQNRVYTFCC,1608,4,11357,Synergistic actions of antibacterial neutrophil defensins and cathelicidins.,Staphylococcusaureus,244
ILPLLLGKVVCAITKKC,1609,4,11358,An atypical member of the brevinin-1 family of antimicrobial peptides isolated from the skin of the European frog Rana dalmatina.,Staphylococcusaureus,824
GSAQPYKQLHKVVNWDPYG,1610,2,11360,The first antimicrobial peptide from sea amphibian.,Escherichiacoli,1734
TVKCGMNGKMPCKHGAFYTDTCDKNVFYRCVWGRPVKKHCGRGLVWNPRGFCDYA,1611,2,11401,Characterization of a novel antimicrobial peptide with chitin-biding domain from Mytilus coruscus.,Escherichiacoli,1735
SCASRCKGHCRARRCGYYVSVLYRGRCYCKCLRC,1612,18,11402,Involvement of mytilins in mussel antimicrobial defense.,Micrococcusluteus,892
GCASRCKAKCAGRRCKGWASASFRRRCYCKCFRC,1612,18,11403,Involvement of mytilins in mussel antimicrobial defense.,Micrococcusluteus,892
KKIGKKIERVGQHTRDATIQTIAVAQQAANVAATLKG,1613,4,11404,"Expression and characterization of a housefly cecropin gene in the methylotrophic yeast, Pichia pastoris.",Staphylococcusaureus,1261
FFQELKEGWKNIKKA,1614,16,11493,"Gene expressions and biological activities of two novel antimicrobial peptides (AMPs) isolated from leucocytes of the rock bream, Oplegnathus fasciatus",Aeromonassalmonicida,1736
FFGRLKAVFRGARQGWKEHRY,1614,16,11494,"Gene expressions and biological activities of two novel antimicrobial peptides (AMPs) isolated from leucocytes of the rock bream, Oplegnathus fasciatus",Aeromonassalmonicida,992
FFSMIPKIATGIASLVKNL,1615,2,11523,Peptidomic analysis of the host-defense peptides in skin secretions of the Trinidadian leaf frog Phyllomedusa trinitatis (Phyllomedusidae),Escherichiacoli,1737
GLVSGLLNSVTGLLGNLAGGGL,1615,2,11524,Peptidomic analysis of the host-defense peptides in skin secretions of the Trinidadian leaf frog Phyllomedusa trinitatis (Phyllomedusidae),Escherichiacoli,1738
FFRNLWKGAKAAFRAGHAAWRA,620,2,11525,Identification and Characterization of Novel Antimicrobial Peptide from Hippocampus comes by In Silico and Experimental Studies.,Escherichiacoli,1739
GLVGTLLGHIGKAILGG,1616,2,11538,Unveiling the Multifaceted Mechanisms of Antibacterial Activity of Buforin II and Frenatin 2.3S Peptides from Skin Micro-Organs of the Orinoco Lime Treefrog (Sphaenorhynchus lacteus).,Escherichiacoli,1740
GFGCPLNERECHSHCQSIGRKFGYCGGTLRLTCICGKE,1617,4,11540,"Triintsin, a human pathogenic fungus-derived defensin with broad-spectrum antimicrobial activity.",Staphylococcusaureus,2323
QSKKCCGRCSSRMCTKREKEEHTEDCRGSFCCLTHRKKK,1618,2,11543,Molecular characterization of a novel ovodefensin gene in chickens.,Escherichiacoli,1741
GWLKKLGKKIERVGQHTRDATIQTIGVAQQAVNVAATLKG,1619,2,11570,"Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide.",Escherichiacoli,1795
KKCKGYRCRPVGFSSPISRRINDSENIYLPFGV,1620,2,11571,Identification and characterization of two novel cathelicidins from the frog Odorrana livida.,Escherichiacoli,1742
RKCNFLCKVKNKLKSVGSKSLIGSATHHGIYRV,1620,2,11572,Identification and characterization of two novel cathelicidins from the frog Odorrana livida.,Escherichiacoli,1817
AFKCKFCCGCCRAGVCGLCCRF,1621,212,11732,Molecular characterization of a hepcidin homologue in starry flounder (Platichthys stellatus) and its synergistic interaction with antibiotics,Vibriovulnificus,2295
FFHHIFNGLVGVGKTIHRLI,1622,2,11762,"Expression analysis and biological activity of moronecidin from rock bream, Oplegnathus fasciatus.",Escherichiacoli,2690
DSEGWKVQPNINRDQDGNTAGSVRVQKQLGNHEVHAGASRVFSGPNRGGPSYNVGATFNW,1623,2,11821,Biological Profiling of Coleoptericins and Coleoptericin-Like Antimicrobial Peptides from the Invasive Harlequin Ladybird Harmonia axyridis.,Escherichiacoli,1743
FLGAVLKVAGKLVPAAICKISKKC,639,4,11867,Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues.,Staphylococcusaureus,245
GVWGIAKIAGKVLGNILPHVFSSNQS,1624,2,11935,"Peptidoglycan potentiates the membrane disrupting effect of the carboxyamidated form of DMS-DA6, a Gram-positive selective antimicrobial peptide isolated from Pachymedusa dacnicolor skin.",Escherichiacoli,1744
LSKYGGQCSLKHNTCTYLKGGRNVIVNCGSAANKRCKSDRHHCEYDEHHRRVDCQTPV,641,110,11936,Rational Design and Biotechnological Production of Novel AfpB-PAF26 Chimeric Antifungal Proteins.,Penicilliumdigitatum,2115
RSICCSFPDPWGGLCCEDHCSYIGKPGGQCSDKGVCTCN,1625,8,11983,"Recombinant AfusinC, an anionic fungal CS?? defensin from Aspergillus fumigatus, exhibits antimicrobial activity against gram-positive bacteria",Bacillussubtilis,246
AKKPFVQRVKNAASKAYNKLKGLAMQSQYGCPIISNMCEDHCRRKKMEGQCDLLDCVCS,648,2,12100,Chemical synthesis of a two-domain scorpion toxin LaIT2 and its single-domain analogs to elucidate structural factors important for insecticidal and antimicrobial activities.,Escherichiacoli,1745
ADSGEGDFLAEGGGVR,1626,18,12111,"Human Antimicrobial Peptide Isolated From Triatoma infestans Haemolymph, Trypanosoma cruzi-Transmitting Vector.",Micrococcusluteus,247
HGVSGHGQHGVHG,1627,79,12129,Further studies on the antiviral activity of alloferon and its analogues.,HSV-1,2127
GVSGHGQHGVHG,1627,79,12130,Further studies on the antiviral activity of alloferon and its analogues.,HSV-1,1746
GTLPCGESCVWIPCISSVVGCSCKSKVCYKN,1628,199,12162,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,2082
GIPCGESCVWIPCISAAIGCSCKSKVCYRN,1628,199,12163,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,2082
GSIPACGESCFKGKCYTPGCSCSKYPLCAKN,1628,199,12164,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,993
GLVPCGETCFTGKCYTPGCSCSYPICKKN,1628,199,12165,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,993
GLPCGETCFTGKCYTPGCSCSYPICKKIN,1628,199,12166,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,993
GLPTCGETCFGGTCNTPGCTCDPWPVCTHN,1628,199,12167,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,2129
GVPCGESCVFIPCITGVIGCSCSSNVCYLN,1628,199,12168,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,2082
GIPCAESCVWIPCTVTALVGCSCSDKVCYN,1628,199,12169,The anthelmintic activity of the cyclotides: natural variants with enhanced activity,Haemonchuscontortus,2082
LNLKKILGKIGVMLSHLN,1629,2,12172,"Molecular cloning and antimicrobial activity of bombolitin, a component of bumblebee Bombus ignitus venom",Escherichiacoli,1747
GIMDTVKNAAKNLAGQLLDKLKCKITAC,655,4,12184,"A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells",Staphylococcusaureus,807
GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN,1630,5,12187,Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis,HIV,993
GVIPCGESCVFIPCISAAIGCSCKNKVCYRN,1631,5,12196,Cyclotides as natural anti-HIV agents,HIV,2082
GTACGESCYVLPCFTVGCTCTSSQCFKN,1631,5,12197,Cyclotides as natural anti-HIV agents,HIV,1082
GIPCGESCVFIPCLTTVAGCSCKNKVCYRN,1631,5,12198,Cyclotides as natural anti-HIV agents,HIV,2082
GFPCGESCVFIPCISAAIGCSCKNKVCYRN,1631,5,12199,Cyclotides as natural anti-HIV agents,HIV,2082
VGTDFSGNDDISDVQK,1632,2,12216,Loxosceles gaucho Spider Venom: An Untapped Source of Antimicrobial Agents.,Escherichiacoli,1748
RRWCFRVCYRGFCYRKCR,1633,2,12230,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III.,Escherichiacoli,1257
RRWCFRVCYKGFCYRKCR,1634,2,12231,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,Escherichiacoli,1257
RRGCFRVCYRGFCFQRCR,1633,2,12233,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III.,Escherichiacoli,1257
RWCFRVCYRGICYRKCR,1634,2,12234,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,Escherichiacoli,1257
KWCFRVCYRGICYRKCR,1634,2,12235,Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III,Escherichiacoli,1257
GFWSSVWDGAKNVGTAIIKNAKVCVYAVCVSHK,664,18,12236,Novel Antimicrobial Peptides from the Arctic Polychaeta Nicomache minor Provide New Molecular Insight into Biological Role of the BRICHOS Domain.,Micrococcusluteus,248
INLKAIAALVKKV,1635,2,12243,Antibacterial effects of gold nanoparticles functionalized with the extracted peptide from Vespa orientalis wasp venom.,Escherichiacoli,1749
GRFKRFRKKLKRLWHKVGPFVGPILHY,669,18,12306,Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action.,Micrococcusluteus,249
RRLRPRRPRLPRPRPRPRPRPR,669,18,12307,Combined Antibacterial Effects of Goat Cathelicidins With Different Mechanisms of Action.,Micrococcusluteus,2710
GGLRSLGRKILRAWKKYGPIIVPIIRI,673,59,12332,A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).,Acinetobacterbaumannii,1005
GWGCNIFGGNDYRCHRHCKSISGYKGGYCKLGGICKCY,1636,4,12351,"Bldesin, the first functionally characterized pathogenic fungus defensin with Kv1.3 channel and chymotrypsin inhibitory activities.",Staphylococcusaureus,2323
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGAGSCQSQCRGCR,1637,106,12392,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides,2230
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGKGSCQSQCRGCR,1637,106,12393,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides,2230
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGEGSCQSQCRGCR,1637,106,12394,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides,2230
AQRCGDQARGAKCPNCLCCGKYGFCGSGDAYCGNGSCQSQCRGCR,1637,106,12395,Novel mode of action of plant defense peptides - hevein-like antimicrobial peptides from wheat inhibit fungal metalloproteases.,Fusariumverticillioides,2230
EQCGRQAGGKLCPNNLCCSQWGWCGSTDEYCSPDHNCQSNCKD,1638,65,12396,Hevein-Like Antimicrobial Peptides of Plants.,Botrytiscinerea,204
IFGAILPLALGALKNLIK,683,115,12404,Evaluation of cytotoxicity features of antimicrobial peptides with potential to control bacterial diseases of citrus.,Xanthomonascitri,2142
GLFSKKGGKGGKSWIKGVFKGIKGIGKEVGGDVIRTGIEIAACKIKGEC,1640,2,12416,Functional Characterization of a Novel Lipopolysaccharide-Binding Antimicrobial and Anti-Inflammatory Peptide in Vitro and in Vivo.,Escherichiacoli,1750
TRGRWGRFKRRAGRFIRRNRWQIISTGLKLIG,1641,2,12428,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli,1751
KKPSKKPKPQAMTFPKVTVEYFPASFSTAALTVPED,1641,2,12436,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli,1752
QSVACTSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSR,685,2,12438,"Structural and Antimicrobial Features of Peptides Related to Myticin C, a Special Defense Molecule from the Mediterranean Mussel Mytilus galloprovincialis.",Escherichiacoli,865
RRSRSPRRKWTWKPRRRGSYTLISQGGNKGKH,1641,2,12448,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli,1753
TRSRWRRFTRRAGGFIRKNRWNIISTALKWIG,1641,2,12449,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli,1751
ASLLSLALMSQTTPIHPTPNYRTAWFLFSGLLGSAGVLFFLEAPTEVRSGG,1641,2,12450,"Roles of polymorphic cathelicidins in innate immunity of soft-shell turtle, Pelodiscus sinensis.",Escherichiacoli,1754
RHCLSQSHRFKGMCVSSNNCANVCRTESFPDGECKSHGLERKCFCKKVC,1642,1,12481,Two novel antimicrobial defensins from rice identified by gene coexpression network analyses.,None_target,805
RTCESQSHRFKGPCARKANCASVCNTEGFPDGYCHGVRRRCMCTKPCP,1642,1,12484,Two novel antimicrobial defensins from rice identified by gene coexpression network analyses.,None_target,292
RQLKSSRRGALVCVRLKLCSAILSRGLSCGMFSCNARR,1643,166,12486,The attack of the phytopathogens and the trumpet solo: Identification of a novel plant antifungal peptide with distinct fold and disulfide bond pattern.,Aspergillusniger,250
FIHHIIGGLFHVGKSIHDLIR,1644,17,12525,Identification of a moronecidin-like antimicrobial peptide in the venomous fish Pterois volitans: Functional and structural study of pteroicidin-?.,Listeriamonocytogenes,1056
FVPAILCSILKTC,1645,156,12532,Host defense peptides in skin secretions of Odorrana tiannanensis: Proof for other survival strategy of the frog than merely anti-microbial.,Candidatropicalis,251
CEKPSKFFSGPCIGSSGKTQCAYLCRRGEGLQDGNCKGLKCVCAC,1646,24,12554,"Astratides: Insulin-Modulating, Insecticidal, and Antifungal Cysteine-Rich Peptides from Astragalus membranaceus.",Fusariumoxysporum,1755
VDCSGACSPFEVPPCGSRDCRCIPIGLVVGFCIYPTG,1646,218,12555,"Astratides: Insulin-Modulating, Insecticidal, and Antifungal Cysteine-Rich Peptides from Astragalus membranaceus.",Spodopterafrugiperda,252
EEESEVAHLRVRRGFGCPLNQGACHRHCRSIRRRGGYCSGIIKQTCTCYRN,1647,18,12614,Hemolymph defensin from the hard tick Haemaphysalis longicornis attacks Gram-positive bacteria.,Micrococcusluteus,2331
RQCKAESNTFTGICIAKPPCRQACIREKFTDGHCSKVLRRCLCTKRC,702,112,12616,Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.,Humancervical,297
FIVPSIFLLKKAFCIALKKC,1649,4,12644,A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model.,Staphylococcusaureus,253
GGVGKIIEYFIGGGVGRYG,708,2,12667,Discovery and structure of the antimicrobial lasso peptide citrocin.,Escherichiacoli,1914
ILELAGNAARDNKKTRIIPRHLQL,1650,2,12671,Acipensins - Novel Antimicrobial Peptides from Leukocytes of the Russian Sturgeon Acipenser gueldenstaedtii.,Escherichiacoli,1756
FIHHIIGGLFSVGKHIHSLIHGH,1651,212,12673,Study of the Antimicrobial Activity of Tilapia Piscidin 3 (TP3) and TP4 and Their Effects on Immune Functions in Hybrid Tilapia (Oreochromis spp.).,Vibriovulnificus,1056
QNCPTRRGLCVTSGLTACRNHCRSCHRGDVGCVRCSNAQCTGFLGTTCTCINPCPRC,712,8,12688,Induction of antibacterial proteins and peptides in the coprophilous mushroom Coprinopsis cinerea in response to bacteria.,Bacillussubtilis,2160
VKVGINGFGRIGRLVTRAAFHGKKVEIVAIND,1652,8,12690,"Antimicrobial function of the GAPDH-related antimicrobial peptide in the skin of skipjack tuna, Katsuwonus pelamis.",Bacillussubtilis,1081
RICTPIPFPMCY,1653,48,12692,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium,254
RTCIPIPLVMC,1653,48,12693,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium,255
RICTAIPLPMCL,1653,48,12694,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium,254
RTCIPIPPVCF,1653,48,12695,"Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis.",Bacillusmegaterium,256
KLKNFAKGVAQSLLNKASCKLSGQC,725,2,12878,Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials.,Escherichiacoli,868
MADVIAKIVEIVKGLIDQFTQK,729,122,12951,Effect of amino acid substitution in the staphylococcal peptides warnericin RK and PSM? on their anti-Legionella and hemolytic activities.,Legionellapneumophila,853
VDFPNKGGKCDRKECRKTCKKLNYRGKCFPNYCRCFPG,733,4,13048,Loop Replacement Enhances the Ancestral Antibacterial Function of a Bifunctional Scorpion Toxin.,Staphylococcusaureus,855
GFGCNGPWDEDDMKCHNHCKSIKGYKGGYCAKAGFVCKCY,1654,4,13058,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,1467
GFGCNGPWDEDDMKCHNHCKSIKGYKGGYCASAGFVCKCY,1654,4,13059,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,1467
GFGCGGPWNEDDMQCHNHCKSIKGYKGGYCASAGFVCKCY,1654,4,13060,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,1467
GFGCNGPWDEDDMKCHNHCKTIKGYKGGYCASAGFVCKCY,1654,4,13061,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,1467
GFGCPGNEKKCHNHCKGIKGYKGGYCDGPYIPFVGRPRCKCY,1654,4,13062,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,2323
GWGCNIFGGNDYRCHRHCKSIKGYKGGYCKLGGICKCY,1654,4,13063,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,1467
GWGCTIFGGNDSRCHRHCKSIRGYRGGYCKLGGICKCY,1654,4,13064,A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms.,Staphylococcusaureus,1467
QSHLSLCRWCCNCCHNKGCGFCCKF,1655,44,13120,"Cloning, characterization and tissue-specific expression of the antimicrobial peptide hepcidin from caspian trout (Salmo caspius) and the antibacterial activity of the synthetic peptide.",Aeromonashydrophila,1597
HRRQGPIFDTRPSPFNPNQPRPGPIY,1656,43,13147,The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.,Plasmodiumfalciparum,424
KWKFFKKIERVGQNIRDGIIKAGPAVQVVGQAATIYKGK,1656,43,13148,The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.,Plasmodiumfalciparum,2096
RWKVFKKIERMGQHIRDGIIKAGPAVAVVGQASTIISG,1656,43,13149,The Drosophila melanogaster antimicrobial peptides Mtk-1 and Mtk-2 are active against the malarial parasite Plasmodium falciparum.,Plasmodiumfalciparum,2096
RRSRFGRFFKKVRKQLGRVLRHSRITVGGRMRF,1658,2,13254,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli,1757
RRSIFRKLRRKIKKGLKKGIQHLLAGGRQGLPQGGRPGMI,1658,2,13255,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli,1758
TRGRWKRFWRGAGRFFRRHKEKIIRAAVDIVLS,1658,2,13256,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli,1759
MAFPFSTQRINPEIEEGNASLADLPVTHAGSLPGIKAQVRTALGIALLLVA,1658,2,13273,"Diversity, immunoregulatory action and structure-activity relationship of green sea turtle cathelicidins.",Escherichiacoli,1801
GLLASLGKVFGGYLAEKLKPK,1659,182,13305,"Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations.",Batrachochytriumdendrobatidis,443
FLPILAGLAANLVPKLICSITKKC,1660,182,13306,Probiotics Modulate a Novel Amphibian Skin Defense Peptide That Is Antifungal and Facilitates Growth of Antifungal Bacteria.,Batrachochytriumdendrobatidis,866
VALTGLTVAEYFR,1662,2,13431,"Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions.",Escherichiacoli,1802
ATCDLLSPFKVGHAACALHCIAMGRRGGWCDGRAVCNCRR,1663,4,13462,Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus.,Staphylococcusaureus,1468
VDKGSYLPRPTPPRPIYNRN,750,2,13548,Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.,Escherichiacoli,565
GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC,1664,4,13623,"LFB: A Novel Antimicrobial Brevinin-Like Peptide from the Skin Secretion of the Fujian Large Headed Frog, Limnonectes fujianensi.",Staphylococcusaureus,807
SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT,752,2,13624,Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues.,Escherichiacoli,1803
GLFDIIKKIAESF,1665,4,13669,AurH1: a new heptapeptide derived from Aurein1.2 antimicrobial peptide with specific and exclusive fungicidal activity.,Staphylococcusaureus,2
INWKALLDAAKKVL,1666,2,13694,The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems.,Escherichiacoli,1804
RECRIGNGQCKNQCHENEIRIAYCIRPGTHCCLQQ,760,41,13730,Antimicrobial activity and structure of a consensus human ?-defensin and its comparison to a novel putative hBD10.,Mycobacteriumtuberculosis,353
QSHLSLCRWCCNCCNRYKGCGFCCKF,1668,25,13803,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus,1597
SLLWRWNSMKPVGASCRDHLECGTKYCRRSICTF,1668,25,13804,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus,1808
KGARQAWKDYKYNRNMQKMNQGYGQQGG,1668,25,13805,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus,354
FFRHIVGAISRIFGQKQRDMAD,1668,25,13806,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus,355
GLLKSLCRKFVKVHLPELIEELTTTD,1668,25,13807,Antimicrobial activity and mechanisms of multiple antimicrobial peptides isolated from rockfish Sebastiscus marmoratus.,Bacilluscereus,524
GFGCPLNQRACHRHCRSIGRRGGFCAGLIKQTCTCYRK,1669,4,13808,"Antibacterial and antifungal activity of defensins from the Australian paralysis tick, Ixodes holocyclus.",Staphylococcusaureus,2331
GFGCPNEWRCNAHCKRNRFRGGYCDSWFRRRCHCYG,1669,4,13809,"Antibacterial and antifungal activity of defensins from the Australian paralysis tick, Ixodes holocyclus.",Staphylococcusaureus,2323
FIHHIIKGIFHIGKMIHSAINRRRH,1670,16,13810,"An insight into piscidins: The discovery, modulation and bioactivity of greater amberjack, Seriola dumerili, piscidin.",Aeromonassalmonicida,1056
GFGGGRGGFGGGRGGFGGGGIGGGGFGGGYGGGKIKG,1671,18,13884,Serrulin: A Glycine-Rich Bioactive Peptide from the Hemolymph of the Yellow Tityus serrulatus Scorpion.,Micrococcusluteus,874
GWLKKIGKKIERVGQHTRDATIQAIGVAQQAANVAATLKG,772,59,13934,Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii.,Acinetobacterbaumannii,1795
MGIIAGIIKFIKGLIEKFTGK,1672,2,13972,Phenol-Soluble-Modulin-Inspired Amphipathic Peptides Have Bactericidal Activity against Multidrug-Resistant Bacteria.,Escherichiacoli,1091
RSGPPGLQGRLQRLLQASGNHAAGILTM,1673,2,13996,Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities.,Escherichiacoli,1805
RKRCRFCCNCCPGKQGCVFCCGF,1674,8,13997,Biochemical and molecular identification of a novel hepcidin type 2-like antimicrobial peptide in the skin mucus of the pufferfish Takifugu pardalis.,Bacillussubtilis,105
KPCTKLSKGWRGLCAPHKCSSYCIHHEGAYHGACLKNRHSKHYGCYCYYRHCY,774,89,14007,Antifungal potency and modes of action of a novel olive tree defensin against closely related ascomycete fungal pathogens.,Fusariumgraminearum,2009
IKVPAIVKDTQKKVAKGVISTVADALSKS,1675,2,14147,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
KIPPVVKDTLKKVAKGVLSAVAGALS,1675,2,14148,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
IKIPPIVKDTLKKVAKGVLSTVADALSKS,1675,2,14149,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,768
LKIPGFVRDTLKKVAKEIFSAVTGAVTQS,1675,2,14150,Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).,Escherichiacoli,1072
GMASKAGAIAGKIAKVALKAL,796,2,14200,Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides,Escherichiacoli,1806
FLGALLKIGAKVLPSVLCGIFKKC,1676,2,14203,"Functional characterization of two novel peptides and their analogs identifed from the skin secretion of Indosylvirana aurantiaca, an endemic frog species of Western Ghats, India",Escherichiacoli,1296
GIKSALLGIAKNVGMSLLQKAQCKLSGSC,1676,2,14205,"Functional characterization of two novel peptides and their analogs identifed from the skin secretion of Indosylvirana aurantiaca, an endemic frog species of Western Ghats, India",Escherichiacoli,870
MSKVISALSKYGPKAVNWAKNHKGQIANWLLHGLSIPDIVQNVKNAVGIK,1677,32,14215,"Identification and characterisation of capidermicin, a novel bacteriocin produced by Staphylococcus capitis.",Lactococcuslactis,1807
APKVNVNALKKGGRVIKKGLGVIGAAGTAHEVYNHVRNRNQG,1678,4,14238,Molecular Identification of a Moricin Family Antimicrobial Peptide (Px-Mor) From Plutella xylostella With Activities Against the Opportunistic Human Pathogen Aureobasidium pullulans.,Staphylococcusaureus,356
MTPLWRIMNSKPFGAYCQNNYECSTGLCRAGHCSTSHRAPSETVNY,1679,2,14244,Molecular Characterization and Gene Expression Data of Liver Expressed Antimicrobial Peptide-2 (LEAP-2) Isolated From Rock Bream ( Oplegnathus fasciatus),Escherichiacoli,1808
GLKEIFKAGLGSLVKGIAAHVAS,798,4,14273,Increases in Hydrophilicity and Charge on the Polar Face of Alyteserin 1c Helix Change its Selectivity towards Gram-Positive Bacteria.,Staphylococcusaureus,2173
GLVNGLLSSVLGGGQGGGGLLGGIL,1680,4,14617,A glycine-leucine-rich peptide structurally related to the plasticins from skin secretions of the frog Leptodactylus laticeps (Leptodactylidae).,Staphylococcusaureus,357
FFGHLFKLATKIIPSLFR,1681,4,14624,Therapeutic Potential of a Scorpion Venom-Derived Antimicrobial Peptide and Its Homologs Against Antibiotic-Resistant Gram-Positive Bacteria.,Staphylococcusaureus,239
FFGALFKLATKIIPSLFR,1681,4,14625,Therapeutic Potential of a Scorpion Venom-Derived Antimicrobial Peptide and Its Homologs Against Antibiotic-Resistant Gram-Positive Bacteria.,Staphylococcusaureus,239
GRFKRFRKKFKKLFKKLSPVIPLLHLG,813,2,14675,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli,1907
KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,813,2,14677,Anti-antimicrobial Peptides: Folding-Mediated Host Defense Antagonists,Escherichiacoli,2096
FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH,1682,4,14831,"Identification and Functional Characterization of the Astacidin Family of Proline-Rich Host Defence Peptides (PcAst) From the Red Swamp Crayfish (Procambarus Clarkii, Girard 1852)",Staphylococcusaureus,358
VMWCYVFGYGFNCAVW,1683,85,14834,"Identification and Characterization of Pantocin wh-1, a Novel Cyclic Polypeptide Produced by Pantoea dispersa W18",Mycobacteriumsmegmatis,1809
GFSSLFKAGAKYLLKQVGKAGAQQLACKAANNC,1684,4,14871,Brevinin-2GHk From Sylvirana guentheri and the Design of Truncated Analogs Exhibiting the Enhancement of Antimicrobial Activity,Staphylococcusaureus,1813
SKTKRRSLLKRLGDGIRGFWNGFRGRK,1685,3,14968,"Marsupial and Monotreme Cathelicidins Display Antimicrobial Activity, Including Against Methicillin-Resistant Staphylococcus Aureus",Pseudomonasaeruginosa,359
KRGLWESLKRKVTKLGDDIRNTLRNFKIKFPVPRQG,1685,3,14969,"Marsupial and Monotreme Cathelicidins Display Antimicrobial Activity, Including Against Methicillin-Resistant Staphylococcus Aureus",Pseudomonasaeruginosa,360
PIRTKRRWKLIKKGGKIVKDLLTKNNIIILPGGNE,1685,3,14970,"Marsupial and Monotreme Cathelicidins Display Antimicrobial Activity, Including Against Methicillin-Resistant Staphylococcus Aureus",Pseudomonasaeruginosa,361
WYQLIRTFGNLIHQKYRKLLEAYRKLRD,827,2,14985,Opossum Cathelicidins Exhibit Antimicrobial Activity Against a Broad Spectrum of Pathogens Including West Nile Virus,Escherichiacoli,1810
IINNPITCMTNGAICWGPCPTAFRQIGNCGHFKVRCCKIR,852,135,15215,A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.,HumanInfluenza,362
IPLRGAFINGRWDSQCHRFSNGAIACA,1686,135,15501,An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.,HumanInfluenza,363
GFGCPFNQGQCHKHCQSIRRRGGYCDGFLKTRCVCYR,1687,4,15563,Scorpion Potassium Channel-blocking Defensin Highlights a Functional Link with Neurotoxin.,Staphylococcusaureus,1467
FLGALFKVASKLVPAAICSISKKC,1688,4,15602,Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential.,Staphylococcusaureus,245
SSRRKPCKGWLCKLKLRGGYTLIGSATNLNRPTYVRA,886,149,15626,Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.,Staphylococcushaemolyticus,364
CRPYGYRCDGVINQCCDPYHCTPPLIGICL,1689,139,15662,Antiviral Cystine Knot ?-Amylase Inhibitors From Alstonia Scholaris,DENV-2,365
FLGAILKIGHALAKTVLPMVTNAFKPKQ,1690,2,15801,"Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps.",Escherichiacoli,1811
RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK,896,4,15840,Antibacterial Activity of Rationally Designed Antimicrobial Peptides.,Staphylococcusaureus,2096
KFFKKLKKSVKKHVKKFFKKPKVIGVSIPF,1692,2,15870,"Characterization of a Cathelicidin from the Colubrinae Snake, Sinonatrix annularis.",Escherichiacoli,1694
FFGHLLRGIVSVGKHIHGLITG,1693,2,15906,"Trematocine, a Novel Antimicrobial Peptide from the Antarctic Fish Trematomus bernacchii: Identification and Biological Activity.",Escherichiacoli,1812
SLFSLIKAGAKFLGKNMLKQGPQYPACKVSKDSENVNWKS,1694,2,16046,"Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens.",Escherichiacoli,1813
GLISTIWNTASNVAGTLTDSVKCKFKKC,1694,2,16047,"Antimicrobial Property and Mode of Action of the Skin Peptides of the Sado Wrinkled Frog, Glandirana susurra, against Animal and Plant Pathogens.",Escherichiacoli,807
GPSGFLGMR,1695,18,16099,Two Tachykinin-Related Peptides with Antimicrobial Activity Isolated from Triatoma infestans Hemolymph,Micrococcusluteus,366
APAAGFFGMR,1695,18,16100,Two Tachykinin-Related Peptides with Antimicrobial Activity Isolated from Triatoma infestans Hemolymph,Micrococcusluteus,367
FALGAVTKVLPKLFCLITRKC,914,4,16101,"Characterisation of a novel peptide, Brevinin-1H, from the skin secretion of Amolops hainanensis and rational design of several analogues.",Staphylococcusaureus,1296
GWGCNIFGGNDYRCHRHCKSIRGYKGGYCKLGGICKCY,920,4,16163,"The second N-terminal aromatic residue of the fungal defensin, blapersin, of Blastomyces percursus is essential for its antibacterial activity.",Staphylococcusaureus,2323
GTCIDLGSRLYCKLIRRRGMCRSRSHRARIAMMRCERSCGRCH,1696,2,16167,AmAMP1 from Acropora millepora and damicornin define a family of coral-specific antimicrobial peptides related to the Shk toxins of sea anemones.,Escherichiacoli,1814
RGTCIDLGSRLYCKLIRRRGMCRSRSHRARIAMMRCERSCGRCH,1696,2,16169,AmAMP1 from Acropora millepora and damicornin define a family of coral-specific antimicrobial peptides related to the Shk toxins of sea anemones.,Escherichiacoli,1814
YLPKVLHQTPGHLKP,1698,201,16334,Two short antimicrobial peptides derived from prosaposin-like proteins in the starry flounder (Platichthys stellatus),Streptococcusiniae,1815
FTKIYGSRLQKVLGN,1698,201,16335,Two short antimicrobial peptides derived from prosaposin-like proteins in the starry flounder (Platichthys stellatus),Streptococcusiniae,1816
FLPGILKVAANVVPGVICAITKKC,936,4,16462,Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri.,Staphylococcusaureus,1296
GLKDWWNKHKDKIVKVVKEMGKAGINAAGK,1701,53,16498,The dinoponeratoxin peptides from the giant ant Dinoponera quadriceps display in vitro antitrypanosomal activity.,Trypanosomacruzi,368
ARSYGNGVYCNNKKCWVNRGEATQSIIGGMISGWASGLAGM,1702,117,16519,Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria.,Listeriaivanovii,649
LLKELWTKMKGAGKAVLGKIKGLL,944,2,16530,Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.,Escherichiacoli,2464
RFRLPFRRPPIRIHPPPFYPPFRRFL,951,2,16644,Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.,Escherichiacoli,1941
FIGAIARLLSKIF,958,8,16936,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis,369
INLKAIAAMAKKLL,958,8,16938,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis,889
FLPIAGKLLSGLSGLL,958,8,16939,Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells,Bacillussubtilis,452
KKCNFFCKLKKKVKSVGSRNLIGSATHHHRIYRV,1703,2,17030,Identification and characterization of novel bi-functional cathelicidins from the black-spotted frog (Pelophylax nigromaculata) with both anti-infective and antioxidant activities.,Escherichiacoli,1817
EGCNILCLLKRKVKAVKNVVKNVVKSVVG,1703,2,17031,Identification and characterization of novel bi-functional cathelicidins from the black-spotted frog (Pelophylax nigromaculata) with both anti-infective and antioxidant activities.,Escherichiacoli,999
SPRVCIRVCRNGVCYRRCWG,1704,4,17237,Structure Elucidation and Functional Studies of a Novel β-hairpin Antimicrobial Peptide from the Marine Polychaeta Capitella teleta.,Staphylococcusaureus,370
KRFKKFWKKIKNSVKKRAKKFFRKPRVIAVSIPF,1705,2,17238,Identification of a Novel Cathelicidin from the Deinagkistrodon acutus Genome with Antibacterial Activity by Multiple Mechanisms.,Escherichiacoli,1694
ACNDRDCSLDCIMKGYNTGSCVRGSCQCRRTSG,984,2,17337,Antimicrobial peptide-like genes in Nasonia vitripennis: a genomic perspective.,Escherichiacoli,1818
KFGGECSLKHNTCTYLKGGKNHVVNCGSAANKKCKSDRHHCEYDEHHKRVDCQTPV,1706,6,17348,"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176.",Aspergillusfumigatus,2115
KRKFHEKHHSHRGY,19,11,495,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans,1899
KRLFKELLFSLRKY,19,11,496,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans,65
KRLFKKLKFSLRKY,19,11,497,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans,65
LLLFLLKKRKKRKY,19,11,498,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans,371
AKRHHGYKRKFH,21,11,558,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans,1899
KRLFKKLLKFSLRKY,21,11,560,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans,372
DLIWKLLSKAQEKFGKNKSR,21,11,562,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans,1722
FKCRRWQWRMKKLG,21,11,563,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans,1206
GKPRPYTPRPTSHPRPIRV,21,11,566,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans,373
KRLFKELKFSLRKY,29,11,726,A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides,Candidaalbicans,65
WSPQEEDRIIEGGI,29,11,727,A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides,Candidaalbicans,374
DSHAKRHHGYKRKF,30,11,728,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
KRHHGYKRKFHEKHHSHR,30,11,729,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
DSHAKRHHGYKR,30,11,731,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
HHGYKRKFHEKH,30,11,735,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
YKRKFHEKHHSH,30,11,736,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
KFHEKHHSHRGY,30,11,737,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
KRHHGYKRKFH,30,11,738,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
AKRHHGYKRKF,30,11,739,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
AKRHHGYKRK,30,11,740,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
AKRHHGYKR,30,11,741,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,375
KCWNLRGSCREKCIKNEKLYIFCTSGKLCCLKPK,57,11,1251,Molecular cloning and characterization of three beta-defensins from canine testes.,Candidaalbicans,376
DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFANVNCWCET,83,11,2076,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCQT,83,11,2077,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCER,83,11,2078,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
NKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2079,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTRNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2080,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSRCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2081,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFLNVNCWCET,83,11,2082,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFINVNCWCET,83,11,2083,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANINCWCET,83,11,2084,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFLNINCWCET,83,11,2085,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWLAVNYTSNCNAECKRRGYKGGHCGSFLNVNCWCET,83,11,2086,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWLAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2087,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
DKLIGSCVWGAVNYTSNCRAECKRRGYKGGHCGSFLNVNCWCET,83,11,2088,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
WKLLSKAQEKFGKNKSR,115,11,3109,A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.,Candidaalbicans,378
SVDGKEDLIWKLLSKAQEKFGKNKSR,115,11,3110,A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.,Candidaalbicans,377
DLIWKLLSKAQEKFGKNKSRSFQLFGSPPGQR,115,11,3111,A one-enzyme strategy to release an antimicrobial peptide from the LFampin-domain of bovine lactoferrin.,Candidaalbicans,378
LAHQKPFIRKSYKCLHKRCR,140,11,4094,"MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.",Candidaalbicans,1868
DSHEERRQGRHGHHEYGRKFHEKH,149,11,4242,Histatins in non-human primates: gene variations and functional effects.,Candidaalbicans,379
DSHEKRHHEHRRKFHEKHHSHRGY,149,11,4243,Histatins in non-human primates: gene variations and functional effects.,Candidaalbicans,1899
KVFKRLEKLFSKIQNDK,193,11,4956,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
FKRLEKLFSKIQNDK,193,11,4957,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
RLEKLFSKIQNDK,193,11,4958,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKLFSKIQN,193,11,4959,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKLFSKI,193,11,4960,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKLFS,193,11,4961,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
KVFKRLEKLFSKI,193,11,4962,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,1212
KVFKRLEKLFS,193,11,4963,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,380
FKRLEKLF,193,11,4964,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,381
WKKVFKRLEKLFSKIWNWK,193,11,4965,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
FKRLEKLFSKIWNWK,193,11,4966,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
FKRLKKLFSKIWNWK,193,11,4967,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
FKRLEKLFKKIWNWK,193,11,4968,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
FKRLKKLFKKIWNWK,193,11,4969,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLRKLFKKI,193,11,4970,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,383
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,202,11,5145,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans,384
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,202,11,5146,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans,384
DAEFRHDSGYEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,202,11,5148,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans,384
AIVVGGVMLGIIAGKNSGVDEAFFVLKQHHVEYGSDHRFEAD,202,11,5149,The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.,Candidaalbicans,1867
DSHAKRHHGYKIKFHENHHSHRGY,203,11,5154,"In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.",Candidaalbicans,1899
DSHAKRHHGYKIKFHEKHHSLRGY,203,11,5155,"In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.",Candidaalbicans,1899
EGRERDHELRHRRHHHQSPKSHFELPHYPGLLAHQKPFIRKSYKCLHKRCR,203,11,5156,"In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.",Candidaalbicans,1868
DSHEKRHHGYKRKFHEKHHSHRGY,211,11,5199,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans,1899
TKCFQWQRNMRKVRGPPVSCIKR,211,11,5200,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans,2324
KRLFRRWQWRMKKY,211,11,5201,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans,1869
KRLFRRLLFSMKKY,211,11,5202,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans,65
FKCKKVVISLRRY,211,11,5203,Fungicidal effect of three new synthetic cationic peptides against Candida albicans.,Candidaalbicans,1870
RFRPPIRRPPIRPPFYPPFRPP,213,11,5253,Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.,Candidaalbicans,1941
RRPPIRPPFYPPFRPP,213,11,5254,Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.,Candidaalbicans,1941
RPPIRPPIFPPIRPPFRPPLGPFP,213,11,5255,Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.,Candidaalbicans,1941
WRKWRKRWWWRKWRKRWW,309,11,6461,Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans.,Candidaalbicans,1871
AKKVFKRLEKLFSKIQNDK,193,11,7551,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKLFSKIQNWK,193,11,7552,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKLFSKIWNDK,193,11,7553,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKLFSKIWNWK,193,11,7554,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVFKRLEKSFSKIQNDK,193,11,7555,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
AKKVSKRLEKLFSKIQNDK,193,11,7556,"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions.",Candidaalbicans,382
FLAKAVAKAAAKALAKAL,376,11,7647,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans,1872
KAGLAFPVGRVHRLLRK,376,11,7648,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans,882
GLARGLREASKALDR,376,11,7649,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans,1873
GLAKGIKEAAKALDKAL,376,11,7650,Predicting antimicrobial peptides from eukaryotic genomes: in silico strategies to develop antibiotics.,Candidaalbicans,1874
CKYLLKWR,517,11,9994,"DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug.",Candidaalbicans,1875
CKYLLRWR,517,11,9999,"DS6: anticandidal, antibiofilm peptide against Candida tropicalis and exhibit synergy with commercial drug.",Candidaalbicans,1875
ADMDFTGIAESIIKKIKETNAKPPA,538,11,10358,"Characterization of TistH, a multifunctional peptide from the scorpion Tityus stigmurus: Structure, cytotoxicity and antimicrobial activity",Candidaalbicans,1876
KEFKRIVQRIKDFLRNLV,543,11,10405,"The Naturally Occurring Host Defense Peptide, LL-37, and Its Truncated Mimetics KE-18 and KR-12 Have Selected Biocidal and Antibiofilm Activities Against Candida albicans, Staphylococcus aureus, and Escherichia coli In vitro.",Candidaalbicans,635
KYHSGPSDKSKVISGKCEWQGGQLNCIAT,623,11,11559,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,2493
IATSPYYACNCPNNCKHKKGSGC,623,11,11560,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,2493
IAGAHKCKPCYGYKTNSCCNSPN,623,11,11561,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,1877
GKCEWQGGQLNCIAT,623,11,11562,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,2493
NNCKHKKGSGC,623,11,11563,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,1878
CCNKGKNKGSH,623,11,11564,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,1879
KYHSGPSDKSKVIS,623,11,11565,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,2493
IATSPYYACNCP,623,11,11566,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,2493
RSGRARDDFRAWATK,681,11,12386,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans,423
RSGRARRRFRAWATK,681,11,12387,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans,423
GRARDDFRA,681,11,12388,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans,1880
GRARRRFRA,681,11,12389,Improved smallest peptides based on positive charge increase of the ?-core motif from P?D1 and their mechanism of action against Candida species.,Candidaalbicans,1881
AKYTGKCYKKKNECKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD,689,11,12491,The Evolutionary Conserved ?-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.,Candidaalbicans,1882
AKYTGKCKTKKNKCKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD,689,11,12492,The Evolutionary Conserved ?-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.,Candidaalbicans,1882
KKIGQKIKNFFQKL,691,11,12498,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
KKIWQKIKNFFQKL,691,11,12499,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
KRIWQKIKNFFQKL,691,11,12500,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
KKIWQRIKNFFQKL,691,11,12501,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
KKIWQKIRNFFQKL,691,11,12502,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
KKIWQKIKRFFQKL,691,11,12503,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
KKIWQKIKNFFRKL,691,11,12504,Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.,Candidaalbicans,875
HLNARVQRELIGWLDWLK,717,11,12777,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKAVQRELIGWLDWLK,717,11,12778,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLLKRVQRELIGWLDWLK,717,11,12779,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKRVQAELIGWLDWLK,717,11,12805,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKRVQRELIGWLDWLA,717,11,12806,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKRVQRELIRWLDWLK,717,11,12807,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKRVQRELRGWLDWLK,717,11,12808,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKRVQRELIGWLRWLK,717,11,12809,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLNKRVQRLLIGWLDWLK,717,11,12810,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
HLLKRVQREIGWLRWLK,717,11,12817,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1883
HLNKRVQRLLIRWLRWLK,717,11,12818,"Effect of alanine, leucine, and arginine substitution on antimicrobial activity against candida albicans and action mechanism of a cationic octadecapeptide derived from ?-amylase of rice.",Candidaalbicans,1862
VAIALKAAAYHTHKE,781,11,14070,Bioinorganic chemistry of calcitermin - the picklock of its antimicrobial activity.,Candidaalbicans,811
VAIALKAAHYHTAKE,781,11,14072,Bioinorganic chemistry of calcitermin - the picklock of its antimicrobial activity.,Candidaalbicans,811
KPPQFTKAQWFAIQHISLNPPKSTIAMKAINNYKWKSKNQNTFLK,792,11,14152,Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides.,Candidaalbicans,1884
RPRGMTSSQWFRIQHMQPSPQASNSAMRNINRHTRRSRDLNTFLH,792,11,14153,Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides.,Candidaalbicans,1648
LRRHASEGGHGPHW,807,11,14432,Identification and characterization of multifunctional cationic peptides derived from peptic hydrolysates of rice bran protein,Candidaalbicans,1885
EKLLGKQDKGVIIRA,807,11,14433,Identification and characterization of multifunctional cationic peptides derived from peptic hydrolysates of rice bran protein,Candidaalbicans,1886
SSFSKGVQRAAF,807,11,14434,Identification and characterization of multifunctional cationic peptides derived from peptic hydrolysates of rice bran protein,Candidaalbicans,1887
ATKAVCVLKGDGPVQGIINF,821,11,14832,In-depth Proteomics and Natural Peptidomics Analyses Reveal Antibacterial Peptides in Human Endometrial Fluid,Candidaalbicans,1888
VKAQEPVKGPVSTKPGSCPIILIRCA,821,11,14833,In-depth Proteomics and Natural Peptidomics Analyses Reveal Antibacterial Peptides in Human Endometrial Fluid,Candidaalbicans,2711
LLVLRSLGPWHPGHCLLR,907,11,16005,Fungicidal activity of peptides encoded by immunoglobulin genes.,Candidaalbicans,1889
FRWKYPKPLKR,925,11,16323,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1890
RWKYPKPLKR,925,11,16324,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1891
RWKQVKVKR,925,11,16325,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1892
RCVRWWKRVCK,925,11,16326,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1893
RWRFKWKK,925,11,16327,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1894
RWRFKWAKK,925,11,16328,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1895
ARWRFKWAKK,925,11,16329,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1896
RWRFKWWKK,925,11,16330,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,1897
GWLIRGAIHAGKAIHGLIHRRRH,927,11,16388,Octominin: A Novel Synthetic Anticandidal Peptide Derived from Defense Protein of Octopus minor.,Candidaalbicans,991
LLCLDGTRKPVTEAQSCHLAVAPNHAVVSR,945,11,16556,Lactoferrin-Derived Peptide Lactofungin Is Potently Synergistic with Amphotericin B.,Candidaalbicans,1898
DSAAKRHHGYKRKFHEKHHSHRGY,966,11,17014,Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.,Candidaalbicans,1899
DSHAKRAAGYKRKFHEKHHSHRGY,966,11,17015,Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.,Candidaalbicans,1899
DSHAKRHHGYKRKFHEKAASHRGY,966,11,17016,Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.,Candidaalbicans,1899
DSHAGYKRKFHEKHHSHRGY,985,11,17338,Metal-binding and nuclease activity of an antimicrobial peptide analogue of the salivary histatin 5.,Candidaalbicans,1899
DSHAKRHHGYKRKFHEKHHSHRGY,19,11,15,Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry,Candidaalbicans,1899
GKPRPYSPRPTSHPRPIRV,21,11,564,Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane,Candidaalbicans,373
DSHAKRHHGYKRKFHEKHHSHRGYRSNYLYDN,995,11,625,"Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans.",Candidaalbicans,1899
RKFHEKHHSHRGYR,30,11,730,"Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5",Candidaalbicans,1899
RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS,1041,11,1156,"Canine cathelicidin (K9CATH): gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide.",Candidaalbicans,875
DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET,83,11,2089,Lead optimization of antifungal peptides with 3D NMR structures analysis.,Candidaalbicans,115
FLPILASLAAKFGPKLFCLVTKKC,1240,11,3536,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans,111
FLPILASLAAKLGPKLFCLVTKKC,1240,11,3537,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans,111
FLPILASLAATLGPKLLCLITKKC,1240,11,3538,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans,111
GILSTFKGLAKGVAKDLAGNLLDKFKCKITGC,1240,11,3539,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans,807
GIMDSVKGLAKNLAGKLLDSLKCKITGC,1240,11,3540,Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii.,Candidaalbicans,807
AALKGCWTKSIPPKPCSGKR,1255,11,3799,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans,2286
AALRGCWTKSIPPKPCSGKR,1255,11,3800,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans,2286
AALRGCWTKSIPPKPCPGKR,1255,11,3801,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans,2286
SALVGCWTKSYPPNPCFGRG,1255,11,3804,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans,2286
AAFRGCWTKNYSPKPCL,1255,11,3828,Bi-functional peptides with both trypsin-inhibitory and antimicrobial activities are frequent defensive molecules in Ranidae amphibian skins.,Candidaalbicans,2286
GIVEQCCASVCSLYQLENYCN,140,11,4095,"MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.",Candidaalbicans,2484
KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC,1276,11,4120,"Isolation, characterization and cloning of a cDNA encoding a new antifungal defensin from Phaseolus vulgaris L. seeds.",Candidaalbicans,423
APPGARPPPGPPPPGPPPPGP,1277,11,4121,Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules.,Candidaalbicans,2485
RPDFCLEPPYTGPCKARMIRYFYNAKAGLCQPFVYGGCRAKRNNFKSSEDCMRTCGGA,1391,11,5395,Bovine pancreatic trypsin inhibitor is a new antifungal peptide that inhibits cellular magnesium uptake.,Candidaalbicans,2486
VVCACRRALCLPLERRAGFCRIRGRIHPLCCRR,227,11,5403,Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.,Candidaalbicans,2487
MLWSASMRIFASAFSTRGLGTRMLMYCSLPSRCWRK,1430,11,5803,Identification of a novel antifungal peptide with chitin-binding property from marine metagenome.,Candidaalbicans,2488
RMKKLGNHKVSCERNTKRCRKAI,1475,11,7005,Antifungal effect and pore-forming action of lactoferricin B like peptide derived from centipede Scolopendra subspinipes mutilans.,Candidaalbicans,2489
FFGTLFKLGSKLIPGVMKLFSKKKER,1565,11,9865,Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,Candidaalbicans,2490
FWSFLVKAASKILPSLIGGGDDNKSSS,1565,11,9866,Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,Candidaalbicans,2491
GILGKIWEGVKSLI,1565,11,9870,Activity of Scorpion Venom-Derived Antifungal Peptides against Planktonic Cells of Candida spp. and Cryptococcus neoformans and Candida albicans Biofilms.,Candidaalbicans,2492
IATSPYYACNCPNNCKHKKGSGCKYHSGPSDKSKVISGKCEWQGGQLNCIAT,623,11,11558,Anti-Candidal Activity and Functional Mapping of Recombinant and Synthetic Neosartorya fischeri Antifungal Protein 2 (NFAP2).,Candidaalbicans,2493
AKYTGKCTKSKNECKYKNDAGKDTFIKCPKFDNKKCTKDNNKCTVDTYNNAVDCD,689,11,12487,The Evolutionary Conserved ?-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.,Candidaalbicans,1882
LSVKAFTGIQLRGVCGIEVKARG,1648,11,12615,"Isolation, functional characterization and biological properties of MCh-AMP1, a novel antifungal peptide from Matricaria chamomilla L.",Candidaalbicans,2494
RTCQSQSHRFRGPCLRRSNCANVCRTEGFPGGRCRGFRRRCFCTTHC,1657,11,13150,Salt-Tolerant Antifungal and Antibacterial Activities of the Corn Defensin ZmD32.,Candidaalbicans,805
GRTSKQELCTWERGSVRQADKTIAG,1661,11,13424,"Isolation and functional characterization of an antifungal hydrophilic peptide, Skh-AMP1, derived from Satureja khuzistanica leaves.",Candidaalbicans,2495
AAFRGCWTKSYSPKPCLGKR,925,11,16322,A designed antifungal peptide with therapeutic potential for clinical drug-resistant Candida albicans.,Candidaalbicans,2286
FWGTLAKWALK,1700,11,16491,Antifungal In Vitro Activity of Pilosulin- and Ponericin-Like Peptides from the Giant Ant Dinoponera quadriceps and Synergistic Effects with Antimycotic Drugs.,Candidaalbicans,2496
FWGTLAKWALKAI,1700,11,16492,Antifungal In Vitro Activity of Pilosulin- and Ponericin-Like Peptides from the Giant Ant Dinoponera quadriceps and Synergistic Effects with Antimycotic Drugs.,Candidaalbicans,2496
FWGTLAKWALKAIPAAMGMKQNK,1700,11,16493,Antifungal In Vitro Activity of Pilosulin- and Ponericin-Like Peptides from the Giant Ant Dinoponera quadriceps and Synergistic Effects with Antimycotic Drugs.,Candidaalbicans,2496
